MDR_REPORT_KEY|MDR_TEXT_KEY|TEXT_TYPE_CODE|PATIENT_SEQUENCE_NUMBER|DATE_REPORT|FOI_TEXT|BRAND_NAME|CATALOG_NUMBER|DATE_RECEIVED|DATE_REMOVED_FLAG|DATE_RETURNED_TO_MANUFACTURER|DEVICE_AGE_TEXT|DEVICE_AVAILABILITY|DEVICE_EVALUATED_BY_MANUFACTUR|DEVICE_EVENT_KEY|DEVICE_OPERATOR|DEVICE_REPORT_PRODUCT_CODE|DEVICE_SEQUENCE_NO|EXPIRATION_DATE_OF_DEVICE|GENERIC_NAME|IMPLANT_FLAG|LOT_NUMBER|MANUFACTURER_D_ADDRESS_1|MANUFACTURER_D_ADDRESS_2|MANUFACTURER_D_CITY|MANUFACTURER_D_COUNTRY_CODE|MANUFACTURER_D_NAME|MANUFACTURER_D_POSTAL_CODE|MANUFACTURER_D_STATE_CODE|MANUFACTURER_D_ZIP_CODE|MANUFACTURER_D_ZIP_CODE_EXT|MODEL_NUMBER|OTHER_ID_NUMBER|filter
6315557|66927054|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL OF AN UNKNOWN SIDE EXPLANT SURGERY OCCURRED AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6315557|66927053|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6233845|68040031|D|1||PHYSICIAN REPORTS SLIGHT AMOUNT OF EFFUSION AROUND THE RIGHT IMPLANT AND SOME HARDENING WITH SOME CAPSULAR CONTRACTURE GRADE III DISTORTING THE BREAST AND GOES ON TO STATE FAIRLY THICK CAPSULE WITH SOME FLUID WITHIN IT ALTHOUGH THE FLUID WAS CLEAR AND NOT IN ANY WAY MILKY A TOTAL CAPSULECTOMY WAS CARRIED OUT AND SENT FOR HISTOLOGY HISTOPATHOLOGY REPORTS THE SPECIMEN COMPRISES A FIBROUS CAPSULE WITH ADHESIONS AND IRREGULARITY OVER THE EXTERNAL SURFACE AS WELL AS SECTIONS OF THE CAPSULE SHOW FIBROUS TISSUE WITH PATCHY MIXED INFLAMMATION HISTOPATHOLOGY CONFIRMS CD30+ AND ALK- THIS IS NOW A CONFIRMED CASE OF ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 110|01/09/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6233845|64197775|N|1||THE EVENTS OF LYMPHOMA CAPSULAR CONTRACTURE AND EDEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST FORMATION OF FIBROUS TISSUE AROUND AN IMPLANTED DEVICE IS A NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS A COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY AND IS ONE OF THE MOST COMMON REASONS FOR REOPERATION THE CAUSE OF CAPSULAR CONTRACTURE IS UNKNOWN HOWEVER IT IS MOST LIKELY MULTIFACTORIAL AND MAY BE MORE COMMON FOLLOWING INFECTION HAEMATOMA AND SEROMA CONTRACTURE DEVELOPS TO VARYING DEGREES UNILATERALLY OR BILATERALLY AND MAY OCCUR WITHIN WEEKS TO YEARS AFTER SURGERY CONTRACTURE OF THE FIBROUS CAPSULAR TISSUE SURROUNDING THE IMPLANT MAY CAUSE A RANGE OF SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES ARE CONSIDERED THE MOST CLINICALLY SIGNIFICANT AND MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT TO CORRECTIVE SURGICAL PROCEDURES DO NOT TREAT CAPSULAR CONTRACTURE BY EXTERNAL COMPRESSION OR MASSAGE WHICH MAY RESULT IN IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 110|01/09/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6540530|74301793|D|1||HEALTHCARE PROFESSIONAL REPORTED Â¿PATIENT PRESENTED WITH SEROMA OF LEFT BREAST CAUSING DISCOMFORTÂ¿ AND Â¿SEROMA LARGE ENOUGH TO CAUSE PATIENT CONCERN AND DISCOMFORT AND ALCL DX IN SEROMA FLUID TREATMENT SPECIFIED AS Â¿SURGICAL INTERVENTION ONLYÂ¿ THE DEVICE WAS EXPLANTED AND A CAPSULECTOMY WAS PERFORMED|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-401|05/03/2017||||N|R||0HP|FTR|1.0|07/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2010555|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6540530|74301792|N|1||THE EVENTS OF LYMPHOMA ALCL AND SEROMA ARE A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE HISTORY RECORD DHR PROVIDES REVIEW OF DHR FOR B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES THAT MAY BE ASSOCIATED WITH THE REPORTED DEVICE EVENT ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT FROM SAP WAS VERIFIED AND THERE WAS NO SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY |STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-401|05/03/2017||||N|R||0HP|FTR|1.0|07/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2010555|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247187|66742201|N|1||THE EVENTS OF LYMPHOMA-ALCL LATE SEROMA AND INFLAMMATION ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE HISTORY RECORD DHR SUMMARY REVIEW OF DHR FOR WORK ORDER 1321464 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT WAS VERIFIED AND THERE WAS NOT ANY SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER 1321464 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6247187|64666747|D|1||REGULATORY AGENCY REPORTED THAT PHYSICIAN REPORTED BIA-ALCL SIDE IS UNKNOWN EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6247187|66742202|D|1||ADDITIONAL INFORMATION RECEIVED FROM THE HEALTH PROFESSIONAL REGARDING THE EVENT IN THE MRI REPORT DATED B6 2016 ADDITIONAL REPORTED EVENT OF IMPLANT SURROUNDED BY A LARGE COLLECTION OF FLUID PATHOLOGY RESULTS FROM B6 2016 REVEALED LEFT PERIPROSTHETIC CAPSULE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED WITH BREAST IMPLANT PATHOLOGY SHOWS ALCL MARKERS OF CD30+ AND ALK- PHYSICIAN ADDITIONALLY REPORTED EVENTS OF PAIN AND A FEELING OF LOCALIZED INFLAMMATION AROUND THE IMPLANT THE EVENT OF PAIN WILL BE NOT DEVICE RELATED AS IT IS A SECONDARY SYMPTOM TO OTHER REPORTED EVENTS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6247187|64666746|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT AND PATIENT DETAILS IS BEING REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6751756|81359984|D|1||COMPETENT AUTHORITY REPORTED A CASE OF ALCL TREATMENT AND AFFECTED SIDE UNKNOWN AS PATHOLOGICAL MARKERS ARE UNKNOWN THIS IS AN UNCONFIRMED CASE OF ALCL AND WILL BE REPORTED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FX-410495|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6751756|81359983|N|1||FOLLOW-UP IS COMPLETE AS REPORTING COMPETENT AUTHORITY WILL NOT PROVIDE ANY FURTHER INFORMATION TO SAFEGUARD THE PRIVACY OF THE INVOLVED PATIENTSÂ¿ THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FX-410495|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6751766|81359645|D|1||COMPETENT AUTHORITY REPORTED A CASE OF ALCL TREATMENT AND AFFECTED SIDE UNKNOWN AS PATHOLOGICAL MARKERS ARE UNKNOWN THIS IS AN UNCONFIRMED CASE OF ALCL AND WILL BE REPORTED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410FX|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6751766|81359644|N|1||FOLLOW-UP IS COMPLETE AS REPORTING COMPETENT AUTHORITY WILL NOT PROVIDE ANY FURTHER INFORMATION TO SAFEGUARD THE PRIVACY OF THE INVOLVED PATIENTSÂ¿ THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410FX|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6378780|69092151|N|1||IN RESPONSE TO FDA REPORT NUMBER MW5067421 THE EVENTS OF LYMPHOMA ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE HISTORY RECORD DHR REPORTS BASED ON THE RISK ANALYSIS PERFORMED THE AE TERM CODE LYMPHOMA-ALCL WAS SELECTED FOR ANALYSIS AS IT REPRESENTS THE HIGHEST RISK FALLING ON THE MONITOR RISK REGION WITH AN APPLICABLE INVESTIGATION LEVEL OF 3 REVIEW OF DHR FOR WORK ORDER 1157904 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES THAT MAY BE ASSOCIATED WITH THE REPORTED DEVICE EVENT ALL SALINE BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT FROM ORACLE WAS VERIFIED AND THERE WAS NO SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS THE QMS LISTING REPORT INDICATES THAT THERE WERE ANY NCMRS OR ERS FOR UNITS MANUFACTURED ON WORK ORDER 1157904 ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER 1157904 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-300|03/04/2017||||Y|*||0HP|FWM|1.0|09/24/2009|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1157904|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6378780|69092152|D|1||HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE SEROMA AND LYMPHOMA ALCL A CAPSULECTOMY WAS PERFORMED AND THE DEVICE WAS EXPLANTED PATIENT IS CURRENTLY BEING WORKED UP BY OUR ONCOLOGISTS WERE AS WELL AS OUR GENETICISTS|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-300|03/04/2017||||Y|*||0HP|FWM|1.0|09/24/2009|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1157904|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6257136|64954239|N|1||DEVICE HISTORY RECORD DHR DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM THIS WORK ORDER WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS THE EVENTS OF LATE SEROMA AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|STYLE 150 EXPANDABLE BREAST IMPLANT|N-27-150386|01/17/2017||||N|R||0HP|FTR|1.0|03/26/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2262674|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6257136|64954240|D|1||PHYSICIAN REPORTED RIGHT SIDE LATE SEROMA WITH POSITIVE CYTOLOGY FOR ANAPLASTIC LARGE CELL LYMPHOMA AS CYTOLOGICAL MARKERS NECESSARY FOR DIAGNOSIS ARE NOT CONFIRMED THIS EVENT OF ALCL WILL BE CAPTURED AS LYMPHOMA AT THIS TIME THERE IS NO MENTION OF EXPLANT|STYLE 150 EXPANDABLE BREAST IMPLANT|N-27-150386|01/17/2017||||N|R||0HP|FTR|1.0|03/26/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2262674|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6559362|74887820|N|1||B4 THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE HISTORY RECORD REVIEW REVIEW OF DHR FOR WORK ORDER 2183997 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT FROM SAP WAS VERIFIED AND THERE WAS NO SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER 2183997 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS REPORTED EVENTS ARE ADDRESSED IN THE LABELING PATIENTS SHOULD BE ADVISED THAT CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWING INFECTION HEMATOMA AND SEROMA AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME CAPSULAR CONTRACTURE OCCURS MORE COMMONLY IN REVISION PATIENTS THAN IN PRIMARY AUGMENTATION OR RECONSTRUCTION PATIENT CAPSULAR CONTRACTURE IS ALSO A RISK FACTOR FOR IMPLANT RUPTURE AND IT IS ONE OF THE MOST COMMON REASONS FOR REOPERATION ALLERGAN HAS NOT TESTED THE EFFECTS OF RADIATION THERAPY IN PATIENTS WHO HAVE BREAST IMPLANTS THE LITERATURE SUGGESTS THAT RADIATION THERAPY MAY INCREASE THE LIKELIHOOD OF CAPSULAR CONTRACTURE NECROSIS AND IMPLANT EXTRUSION POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY SIMILAR TO A BRUISE A SEROMA OCCURS WHEN THE WATERY PORTION OF THE BLOOD COLLECTS AROUND A SURGICAL INCISION OR AROUND A BREAST IMPLANT YOU SHOULD PERFORM SELF-EXAMINATION OF YOUR BREASTS EVERY MONTH FOR CANCER SCREENING HOWEVER THIS MAY BE MORE DIFFICULT WITH IMPLANTS YOU SHOULD ASK YOUR SURGEON TO HELP YOU DISTINGUISH THE IMPLANT FROM YOUR BREAST TISSUE THE PRESENCE OF LUMPS PERSISTENT PAIN SWELLING HARDENING OR CHANGES IN IMPLANT SHAPE MAY BE SIGNS OF A RUPTURE OF THE IMPLANT THESE SIGNS SHOULD BE REPORTED TO YOUR SURGEON AND POSSIBLY EVALUATED WITH AN MRI AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM445|05/10/2017||||N|R||0HP|FTR|1.0|10/11/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2183997|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6559362|74887821|D|1||PHYSICIAN REPORTED CASE OF LYMPHOMA ALCL PAIN RUPTURE LARGE SEROMA PRESENT FOR 2 YEARS AND CAPSULAR CONTRACTURE BAKER GRADE II CD30+ AND ALK- CONFIRMED MICROSCOPIC ANALYSIS FOUND CHRONIC INFLAMMATION AROUND A CAVITATION PATIENT HAD A LEFT SIDE CAPSULECTOMY WITH IMPLANT REMOVAL AND REPLACEMENT THESE EVENTS OCCURRED ON THE LEFT SIDE|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM445|05/10/2017||||N|R||0HP|FTR|1.0|10/11/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2183997|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6576687|75473262|N|1||THE EVENTS OF LYMPHOMA ALCL CAPSULAR CONTRACTURE AND EDEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING ADDRESSES NATRELLEÂ® SILICONE-FILLED BREAST IMPLANTS AND NATRELLE INSPIRAÂ¿ BREAST IMPLANTS ARE INDICATED FOR WOMEN FOR THE FOLLOWING BREAST AUGMENTATION FOR WOMEN AT LEAST 22 YEARS OLD BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL PATIENTS SHOULD BE ADVISED THAT CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWING INFECTION HEMATOMA AND SEROMA AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME CAPSULAR CONTRACTURE OCCURS MORE COMMONLY IN REVISION PATIENTS THAN IN PRIMARY AUGMENTATION OR RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE IS ALSO A RISK FACTOR FOR IMPLANT RUPTURE AND IT IS ONE OF THE MOST COMMON REASONS FOR REOPERATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/18/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6460137|71714491|N|1||ARTICLE CITATION Â¿A CASE OF SUSPECTED LATE-STAGE RECURRENCE OF ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA AT BREAST IMPLANT INSERTION SITEÂ¿ BY BY Y FUKUSHIMA M ISHII T INOUE T SAKURAI PUBLISHED IN THE JOURNAL OF JAPANESE PATHOLOGY ASSOCIATION VOL 102 NUMBER 1 PG 137 APR 2013 THE EVENTS OF LYMPHOMA AND LUMPNODULE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING THE EVENT PRODUCT ANDOR PATIENT DETAILS WAS REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/05/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6654587|78019288|D|1||HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE Â¿CHRONICÂ¿ SEROMA AND LYMPHOMA ALCL PATIENT DEVELOPED A RIGHT BREAST ABSCESS A SEROMA AND A Â¿PURPLISH EXOPHYTIC SKIN MASSÂ¿ WAS OBSERVED DURING DEVICE REMOVAL A CAPSULECTOMY WAS PERFORMED AND CAPSULE WITH DEVICE WAS SENT FOR PATHOLOGY PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL HAVE BEEN RECEIVED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-300|06/20/2017||||N|R||0HP|FTR|1.0|12/27/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2232205|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6654587|78019287|N|1||B4 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE HISTORY REVIEW DHR REPORTS REVIEW OF DHR FOR B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT FROM SAP WAS VERIFIED AND THERE WAS NOT ANY SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-300|06/20/2017||||N|R||0HP|FTR|1.0|12/27/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2232205|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6323445|67166355|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6323445|67166356|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL OF AN UNKNOWN SIDE EXPLANT SURGERY OCCURRED AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6744780|81082640|D|1||PHYSICIAN REPORTED LATE SEROMA IN IMPLANT BEARING WAS FOUND PHYSICIAN REPORTED A CASE OF ALCL CONFIRMED VIA CYTOLOGY OF FLUID IN THE IMPLANT CAPSULE ON THE LEFT SIDE CD30+ HAS BEEN CONFIRMED BUT ALL PATHOLOGICAL MARKERS HAVE NOT BEEN CONFIRMED EVENT WILL BE REPORTED AS LYMPHOMA TREATMENT UNKNOWN|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSM520|07/26/2017||||N|R||0HP|FTR|1.0|10/04/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180982|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6744780|81082639|N|1||THE EVENTS OF LYMPHOMA AND LATE SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSM520|07/26/2017||||N|R||0HP|FTR|1.0|10/04/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180982|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6745299|81111775|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|07/26/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6745299|81111776|D|1||HEALTHCARE PROFESSIONAL REPORTED THEIR FIRST ALCL CASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|07/26/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6331755|67482135|N|1||FURTHER CLARIFICATION REGARDING THE EVENT THE EVENT OF A CASE IS BEING CONSIDERED AS LYMPHOMA AS THE EVENT WAS STATED AS TO HAVE BEEN RECEIVED FROM THE PROFILE REGISTRY WHICH IS A DATABASE DEDICATED TO CAPTURING REPORTS OF ALCL THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLAINT AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING THE EVENT PRODUCT ANDOR PATIENT DETAILS WAS REQUESTED UPON ADDITIONAL FOLLOW UP WITH THE PHYSICIAN IT WAS DETERMINED THAT THERE WAS NO ADDITIONAL INFORMATION AVAILABLE DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/15/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6331760|67507919|N|1||FURTHER CLARIFICATION REGARDING THE EVENT THE EVENT OF A CASE IS BEING CONSIDERED AS LYMPHOMA AS THE EVENT WAS STATED AS TO HAVE BEEN RECEIVED FROM THE PROFILE REGISTRY WHICH IS A DATABASE DEDICATED TO CAPTURING REPORTS OF ALCL THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLAINT AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING THE EVENT PRODUCT ANDOR PATIENT DETAILS WAS REQUESTED UPON ADDITIONAL FOLLOW UP WITH THE PHYSICIAN IT WAS DETERMINED THAT THERE WAS NO ADDITIONAL INFORMATION AVAILABLE DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/15/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6497135|72921040|D|1||PATIENT REPORTED LEFT SIDE MASSIVE SWELLING AND LEFT BREAST HAD DOUBLED IN SIZE PATIENT ADDITIONALLY REPORTED GETTING REALLY SICK AND WAS DIAGNOSED WITH BREAST IMPLANT ANAPLASTIC LARGE CELL LYMPHOMA ON B6 2016 PATIENT ADDITIONALLY REPORTED PATHOLOGY SHOWED LEFT SIDE MASS HAD SPREAD OUTSIDE OF THE CAPSULE HEALTHCARE PROFESSIONAL CONFIRMED THE REPORTED EVENTS HEALTHCARE PROFESSIONAL ADDITIONALLY REPORTED LEFT SIDE Â¿PERIPROSTHETIC FLUID AT TIME OF DIAGNOSISÂ¿ AND SPONTANEOUS LARGE LEFT SIDED SEROMA A TOTAL CAPSULECTOMY AND EXPLANTATION WAS PERFORMED PATHOLOGY RESULTS SHOWED ALCL WITHIN THE LEFT CAPSULE AND SMALL LEFT BREAST MASS|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRF415|04/17/2017||||N|R||0HP|FTR|1.0|04/29/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2109766|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6497135|72921039|N|1||B4 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE HISTORY RECORD DHR REPORTS BASED ON THE RISK ANALYSIS PERFORMED THE AE TERM CODE LYMPHOMA ALCL WAS SELECTED FOR ANALYSIS AS IT REPRESENTS THE HIGHEST RISK FALLING ON THE MONITOR RISK REGION WITH AN APPLICABLE INVESTIGATION LEVEL OF THREE REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT FROM SAP WAS VERIFIED AND THERE WAS NOT ANY SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS A QUERY WAS PERFORMED IN THE QMS SYSTEM AND NO DEVIATIONS OR NON-CONFORMANCES WERE FOUND TO BE RELATED TO WORK ORDER B4  ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRF415|04/17/2017||||N|R||0HP|FTR|1.0|04/29/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2109766|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6634993|81178349|D|1||THE B4 ARTICLE TITLED Â¿A SHOCKING DIAGNOSIS BREAST IMPLANTS Â¿GAVE ME CANCERÂ¿Â¿ REPORTED IN 2012 PATIENT BECAME SHORT OF BREATH AND HAD PAIN AND SWELLING IN PATIENT BREAST A LUMP IN PATIENT CHEST AND SWOLLEN LYMPH NODES IN PATIENT CHEST AND NECK PATIENT WAS HOSPITALIZED FOR TWO MONTHS WORSENING STEADILY AS DOCTORS STRUGGLED TO DETERMINE WHAT WAS WRONG TESTING FOR LYMPHOMA WAS SUGGESTED AND THE DIAGNOSIS WAS FINALLY MADE BY THEN PATIENT WAS CRITICALLY ILL ON A VENTILATOR PATIENT IMPROVED WITH CHEMOTHERAPY AND CAME HOME FROM THE HOSPITAL WHEN PATIENT WAS CONSIDERED STRONG ENOUGH FOR SURGERY PATIENT WENT BACK TO THE HOSPITAL TO HAVE THE IMPLANT REMOVED PATIENTÂ¿S HEART STOPPED ON THE OPERATING TABLE PATIENT WAS RESUSCITATED BUT DIED TWO WEEKS LATERÂ¿ AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA SIDE EXPERIENCING EVENTS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/12/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6634993|77375388|N|1||B4 CLARIFICATION TO PATIENTS EXACT DATE OF DEATH WAS NOT PROVIDED THE ONLY KNOWN INFORMATION IS THE YEAR 2012 ARTICLE CITATION A SHOCKING DIAGNOSIS BREAST IMPLANTS GAVE ME CANCER DENISE GRADY THE NEW YORK TIMES MAY 14 2017 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT AND PRODUCT DETAILS CANNOT BE OBTAINED AS PATIENT AND EXPLANTING PHYSICIAN CONTACT INFORMATION WAS NOT PROVIDED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT MISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/12/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6634993|77375389|D|1||THE NEW YORK TIMES ARTICLE TITLED Â¿A SHOCKING DIAGNOSIS BREAST IMPLANTS Â¿GAVE ME CANCERÂ¿Â¿ REPORTED IN 2012 PATIENT BECAME SHORT OF BREATH AND HAD PAIN AND SWELLING IN PATIENT BREAST A LUMP IN PATIENT CHEST AND SWOLLEN LYMPH NODES IN PATIENT CHEST AND NECK PATIENT WAS HOSPITALIZED FOR TWO MONTHS WORSENING STEADILY AS DOCTORS STRUGGLED TO DETERMINE WHAT WAS WRONG TESTING FOR LYMPHOMA WAS SUGGESTED AND THE DIAGNOSIS WAS FINALLY MADE BY THEN PATIENT WAS CRITICALLY ILL ON A VENTILATOR PATIENT IMPROVED WITH CHEMOTHERAPY AND CAME HOME FROM THE HOSPITAL WHEN PATIENT WAS CONSIDERED STRONG ENOUGH FOR SURGERY PATIENT WENT BACK TO THE HOSPITAL TO HAVE THE IMPLANT REMOVED PATIENTÂ¿S HEART STOPPED ON THE OPERATING TABLE PATIENT WAS RESUSCITATED BUT DIED TWO WEEKS LATERÂ¿ AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA SIDE EXPERIENCING EVENTS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/12/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6498449|72963714|D|1||FDA REPORTS Â¿THE FDA HAS RECEIVED A TOTAL OF 359 MEDICAL DEVICE REPORTS MDRS OF BIA-ALCL INCLUDING NINE DEATHSÂ¿ THE MEDIAN REPORTED AGE OF PATIENTS AS 53 WITH A RANGE OF 25-91 WITHIN SPECIFIED REPORTS THE MEDIAN REPORTED TIME FROM IMPLANT TO ALCL DIAGNOSIS WAS 7 YEARS WITH A RANGE OF 0-40 YEARS WITHIN SPECIFIED REPORTS A 203 OF THE REPORTED DEVICES WERE SPECIFIED AS TEXTURED AND 28 AS SMOOTH 128 WERE NOT SPECIFIED A 186 OF THE REPORTED DEVICES WERE SPECIFIED AS SILICONE AND 126 AS SALINE 47 WERE NOT SPECIFIED PRESENTATION OF ALCL INCLUDED SEROMA IN 158 REPORTS CAPSULAR CONTRACTURE IN 21 REPORTS PERI-IMPLANT MASS IN 21 REPORTS AND Â¿OTHERSÂ¿ IN 46 REPORTS A 119 OF THESE CASES TESTED NEGATIVE FOR ALK 240 WERE UNSPECIFIED A 120 CASES TESTED POSITIVE FOR CD30 239 WERE UNSPECIFIED MANUFACTURER OF THESE DEVICES IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6498449|72963713|N|1||THIS REPORT IS SUBMITTED IN RESPONSE TO FDA NOTICE TITLED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCL PROVIDED ON 21MAR2017 THE TOTAL NUMBER OF CASES REFERENCED IN THE NOTICE IS 359 INCLUDING 9 DEATHS THE INFORMATION PROVIDED IN THE NOTICE CLASSIFIES THE ALCL EVENTS IN DIFFERENT CATEGORIES INCLUDING TYPES OF DEVICE ASSOCIATED ADVERSE EVENTS PRESENTATION AND DIAGNOSIS DETAILS BUT DOES NOT IDENTIFY SPECIFIC DEVICES OR PATIENTS IT IS NOT POSSIBLE TO INDIVIDUALIZE THIS INFORMATION INTO SPECIFIC REPORTS AND BY DEFINITION ALREADY INCLUDES EVENTS REPORTED BY ALLERGAN IN THE PAST THEREFORE IN ACCORDANCE WITH 21 CFR 803 THIS REPORT WILL REPRESENT ACKNOWLEDGEMENT OF RECEIPT OF THE NOTICE AND DOCUMENTATION OF ALLERGANS ATTEMPT TO INVESTIGATE ADVERSE EVENTS IDENTIFIED IN THAT NOTICE THIS REPORT WILL NOT SUBSTITUTE FOR ANY INVESTIGATION INTO COMPLAINTS RECEIVED WHERE INDIVIDUAL PATIENTS OR ALLERGAN DEVICES ARE IDENTIFIED INCLUSIVE OR EXCLUSIVE OF THE 359 CASES MENTIONED IN THE NOTICE B4 THE EVENTS OF DEATH LYMPHOMA-ALCL LYMPHOMA SEROMA CAPSULAR CONTRACTURE AND BREAST LUMPS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS SALINE DEVICE LABELING RADIATION TO THE BREAST Â¿ ALLERGAN HAS NOT TESTED THE IN VIVO EFFECTS OF RADIATION THERAPY IN PATIENTS WHO HAVE BREAST IMPLANTS THE LITERATURE SUGGESTS THAT RADIATION THERAPY MAY INCREASE THE LIKELIHOOD OF CAPSULAR CONTRACTURE NECROSIS AND IMPLANT EXTRUSION POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY CAPSULAR CONTRACTURE Â¿ PATIENTS SHOULD BE ADVISED THAT CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWING INFECTION HEMATOMA AND SEROMA AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME CAPSULAR CONTRACTURE OCCURS MORE COMMONLY IN REVISION PATIENTS THAN IN PRIMARY AUGMENTATION OR RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE IS ALSO A RISK FACTOR FOR IMPLANT DEFLATION AND IT IS ONE OF THE MOST COMMON REASONS FOR REOPERATION PATIENTS SHOULD ALSO BE ADVISED THAT ADDITIONAL SURGERY MAY BE NEEDED IN CASES WHERE PAIN ANDOR FIRMNESS ARE SEVERE THIS SURGERY RANGES FROM REMOVAL OF THE IMPLANT CAPSULE TISSUE TO REMOVAL AND POSSIBLE REPLACEMENT OF THE IMPLANT ITSELF THIS SURGERY MAY RESULT IN LOSS OF BREAST TISSUE CAPSULAR CONTRACTURE MAY HAPPEN AGAIN AFTER THESE ADDITIONAL SURGERIES CAPSULAR CONTRACTURE MAY INCREASE THE RISK OF DEFLATION ADDITIONAL COMPLICATIONS Â¿ AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS IN THE PASS STUDY AT LEAST 1 REOPERATION WAS PERFORMED ON 315 PATIENTS 365 THROUGH 10 YEARS A TOTAL OF 424 REOPERATIONS WERE PERFORMED THE PRIMARY REASON FOR REOPERATION THROUGH 10 YEARS ON AUGMENTATION PATIENTS WAS IMPLANT DEFLATION AT 217 THE PERCENTAGE OF REOPERATIONS DUE TO LUMPMASSCYST INCREASED FROM 85 OF 293 REOPERATIONS THROUGH 5 YEARS TO 139 OF 424 REOPERATIONS THROUGH 10 YEARS THE OCCURRENCE OF LUMPS MASSES AND CYSTS CAN BE EXPECTED TO NATURALLY INCREASE AS PATIENTS AGE AND COULD BE AN EXPLANATION FOR THE INCREASE BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL FOR MORE COMPLETE AND UP-TO-DATE INFORMATION ON FDAÂ¿S ANALYSIS AND REVIEW OF THE ALCL IN PATIENTS WITH BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM YOU ARE ALSO REQUIRED TO REPORT ANY PRODUCT PROBLEM OR SERIOUS ADVERSE EVENT TO ALLERGAN DEATHS MUST BE REPORTED TO ALLERGAN AND FDA SILICONE DEVICE LABELING ONE OF THE KEY COMPLICATIONS REPORTED IS CALLED Â¿CAPSULAR CONTRACTUREÂ¿ CAPSULAR CONTRACTURE IS A TIGHTENING OF THE SCAR TISSUE ALSO CALLED A CAPSULE THAT NORMALLY FORMS AROUND THE BREAST IMPLANT DURING THE HEALING PROCESS AFTER SURGERY IN SOME WOMEN THE SCAR TISSUE CAPSULE SQUEEZES THE IMPLANT THIS RESULTS IN FIRMNESS OR HARDENING OF THE BREAST AND IT IS A RISK FOR IMPLANT RUPTURE DEGREES OF CAPSULAR CONTRACTURE ARE CLASSIFIED BY THE BAKER GRADING SCALE1 CAPSULAR CONTRACTURE BAKER GRADES III AND IV ARE THE MOST SEVERE BAKER GRADE III OFTEN RESULTS IN THE NEED FOR ADDITIONAL SURGERY REOPERATION BECAUSE OF PAIN AND POSSIBLY ABNORMAL APPEARANCE BAKER GRADE IV USUALLY RESULTS IN THE NEED FOR REOPERATION BECAUSE OF PAIN AND UNACCEPTABLE APPEARANCE DO NOT TREAT CAPSULAR CONTRACTURE BY CLOSED CAPSULOTOMY OR FORCEFUL EXTERNAL COMPRESSION WHICH WILL LIKELY RESULT IN IMPLANT DAMAGE RUPTURE FOLDS ANDOR HEMATOMA ALLERGAN HAS NOT TESTED THE EFFECTS OF RADIATION THERAPY IN PATIENTS WHO HAVE BREAST IMPLANTS THE LITERATURE SUGGESTS THAT RADIATION THERAPY MAY INCREASE THE LIKELIHOOD OF CAPSULAR CONTRACTURE NECROSIS AND IMPLANT EXTRUSION POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY SIMILAR TO A BRUISE A SEROMA OCCURS WHEN THE WATERY PORTION OF THE BLOOD COLLECTS AROUND A SURGICAL INCISION OR AROUND A BREAST IMPLANT YOU SHOULD PERFORM SELF-EXAMINATION OF YOUR BREASTS EVERY MONTH FOR CANCER SCREENING HOWEVER THIS MAY BE MORE DIFFICULT WITH IMPLANTS YOU SHOULD ASK YOUR SURGEON TO HELP YOU DISTINGUISH THE IMPLANT FROM YOUR BREAST TISSUE THE PRESENCE OF LUMPS PERSISTENT PAIN SWELLING HARDENING OR CHANGES IN IMPLANT SHAPE MAY BE SIGNS OF A RUPTURE OF THE IMPLANT THESE SIGNS SHOULD BE REPORTED TO YOUR SURGEON AND POSSIBLY EVALUATED WITH AN MRI AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL FOR MORE COMPLETE AND UP-TO-DATE INFORMATION ON FDAÂ¿S ANALYSIS AND REVIEW OF THE ALCL IN PATIENTS WITH BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6571801|75326411|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE RUPTURE WHILE IMPLANTED PATIENT ADDITIONALLY EXPERIENCED Â¿PATIENT WAS ALSO DIAGNOSED WITH PALPITATION AROUND THE TIME OF PATIENT SURGERY AND HAS HAD 2 ABLATIONS IN YEAR 2000Â¿ Â¿PATIENT DEVELOPED NONSPECIFIC SYMPTOMS WHICH INCLUDE GENERALIZED ACHES AND PAINS FATIGUE DRY EYES AND DRY MOUTH FOR WHICH PATIENT WAS DIAGNOSED WITH NONSPECIFIC CONNECTIVE TISSUE DISEASE IN 2005Â¿ PATIENT RECEIVED PLAQUENIL TREATMENT IN 2010 IN THE PAST 2 YEARS PATIENT ADDITIONALLY STARTED HAVING A LOT OF DISCOMFORT IN PATIENT LEFT BREAST FATIGUE WEAKNESS AND SOME WEIGHT CHANGES PATIENT ALSO GAVE A HISTORY OF AT LEAST Â¿2 EPISODES OF VERY SEVERE SOAKING NIGHT SWEATS AND SINCE THE LAST 2-3 MONTHS AT LEAST 2-3 TIMES A WEEK OF DRENCHING NIGHT SWEATS REQUIRING PATIENT TO CHANGE PATIENT NIGHTGOWNÂ¿ Â¿PATIENT HAS CHILLS AND SUBJECTIVE FEVER PATIENT ALSO COMPLAINS OF A SKIN RASH ON PATIENT LATERAL ASPECT OF OUTER UPPER QUADRANT OF LEFT BREAST AS WELL AS POSTERIOR ASPECT OF PATIENT LEFT THIGH IN THE LAST 1 MONTH PATIENT SYMPTOMS HAVE GOTTEN PROGRESSIVELY WORSE WITH INCREASE IN SIZE OF PATIENT LEFT BREAST PATIENT HAS NOTED SOME PEA-SIZED NODULES IN THE LEFT AXILLA FOR 2 YEARS ADDITIONAL REPORT OF Â¿THERE IS A FLUID COLLECTION SURROUNDING THE RUPTURED IMPLANTÂ¿ AND Â¿LARGE SWOLLEN LEFT BREAST WITH FLUID WAVEÂ¿ PATIENT REPORTED Â¿LYMPHOMA ALCLÂ¿ HEALTHCARE PROFESSIONAL STATED Â¿PT HAS ALCLÂ¿ PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL HAVE NOT BEEN RECEIVED|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-420|05/17/2017||||N|R||0HP|FTR|1.0|04/15/2004|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||49463|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6571801|75326410|N|1||CONCOMITANT MEDICAL PRODUCTS NITROGLYCERIN VALIUM 2 ZOLOFT B4 FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE HISTORY RECORD DHR REPORTS REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES THAT MAY BE ASSOCIATED WITH THE REPORTED DEVICE EVENT ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BREAST IMPLANTS ARE NOT LIFETIME DEVICES BREAST IMPLANTS RUPTURE WHEN THE SHELL DEVELOPS A TEAR OR HOLE RUPTURES CAN OCCUR AT ANY TIME AFTER IMPLANTATION BUT THEY ARE MORE LIKELY TO OCCUR THE LONGER THE IMPLANT IS IMPLANTED THE FOLLOWING THINGS MAY CAUSE IMPLANTS TO RUPTURE DAMAGE BY SURGICAL INSTRUMENTS STRESSING THE IMPLANT DURING IMPLANTATION AND WEAKENING IT FOLDING OR WRINKLING OF THE IMPLANT SHELL EXCESSIVE FORCE TO THE CHEST EG DURING CLOSED CAPSULOTOMY WHICH IS CONTRAINDICATED TRAUMA COMPRESSION DURING MAMMOGRAPHIC IMAGING AND SEVERE CAPSULAR CONTRACTURE BREAST IMPLANTS MAY ALSO SIMPLY WEAR OUT OVER TIME LABORATORY STUDIES HAVE IDENTIFIED SOME OF THE CAUSES OF RUPTURE FOR ALLERGANÂ¿S PRODUCT IT IS NOT CONCLUSIVELY KNOWN WHETHER THESE TESTS HAVE IDENTIFIED ALL CAUSES OF RUPTURE LABORATORY STUDIES TO IDENTIFY ANY ADDITIONAL CAUSES OF RUPTURE ARE ONGOING SILICONE GEL FILLED IMPLANT RUPTURES ARE MOST OFTEN SILENT THIS MEANS THAT MOST OF THE TIME NEITHER YOU NOR YOUR PATIENT WILL KNOW IF THE IMPLANT HAS A TEAR OR HOLE IN THE SHELL MRI EXAMINATION IS CURRENTLY THE BEST METHOD TO SCREEN FOR RUPTURE SOMETIMES THERE ARE SYMPTOMS ASSOCIATED WITH GEL IMPLANT RUPTURE THESE SYMPTOMS INCLUDE HARD KNOTS OR LUMPS SURROUNDING THE IMPLANT OR IN THE ARMPIT CHANGE OR LOSS OF SIZE OR SHAPE OF THE BREAST OR IMPLANT PAIN TINGLING SWELLING NUMBNESS BURNING AND HARDENING OF THE BREAST WHEN MRI SIGNS OF RUPTURE ARE FOUND SUCH AS SUBCAPSULAR LINES CHARACTERISTIC FOLDED WAVY LINES TEARDROP SIGN KEYHOLE SIGN NOOSE SIGN OR IF THERE ARE SIGNS OR SYMPTOMS OF RUPTURE YOU SHOULD REMOVE THE IMPLANT AND ANY GEL YOU DETERMINE YOUR PATIENT HAS WITH OR WITHOUT REPLACEMENT OF THE IMPLANT IT ALSO MAY BE NECESSARY TO REMOVE THE TISSUE CAPSULE THERE ARE ALSO CONSEQUENCES OF RUPTURE IF RUPTURE OCCURS SILICONE GEL MAY EITHER REMAIN WITHIN THE SCAR TISSUE CAPSULE SURROUNDING THE IMPLANT INTRACAPSULAR RUPTURE MOVE OUTSIDE THE CAPSULE EXTRACAPSULAR RUPTURE OR MOVE OUTSIDE THE BREAST GEL MIGRATION THERE IS ALSO A POSSIBILITY THAT RUPTURE MAY PROGRESS FROM INTRACAPSULAR TO EXTRACAPSULAR AND BEYOND|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-420|05/17/2017||||N|R||0HP|FTR|1.0|04/15/2004|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||49463|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6670624|78496499|N|1||FURTHER INFORMATION FROM THE REPORTER REGARDING THE EVENT PRODUCT ANDOR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING ADDRESSES THE REPORTED EVENT AS FOLLOWS BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/27/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6460158|71723776|N|1||ARTICLE CITATION Â¿A CASE OF SUSPECTED LATE-STAGE RECURRENCE OF ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA AT BREAST IMPLANT INSERTION SITEÂ¿ BY Y FUKUSHIMA M ISHII T INOUE T SAKURAI PUBLISHED IN THE JOURNAL OF JAPANESE PATHOLOGY ASSOCIATION VOL 102 NUMBER 1 PG 137 APR 2013 THE EVENTS OF LYMPHOMA AND LUMPNODULE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING THE EVENT PRODUCT ANDOR PATIENT DETAILS WAS REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/05/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6732214|80691506|D|1||ALCL IN PREVIOUS BREAST AUGMENTATION WITH TEXTURED DEVICE|INAMED||07/20/2017||||N|I||0HP|FTR|1.0||BREAST IMPLANT||||||US|INAMED/ALLERGAN|||||INAMED 410 TEXTURED IMPLANT||True
6734621|80749897|N|1||THE DEVICE REMAINS IMPLANTED THE EVENT OF BREAST CANCER IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT A REVIEW OF THE DEVICE HISTORY RECORD HAS BEEN INITIATED IF ANY NEW CHANGED OR CORRECTED INFORMATION IS NOTED A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY CANCER PUBLISHED STUDIES INDICATE THAT BREAST CANCER IS NO MORE COMMON IN WOMEN WITH IMPLANTS THAN THOSE WITHOUT IMPLANTS A LARGE LONG-TERM FOLLOW-UP FOUND NO SIGNIFICANT INCREASES IN THE RISK RATES FOR A WIDE VARIETY OF CANCERS INCLUDING STOMACH CANCER LEUKEMIA AND LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL FOR MORE COMPLETE AND UP-TO-DATE INFORMATION ON FDAÂ¿S ANALYSIS AND REVIEW OF THE ALCL IN PATIENTS WITH BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM|STYLE 68 SALINE FILLED BREAST IMPLANT|68-240|07/21/2017||||N|R||0HP|FWM|1.0|04/05/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1257756|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6293034|66256105|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLAINT AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING THE EVENT PRODUCT ANDOR PATIENT DETAILS WAS REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOÂ¬MA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/01/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6293034|66256106|D|1||RECEIVED A REPORT FROM THE THERAPEUTIC GOODS ADMINISTRATION REPORTING Â¿CONFIRMED ALCLÂ¿ FOR AN UNKNOWN Â¿ALLERGANMCGHANÂ¿ DEVICE SIDE UNKNOWN THE DEVICE WAS EXPLANTED AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT OF CONFIRMED ALCL WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/01/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6323429|67161072|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL OF AN UNKNOWN SIDE EXPLANT SURGERY OCCURRED AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6323429|67161071|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6638620|77500427|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/13/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6638620|77500428|D|1||HEALTHCARE PROFESSIONAL REPORTED CONFIRMED CASE OF ALCL OF AN UNKNOWN SIDE AS PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/13/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6315868|67108884|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL OF AN UNKNOWN SIDE EXPLANT SURGERY OCCURRED AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6315868|67108883|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6752720|81359776|D|1||COMPETENT AUTHORITY REPORTED A CASE OF ALCL TREATMENT AND AFFECTED SIDE UNKNOWN AS PATHOLOGICAL MARKERS ARE UNKNOWN THIS IS AN UNCONFIRMED CASE OF ALCL AND WILL BE REPORTED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410MF|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6752720|81359775|N|1||FOLLOW-UP IS COMPLETE AS REPORTING COMPETENT AUTHORITY WILL NOT PROVIDE ANY FURTHER INFORMATION TO SAFEGUARD THE PRIVACY OF THE INVOLVED PATIENTSÂ¿ THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410MF|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6460781|74854380|D|1||HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE ALCL LYMPHOMA PATIENT ADDITIONALLY EXPERIENCED Â¿SEVERE SEROMAÂ¿ AND SWOLLEN RIGHT BREAST SEROMA WAS ASPIRATED ON B6 2016 PATIENT RECEIVED ALCL DIAGNOSIS ON B6 2016 MARKERS WERE FOUND IN SEROMA FLUID AND CAPSULE DEVICE INFORMATION PROVIDED AS TEXTURED ROUND SALINE MCGHAN 350CC DEVICE CAPSULECTOMY WAS PERFORMED AND DEVICE WAS EXPLANTED PATIENT DID NOT RECEIVE REPLACEMENT DEVICES PATIENTS STATUS REPORTED AS DOING WELL THUS FAR WITH NO RETURN OF SYMPTOMS AND REMAINS DISEASE FREE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|04/05/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6460781|74854379|N|1||THE EVENTS OF LYMPHOMA ALCL SEROMA AND EDEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|04/05/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6460781|71746777|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|04/05/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6460781|71746778|D|1||HEALTHCARE PROFESSIONAL REPORTED ALCL ON AN UNKNOWN SIDE THE EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|04/05/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6744036|81049027|D|1||HEALTHCARE PROFESSIONAL REPORTED ALCL TREATMENT AND AFFECTED LOCATION UNKNOWN AS PATHOLOGICAL MARKERS HAVE NOT BEEN PROVIDED THIS IS NOT A CONFIRMED CASE OF ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/26/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6744036|81049026|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/26/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6677037|78706810|N|1||FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME THE REPORTED EVENT IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT REPORTED EVENT IS ADDRESSED IN THE LABELING ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/29/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6677037|78706811|D|1||COMPANY REPRESENTATIVE REPORTED THAT DURING A CONFERENCE THEY LEARNED OF A CASE OF ALCL EVENT WAS CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS ARE UNKNOWN SIDE IS UNKNOWN TREATMENT IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/29/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6341238|67800491|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED FOR DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6341238|67800492|D|1||PHYSICIAN REPORTS BREAST IMPLANT ASSOCIATED ALCL ON THE RIGHT SIDE DEVICE WAS EXPLANTED AS PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED TO CONFIRM ALCL DIAGNOSIS THIS EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6498277|72952111|N|1||THE EVENTS OF LYMPHOMA AND EDEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6498277|72952112|D|1||PATIENT REPORTED LEFT BREAST DOUBLED IN SIZE WITH SUDDEN SWELLING AND LYMPHOMA ALCL PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THEREFORE THE EVENT WILL BE CAPTURED AS LYMPHOMA EXPLANT SURGERY HAS NOT OCCURRED MANUFACTURER OF DEVICE IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6247063|64661472|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAVE BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME THE EVENTS OF SEROMA AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/12/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6247063|64661472|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAVE BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME THE EVENTS OF SEROMA AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSLP280|01/12/2017|||DA|*|*||0HP|FTR|1.0|05/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1845063|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247063|64661473|D|1||PHYSICIAN REPORTS CHRONIC IMPLANT RELATED SEROMA WHICH WAS EXCISED BUT WAS SUBSEQUENTLY DIAGNOSED WITH ALCL ON CYTOLOGY SIDE UNKNOWN HEALTHCARE PROFESSIONAL REPORTED A CAPSULECTOMY WAS PERFORMED AND WE ARE IN THE PROCESS OF TREATING THE PATIENT FOR THIS WITHOUT SPECIFYING THE TYPE OF TREATMENT EVENT OF ALCL WILL BE CAPTURED AS LYMPHOMA AT THIS TIME AS REQUIRED CYTOLOGICAL MARKERS HAVE NOT BEEN REPORTED MANUFACTURER OF DEVICE IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/12/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6247063|64661473|D|1||PHYSICIAN REPORTS CHRONIC IMPLANT RELATED SEROMA WHICH WAS EXCISED BUT WAS SUBSEQUENTLY DIAGNOSED WITH ALCL ON CYTOLOGY SIDE UNKNOWN HEALTHCARE PROFESSIONAL REPORTED A CAPSULECTOMY WAS PERFORMED AND WE ARE IN THE PROCESS OF TREATING THE PATIENT FOR THIS WITHOUT SPECIFYING THE TYPE OF TREATMENT EVENT OF ALCL WILL BE CAPTURED AS LYMPHOMA AT THIS TIME AS REQUIRED CYTOLOGICAL MARKERS HAVE NOT BEEN REPORTED MANUFACTURER OF DEVICE IS UNKNOWN|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSLP280|01/12/2017|||DA|*|*||0HP|FTR|1.0|05/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1845063|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247063|73823203|D|1||ADDITIONAL INFORMATION RECEIVED FROM HEALTHCARE PROFESSIONAL CONFIRMING EVENT IS AGAINST THE LEFT SIDE DEVICE CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED THIS IS A CONFIRMED CASE OF ALCL PHYSICIAN ADDITIONALLY REPORTED EVENT OF CAPSULAR CONTRACTURE AT PRESENTATION BAKER GRADE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/12/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6247063|73823203|D|1||ADDITIONAL INFORMATION RECEIVED FROM HEALTHCARE PROFESSIONAL CONFIRMING EVENT IS AGAINST THE LEFT SIDE DEVICE CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED THIS IS A CONFIRMED CASE OF ALCL PHYSICIAN ADDITIONALLY REPORTED EVENT OF CAPSULAR CONTRACTURE AT PRESENTATION BAKER GRADE UNKNOWN|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSLP280|01/12/2017|||DA|*|*||0HP|FTR|1.0|05/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1845063|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247160|68260911|D|1||PHYSICIAN REPORTS THE PATIENT PRESENTED TO ER WITH ANEMIA AND WEIGHT LOSS IN B6 2016 PATIENT WAS DIAGNOSED WITH BIA-ALCL ON B6 2016 PHYSICIAN REPORTED RIGHT SIDE RUPTURE AND RIGHT SIDE CAPSULAR CONTRACTURE BAKER GRADE NOT SPECIFIED EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2017-00006 FOR THE LEFT SIDE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247160|64710080|N|1||B6 -WEIGHT FLUCTUATIONS THE EVENTS OF WEIGHT LOSS ANEMIA CAPSULAR CONTRACTURE AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST FORMATION OF FIBROUS TISSUE AROUND AN IMPLANTED DEVICE IS A NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS A COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY AND IS ONE OF THE MOST COMMON REASONS FOR REOPERATION THE CAUSE OF CAPSULAR CONTRACTURE IS UNKNOWN HOWEVER IT IS MOST LIKELY MULTIFACTORIAL AND MAY BE MORE COMMON FOLLOWING INFECTION HAEMATOMA AND SEROMA CONTRACTURE DEVELOPS TO VARYING DEGREES UNILATERALLY OR BILATERALLY AND MAY OCCUR WITHIN WEEKS TO YEARS AFTER SURGERY CONTRACTURE OF THE FIBROUS CAPSULAR TISSUE SURROUNDING THE IMPLANT MAY CAUSE A RANGE OF SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES ARE CONSIDERED THE MOST CLINICALLY SIGNIFICANT AND MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT TO CORRECTIVE SURGICAL PROCEDURES DO NOT TREAT CAPSULAR CONTRACTURE BY EXTERNAL COMPRESSION OR MASSAGE WHICH MAY RESULT IN IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247160|64710081|D|1||PHYSICIAN REPORTS THE PATIENT PRESENTED TO ER WITH ANEMIA AND WEIGHT LOSS IN B6 2016 PATIENT WAS DIAGNOSED WITH BIA-ALCL ON B6 2016 PHYSICIAN REPORTED RIGHT SIDE RUPTURE AND RIGHT SIDE CAPSULAR CONTRACTURE BAKER GRADE NOT SPECIFIED EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2017-00006 FOR THE LEFT SIDE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6395062|73128949|D|1||HEALTH PROFESSIONAL REPORTED A PATIENT DIAGNOSED WITH RIGHT SIDE Â¿ALCLÂ¿ FOUND WITHIN A Â¿PERI-IMPLANT MASSÂ¿ AND Â¿SEROMAÂ¿ 13 YEARS AFTER HAVING A BREAST AUGMENTATION SURGERY PATHOLOGICAL MARKERS WERE INCLUDED THE PATIENT RECEIVED CHEMOTHERAPY SPECIFIED AS Â¿CHOPÂ¿ AFTER CHEMOTHERAPY THE DEVICE WAS EXPLANTED AND PATIENT RECEIVED ADDITIONAL TREATMENT OF RADIATION THERAPY SPECIFIED AS Â¿30 GREYÂ¿ THE PATIENT CURRENTLY DOES NOT HAVE ANY EVIDENCE OF ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/10/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6395062|69619795|N|1||THE EVENTS OF LYMPHOMA SEROMA AND LUMPNODULE ARE A PHYSIOLOGICAL COMPLAINT AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING THE EVENT PRODUCT ANDOR PATIENT DETAILS WAS REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/10/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6395062|69619796|D|1||HEALTH PROFESSIONAL REPORTED A PATIENT DIAGNOSED WITH RIGHT SIDE Â¿ALCLÂ¿ FOUND WITHIN A Â¿PERI-IMPLANT MASSÂ¿ AND Â¿SEROMAÂ¿ 13 YEARS AFTER HAVING A BREAST AUGMENTATION SURGERY PATHOLOGICAL MARKERS WERE INCLUDED THE PATIENT RECEIVED CHEMOTHERAPY SPECIFIED AS Â¿CHOPÂ¿ AFTER CHEMOTHERAPY THE DEVICE WAS EXPLANTED AND PATIENT RECEIVED ADDITIONAL TREATMENT OF RADIATION THERAPY SPECIFIED AS Â¿30 GREYÂ¿ THE PATIENT CURRENTLY DOES NOT HAVE ANY EVIDENCE OF ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/10/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6309206|66741539|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLAINT AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING THE EVENT PRODUCT ANDOR PATIENT DETAILS WAS REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/07/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6309206|66741540|D|1||RECEIVED A REPORT FROM THE THERAPEUTIC GOODS ADMINISTRATION REPORTING Â¿CONFIRMED ALCLÂ¿ FOR AN UNKNOWN Â¿ALLERGANMCGHANÂ¿ DEVICE SIDE UNKNOWN THE DEVICE WAS EXPLANTED AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT OF CONFIRMED ALCL WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/07/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6595799|76126751|D|1||HEALTHCARE PROFESSIONAL REPORTED 5 ALCL CASES THAT WERE Â¿PREVIOUSLY REPORTEDÂ¿ TO A FOREIGN COMPETENT HEALTH AUTHORITY EVENT DETAILS MANUFACTURER AND TREATMENT INFORMATION IS UNKNOWN AT THIS TIME AS HISTOLOGICAL MARKERS ARE UNCONFIRMED THIS WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/26/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6595799|76126751|D|1||HEALTHCARE PROFESSIONAL REPORTED 5 ALCL CASES THAT WERE Â¿PREVIOUSLY REPORTEDÂ¿ TO A FOREIGN COMPETENT HEALTH AUTHORITY EVENT DETAILS MANUFACTURER AND TREATMENT INFORMATION IS UNKNOWN AT THIS TIME AS HISTOLOGICAL MARKERS ARE UNCONFIRMED THIS WILL BE CAPTURED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410LX|05/26/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6595799|76126750|N|1||FOLLOW-UP IS BEING PERFORMED FOR FURTHER INFORMATION REGARDING THIS REPORT IF NEW INFORMATION IS RECEIVED IT WILL BE REPORTED IN A SUPPLEMENTAL REPORT THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN THE LABELING ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/26/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6595799|76126750|N|1||FOLLOW-UP IS BEING PERFORMED FOR FURTHER INFORMATION REGARDING THIS REPORT IF NEW INFORMATION IS RECEIVED IT WILL BE REPORTED IN A SUPPLEMENTAL REPORT THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN THE LABELING ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410LX|05/26/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6617685|76841699|D|1||MEDICAL STAFF REPORTED A PERIPROSTHETIC SEROMA PERIPROSTHETIC LINE WAS OBSERVED BY MAMMOGRAPHY AND RESULTED IN SUSPICION OF INTRACAPSULAR RUPTURE PATIENT EXPERIENCED VOLUME INCREASE OF RIGHT BREAST AND RIGHT PROSTHESIS WAS REMOVED AND A CAPSULECTOMY WAS PERFORMED ALK- ALCL WAS DIAGNOSED AGAINST THE CAPSULE WITH PATHOLOGICAL ANALYSIS AS ALL PATHOLOGICAL MARKERS HAVE NOT BEEN CONFIRMED THIS CASE OF ALCL WILL BE REPORTED AS LYMPHOMA|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|06/07/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6617685|76841698|N|1||ALLERGAN IS UNABLE TO CONFIRM WITH THE HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL EVENT PRODUCT OR PATIENT DETAILS ARE NOT ATTAINABLE THE REPORTED EVENTS OF LYMPHOMA SEROMA AND EDEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN THE LABELING THE PATIENT SHOULD BE TOLD THAT THE PRESENCE OF LUMPS PERSISTENT PAIN SWELLING HARDENING OR CHANGE IN THE IMPLANT SHAPE MAY BE SIGNS OF SYMPTOMATIC RUPTURE OF THE IMPLANT IF THE PATIENT HAS ANY OF THESE SIGNS SHE SHOULD BE TOLD TO REPORT THEM AND POSSIBLY HAVE AN MRI EVALUATION TO SCREEN FOR RUPTURE POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY SIMILAR TO A BRUISE A SEROMA OCCURS WHEN THE WATERY PORTION OF THE BLOOD COLLECTS AROUND A SURGICAL INCISION OR AROUND A BREAST IMPLANT AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|06/07/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6309203|66741187|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLAINT AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING THE EVENT PRODUCT ANDOR PATIENT DETAILS WAS REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/07/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6309203|66741188|D|1||RECEIVED A REPORT FROM THE THERAPEUTIC GOODS ADMINISTRATION REPORTING Â¿CONFIRMED ALCLÂ¿ FOR AN UNKNOWN Â¿ALLERGANMCGHANÂ¿ DEVICE SIDE UNKNOWN THE DEVICE WAS EXPLANTED AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT OF CONFIRMED ALCL WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/07/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6663360|78278939|N|1||FOLLOW-UP IS BEING PERFORMED FOR FURTHER INFORMATION REGARDING THIS EVENT NEW INFORMATION RECEIVED WILL BE REPORTED IN A SUPPLEMENTAL REPORT THE REPORTED EVENT IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT REPORTED EVENTS ARE ADDRESSED IN THE LABELING ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|TSF385|06/23/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6574813|75416230|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMABÂ¿ BY BY L JOHNSON J ODONOGHUE H STARK N COLLIS A LENNARD M BUTTERWORTH N MCLEAN M YOUSSEF G GUI I LYBURN J BRISTOL J HURREN S SMITH R JACKLIN D CUNNINGHAM AND F MACNEILL PUBLISHED IN CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN THE LABELING THE OCCURRENCE OF LUMPS MASSES AND CYSTS CAN BE EXPECTED TO NATURALLY INCREASE AS PATIENTS AGE AND COULD BE AN EXPLANATION FOR THE INCREASE ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL REPORTS IN THE MEDICAL LITERATURE INDICATE THAT PATIENTS WITH BREAST IMPLANTS ARE NOT AT A GREATER RISK THAN THOSE WITHOUT BREAST IMPLANTS FOR DEVELOPING BREAST CANCER REPORTS HAVE SUGGESTED THAT BREAST IMPLANTS MAY INTERFERE WITH OR DELAY BREAST CANCER DETECTION BY MAMMOGRAPHY ANDOR BIOPSY HOWEVER OTHER REPORTS IN THE PUBLISHED MEDICAL LITERATURE INDICATE THAT BREAST IMPLANTS NEITHER SIGNIFICANTLY DELAY BREAST CANCER DETECTION NOR ADVERSELY AFFECT CANCER SURVIVAL OF WOMEN WITH BREAST IMPLANTS A LARGE FOLLOW-UP STUDY REPORTED NO EVIDENCE OF AN ASSOCIATION BETWEEN BREAST IMPLANTS AND CANCER AND EVEN SHOWED A DECREASED INCIDENCE OF BREAST CANCER COMPARED TO THE GENERAL POPULATION ONE STUDY HAS REPORTED AN INCREASED INCIDENCE OF BRAIN CANCER IN WOMEN WITH BREAST IMPLANTS AS COMPARED TO THE GENERAL POPULATION THE INCIDENCE OF BRAIN CANCER HOWEVER WAS NOT SIGNIFICANTLY INCREASED IN WOMEN WITH BREAST IMPLANTS WHEN COMPARED TO WOMEN WHO HAD OTHER PLASTIC SURGERIES A PUBLISHED REVIEW OF 4 LARGE STUDIES IN WOMEN WITH COSMETIC IMPLANTS AND AN ADDITIONAL LONG-TERM FOLLOW-UP STUDY CONCLUDED THAT THE EVIDENCE DOES NOT SUPPORT AN ASSOCIATION BETWEEN BRAIN CANCER AND BREAST IMPLANTS AN EPIDEMIOLOGICAL REVIEW ALSO LENT SUPPORT TO THE LACK OF CAUSATION BETWEEN IMPLANTS AND ANY TYPE OF CANCER STUDIES HAVE REPORTED AN INCREASED INCIDENCE OF RESPIRATORYLUNG CANCER IN WOMEN WITH BREAST IMPLANTS OTHER STUDIES OF WOMEN IN SWEDEN AND DENMARK HAVE FOUND THAT WOMEN WHO GET BREAST IMPLANTS ARE MORE LIKELY TO BE CURRENT SMOKERS THAN WOMEN WHO GET BREAST REDUCTION SURGERY OR OTHER TYPES OF COSMETIC SURGERY SEVERAL LARGE STUDIES HAVE FOUND NO ASSOCIATION BETWEEN BREAST IMPLANTS AND RESPIRATORYLUNG CANCER TWO STUDIES REPORTED AN INCREASED INCIDENCE OF CERVICALVULVAR CANCER IN WOMEN WITH BREAST IMPLANTS ANOTHER LONG-TERM FOLLOW-UP STUDY SHOWED EQUIVALENT INCIDENCES OF CERVICAL CANCER IN WOMEN WITH BREAST IMPLANTS COMPARED TO THE GENERAL POPULATION OTHER RECENT LARGE STUDIES CONCLUDED THAT THE EVIDENCE DOES NOT SUPPORT AN ASSOCIATION BETWEEN REPRODUCTIVE SYSTEM CANCERS AND BREAST IMPLANTS THERE HAVE BEEN SEVERAL STUDIES PUBLISHED THAT EXAMINED THE RISK OF OTHER TYPES OF CANCERS EG THYROID CANCERS URINARY SYSTEM CANCERS SARCOMA ENDOCRINE CANCER CONNECTIVE TISSUE CANCER CANCER OF THE EYE AND UNSPECIFIED CANCERS IN WOMEN WITH BREAST IMPLANTS ALL OF THOSE STUDIES FOUND NO INCREASED RISK IN WOMEN WITH BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6574813|75416231|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS Â¿PATIENTS PRESENTED WITH STAGE IIA DISEASE AND ONE OF THE PATIENTS HAD BBA AND PRESENTED WITH A MASS ADJACENT TO THE IMPLANT AND PROGRESSED RAPIDLY THROUGH NEOADJUVANT CHOP TO DEVELOP LIFE THREATENING CHEST WALLTHORACIC CAVITY INVOLVEMENT PATIENT ACHIEVED COMPLETE PATHOLOGICAL RESPONSE WITH SIX CYCLES OF BRENTUXIMAB FOLLOWED BY BILATERAL TOTAL CAPSULECTOMY AND IMPLANT REMOVAL THIS IS THE FIRST REPORTED CASE OF NEO-ADJUVANT ANTIBODY THERAPY IN BIA-ALCLÂ¿ EVENT OF ALCL WILL BE CAPTURED AS LYMPHOMA AS THE NECESSARY HISTOLOGICAL MARKERS ARE NOT CONFIRMED MANUFACTURER OF DEVICE IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6574824|75417105|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS Â¿PATIENTS PRESENTED WITH STAGE IIA DISEASE ONE HAD PREVIOUS RRM AND IMPLANT RECONSTRUCTION AND PRESENTED WITH A MASS TREATMENT WAS CHOP+ ECHELON2 TRIAL RADIOTHERAPY AND IMPLANT REMOVALREMAINS WELL AT TWO YEARSÂ¿ EVENT OF ALCL WILL BE CAPTURED AS LYMPHOMA AS THE NECESSARY HISTOLOGICAL MARKERS ARE NOT CONFIRMED MANUFACTURER OF DEVICE IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6574824|75417104|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMABÂ¿ BY BY L JOHNSON J ODONOGHUE H STARK N COLLIS A LENNARD M BUTTERWORTH N MCLEAN M YOUSSEF G GUI I LYBURN J BRISTOL J HURREN S SMITH R JACKLIN D CUNNINGHAM AND F MACNEILL PUBLISHED IN CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN THE LABELING THE OCCURRENCE OF LUMPS MASSES AND CYSTS CAN BE EXPECTED TO NATURALLY INCREASE AS PATIENTS AGE AND COULD BE AN EXPLANATION FOR THE INCREASE ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6597657|76167628|D|1||DEVELOPED ALCL ANAPLASTIC LARGE CELL LYMPHOMA AFTER BREAST IMPLANTS WITH TEXTURED SILICONE DEVICES PREVIOUS RIGHT BREAST IMPLANT ALSO NATRELLE 120-300 SERIAL NUMBER B4 IMPLANTED ON B6 2008 THIS IMPLANT WAS REMOVED AND SEROMA FLUID EXAMINED THEN BUT FOUND TO BE NORMAL|NATRELLE||05/26/2017||||*|I||I|FTR|2.0||SILICONE-FILLED TEXTURED BREAST|||||GOLETA|US|ALLERGAN|93117|CA|93117||||True
6597657|76167628|D|1||DEVELOPED ALCL ANAPLASTIC LARGE CELL LYMPHOMA AFTER BREAST IMPLANTS WITH TEXTURED SILICONE DEVICES PREVIOUS RIGHT BREAST IMPLANT ALSO NATRELLE 120-300 SERIAL NUMBER B4 IMPLANTED ON B6 2008 THIS IMPLANT WAS REMOVED AND SEROMA FLUID EXAMINED THEN BUT FOUND TO BE NORMAL|NATRELLE|120-300|05/26/2017||||Y|I||0HP|FTR|1.0||SILICONE-FILLED TEXTURED BREAST|||||GOLETA|US|ALLERGAN|93117|CA|93117||120-300||True
6315886|67108821|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6315886|67108822|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL OF AN UNKNOWN SIDE EXPLANT SURGERY OCCURRED AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6323469|67162001|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL OF AN UNKNOWN SIDE EXPLANT SURGERY OCCURRED AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6323469|67162000|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6584653|75765031|N|1||B4 THE EVENTS OF LYMPHOMA LUMPNODULE SKIN RASHDERMATITIS AND CAPSULAR CONTRACTURE BAKER GRADE III ARE A PHYSIOLOGICAL COMPLAINT AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING THE EVENT PRODUCT ANDOR PATIENT DETAILS WAS REQUESTED DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL FOR MORE COMPLETE AND UP-TO-DATE INFORMATION ON FDAÂ¿S ANALYSIS AND REVIEW OF THE ALCL IN PATIENTS WITH BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM LITERATURE REPORTS HAVE ALSO BEEN MADE ASSOCIATING SILICONE BREAST IMPLANTS WITH VARIOUS RHEUMATOLOGICAL SIGNS AND SYMPTOMS SUCH AS SKIN RASHES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE CAPSULAR CONTRACTURE PATIENTS SHOULD BE ADVISED THAT CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWING INFECTION HEMATOMA AND SEROMA AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME CAPSULAR CONTRACTURE OCCURS MORE COMMONLY IN REVISION PATIENTS THAN IN PRIMARY AUGMENTATION OR RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE IS ALSO A RISK FACTOR FOR IMPLANT RUPTURE AND IT IS ONE OF THE MOST COMMON REASONS FOR REOPERATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/23/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6613947|76724095|N|1||B4 THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN THE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY SIMILAR TO A BRUISE A SEROMA OCCURS WHEN THE WATERY PORTION OF THE BLOOD COLLECTS AROUND A SURGICAL INCISION OR AROUND A BREAST IMPLANT AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX140-520|06/06/2017|||DA|N|R||0HP|FTR|1.0|10/31/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1777073|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6613947|81168106|D|1||PHYSICIAN REPORTS CASE OF RIGHT SIDE ALK- ALCL PHYSICIAN ADDITIONALLY REPORTED SENSATION OF SWELLING OF PERIPROSTHETIC TISSUES LOCAL DISCOMFORT MILD ASTHENIA AND FINDINGS OF PERIPROSTHETIC FLUID AS ALL PATHOLOGICAL MARKERS HAVE NOT BEEN CONFIRMED THIS CASE OF ALCL WILL BE CAPTURED AS LYMPHOMA DEVICE WAS EXPLANTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX140-520|06/06/2017|||DA|N|R||0HP|FTR|1.0|10/31/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1777073|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6613947|76724096|D|1||PHYSICIAN REPORTS CASE OF RIGHT SIDE ALK- ALCL PHYSICIAN ADDITIONALLY REPORTED SENSATION OF SWELLING OF PERIPROSTHETIC TISSUES LOCAL DISCOMFORT MILD ASTHENIA AND FINDINGS OF PERIPROSTHETIC FLUID AS ALL PATHOLOGICAL MARKERS HAVE NOT BEEN CONFIRMED THIS CASE OF ALCL WILL BE CAPTURED AS LYMPHOMA DEVICE WAS EXPLANTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX140-520|06/06/2017|||DA|N|R||0HP|FTR|1.0|10/31/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1777073|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247152|64673721|D|1||PHYSICIAN REPORTS THE PATIENT PRESENTED TO ER WITH ANEMIA AND WEIGHT LOSS IN B6 2016 PATIENT WAS DIAGNOSED WITH BIA-ALCL ON B6 2016 PHYSICIAN REPORTED LEFT SIDE CAPSULAR CONTRACTURE BAKER GRADE NOT SPECIFIED PATIENT WAS ADDITIONALLY FOUND TO HAVE A LEFT AXILLARY LYMPH NODE WITH LYMPHOMA CELLS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED THIS MEDWATCH REPRESENTS THE LEFT SIDE SEE MFR  9617229-2017-00007 FOR THE RIGHT SIDE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247152|68396193|D|1||PHYSICIAN REPORTS THE PATIENT PRESENTED TO ER WITH ANEMIA AND WEIGHT LOSS IN B6 2016 PATIENT WAS DIAGNOSED WITH BIA-ALCL ON B6 2016 PHYSICIAN REPORTED LEFT SIDE CAPSULAR CONTRACTURE BAKER GRADE NOT SPECIFIED PATIENT WAS ADDITIONALLY FOUND TO HAVE A LEFT AXILLARY LYMPH NODE WITH LYMPHOMA CELLS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED THIS MEDWATCH REPRESENTS THE LEFT SIDE SEE MFR  9617229-2017-00007 FOR THE RIGHT SIDE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247152|64673720|N|1||B4 THE EVENTS OF WEIGHT LOSS ANEMIA CAPSULAR CONTRACTURE LYMPHADENOPATHY AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST FORMATION OF FIBROUS TISSUE AROUND AN IMPLANTED DEVICE IS A NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS A COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY AND IS ONE OF THE MOST COMMON REASONS FOR REOPERATION THE CAUSE OF CAPSULAR CONTRACTURE IS UNKNOWN HOWEVER IT IS MOST LIKELY MULTIFACTORIAL AND MAY BE MORE COMMON FOLLOWING INFECTION HAEMATOMA AND SEROMA CONTRACTURE DEVELOPS TO VARYING DEGREES UNILATERALLY OR BILATERALLY AND MAY OCCUR WITHIN WEEKS TO YEARS AFTER SURGERY CONTRACTURE OF THE FIBROUS CAPSULAR TISSUE SURROUNDING THE IMPLANT MAY CAUSE A RANGE OF SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES ARE CONSIDERED THE MOST CLINICALLY SIGNIFICANT AND MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT TO CORRECTIVE SURGICAL PROCEDURES DO NOT TREAT CAPSULAR CONTRACTURE BY EXTERNAL COMPRESSION OR MASSAGE WHICH MAY RESULT IN IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6551502|74631918|N|1||B4 FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME THE EVENTS OF LYMPHOMA LATE SEROMA LYMPHADENOPATHY AND BREAST LUMPS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS EVENTS ARE ADDRESSED IN THE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY ADDITIONAL COMPLICATIONS Â¿ AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS THE OCCURRENCE OF LUMPS MASSES AND CYSTS CAN BE EXPECTED TO NATURALLY INCREASE AS PATIENTS AGE AND COULD BE AN EXPLANATION FOR THE INCREASE BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/08/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6551502|74631919|D|1||PHYSICIAN REPORTED A COMPLETE RIGHT CAPSULECTOMY AND BIOPSY OF THREE MACROSCOPICALLY AFFECTED LYMPH NODES WERE PERFORMED PATIENT COMPLAINED OF CHRONIC SEROMA AND UNDERWENT REMOVAL OF IMPLANT AS A RESULT OF WHICH THE SEROMA RESOLVED PATIENT THEN NOTICED A NODULE IN THE RIGHT BREAST CONFIRMED AS ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING CORE NEEDLE BIOPSY CASE OF ALCL WILL BE REPORTED AS LYMPHOMA AS NECESSARY PATHOLOGICAL MARKERS HAVE NOT BEEN CONFIRMED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/08/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6380550|69150039|D|1||DIAGNOSED WITH BIA ALCL|BREAST IMPLANT||03/05/2017||||Y|I||0LP|FWM|2.0||BREAST IMPLANT|||||||MENTOR|||||||True
6380550|69150039|D|1||DIAGNOSED WITH BIA ALCL|BREAST IMPLANT||03/05/2017||||Y|I||0LP|FWM|1.0||BREAST IMPLANT|||||||MENTOR|||||||True
6323298|67155236|N|1||B4 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS DEVICE CURRENTLY REMAINS IMPLANTED AND WILL BE REQUESTED AFTER PLANNED EXPLANT THE EVENTS OF LYMPHOMA PLEURAL EFFUSION LATE SEROMA COLLAPSED IPSILATERAL LUNG LYMPHADENOPATHY BREAST LUMPS AND DYSPNEA AND ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING DEVICE DETAILS IS BEING REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY|INSPIRA SMOOTH SILICONE GEL FILLED BREAST IMPLANT|SSF370|02/10/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6323298|67155237|D|1||PHYSICIAN REPORTS TUMOR IN SOFT TISSUE OF LOWER INNER QUADRANT OF THE LEFT BREAST WITH PLEURITIC PAIN AND PROGRESSIVE DYSPNEA SECONDARY TO SEVERE LEFT PLEURAL EFFUSION WITH COLLAPSE OF IPSILATERAL LUNG ADDITIONALLY PHYSICIAN REPORTED MASSIVE NODE IN LEFT INTERNAL MAMMARY NODAL CHAIN RESULTS OF TESTING SHOW CYTOLOGY AND FLOW CYTOMETRY OF EXUDATIVE PLEURAL EFFUSION FLUID ARE NEGATIVE FOR LYMPHOMATOUS INFILTRATION ADENOPATHY ADDITIONALLY REPORTED THOUGH THE TRANSLATION STATES PLEURAL EFFUSION FLUID ARE NEGATIVE FOR LYMPHOMATOUS INFILTRATION PHYSICIAN REPORTED B6 2016 AS THE DATE OF DIAGNOSIS FOR ALCL AT THIS TIME ALCL HAS NOT BEEN CONFIRMED BY PATHOLOGICAL MARKERS UNTIL ALLERGAN RECEIVES CONFIRMATION OF THE MARKERS THIS WILL BE TERM CODED AS LYMPHOMA DEVICE REMAINS IMPLANTED REMOVAL PENDING THIS CASE WAS ORIGINALLY REPORTED IN MFR  9617229-2016-00250 BUT FOLLOW-UP REVEALED THAT COMPLAINT WAS AGAINST A SUBSEQUENT DEVICE|INSPIRA SMOOTH SILICONE GEL FILLED BREAST IMPLANT|SSF370|02/10/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6752840|81359305|D|1||COMPETENT AUTHORITY REPORTED A CASE OF ALCL TREATMENT AND AFFECTED SIDE UNKNOWN AS PATHOLOGICAL MARKERS ARE UNKNOWN THIS IS AN UNCONFIRMED CASE OF ALCL AND WILL BE REPORTED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410MX|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6752840|81359304|N|1||FOLLOW-UP IS COMPLETE AS REPORTING COMPETENT AUTHORITY WILL NOT PROVIDE ANY FURTHER INFORMATION TO SAFEGUARD THE PRIVACY OF THE INVOLVED PATIENTSÂ¿ THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410MX|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6574800|75414969|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMABÂ¿ BY BY L JOHNSON J ODONOGHUE H STARK N COLLIS A LENNARD M BUTTERWORTH N MCLEAN M YOUSSEF G GUI I LYBURN J BRISTOL J HURREN S SMITH R JACKLIN D CUNNINGHAM AND F MACNEILL PUBLISHED IN CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN THE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY SIMILAR TO A BRUISE A SEROMA OCCURS WHEN THE WATERY PORTION OF THE BLOOD COLLECTS AROUND A SURGICAL INCISION OR AROUND A BREAST IMPLANT AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6574800|75414970|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS Â¿STAGE I CASES THAT PRESENTED WITH RECURRENT SEROMA WERE TREATED SUCCESSFULLY WITH IMPLANT REMOVAL AND TOTAL CAPSULECTOMY FOUR PATIENTS HAD BILATERAL BREAST AUGMENTATION BBAÂ¿ THIS MEDWATCH REPORT REPRESENTS THESE FOUR STAGE I CASES OF PATIENTS WITH BILATERAL BREAST AUGMENTATION REGARDING TREATMENT ABSTRACT REPORTS SOME CASES Â¿HAD SURGERY TO REMOVE BOTH IMPLANTS AND IPSILATERAL TOTAL CAPSULECTOMY AND OTHERS CONTRALATERAL CAPSULECTOMY AND THE PATHOLOGY WAS BENIGN OR UNILATERAL CAPSULECTOMY AND BILATERAL EXCHANGE OF IMPLANTSÂ¿ WITH THE CURRENT INFORMATION PROVIDED IT IS IMPOSSIBLE TO KNOW WHICH SPECIFIC TREATMENT WAS USED IN THESE CASES EVENT OF ALCL WILL BE CAPTURED AS LYMPHOMA AS THE NECESSARY HISTOLOGICAL MARKERS ARE NOT CONFIRMED MANUFACTURER OF DEVICE IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6434492|70859690|N|1||B4 THE EVENTS OF LYMPHOMA ALCL SEROMA LUMPNODULE AND EDEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE HISTORY RECORD DHR REPORTS BASED ON THE RISK ANALYSIS PERFORMED THE AE TERM CODE LYMPHOMA-ALCL WAS SELECTED FOR ANALYSIS AS IT REPRESENTS THE HIGHEST RISK FALLING ON THE MONITOR RISK REGION WITH AN APPLICABLE INVESTIGATION LEVEL OF 3 REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT FROM SAP WAS VERIFIED AND THERE WAS NO SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER 2493185 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410535|03/24/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2493185|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6434492|70859691|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE SWELLING AND FLUID COLLECTION PATHOLOGY ADDITIONALLY PROVIDES THE EVENT OF Â¿UNSPECIFIED LUMP IN BREASTÂ¿ PATHOLOGICAL MARKERS ALK- AND CD30+ CONFIRMING LYMPHOMA ALCL HAVE BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410535|03/24/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2493185|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6751820|81359311|D|1||COMPETENT AUTHORITY REPORTED A CASE OF ALCL TREATMENT AND AFFECTED SIDE UNKNOWN AS PATHOLOGICAL MARKERS ARE UNKNOWN THIS IS AN UNCONFIRMED CASE OF ALCL AND WILL BE REPORTED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6751820|81359250|N|1||FOLLOW-UP IS COMPLETE AS REPORTING COMPETENT AUTHORITY WILL NOT PROVIDE ANY FURTHER INFORMATION TO SAFEGUARD THE PRIVACY OF THE INVOLVED PATIENTSÂ¿ THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6641177|77604162|N|1||FOLLOW-UP IS BEING PERFORMED FOR FURTHER INFORMATION REGARDING THIS EVENT NEW INFORMATION RECEIVED WILL BE REPORTED IN A SUPPLEMENTAL REPORT THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REVIEW OF DHR FOR WORK ORDER 2436682 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES THAT MAY BE ASSOCIATED WITH THE REPORTED DEVICE EVENT ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT FROM SAP WAS VERIFIED AND THERE WAS NOT SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS THE QMS LISTING REPORT INDICATES THAT THERE WERE NO NCMRS OR DEVIATIONS RELATED FOR UNITS MANUFACTURED ON WORK ORDER 2436682 ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER 2436682 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS REPORTED EVENTS ARE ADDRESSED IN THE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY SIMILAR TO A BRUISE A SEROMA OCCURS WHEN THE WATERY PORTION OF THE BLOOD COLLECTS AROUND A SURGICAL INCISION OR AROUND A BREAST IMPLANT AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF130-375|06/14/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2436682|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6638628|77497013|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/13/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6638628|77497014|D|1||HEALTHCARE PROFESSIONAL REPORTED CONFIRMED CASE OF ALCL OF AN UNKNOWN SIDE AS PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/13/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6544056|74409596|D|1||PHYSICIAN REPORTED EVENT OF LEFT SIDE ALCL TO B6 CD30+ MARKER HAS BEEN CONFIRMED PHYSICIAN REPORTED EVENTS OF PAIN LOSS OF 10 KG IN 1 YEAR RECURRENT LYMPHORREA INCREASE IN VOLUME TIGHTENING PERIPHERAL INFLAMMATION FIBRINOID NECROSIS AXILLARY ADENOPATHY ABUNDANT INTRACAPSULAR EFFUSION MASS AND ADENOFIBROMA PHYSICIAN ADDITIONALLY REPORTED THERE IS HYPERVASCULAR TISSUE THICKENING VISIBLE BY THE QUASI-CIRCUMFERENTIAL CAPSULE BUT PREDOMINANT IN INFERIOR-INTERNAL AND SUPERIOR-EXTERNAL PROJECTION THIS ALCL CASE WILL BE CAPTURED AS LYMPHOMA AS ALK NEGATIVE MARKER WAS NOT CONFIRMED DEVICE WAS EXPLANTED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|TRM310|05/04/2017||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1327562|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6544056|74409595|N|1||B4 FOLLOW-UP IS CURRENTLY BEING PERFORMED FOR FURTHER DETAILS REGARDING THIS CASE IF ANY NEW INFORMATION IS RECEIVED IT WILL BE SENT IN A SUPPLEMENTAL MEDWATCH THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REVIEW OF DHR DEVICE HISTORY RECORD FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS DHR FOR WORK ORDER B4 INDICATES THAT THERE WAS A REPROCESS FOR TWO UNITS ON THE PRIMARY PACKAGING OPERATION HOWEVER THIS WAS COMPLETED ON A DIFFERENT SERIAL NUMBER UNIT AND THIS HAS NO RELATION NEITHER CAN CAUSE THE REPORTED EVENT THE DHR ASSEMBLY REPORT FROM ORACLE WAS VERIFIED AND THERE WAS NOT ANY SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS REPORTED EVENTS ARE ADDRESSED IN THE LABELING ALLERGAN HAS NOT TESTED THE EFFECTS OF RADIATION THERAPY IN PATIENTS WHO HAVE BREAST IMPLANTS THE LITERATURE SUGGESTS THAT RADIATION THERAPY MAY INCREASE THE LIKELIHOOD OF CAPSULAR CONTRACTURE NECROSIS AND IMPLANT EXTRUSION POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY SIMILAR TO A BRUISE A SEROMA OCCURS WHEN THE WATERY PORTION OF THE BLOOD COLLECTS AROUND A SURGICAL INCISION OR AROUND A BREAST IMPLANT YOU SHOULD PERFORM SELF-EXAMINATION OF YOUR BREASTS EVERY MONTH FOR CANCER SCREENING HOWEVER THIS MAY BE MORE DIFFICULT WITH IMPLANTS YOU SHOULD ASK YOUR SURGEON TO HELP YOU DISTINGUISH THE IMPLANT FROM YOUR BREAST TISSUE THE PRESENCE OF LUMPS PERSISTENT PAIN SWELLING HARDENING OR CHANGES IN IMPLANT SHAPE MAY BE SIGNS OF A RUPTURE OF THE IMPLANT THESE SIGNS SHOULD BE REPORTED TO YOUR SURGEON AND POSSIBLY EVALUATED WITH AN MRI AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|TRM310|05/04/2017||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1327562|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6439143|71165412|D|1||I HAVE RECENTLY READ ARTICLES ABOUT BREAST IMPLANTS BEING LINKED TO ALCL I HAVE A SIMILAR CONDITION CALLED APLASTIC ANEMIA THAT HAS NOW MORPHED INTO PNH IN B6 OF 2004 I RECEIVED BREAST IMPLANTS IN B6 OF 2004 I WAS DIAGNOSED WITH APLASTIC ANEMIA I HAVE ALWAYS WONDERED IF MY BREAST AUGMENTATION COULD BE LINKED TO MY CONDITION AS I WAS COMPLETELY HEALTHY PRIOR TO THIS NOW I AM LIVING WITH A CRITICAL AND TERMINAL ILLNESS AND MY LIFE HAS NEVER BEEN THE SAME ALCL AND APLASTIC ANEMIA ARE SIMILAR CONDITIONS AND I AM CONCERNED THERE MAY BE A LINK I WANTED TO REPORT TO THE PROPER CHANNELS TO ENSURE COMPLETE INVESTIGATION OF BREASTS IMPLANTS AFFECTS ON BLOOD CANCERS AND DISEASES|BREAST IMPLANTS||03/24/2017||||Y|I||I|FWM|1.0||BREAST IMPLANTS|||||||ALLERGAN|||||||True
6439143|71165412|D|1||I HAVE RECENTLY READ ARTICLES ABOUT BREAST IMPLANTS BEING LINKED TO ALCL I HAVE A SIMILAR CONDITION CALLED APLASTIC ANEMIA THAT HAS NOW MORPHED INTO PNH IN B6 OF 2004 I RECEIVED BREAST IMPLANTS IN B6 OF 2004 I WAS DIAGNOSED WITH APLASTIC ANEMIA I HAVE ALWAYS WONDERED IF MY BREAST AUGMENTATION COULD BE LINKED TO MY CONDITION AS I WAS COMPLETELY HEALTHY PRIOR TO THIS NOW I AM LIVING WITH A CRITICAL AND TERMINAL ILLNESS AND MY LIFE HAS NEVER BEEN THE SAME ALCL AND APLASTIC ANEMIA ARE SIMILAR CONDITIONS AND I AM CONCERNED THERE MAY BE A LINK I WANTED TO REPORT TO THE PROPER CHANNELS TO ENSURE COMPLETE INVESTIGATION OF BREASTS IMPLANTS AFFECTS ON BLOOD CANCERS AND DISEASES|BREAST IMPLANTS||03/24/2017||||Y|I||I|FWM|2.0||BREAST IMPLANTS|||||||ALLERGAN|||||||True
6574799|75414182|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMABÂ¿ BY BY L JOHNSON J ODONOGHUE H STARK N COLLIS A LENNARD M BUTTERWORTH N MCLEAN M YOUSSEF G GUI I LYBURN J BRISTOL J HURREN S SMITH R JACKLIN D CUNNINGHAM AND F MACNEILL PUBLISHED IN CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN THE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY SIMILAR TO A BRUISE A SEROMA OCCURS WHEN THE WATERY PORTION OF THE BLOOD COLLECTS AROUND A SURGICAL INCISION OR AROUND A BREAST IMPLANT AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6574799|75414183|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS STAGE I CASE OF ALCL AND TWO HAD BILATERAL RISK-REDUCING MASTECTOMIES RRM WITH IMPLANT RECONSTRUCTION THIS MEDWATCH REPORT REPRESENTS TWO STAGE I CASES OF PATIENTS WHO HAD BILATERAL RISK-REDUCING MASTECTOMIES WITH IMPLANT RECONSTRUCTION REGARDING TREATMENT ABSTRACT REPORTS SOME CASES Â¿HAD SURGERY TO REMOVE BOTH IMPLANTS AND IPSILATERAL TOTAL CAPSULECTOMY AND OTHERS CONTRALATERAL CAPSULECTOMY AND THE PATHOLOGY WAS BENIGN OR UNILATERAL CAPSULECTOMY AND BILATERAL EXCHANGE OF IMPLANTSÂ¿ WITH THE CURRENT INFORMATION PROVIDED IT IS IMPOSSIBLE TO KNOW WHICH SPECIFIC TREATMENT WAS USED IN THESE CASES EVENT OF ALCL WILL BE CAPTURED AS LYMPHOMA AS THE NECESSARY HISTOLOGICAL MARKERS ARE NOT CONFIRMED MANUFACTURER OF DEVICE IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6574818|75418664|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS STAGE I ALCL CASE OF PATIENT WITH UNILATERAL MASTECTOMY AND IMPLANT RECONSTRUCTION FOR BREAST CANCER REGARDING TREATMENT ABSTRACT STATES STAGE I CASES THAT PRESENTED WITH RECURRENT SEROMA WERE TREATED SUCCESSFULLY WITH IMPLANT REMOVAL AND TOTAL CAPSULECTOMY EVENT OF ALCL WILL BE CAPTURED AS LYMPHOMA AS THE NECESSARY HISTOLOGICAL MARKERS ARE NOT CONFIRMED MANUFACTURER OF DEVICE IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6574818|75418663|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMABÂ¿ BY BY L JOHNSON J ODONOGHUE H STARK N COLLIS A LENNARD M BUTTERWORTH N MCLEAN M YOUSSEF G GUI I LYBURN J BRISTOL J HURREN S SMITH R JACKLIN D CUNNINGHAM AND F MACNEILL PUBLISHED IN CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN THE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY SIMILAR TO A BRUISE A SEROMA OCCURS WHEN THE WATERY PORTION OF THE BLOOD COLLECTS AROUND A SURGICAL INCISION OR AROUND A BREAST IMPLANT AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6635007|77400540|D|1||THE B6 ARTICLE TITLED Â¿A SHOCKING DIAGNOSIS BREAST IMPLANTS Â¿GAVE ME CANCERÂ¿Â¿ REPORTS Â¿PATIENT LEARNED LAST MAY THAT PATIENT HAD LYMPHOMA FROM TEXTURED IMPLANTS PATIENT HAD FOR MORE THAN 10 YEARS BUT INSTEAD OF REMOVING THE IMPLANTS AND CAPSULES IMMEDIATELY PATIENT DOCTOR PRESCRIBED SIX ROUNDS OF CHEMOTHERAPY AND 25 ROUNDS OF RADIATION A YEAR LATER PATIENT STILL HAS THE IMPLANTSÂ¿ AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA AFFECTED LOCATION IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/12/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6635007|77400539|N|1||ARTICLE CITATION A SHOCKING DIAGNOSIS BREAST IMPLANTS GAVE ME CANCER B6 B6 MAY 14 2017 THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT AND PRODUCT DETAILS CANNOT BE OBTAINED AS PATIENT AND EXPLANTING PHYSICIAN CONTACT INFORMATION WAS NOT PROVIDED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/12/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6545873|74473872|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE ANAPLASTIC LARGE CELL LYMPHOMA PATIENTÂ¿S INITIAL DIAGNOSIS PROVIDED AS Â¿FIBROCYSTIC BREAST DISEASEÂ¿ BUT AMENDED TO LYMPHOMA ALCL PATIENT ADDITIONALLY EXPERIENCED LEFT SIDE SWELLING AND A SEROMA A CAPSULECTOMY WAS PERFORMED AND THE DEVICE WAS REMOVED APPROXIMATELY 200 RNL OF CHALKY WHITE FLUID WAS FOUND UPON ENTERING THE CAPSULE PHYSICIAN ADDITIONALLY REPORTED THERE WAS A LARGE THICK RIND AROUND THE CAPSULE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410740|05/04/2017||||N|R||0HP|FTR|1.0|08/24/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||236550|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6545873|74473871|N|1||B4 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE HISTORY RECORD DHR PROVIDES REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES THAT MAY BE ASSOCIATED WITH THE REPORTED DEVICE EVENT ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY |STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410740|05/04/2017||||N|R||0HP|FTR|1.0|08/24/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||236550|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6529881|74123089|D|1||I HAD A BREAST DEFORMITY AS A CHILDTEENAGER I WAS BORN WITH IT INSURANCE PAID FOR BOTH OF MY SURGERIES I WAS IMPLANTED OVER MUSCLE WITH SMOOTH SALINE IN 1993 IN 1994 I STARTED TO HAVE MAJOR FATIGUE WEIRD CHEMICAL SENSITIVITIES A GROIN CYST DEVELOPED OUT OF NO WHERE THAT EVERYONE SAID IS JUST FAT BUT NEVER BEEN TESTED AND INTERSTITIAL CYSTITIS INFLAMMATION OF BLADDER IN 1995 THYROID CANCER AS WELL THYROID REMOVED IN 1996 CAPSULAR CONTRACTURE REMOVED IMPLANTS PUT UNDER MUSCLE TEXTURED SALINE PS WHO DID SURGERY WHO GOT HIS LICENSE TAKEN AWAY YEARS LATER FOR DOING CRYSTAL METH AND HAVING SEX WITH PATIENTS PUTTING IN IMPLANTS BIGGER THAN WHAT GIRLS WANTED EVEN GAUZE WAS FOUND INSIDE ONE GIRLS BREASTS YEARS LATER WHEN SHE WAS HAVING A LOT OF PAIN AND THEY COULDNT FIGURE WHAT IT WAS SAID HE HAD TO MAKE MY IMPLANTS LARGER THAN WHAT I WAS A SMALL C I ASKED FOR A LARGE C I WOKE A DD TODAY I AM A DDD BECAUSE IVE GAINED WEIGHT DIAGNOSED WITH CHRONIC FATIGUE SYNDROME THEN LATER FIBROMYALGIA TWENTY TWO YEARS OF CHRONIC NECK PAIN STIFFNESS AND NOW ARTHRITIS IN MY NECK WEIRD ONION ALLERGY DEVELOPED IN 1997 FREEZING COLD AND TINGLING AND NUMBNESS RIGHT HAND FINGERS AND RIGHT FOOT TOES WEIRD AND RANDOM ITCHING CREEPY CRAWLY FEELINGS IN SCALP AND OTHER PARTS OF BODY CHRONIC BODY CHILLS CHRONIC CERVICAL MIGRAINES MAJOR WEIGHT GAIN CANT LOSE WEIGHT DESPITE DIETING EXTREME DRY SCALP FIBROIDS LOW SEX DRIVE GETTING WORSE BLURRY VISION RANDOM TOOTH SENSITIVITIES CHOLESTASIS DURING PREGNANCY BREASTS PAINS CHRONIC INSOMNIA DONT GO INTO 4TH STAGE OF SLEEP DARK EYE CIRCLES GETTING WORSE YEAR BY YEAR UPPER ARM PAIN BY IMPLANTS KNEE PAIN WEIRD AND RANDOM ELBOW PAIN JOINT PAINS MUSCLE STIFFNESS UNDER ARM PIT SWOLLEN LYMPH NODES MAJOR EXERCISE INTOLERANCE IBS ISSUES UNEXPLAINED RAISED LIVER ENZYMES HIGH CHOLESTEROL CHRONIC CONSTIPATION GASTRITIS WITH BLEEDING STOMACH ACID ISSUES CHRONIC SORE THROATS IN BEGINNING WEIRD UNDER EYE TWITCHING SWOLLEN LYMPH NODES WEAKNESS HAIR LOSS RIGHT HAND PAINSTIFFNESS WHEN WRITING ISCHEMIC COLITIS FROM PASSING OUT FOR NO EXPLAINED REASON MAJOR BRAIN FOG MAJOR CONCENTRATION ISSUES MAJOR MEMORY ISSUES CHRONIC AND UNEXPLAINED POST NASAL DRIP FOR 20 PLUS YEARS SOMETIMES WITH BLACK STREAKS HIATAL HERNIA COMPLETE NUMBNESS IN THE BOTTOM OF MY RIGHT THUMB AFTER EATING OR DRINKING SOMETHING COLD INABILITY TO HAVE A SECOND CHILD RANDOM HEART PALPITATIONS WOLF PARKINSONS WHITE HAD TO HAVE HEART ABLATION GALLSTONES POSSIBLE GALLBLADDER REMOVAL BECAUSE OF POSSIBLE POLYP IM NOW SCARED OF THE CANCER CALLED ALCL NOW LINKED TO BREASTS IMPLANTS ESPECIALLY THE TEXTURED ONE WHICH I HAVE IM A MESS AND AM JUST USE TO IT I HAVE LOST MY LIFE MY QUALITY OF LIFE AND MY CAREER THESE ILLNESSES HAVE PUT ME INTO DEBT I CAN BARELY WORK OR TAKE CARE OF MY DAUGHTER BY MYSELF AT LEAST I CANT DO BOTH OTS ONE OR THE OTHER THANK GOD I HAVE A HUSBAND WHO CAN STEP IN AND BE THE MOM AND THE HOUSE KEEPER AND THE COOK ETC IVE FOCUSED ON EVERY BODY PART WITH EVERY SPECIALIST IN EVERY FIELD BUT I NEVER FOCUSED ON MY BREASTS BECAUSE I WAS ALWAYS TOLD IT COULDNT BE MY IMPLANTS LAST WEEK I HAD A BREAST SONOGRAM AND IT SHOWED A 7CM SWOLLEN LYMPH NODE IN MY RIGHT BREAST NOT SUSPICIOUS FOR CANCER TODAY I WAS DIAGNOSED WITH BAKER GRADE 4 CAPSULAR CONTRACTURE IN MY RIGHT BREAST BY A RECONSTRUCTIVE BREAST SURGEON GOD ONLY KNOWS HOW LONG IVE HAD IT SOMETHING HAS TO BE DONE AND SOMEONE NEEDS TO BE HELD ACCOUNTABLE FOR THOUSANDS OF WOMEN LOSING THEIR LIVES AND QUALITY OF LIVES FROM EITHER SALINE OR SILICONE BREAST IMPLANTS IMPORTANT INFORMATION MCGHAN SILTEX SALINE FILLED MAMMARY PROTHESIS LOT FW7879 LEFT 390CC AND LOT FW2756 RIGHT 390CC IMPLANTED BY DR B6 OF B6 ON B6 1993 OVER THE MUSCLE WITH RECONSTRUCTION AFTER CAPSULAR CONTRACTURE AND IMPLANT RUPTURES MCGHAN STYLE 468 TEXTURED SALINE IMPLANTS CAT 27-468561 LEFT HK6992 650CCS RIGHT LOT GK5386 700CCS WAS IMPLANTED BY DR B6 OF B6 ON B6 1996 ON B6 2017 CAPSULAR CONTRACTION AGAIN IMPLANTS TO BE REMOVED AND TOTAL ENBLOC CAPSULECTOMY SOON HOPEFULLY I AM IN A B6 GROUP WITH OVER 17800 WOMEN AND CONSTANTLY GROWING WITH SIMILAR STORIES AS MINE WHO HAVE EITHER SILICONE OR SALINE BREASTS IMPLANTS WHEN THEY EXPLANT THEM VIA AN ENBLOC CAPSULECTOMY ALL OF THEIR SYMPTOMS AND ILLNESSES GO AWAY TESTS GO BACK TO NORMAL WOMENS EYES FACES SKIN START TO LOOK BETTER HEALTHIER AND WOMENS AUTOIMMUNE ISSUES DISAPPEAR THEY START TO DETOX AND HEAL AND CAN START TO REGAIN SOME OF THEIR LIVES IMPLANTS COME OUT WITH MOLD AND TOXINS THE IMPLANTS AND THE WOMENS BODIES ARE TESTED AND ARE FOUND TO HAVE TOXINS MOLDS SILICONE AND THE CHEMICALS WHICH MAKE UP SILICONE IN THEM AND ALL OVER THEM THE BREAST IMPLANT INDUSTRY KNOWS WHAT THEY ARE PUTTING INTO WOMENS BODIES AND WHAT IS HAPPENING TO THEM IT JUST NEEDS TO BE PROVEN IN A COURT OF LAW AND ITS TIME CANCER IS NOW LINKED TO BREAST IMPLANTS AND THE ONLY WAY TO KNOW IF YOU HAVE THAT TYPE OF CANCER BEFORE ITS TOO LATE IS TO TAKE OUT THE IMPLANTS AND TEST THE FLUID AROUND THE IMPLANTS WOMEN ARE DYING AND WE NEED THE FDAS HELP PLEASE|SALINE TEXTURED BREAST IMPLANT|27-468561|04/26/2017||||Y|I||0HP|FWM|4.0||BREAST IMPLANTS||L-HK6992 R-GK5386|||||MCGHAN/ALLERGAN|||||468||True
6529881|74123089|D|1||I HAD A BREAST DEFORMITY AS A CHILDTEENAGER I WAS BORN WITH IT INSURANCE PAID FOR BOTH OF MY SURGERIES I WAS IMPLANTED OVER MUSCLE WITH SMOOTH SALINE IN 1993 IN 1994 I STARTED TO HAVE MAJOR FATIGUE WEIRD CHEMICAL SENSITIVITIES A GROIN CYST DEVELOPED OUT OF NO WHERE THAT EVERYONE SAID IS JUST FAT BUT NEVER BEEN TESTED AND INTERSTITIAL CYSTITIS INFLAMMATION OF BLADDER IN 1995 THYROID CANCER AS WELL THYROID REMOVED IN 1996 CAPSULAR CONTRACTURE REMOVED IMPLANTS PUT UNDER MUSCLE TEXTURED SALINE PS WHO DID SURGERY WHO GOT HIS LICENSE TAKEN AWAY YEARS LATER FOR DOING CRYSTAL METH AND HAVING SEX WITH PATIENTS PUTTING IN IMPLANTS BIGGER THAN WHAT GIRLS WANTED EVEN GAUZE WAS FOUND INSIDE ONE GIRLS BREASTS YEARS LATER WHEN SHE WAS HAVING A LOT OF PAIN AND THEY COULDNT FIGURE WHAT IT WAS SAID HE HAD TO MAKE MY IMPLANTS LARGER THAN WHAT I WAS A SMALL C I ASKED FOR A LARGE C I WOKE A DD TODAY I AM A DDD BECAUSE IVE GAINED WEIGHT DIAGNOSED WITH CHRONIC FATIGUE SYNDROME THEN LATER FIBROMYALGIA TWENTY TWO YEARS OF CHRONIC NECK PAIN STIFFNESS AND NOW ARTHRITIS IN MY NECK WEIRD ONION ALLERGY DEVELOPED IN 1997 FREEZING COLD AND TINGLING AND NUMBNESS RIGHT HAND FINGERS AND RIGHT FOOT TOES WEIRD AND RANDOM ITCHING CREEPY CRAWLY FEELINGS IN SCALP AND OTHER PARTS OF BODY CHRONIC BODY CHILLS CHRONIC CERVICAL MIGRAINES MAJOR WEIGHT GAIN CANT LOSE WEIGHT DESPITE DIETING EXTREME DRY SCALP FIBROIDS LOW SEX DRIVE GETTING WORSE BLURRY VISION RANDOM TOOTH SENSITIVITIES CHOLESTASIS DURING PREGNANCY BREASTS PAINS CHRONIC INSOMNIA DONT GO INTO 4TH STAGE OF SLEEP DARK EYE CIRCLES GETTING WORSE YEAR BY YEAR UPPER ARM PAIN BY IMPLANTS KNEE PAIN WEIRD AND RANDOM ELBOW PAIN JOINT PAINS MUSCLE STIFFNESS UNDER ARM PIT SWOLLEN LYMPH NODES MAJOR EXERCISE INTOLERANCE IBS ISSUES UNEXPLAINED RAISED LIVER ENZYMES HIGH CHOLESTEROL CHRONIC CONSTIPATION GASTRITIS WITH BLEEDING STOMACH ACID ISSUES CHRONIC SORE THROATS IN BEGINNING WEIRD UNDER EYE TWITCHING SWOLLEN LYMPH NODES WEAKNESS HAIR LOSS RIGHT HAND PAINSTIFFNESS WHEN WRITING ISCHEMIC COLITIS FROM PASSING OUT FOR NO EXPLAINED REASON MAJOR BRAIN FOG MAJOR CONCENTRATION ISSUES MAJOR MEMORY ISSUES CHRONIC AND UNEXPLAINED POST NASAL DRIP FOR 20 PLUS YEARS SOMETIMES WITH BLACK STREAKS HIATAL HERNIA COMPLETE NUMBNESS IN THE BOTTOM OF MY RIGHT THUMB AFTER EATING OR DRINKING SOMETHING COLD INABILITY TO HAVE A SECOND CHILD RANDOM HEART PALPITATIONS WOLF PARKINSONS WHITE HAD TO HAVE HEART ABLATION GALLSTONES POSSIBLE GALLBLADDER REMOVAL BECAUSE OF POSSIBLE POLYP IM NOW SCARED OF THE CANCER CALLED ALCL NOW LINKED TO BREASTS IMPLANTS ESPECIALLY THE TEXTURED ONE WHICH I HAVE IM A MESS AND AM JUST USE TO IT I HAVE LOST MY LIFE MY QUALITY OF LIFE AND MY CAREER THESE ILLNESSES HAVE PUT ME INTO DEBT I CAN BARELY WORK OR TAKE CARE OF MY DAUGHTER BY MYSELF AT LEAST I CANT DO BOTH OTS ONE OR THE OTHER THANK GOD I HAVE A HUSBAND WHO CAN STEP IN AND BE THE MOM AND THE HOUSE KEEPER AND THE COOK ETC IVE FOCUSED ON EVERY BODY PART WITH EVERY SPECIALIST IN EVERY FIELD BUT I NEVER FOCUSED ON MY BREASTS BECAUSE I WAS ALWAYS TOLD IT COULDNT BE MY IMPLANTS LAST WEEK I HAD A BREAST SONOGRAM AND IT SHOWED A 7CM SWOLLEN LYMPH NODE IN MY RIGHT BREAST NOT SUSPICIOUS FOR CANCER TODAY I WAS DIAGNOSED WITH BAKER GRADE 4 CAPSULAR CONTRACTURE IN MY RIGHT BREAST BY A RECONSTRUCTIVE BREAST SURGEON GOD ONLY KNOWS HOW LONG IVE HAD IT SOMETHING HAS TO BE DONE AND SOMEONE NEEDS TO BE HELD ACCOUNTABLE FOR THOUSANDS OF WOMEN LOSING THEIR LIVES AND QUALITY OF LIVES FROM EITHER SALINE OR SILICONE BREAST IMPLANTS IMPORTANT INFORMATION MCGHAN SILTEX SALINE FILLED MAMMARY PROTHESIS LOT FW7879 LEFT 390CC AND LOT FW2756 RIGHT 390CC IMPLANTED BY DR B6 OF B6 ON B6 1993 OVER THE MUSCLE WITH RECONSTRUCTION AFTER CAPSULAR CONTRACTURE AND IMPLANT RUPTURES MCGHAN STYLE 468 TEXTURED SALINE IMPLANTS CAT 27-468561 LEFT HK6992 650CCS RIGHT LOT GK5386 700CCS WAS IMPLANTED BY DR B6 OF B6 ON B6 1996 ON B6 2017 CAPSULAR CONTRACTION AGAIN IMPLANTS TO BE REMOVED AND TOTAL ENBLOC CAPSULECTOMY SOON HOPEFULLY I AM IN A B6 GROUP WITH OVER 17800 WOMEN AND CONSTANTLY GROWING WITH SIMILAR STORIES AS MINE WHO HAVE EITHER SILICONE OR SALINE BREASTS IMPLANTS WHEN THEY EXPLANT THEM VIA AN ENBLOC CAPSULECTOMY ALL OF THEIR SYMPTOMS AND ILLNESSES GO AWAY TESTS GO BACK TO NORMAL WOMENS EYES FACES SKIN START TO LOOK BETTER HEALTHIER AND WOMENS AUTOIMMUNE ISSUES DISAPPEAR THEY START TO DETOX AND HEAL AND CAN START TO REGAIN SOME OF THEIR LIVES IMPLANTS COME OUT WITH MOLD AND TOXINS THE IMPLANTS AND THE WOMENS BODIES ARE TESTED AND ARE FOUND TO HAVE TOXINS MOLDS SILICONE AND THE CHEMICALS WHICH MAKE UP SILICONE IN THEM AND ALL OVER THEM THE BREAST IMPLANT INDUSTRY KNOWS WHAT THEY ARE PUTTING INTO WOMENS BODIES AND WHAT IS HAPPENING TO THEM IT JUST NEEDS TO BE PROVEN IN A COURT OF LAW AND ITS TIME CANCER IS NOW LINKED TO BREAST IMPLANTS AND THE ONLY WAY TO KNOW IF YOU HAVE THAT TYPE OF CANCER BEFORE ITS TOO LATE IS TO TAKE OUT THE IMPLANTS AND TEST THE FLUID AROUND THE IMPLANTS WOMEN ARE DYING AND WE NEED THE FDAS HELP PLEASE|SALINE TEXTURED BREAST IMPLANT|27-468561|04/26/2017||||Y|I||0HP|FWM|3.0||BREAST IMPLANTS||L-HK6992 R-GK5386|||||MCGHAN/ALLERGAN|||||468||True
6529881|74123089|D|1||I HAD A BREAST DEFORMITY AS A CHILDTEENAGER I WAS BORN WITH IT INSURANCE PAID FOR BOTH OF MY SURGERIES I WAS IMPLANTED OVER MUSCLE WITH SMOOTH SALINE IN 1993 IN 1994 I STARTED TO HAVE MAJOR FATIGUE WEIRD CHEMICAL SENSITIVITIES A GROIN CYST DEVELOPED OUT OF NO WHERE THAT EVERYONE SAID IS JUST FAT BUT NEVER BEEN TESTED AND INTERSTITIAL CYSTITIS INFLAMMATION OF BLADDER IN 1995 THYROID CANCER AS WELL THYROID REMOVED IN 1996 CAPSULAR CONTRACTURE REMOVED IMPLANTS PUT UNDER MUSCLE TEXTURED SALINE PS WHO DID SURGERY WHO GOT HIS LICENSE TAKEN AWAY YEARS LATER FOR DOING CRYSTAL METH AND HAVING SEX WITH PATIENTS PUTTING IN IMPLANTS BIGGER THAN WHAT GIRLS WANTED EVEN GAUZE WAS FOUND INSIDE ONE GIRLS BREASTS YEARS LATER WHEN SHE WAS HAVING A LOT OF PAIN AND THEY COULDNT FIGURE WHAT IT WAS SAID HE HAD TO MAKE MY IMPLANTS LARGER THAN WHAT I WAS A SMALL C I ASKED FOR A LARGE C I WOKE A DD TODAY I AM A DDD BECAUSE IVE GAINED WEIGHT DIAGNOSED WITH CHRONIC FATIGUE SYNDROME THEN LATER FIBROMYALGIA TWENTY TWO YEARS OF CHRONIC NECK PAIN STIFFNESS AND NOW ARTHRITIS IN MY NECK WEIRD ONION ALLERGY DEVELOPED IN 1997 FREEZING COLD AND TINGLING AND NUMBNESS RIGHT HAND FINGERS AND RIGHT FOOT TOES WEIRD AND RANDOM ITCHING CREEPY CRAWLY FEELINGS IN SCALP AND OTHER PARTS OF BODY CHRONIC BODY CHILLS CHRONIC CERVICAL MIGRAINES MAJOR WEIGHT GAIN CANT LOSE WEIGHT DESPITE DIETING EXTREME DRY SCALP FIBROIDS LOW SEX DRIVE GETTING WORSE BLURRY VISION RANDOM TOOTH SENSITIVITIES CHOLESTASIS DURING PREGNANCY BREASTS PAINS CHRONIC INSOMNIA DONT GO INTO 4TH STAGE OF SLEEP DARK EYE CIRCLES GETTING WORSE YEAR BY YEAR UPPER ARM PAIN BY IMPLANTS KNEE PAIN WEIRD AND RANDOM ELBOW PAIN JOINT PAINS MUSCLE STIFFNESS UNDER ARM PIT SWOLLEN LYMPH NODES MAJOR EXERCISE INTOLERANCE IBS ISSUES UNEXPLAINED RAISED LIVER ENZYMES HIGH CHOLESTEROL CHRONIC CONSTIPATION GASTRITIS WITH BLEEDING STOMACH ACID ISSUES CHRONIC SORE THROATS IN BEGINNING WEIRD UNDER EYE TWITCHING SWOLLEN LYMPH NODES WEAKNESS HAIR LOSS RIGHT HAND PAINSTIFFNESS WHEN WRITING ISCHEMIC COLITIS FROM PASSING OUT FOR NO EXPLAINED REASON MAJOR BRAIN FOG MAJOR CONCENTRATION ISSUES MAJOR MEMORY ISSUES CHRONIC AND UNEXPLAINED POST NASAL DRIP FOR 20 PLUS YEARS SOMETIMES WITH BLACK STREAKS HIATAL HERNIA COMPLETE NUMBNESS IN THE BOTTOM OF MY RIGHT THUMB AFTER EATING OR DRINKING SOMETHING COLD INABILITY TO HAVE A SECOND CHILD RANDOM HEART PALPITATIONS WOLF PARKINSONS WHITE HAD TO HAVE HEART ABLATION GALLSTONES POSSIBLE GALLBLADDER REMOVAL BECAUSE OF POSSIBLE POLYP IM NOW SCARED OF THE CANCER CALLED ALCL NOW LINKED TO BREASTS IMPLANTS ESPECIALLY THE TEXTURED ONE WHICH I HAVE IM A MESS AND AM JUST USE TO IT I HAVE LOST MY LIFE MY QUALITY OF LIFE AND MY CAREER THESE ILLNESSES HAVE PUT ME INTO DEBT I CAN BARELY WORK OR TAKE CARE OF MY DAUGHTER BY MYSELF AT LEAST I CANT DO BOTH OTS ONE OR THE OTHER THANK GOD I HAVE A HUSBAND WHO CAN STEP IN AND BE THE MOM AND THE HOUSE KEEPER AND THE COOK ETC IVE FOCUSED ON EVERY BODY PART WITH EVERY SPECIALIST IN EVERY FIELD BUT I NEVER FOCUSED ON MY BREASTS BECAUSE I WAS ALWAYS TOLD IT COULDNT BE MY IMPLANTS LAST WEEK I HAD A BREAST SONOGRAM AND IT SHOWED A 7CM SWOLLEN LYMPH NODE IN MY RIGHT BREAST NOT SUSPICIOUS FOR CANCER TODAY I WAS DIAGNOSED WITH BAKER GRADE 4 CAPSULAR CONTRACTURE IN MY RIGHT BREAST BY A RECONSTRUCTIVE BREAST SURGEON GOD ONLY KNOWS HOW LONG IVE HAD IT SOMETHING HAS TO BE DONE AND SOMEONE NEEDS TO BE HELD ACCOUNTABLE FOR THOUSANDS OF WOMEN LOSING THEIR LIVES AND QUALITY OF LIVES FROM EITHER SALINE OR SILICONE BREAST IMPLANTS IMPORTANT INFORMATION MCGHAN SILTEX SALINE FILLED MAMMARY PROTHESIS LOT FW7879 LEFT 390CC AND LOT FW2756 RIGHT 390CC IMPLANTED BY DR B6 OF B6 ON B6 1993 OVER THE MUSCLE WITH RECONSTRUCTION AFTER CAPSULAR CONTRACTURE AND IMPLANT RUPTURES MCGHAN STYLE 468 TEXTURED SALINE IMPLANTS CAT 27-468561 LEFT HK6992 650CCS RIGHT LOT GK5386 700CCS WAS IMPLANTED BY DR B6 OF B6 ON B6 1996 ON B6 2017 CAPSULAR CONTRACTION AGAIN IMPLANTS TO BE REMOVED AND TOTAL ENBLOC CAPSULECTOMY SOON HOPEFULLY I AM IN A B6 GROUP WITH OVER 17800 WOMEN AND CONSTANTLY GROWING WITH SIMILAR STORIES AS MINE WHO HAVE EITHER SILICONE OR SALINE BREASTS IMPLANTS WHEN THEY EXPLANT THEM VIA AN ENBLOC CAPSULECTOMY ALL OF THEIR SYMPTOMS AND ILLNESSES GO AWAY TESTS GO BACK TO NORMAL WOMENS EYES FACES SKIN START TO LOOK BETTER HEALTHIER AND WOMENS AUTOIMMUNE ISSUES DISAPPEAR THEY START TO DETOX AND HEAL AND CAN START TO REGAIN SOME OF THEIR LIVES IMPLANTS COME OUT WITH MOLD AND TOXINS THE IMPLANTS AND THE WOMENS BODIES ARE TESTED AND ARE FOUND TO HAVE TOXINS MOLDS SILICONE AND THE CHEMICALS WHICH MAKE UP SILICONE IN THEM AND ALL OVER THEM THE BREAST IMPLANT INDUSTRY KNOWS WHAT THEY ARE PUTTING INTO WOMENS BODIES AND WHAT IS HAPPENING TO THEM IT JUST NEEDS TO BE PROVEN IN A COURT OF LAW AND ITS TIME CANCER IS NOW LINKED TO BREAST IMPLANTS AND THE ONLY WAY TO KNOW IF YOU HAVE THAT TYPE OF CANCER BEFORE ITS TOO LATE IS TO TAKE OUT THE IMPLANTS AND TEST THE FLUID AROUND THE IMPLANTS WOMEN ARE DYING AND WE NEED THE FDAS HELP PLEASE|SILTEX SALINE FILLED MAMMARY PROSTHESIS||04/26/2017||||Y|I||0HP|FWM|1.0||PROSTHESIS, BREAST||L-FW7879 R-FW2756|||||MCGHAN/ALLERGAN|||||||True
6529881|74123089|D|1||I HAD A BREAST DEFORMITY AS A CHILDTEENAGER I WAS BORN WITH IT INSURANCE PAID FOR BOTH OF MY SURGERIES I WAS IMPLANTED OVER MUSCLE WITH SMOOTH SALINE IN 1993 IN 1994 I STARTED TO HAVE MAJOR FATIGUE WEIRD CHEMICAL SENSITIVITIES A GROIN CYST DEVELOPED OUT OF NO WHERE THAT EVERYONE SAID IS JUST FAT BUT NEVER BEEN TESTED AND INTERSTITIAL CYSTITIS INFLAMMATION OF BLADDER IN 1995 THYROID CANCER AS WELL THYROID REMOVED IN 1996 CAPSULAR CONTRACTURE REMOVED IMPLANTS PUT UNDER MUSCLE TEXTURED SALINE PS WHO DID SURGERY WHO GOT HIS LICENSE TAKEN AWAY YEARS LATER FOR DOING CRYSTAL METH AND HAVING SEX WITH PATIENTS PUTTING IN IMPLANTS BIGGER THAN WHAT GIRLS WANTED EVEN GAUZE WAS FOUND INSIDE ONE GIRLS BREASTS YEARS LATER WHEN SHE WAS HAVING A LOT OF PAIN AND THEY COULDNT FIGURE WHAT IT WAS SAID HE HAD TO MAKE MY IMPLANTS LARGER THAN WHAT I WAS A SMALL C I ASKED FOR A LARGE C I WOKE A DD TODAY I AM A DDD BECAUSE IVE GAINED WEIGHT DIAGNOSED WITH CHRONIC FATIGUE SYNDROME THEN LATER FIBROMYALGIA TWENTY TWO YEARS OF CHRONIC NECK PAIN STIFFNESS AND NOW ARTHRITIS IN MY NECK WEIRD ONION ALLERGY DEVELOPED IN 1997 FREEZING COLD AND TINGLING AND NUMBNESS RIGHT HAND FINGERS AND RIGHT FOOT TOES WEIRD AND RANDOM ITCHING CREEPY CRAWLY FEELINGS IN SCALP AND OTHER PARTS OF BODY CHRONIC BODY CHILLS CHRONIC CERVICAL MIGRAINES MAJOR WEIGHT GAIN CANT LOSE WEIGHT DESPITE DIETING EXTREME DRY SCALP FIBROIDS LOW SEX DRIVE GETTING WORSE BLURRY VISION RANDOM TOOTH SENSITIVITIES CHOLESTASIS DURING PREGNANCY BREASTS PAINS CHRONIC INSOMNIA DONT GO INTO 4TH STAGE OF SLEEP DARK EYE CIRCLES GETTING WORSE YEAR BY YEAR UPPER ARM PAIN BY IMPLANTS KNEE PAIN WEIRD AND RANDOM ELBOW PAIN JOINT PAINS MUSCLE STIFFNESS UNDER ARM PIT SWOLLEN LYMPH NODES MAJOR EXERCISE INTOLERANCE IBS ISSUES UNEXPLAINED RAISED LIVER ENZYMES HIGH CHOLESTEROL CHRONIC CONSTIPATION GASTRITIS WITH BLEEDING STOMACH ACID ISSUES CHRONIC SORE THROATS IN BEGINNING WEIRD UNDER EYE TWITCHING SWOLLEN LYMPH NODES WEAKNESS HAIR LOSS RIGHT HAND PAINSTIFFNESS WHEN WRITING ISCHEMIC COLITIS FROM PASSING OUT FOR NO EXPLAINED REASON MAJOR BRAIN FOG MAJOR CONCENTRATION ISSUES MAJOR MEMORY ISSUES CHRONIC AND UNEXPLAINED POST NASAL DRIP FOR 20 PLUS YEARS SOMETIMES WITH BLACK STREAKS HIATAL HERNIA COMPLETE NUMBNESS IN THE BOTTOM OF MY RIGHT THUMB AFTER EATING OR DRINKING SOMETHING COLD INABILITY TO HAVE A SECOND CHILD RANDOM HEART PALPITATIONS WOLF PARKINSONS WHITE HAD TO HAVE HEART ABLATION GALLSTONES POSSIBLE GALLBLADDER REMOVAL BECAUSE OF POSSIBLE POLYP IM NOW SCARED OF THE CANCER CALLED ALCL NOW LINKED TO BREASTS IMPLANTS ESPECIALLY THE TEXTURED ONE WHICH I HAVE IM A MESS AND AM JUST USE TO IT I HAVE LOST MY LIFE MY QUALITY OF LIFE AND MY CAREER THESE ILLNESSES HAVE PUT ME INTO DEBT I CAN BARELY WORK OR TAKE CARE OF MY DAUGHTER BY MYSELF AT LEAST I CANT DO BOTH OTS ONE OR THE OTHER THANK GOD I HAVE A HUSBAND WHO CAN STEP IN AND BE THE MOM AND THE HOUSE KEEPER AND THE COOK ETC IVE FOCUSED ON EVERY BODY PART WITH EVERY SPECIALIST IN EVERY FIELD BUT I NEVER FOCUSED ON MY BREASTS BECAUSE I WAS ALWAYS TOLD IT COULDNT BE MY IMPLANTS LAST WEEK I HAD A BREAST SONOGRAM AND IT SHOWED A 7CM SWOLLEN LYMPH NODE IN MY RIGHT BREAST NOT SUSPICIOUS FOR CANCER TODAY I WAS DIAGNOSED WITH BAKER GRADE 4 CAPSULAR CONTRACTURE IN MY RIGHT BREAST BY A RECONSTRUCTIVE BREAST SURGEON GOD ONLY KNOWS HOW LONG IVE HAD IT SOMETHING HAS TO BE DONE AND SOMEONE NEEDS TO BE HELD ACCOUNTABLE FOR THOUSANDS OF WOMEN LOSING THEIR LIVES AND QUALITY OF LIVES FROM EITHER SALINE OR SILICONE BREAST IMPLANTS IMPORTANT INFORMATION MCGHAN SILTEX SALINE FILLED MAMMARY PROTHESIS LOT FW7879 LEFT 390CC AND LOT FW2756 RIGHT 390CC IMPLANTED BY DR B6 OF B6 ON B6 1993 OVER THE MUSCLE WITH RECONSTRUCTION AFTER CAPSULAR CONTRACTURE AND IMPLANT RUPTURES MCGHAN STYLE 468 TEXTURED SALINE IMPLANTS CAT 27-468561 LEFT HK6992 650CCS RIGHT LOT GK5386 700CCS WAS IMPLANTED BY DR B6 OF B6 ON B6 1996 ON B6 2017 CAPSULAR CONTRACTION AGAIN IMPLANTS TO BE REMOVED AND TOTAL ENBLOC CAPSULECTOMY SOON HOPEFULLY I AM IN A B6 GROUP WITH OVER 17800 WOMEN AND CONSTANTLY GROWING WITH SIMILAR STORIES AS MINE WHO HAVE EITHER SILICONE OR SALINE BREASTS IMPLANTS WHEN THEY EXPLANT THEM VIA AN ENBLOC CAPSULECTOMY ALL OF THEIR SYMPTOMS AND ILLNESSES GO AWAY TESTS GO BACK TO NORMAL WOMENS EYES FACES SKIN START TO LOOK BETTER HEALTHIER AND WOMENS AUTOIMMUNE ISSUES DISAPPEAR THEY START TO DETOX AND HEAL AND CAN START TO REGAIN SOME OF THEIR LIVES IMPLANTS COME OUT WITH MOLD AND TOXINS THE IMPLANTS AND THE WOMENS BODIES ARE TESTED AND ARE FOUND TO HAVE TOXINS MOLDS SILICONE AND THE CHEMICALS WHICH MAKE UP SILICONE IN THEM AND ALL OVER THEM THE BREAST IMPLANT INDUSTRY KNOWS WHAT THEY ARE PUTTING INTO WOMENS BODIES AND WHAT IS HAPPENING TO THEM IT JUST NEEDS TO BE PROVEN IN A COURT OF LAW AND ITS TIME CANCER IS NOW LINKED TO BREAST IMPLANTS AND THE ONLY WAY TO KNOW IF YOU HAVE THAT TYPE OF CANCER BEFORE ITS TOO LATE IS TO TAKE OUT THE IMPLANTS AND TEST THE FLUID AROUND THE IMPLANTS WOMEN ARE DYING AND WE NEED THE FDAS HELP PLEASE|SILTEX SALINE FILLED MAMMARY PROSTHESIS||04/26/2017||||Y|I||0HP|FWM|2.0||PROSTHESIS, BREAST||L-FW7879 R-FW2756|||||MCGHAN/ALLERGAN|||||||True
6315895|67104048|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6315895|67104049|D|1||THERAPEUTIC GOODS ADMINISTRATION REPORTED CONFIRMED ALCL OF AN UNKNOWN SIDE EXPLANT SURGERY OCCURRED AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6574798|75415102|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMABÂ¿ BY BY L JOHNSON J ODONOGHUE H STARK N COLLIS A LENNARD M BUTTERWORTH N MCLEAN M YOUSSEF G GUI I LYBURN J BRISTOL J HURREN S SMITH R JACKLIN D CUNNINGHAM AND F MACNEILL PUBLISHED IN CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN THE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY SIMILAR TO A BRUISE A SEROMA OCCURS WHEN THE WATERY PORTION OF THE BLOOD COLLECTS AROUND A SURGICAL INCISION OR AROUND A BREAST IMPLANT AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6574798|75415103|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS STAGE I ALCL CASE OF PATIENT WITH UNILATERAL MASTECTOMY AND IMPLANT RECONSTRUCTION FOR BREAST CANCER REGARDING TREATMENT ABSTRACT STATES STAGE I CASES THAT PRESENTED WITH RECURRENT SEROMA WERE TREATED SUCCESSFULLY WITH IMPLANT REMOVAL AND TOTAL CAPSULECTOMY EVENT OF ALCL WILL BE CAPTURED AS LYMPHOMA AS THE NECESSARY HISTOLOGICAL MARKERS ARE NOT CONFIRMED MANUFACTURER OF DEVICE IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6574819|75418485|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMABÂ¿ BY BY L JOHNSON J ODONOGHUE H STARK N COLLIS A LENNARD M BUTTERWORTH N MCLEAN M YOUSSEF G GUI I LYBURN J BRISTOL J HURREN S SMITH R JACKLIN D CUNNINGHAM AND F MACNEILL PUBLISHED IN CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN THE LABELING THE OCCURRENCE OF LUMPS MASSES AND CYSTS CAN BE EXPECTED TO NATURALLY INCREASE AS PATIENTS AGE AND COULD BE AN EXPLANATION FOR THE INCREASE ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6574819|75418486|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE AND FIRST REPORTED CASE OF NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS Â¿PATIENTS PRESENTED WITH STAGE IIA DISEASE AND ONE PATIENT WITH PREVIOUS BBA FOLLOWING A ROUTINE IMPLANT EXCHANGE DEVELOPED A BIA-ALCL MASS AT THE DRAIN SITE PATIENT WAS TREATED WITH LOCAL EXCISION ADJUVANT CHOP AND RADIOTHERAPY PATIENT IS WELL AT FOUR YEARSÂ¿ EVENT OF ALCL WILL BE CAPTURED AS LYMPHOMA AS THE NECESSARY HISTOLOGICAL MARKERS ARE NOT CONFIRMED MANUFACTURER OF DEVICE IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6498283|72956470|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6498283|72956471|D|1||PATIENT LYMPHOMA ALCL OF AN UNKNOWN SIDE PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THEREFORE THE EVENT WILL BE CAPTURED AS LYMPHOMA MANUFACTURER OF DEVICE IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6498189|72956287|D|1||A B6 FEMALE WITH BREAST AUGMENTATION 1995 WITH MCGHAN 350CC TEXTURED SALINE BREAST IMPLANTS PT NOTED SWOLLEN RIGHT BREAST B6 2016 US GUIDED ASPIRATION OF FLUID SENT FOR PATH ALCL DX CONFIRMED B6 2016 SURGERY ON B6 2016 TO REMOVE IMPLANTS AND COMPLETE OPEN CAPSULECTOMIES PET CT DONE PRE-OPERATIVELY SHOWED NO DISSEMINATED DISEASE NO CHEMO OR RADIATION INDICATED PT DOING WELL THUS FAR WITH NO RETURN OF SYMPTOMS AND REMAINS DISEASE FREE|MCGHAN||04/16/2017||||Y|I||0HP|FWM|2.0||SALINE BREAST IMPLANTS||||||US|MCGHAN|||||||True
6498189|72956287|D|1||A B6 FEMALE WITH BREAST AUGMENTATION 1995 WITH MCGHAN 350CC TEXTURED SALINE BREAST IMPLANTS PT NOTED SWOLLEN RIGHT BREAST B6 2016 US GUIDED ASPIRATION OF FLUID SENT FOR PATH ALCL DX CONFIRMED B6 2016 SURGERY ON B6 2016 TO REMOVE IMPLANTS AND COMPLETE OPEN CAPSULECTOMIES PET CT DONE PRE-OPERATIVELY SHOWED NO DISSEMINATED DISEASE NO CHEMO OR RADIATION INDICATED PT DOING WELL THUS FAR WITH NO RETURN OF SYMPTOMS AND REMAINS DISEASE FREE|MCGHAN||04/16/2017||||Y|I||0HP|FWM|1.0||SALINE BREAST IMPLANTS||||||US|MCGHAN|||||||True
6352879|68133174|D|1||HEALTHCARE PROFESSIONAL REPORTED PATIENT HAS BEEN REFERRED FOR TREATMENT DUE TO Â¿CONFIRMED ALCLÂ¿ PATIENT HAS AN ALLERGAN IMPLANT NO ADDITIONAL INFORMATION PROVIDED AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/23/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6352879|68133173|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/23/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6275633|65693785|D|1||PT HAD MCGHAN 363LF SALINE FILLED IMPLANTS PLACED ON B6 2016 PRESENTED WITH LARGE RIGHT BREAST SEROMA ON B6 2016 ULTRASOUND GUIDED ASPIRATION OF SEROMA PERFORMED ON B6 2016 AFTER ULTRASOUND AND MRI SHOWED LARGE LOCULATED RIGHT BREAST FLUID COLLECTION ASPIRATED FLUID SHOWED CD30+ AND ALK1 - CELLS LEADING TO THE DIAGNOSIS OF ALCL SHE HAD BILATERAL CAPSULECTOMIES AND REMOVAL OF IMPLANTS ON B6 2017 PATHOLOGY DID NOT REVEAL ANY EXTENSION OF THE ALCL INTO THE CAPSULAR SHE IS CURRENTLY BEING WORKED UP BY OUR ONCOLOGISTS WERE AS WELL AS OUR GENETICISTS|MCGHAN 363 LF||01/23/2017||||*|*||I|FWM|2.0||SALINE FILLED BREAST IMPLANTS||1262358|||||MCGHAN|||||363LF-300||True
6275633|65693785|D|1||PT HAD MCGHAN 363LF SALINE FILLED IMPLANTS PLACED ON B6 2016 PRESENTED WITH LARGE RIGHT BREAST SEROMA ON B6 2016 ULTRASOUND GUIDED ASPIRATION OF SEROMA PERFORMED ON B6 2016 AFTER ULTRASOUND AND MRI SHOWED LARGE LOCULATED RIGHT BREAST FLUID COLLECTION ASPIRATED FLUID SHOWED CD30+ AND ALK1 - CELLS LEADING TO THE DIAGNOSIS OF ALCL SHE HAD BILATERAL CAPSULECTOMIES AND REMOVAL OF IMPLANTS ON B6 2017 PATHOLOGY DID NOT REVEAL ANY EXTENSION OF THE ALCL INTO THE CAPSULAR SHE IS CURRENTLY BEING WORKED UP BY OUR ONCOLOGISTS WERE AS WELL AS OUR GENETICISTS|MCGHAN 363 LF||01/23/2017||||Y|*||0HP|FWM|1.0||SALINE FILLED BREAST IMPLANTS||1157904|||||MCGHAN|||||363LF-300||True
6436022|70908687|D|1||I HAVE BREAST IMPLANTS SINCE 1993 IN 2016 I HAD A BREAST REDUCTION WITH OLD IMPLANTS REMOVED AND NEW IMPLANTS TO PUT IN I WAS DIAGNOSED WITH ALCL IN 2016 WENT THROUGH CHEMO THEN HAD A STEM CELL TRANSPLANT IN B6 2016|SX RND MPP GEL-FILLED MAMMORY PROSTH||03/24/2017||||Y|I||I|FTR|1.0||"GEL-FILLED BREAST IMPLANT: DEVICE 1 -2"""||265879|||||MENTOR|||||||True
6436022|70908687|D|1||I HAVE BREAST IMPLANTS SINCE 1993 IN 2016 I HAD A BREAST REDUCTION WITH OLD IMPLANTS REMOVED AND NEW IMPLANTS TO PUT IN I WAS DIAGNOSED WITH ALCL IN 2016 WENT THROUGH CHEMO THEN HAD A STEM CELL TRANSPLANT IN B6 2016|SX RND MPP GEL-FILLED MAMMORY PROSTH||03/24/2017||||Y|I||I|FTR|2.0||"GEL-FILLED BREAST IMPLANT: DEVICE 1 -2"""||265879|||||MENTOR|||||||True
1888850|1687082|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF SEROMA AND ANAPLASTIC LARGE CELL LYMPHOMA ALCL FU FINDINGS PT HAS TEXTURED SALINE BREAST IMPLANT MFR UNK ALLERGAN TAKES THE CONSERVATIVE APPROACH TO REPORTING FU FINDINGS PT HAD WELL CARE APPOINTMENT TWO MONTHS AFTER MULTIPLE BIOPSIES TWO DAYS LATER DEVELOPED BREAST SWELLING PT THEN HAD A GENERAL SURGERY CONSULTATION AND EVAL WITH THREE PERCUTANEOUS DRAINAGE PROCEDURES AND BIOPSIES DIAGNOSIS OF ALCL MADE PRIMARY VS SECONDARY BREAST ALCL UNCLEAR BUT STAGE IV AT DIAGNOSIS MULTI-AGENT CHEMOTHERAPY PROVIDED REFRACTORY TO CHEMOTHERAPY MEDIASTINAL LYMPH NODES IDENTIFIED BY CT SCAN FU FINDINGS PT HAD SUPRA CLAVICULAR AND AXILLARY NODES IN ADDITION TO PRESENTING WITH SWOLLEN BREAST LIVER CHEST WALL MEDIASTINAL LYMPHADENOPATHY RIGHT PLEURAL EFFUSION LUNG NODULES ABDOMINAL WALL RETROPERITONEAL LYMPH NODES FINDINGS INVESTIGATION CONTINUES|UNKNOWN SALINE IMPLANT|UNK SALINE IMPLANT|10/19/2010|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
1735704|1340867|D|1||HEALTHCARE PROFESSIONAL REPORTS A DIAGNOSED CASE OF ALCL AND THE DEATH OF THIS PATIENT|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/23/2010|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2392146|2455460|D|1||RECEIVED PRODUCT FIELD NOTES PFN VIA E-MAIL FROM ALLERGAN B4 REPORTING ALCL THE SURGEON COULD NOT PROVIDE MUCH INFO AT THE TIME OF THIS REPORT ON B6 2011 PT PRESENTED WITH PAIN AND SWELLING TO RIGHT BREAST EFFUSION SERUM PRESENTED ON ULTRA SOUND ASPIRATION CYSTOLOGY SHOWED ALCL AUGMENTATION ON B6 2006 WITH SILICON IMPLANTS SUBMUSCULAR PLACEMENT REMOVAL OF CAPSULE AND IMPLANTS ON B6 2011 PATHOLOGY AND CYTOLOGY ARE STILL PENDING AN ONGOING INVESTIGATION IS BEING CARRIED OUT ANY ADDITIONAL INFO REGARDING THESE EVENTS WILL BE UPDATED IN THIS FILE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120401|12/21/2011|||DA|N|R||0HP|FTR|1.0|05/30/2010|nan||413555|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2112878|2143713|D|1||ALCL CASE REPORT B6 FEMALE B6 ALCL DIAGNOSIS DATE OF DIAGNOSIS - B6 2011 ANATOMIC SITE OF ALCL LEFT BREAST IMPLANT CAPSULE PRIMARY SITE CONFIRMED BY PATHOLOGY INITIAL CLINICAL PRESENTATION B6 2010 THIS IS B6 FEMALE WITH A HISTORY OF DUCTAL CARCINOMA IN SITU OF THE LEFT BREAST DIAGNOSED IN 1998 SHE SUBSEQUENTLY UNDERWENT A LEFT MASTECTOMY WHERE THE SPECIMEN WEIGHT WAS 596 GRAMS SHE UNDERWENT IMMEDIATE RECONSTRUCTION WITH PLACEMENT OF SUBMUSCULAR TISSUE EXPANDER BY PLASTIC SURGEON 1 THE TISSUE EXPANDER WAS PLACED COMPLETELY SUBPECTORAL AND ALSO IN A SUBSERRATUS POCKET THE EXPANDER WAS REMOVED IN 1999 AND REPLACED WITH A MCGHAN 440 ML DUAL-CHAMBER SILICONE AND SALINE-FILLED IMPLANT SHE RECEIVED NO POSTOPERATIVE CHEMOTHERAPY OR RADIATION THERAPY WITHIN A YEAR SHE DEVELOPED SIGNIFICANT HARDENING AND DISTORTION OF THE LEFT RECONSTRUCTED BREAST WITH GRADUAL ELEVATION OF THE IMPLANT TIGHTENING OF THE TISSUE AROUND THE IMPLANT AND DISCOMFORT IN THE LEFT CHEST WALL SHE WAS SEEN IN EVALUATION IN 2006 BY PLASTIC SURGEON 2 WHO RE-OPERATED ON HER LEFT BREAST AND REMOVED THE EXISTING IMPLANT PERFORMED PERIPROSTHETIC CAPSULOTOMIES WHICH WERE NOT SPECIFIED IN THE OPERATIVE NOTE SUBMITTED CAPSULAR TISSUE FOR HISTOLOGIC EXAMINATION INTERPRETED AS NEGATIVE AND REPLACED A SMALLER SALINE IMPLANT THIS WAS AN ALLERGAN-STYLE 68MP SALINE IMPLANT SIZE 390-420 ML THIS RECONSTRUCTION WAS SOFT FOR SEVERAL MONTHS BUT WITHIN 1 YEAR SHE HAD RECURRENCE OF THE CAPSULAR CONTRACTURE WITH TIGHTENING OF THE TISSUE AROUND THE IMPLANT GRADUAL ELEVATION OF THE IMPLANT LOCATION AND DISCOMFORT IN THE LEFT CHEST WALL SHE WAS SEEN IN EVALUATION IN 2009 BY PLASTIC SURGEON 4 WHO RECOMMENDED THAT SHE CONSIDER REVISION OF HER RECONSTRUCTION WITH THE ADDITION OF AN CELLULAR DERMAL MATRIX TO REDUCE THE POTENTIAL FOR RECURRENCE OF HER CAPSULAR CONTRACTURE AROUND THE DEVICE PLASTIC SURGEON 4 ALSO RECOMMENDED AUTOLOGOUS ABDOMINAL FLAP RECONSTRUCTION PROCEDURES THE PT WAS INTERESTED IN CONSIDERING A DIEP FLAP AND PLASTIC SURGEON 4 REFERRED HER TO ME B6 SURGEON 5 FOR EVALUATION AND CONSIDERATION OF A FREE FLAP BREAST RECONSTRUCTION PROCEDURE THE PTS PAST MEDICAL HISTORY WAS ADDITIONALLY SIGNIFICANT FOR A HISTORY OF HYPOTHYROIDISM AND BLADDER PROLAPSE HER MEDICATIONS INCLUDED SYNTHROID 88 MCG DAILY VITAMIN D AND ADVIL SHE IS A NONSMOKER AND DRINKS ALCOHOL RARELY INITIAL PHYSICAL EXAMINATION B6 2010 SHOWED THE PT WAS 155 CM TALL 703 KG THE LEFT BREAST WAS ABSENT THROUGH A TRANSVERSE STEWART-TYPE MASTECTOMY INCISION THERE WAS AN IMPLANT PRESENT IN THE SUBPECTORAL POSITION ON THE LEFT SIDE THERE WAS A BAKER GRADE IV CAPSULE CONTRACTURE AROUND THIS DEVICE WHICH WAS RIGIDLY AFFIXED TO HER CHEST WALL AND SOMEWHAT TENDER TO MANIPULATION THE WOUNDS WERE WELL HEALED WITH NO EVIDENCE OF SCAR HYPERTROPHY THE RIGHT BREAST WAS MORE PTOTIC WITH A DEGREE OF PSEUDOPTOSIS LATERAL BOTTOMING OUT AND A WISE-PATTERN SCAR FROM PREVIOUS MASTOPEXY - RESULTING IN SUBSTANTIAL SHAPE AND VOLUME ASYMMETRY ON THE LEFT SIDE THE STERNAL NOTCH TO INFRAMAMMARY FOLD DISTANCE WAS 20 CM ON THE RIGHT SIDE THE STERNAL NOTCH TO INFRAMAMMARY FOLD DISTANCE WAS 23 CM THE MID-CLAVICULAR POINT TO NIPPLE DISTANCE ON THE RIGHT WAS 21 CM EXAMINATION OF THE ABDOMEN SHOWED A GENEROUS AMOUNT OF TISSUE IN THE LOWER 13 OF THE ABDOMEN FOR ABDOMINAL FLAP CONSIDERATION INITIAL IMPRESSION B6 2010 THIS WAS A B6 FEMALE WITH RECURRENT CAPSULAR CONTRACTURE FOLLOWING 2 PREVIOUS IMPLANT-BASED RECONSTRUCTION SURGERIES ON THE LEFT SIDE THE LEFT BREAST RECONSTRUCTION SHOWED ELEVATION OF THE INFRAMAMMARY FOLD AND A SEVERE CAPSULAR CONTRACTURE AROUND THE EXISTING IMPLANT I RECOMMENDED REMOVAL OF THE EXISTING LEFT BREAST IMPLANT RECONSTRUCTION OF THE ORIGINS OF THE LEFT PECTORALIS MAJOR MUSCLE AND RECONSTRUCTION OF THE LEFT BREAST WITH A FREE ABDOMINAL FLAP OPERATIVE FINDINGS ON B6 2011 THE LEFT BREAST IMPLANT CAPSULE WAS OPENED AND CONTAINED A CLOUDY YELLOW FLUID UNDER ENORMOUS PRESSURE THE FLUID SQUIRTED OUT OF THE CAPSULAR INCISION AND TRAVELED AT LEAST 56 INCHES THERE WAS A COLLECTION OF GELATINOUS MATERIAL WITHIN THE CAPSULE AS WELL AS AN INTACT SALINE BREAST IMPLANT THE CAPSULE WAS THICKENED AND COVERED WITH PLAQUE-LIKE LESIONS INTERNALLY A TOTAL CAPSULECTOMY WAS PERFORMED THE PECTORALIS MAJOR MUSCLE WAS REATTACHED TO ITS 5TH RIB ORIGINS THE PERIPROSTHETIC FLUID WAS CAPTURED AND ALL MATERIAL WAS SENT FOR PATHOLOGIC AND CYTOLOGIC EVALUATION INCLUDING FROZEN SECTION WHICH WAS CONSISTENT WITH A DIAGNOSIS OF ALCL THE REMAINING RECONSTRUCTION WAS ABANDONED PENDING FINAL PATHOLOGY EVALUATION SPECIMEN DETAILED PATHOLOGY FINDINGS LEFT BREAST PERI-PROSTHETIC MATERIAL LARGE ATYPICAL CELLS PRESENT MOST CONSISTENT WITH INVOLVEMENT BY ANAPLASTIC LARGE CELL LYMPHOMA IMPLANT LEFT BREAST IMPLANT CAPSULE INVOLVEMENT BY ANAPLASTIC LARGE CELL LYMPHOMA B6|MODERATE PROFILE SMOOTH ROUND SALINE BREAST IMPLANT||05/27/2011||||Y|||0HP|FWM|1.0||68MP 390CC||1316501|||||MCGHAN MEDICAL - AKA ALLERGAN MEDICAL|||||68MP 390CC||True
2097844|18413658|D|1||COMPANY SALES REPRESENTATIVE REPORTED ANAPLASTIC LARGE CELL LYMPHOMA ALCL IN RIGHT BREAST CONFIRMED BY HEALTH PROFESSIONAL CYTOLOGY CONFIRMED DIAGNOSIS CD30 POSITIVE ALK NEGATIVE PATIENT HAS A HISTORY OF LEFT SIDE BREAST CANCER THE PATIENT PRESENTED WITH SEROMA ONLY NO SYSTEMIC SYMPTOMS|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|05/04/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210614|15512186|D|1||RECEIVED AN ABSTRACT ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA OF THE BREAST OCCURRING IN PTS WITH SILICONE BREAST IMPLANTS WILL BE PUBLISHED IN THE FINAL ARTICLE ENTITLED LEUKEMIA AND LYMPHOMA AUG 20115281481-1487 WITHIN THE ARTICLE THIS PT IS IDENTIFIED AS PT 6 SHE IS A COSMETIC AUGMENTATION PT WHO WAS FOUND TO HAVE A NODULE IN THE INFRAMAMMARY FOLD OF THE LEFT BREAST WHICH GREW OVER SEVERAL MONTHS BUT WAS NEGATIVE BY MAMMOGRAM SHE HAD HER LEFT IMPLANT REMOVED AND THE TISSUE IN THE FIBROUS CAPSULE WAS DIAGNOSED AS ALCL THE PT WAS TREATED WITH 6 CYCLES OF CHOP BUT EXPERIENCED TUMOR REGROWTH WITHIN 2 WEEKS OF COMPLETION ICE SALVAGE WAS GIVEN WITH RADIATION BUT WAS INEFFECTIVE FINALLY SHE RECEIVED AN AUTOLOGUS TRANSPLANT USING CBV CYCLOPHOSPHAMIDE CARMUSTINE AND ETOPOSIDE CONDITIONING REGIMEN AND HAD BEEN IN REMISSION FOR 75 YEARS AT LAST FU THIS MW IS FOR THE LEFT SIDE REFER TO MFR REPORT 2024601-2011-00674 FOR THE RIGHT SIDE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
1821178|1710428|D|1||A B6 YEAR OLD WOMAN DIAGNOSED WITH ALCL IN THE RIGHT BREAST IN 2008 HER HISTORY IS REPORTED BY DR B6 IN 2002 SHE HAD A RIGHT BREAST ADENOCARCINOMA RECONSTRUCTED WITH BILATERAL MCGHAN SALINE IMPLANTS IN 2007 SHE UNDERWENT BILATERAL CAPSULECTOMIES AND HER IMPLANTS WERE REPLACED WITH MENTOR SMOOTH GEL STYLE 350-5504BC IN 2008 SHE AGAIN UNDERWENT A CAPSULECTOMY ON THE RIGHT AND THAT IMPLANT WAS REPLACED WITH A MENTOR 550CC HIGH PROFILE IMPLANT REF 350-5504BC SERIAL B4 LOT 5765778 UPON DIAGNOSIS OF HER ALCL SHE WAS TREATED WITH EXPLANTATION CHEMOTHERAPY AND RADIOTHERAPY AND WAS SEEN OUT SOCIALLY EARLIER THIS YEAR BY DR B6|MENTOR|350-5504BC|08/25/2010||||N|R||0HP|FTR|1.0||GEL-FILLED MAMMARY PROSTHESIS||5765778|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR WORLDWIDE LLC|75038|TX|75038||||True
2230846|19185696|D|1||ON B61988 PT WAS SEEN BY HEALTHCARE PROFESSIONAL AND WAS DIAGNOSED WITH RIGHT BREAST CANCER AND DECIDED TO HAVE A BILATERAL MASTECTOMY ON B6 1988 MCGHAN TE WERE PLACED 30-35650 WERE PLACED BILATERALLY ON B61989 MCGHAN SILICONE BREAST STYLE 120-600CC IMPLANTS WERE PLACED BILATERALLY USING SERIAL NUMBER B4 AND B4 ON B61989 THE PT WAS SEEN FOR NIPPLE RECONSTRUCTION ON B6 2005 THE PT WAS SEEN BY A DIFFERENT HEALTHCARE PROFESSIONAL FOR A REVISION SURGERY DUE TO ASYMMETRY IT WOULD APPEAR THAT THESE WERE REMOVED DUE TO A POSSIBLE CAPSULAR CONTRACTURE DURING SURGERY THE DEVICES WERE FOUND TO BE INTACT ON B6 2005 SHE THEN HAD REVISION SURGERY AND REPLACES WITH MENTOR DEVICES B4 ON THE LEFT AND B4 ON THE RIGHT SILTEX GEL IMPLANTS THE POST-OP COURSE HAD BEEN UNREMARKABLE UNTIL B6 2007 WHEN THE PT PRESENTS WITH A POSSIBLE LEAK ON THE LEFT SIDE LEFT SIDE LOOKED LARGER THAN THE RIGHT SHE STATES THERE WAS NO HISTORY OF TRAUMA IT WAS A POSSIBLE SEROMA IT WAS SUGGESTED THAT THE PT BE TAKEN TO SURGERY ON B6 2007 THE PT WAS TAKEN TO SURGERY FOR AN EXPLORATION OF THE LEFT BREAST DRAINAGE OF THE SEROMA AND A PARTIAL CAPSULECTOMY ONCE THE INCISION WAS MADE 600CC OF SEROUS FLUID WAS REMOVED THE IMPLANT WAS ALSO REMOVED AND WAS FOUND TO BE INTACT THERE WAS FIBROUS MATERIAL OVER IT BUT INTACT ON B6 2007 THE DIAGNOSIS OF ALCL WAS MADE|25-00501|25-00501|08/22/2011|||DA|N|R||0HP|FWM|1.0||nan||9-107475|||GOLETA|US|ALLERGAN||CA|||||True
2348478|15756117|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF ALCL AND RIGHT CHEST WALL MASS VIA VOLUNTARY MW B4 HEALTHCARE PROFESSIONAL REPORTS THE PT WAS IMPLANTED B6 1994 FOR A BILATERAL AUGMENTATION THE PT PRESENTED TO THE OFFICE ON B6 2011 WITH RIGHT BREAST ENLARGEMENT AND CHEST MALL MASS A BIOPSY OF MASS WAS CARRIED OUT THERE WAS NO CAPSULAR CONTRACTURE NOTED AT THE TIME OF THE BIOPSY THE DIAGNOSIS OF ALCL WAS MADE THE PT RETURNED FOR EXPLANATION OF THE DEVICE ON B6 2011 IT WAS AT THIS TIME SEROMA WAS ENCOUNTERED THE SEROMA WAS SENT FOR CYTOLOGICAL EVAL A PET SCAN WAS ALSO CARRIED OUT WHICH REVEALED AN ABDOMINAL WALL MASS AND TWO AXILLARY NODES THE PT HAS BEGUN CHOP THERAPY AS OF B6 2011|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|09/30/2011|||DA|N|R||0HP|FWM|1.0|07/01/1998|nan||2-514321|||GOLETA|US|ALLERGAN||CA|||||True
2029741|1917664|D|1||ALCL CASE REPORT A B6 TEXTURED SILICONE BREAST IMPLANTS IMPLANTED 12 YEARS AGO DEVELOPED LEFT BREAST SWELLING ABOUT 2 YEARS AGO THAT WAS DRAINED PT WAS DOING WELL UNTIL ABOUT TWO MONTHS AGO WHEN SHE AGAIN NOTED SWELLING OF LEFT BREAST SUBSEQUENTLY DRAINED AND SENT FOR PATHOLOGY NO OTHER SYMPTOMS|TEXTURED SALINE BREAST IMPLANTS||03/21/2011||||N|||0|FWM|1.0||NONE|||||||nan|||||||True
2097862|20792559|D|1||HEALTHCARE PROFESSIONAL REPORTS TO MEDICAL AFFAIRS A CASE OF POSSIBLE LYMPHOMA A CALL WAS PLACED TO THE HEALTHCARE PROVIDER WHO WAS ABLE TO PROVIDE THE FOLLOWING INFORMATION THE PATHOLOGY SPECIMEN WAS NOT SENT IN THE PATIENT IS ALLEGEDLY POSITIVE FOR ALCL THE STATUS ON THE CYTOLOGY IS UNKNOWN AN ONGOING INVESTIGATION IS BEING CARRIED OUT ANY ADDITIONAL INFORMATION REGARDING THESE EVENTS WILL BE UPDATED IN THIS FILE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/04/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210613|2193837|D|1||ABSTRACT RECEIVED ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA OF THE BREAST OCCURRING IN PTS WITH SILICONE BREAST IMPLANTS WAS REPORTED AND WILL BE PUBLISHED IN THE FINAL ARTICLE ENTITLED LEUKEMIA AND LYMPHOMA AUG 20115281481-1487 WITHIN THE ARTICLE THIS PT IS IDENTIFIED AS PT 1 IT INDICATES THAT SHE IS A COSMETIC AUGMENTATION WHO ORIGINALLY PRESENTED WITH SWELLING OF THE LEFT BREAST AFTER DRAINAGE OF THE FLUID THE FLUID SHOWED LARGE AMOUNTS OF ATYPICAL LYMPHOCYTES THE FLUID ACCUMULATION DID NOT RECUR FOR 2 YEARS AT WHICH TIME SHE EXPERIENCED RAPID SWELLING OF THE LEFT BREAST THE WORK-UP YIELDED A DIAGNOSIS OF ALCL ALK- THE PT PRESENTED TO CITY OF HOPE FOR A SECOND OPINION CHOP WAS RECOMMENDED BUT TREATMENT WAS CARRIED OUT ELSEWHERE AND OUTCOME IS UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2027271|1955552|D|1||A B6 FEMALE DIAGNOSED WITH BREAST-IMPLANT RELATED ANAPLASTIC LARGE CELL LYMPHOMA PT HAD BILATERAL MASTECTOMIES WITH SALINE IMPLANT RECONSTRUCTION IN 1992 DEVELOPED LEFT SIDED IDIOPATHIC LARGE VOLUME SEROMA IN 2009 IMPLANTS REMOVED AND PARTIAL CAPSULECTOMY PERFORMED BY A DIFFERENT PLASTIC SURGEON NO REPLACEMENT OF IMPLANTS AT THAT TIME PATHOLOGY REPORTS NEGATIVE AT THAT TIME RECURRENT SEROMA FOLLOWING EXPLANTATION REQUIRING REPEAT CAPSULECTOMY AND DRAIN PLACEMENT B6 2010 AGAIN NEGATIVE PATHOLOGY REPORT PT PRESENTED FOR DELAYED TWO-STAGE RECONSTRUCTION IN MY PRACTICE PERFORMED ON B6 2011 LEFT BREAST SEROMA SMALL AND CAPSULE IDENTIFIED COMPLETELY REMOVED PATHOLOGY REPORTS CONFIRMED ALCL OF THE LEFT BREAST CAPSULE ALK-1 NEGATIVE SALINE BREAST IMPLANT UNKNOWN MANUFACTURER NOT SURE IF IT WAS TEXTURED OR SMOOTH PT DOES NOT HAVE RECORDS AND SURGEON WHO REMOVED THE IMPLANTS DOES NOT RECALL OTHER THAN THEY WERE SALINE PATHOLOGY REPORT DOES NOT INDICATE TEXTURED VS SMOOTH|UNK||03/17/2011||||N|||0|FWM|1.0||SALINE BREAST IMPLANT||UNK|||||UNK|||||||True
1976504|1728474|D|1||A B6 FEMALE PRESENTS WITH PERICAPSULAR INFECTION AROUND MCGHAN STYLE 68 TEXTURED SALINE IMPLANTS INSERTED IN THE MID 1990S POST REMOVAL OF IMPLANTS PT WAS FOUND TO HAVE ALCL IN THE RIGHT BREAST CAPSULE PT UNDERWENT COMPLETE BILATERAL CAPSULECTOMIES ON B6 2010 POST OPERATIVE PET SCAN NEGATIVE FOR LYMPHOMA CAPSULE AND FLUID SENT TO B6 ADDITIONAL MATERIAL HELD AT B6 DATES OF USE 1 AND 2 - B6 1993 - B6 2010 DIAGNOSIS OR REASON FOR USE HYPOMASTIA RIGHT  LEFT BREASTS|MCGHAN TEXTURED SALINE IMPLANTS||01/26/2011||||N|||0HP|FWM|1.0||SAME 800 CC SALINE IMPLANTS||GA9039|||||MCGHAN|||||||True
1976504|1728474|D|1||A B6 FEMALE PRESENTS WITH PERICAPSULAR INFECTION AROUND MCGHAN STYLE 68 TEXTURED SALINE IMPLANTS INSERTED IN THE MID 1990S POST REMOVAL OF IMPLANTS PT WAS FOUND TO HAVE ALCL IN THE RIGHT BREAST CAPSULE PT UNDERWENT COMPLETE BILATERAL CAPSULECTOMIES ON B6 2010 POST OPERATIVE PET SCAN NEGATIVE FOR LYMPHOMA CAPSULE AND FLUID SENT TO B6 ADDITIONAL MATERIAL HELD AT B6 DATES OF USE 1 AND 2 - B6 1993 - B6 2010 DIAGNOSIS OR REASON FOR USE HYPOMASTIA RIGHT  LEFT BREASTS|MCGHAN TEXTURED SALINE IMPLANTS||01/26/2011||||N|||0HP|FWM|2.0||SAME 800CC SALINE IMPLANTS||GB6620|||||MCGHAN|||||||True
2348477|18501906|D|1||HEALTHCARE PROFESSIONAL REPORTS VIA VOLUNTARY MW B4 A CASE OF ALCL INFECTION PAIN AND BREAST ENLARGEMENT THE HEALTH PROFESSIONAL REPORTS WHITE FEMALE PRESENTED TO MY OFFICE IN 2010 WITH AN INFECTED RIGHT BREAST IMPLANT SHE HAD PREVIOUS SILICONE BREAST IMPLANTS 17 YRS PRIOR TO A LITTLE OVER A YR OF SYMPTOMS INCLUDING PAIN ENLARGEMENT AND MORE RECENTLY REDNESS THERE WAS A FAILED COURSE OF ANTIBIOTIC THERAPY AT THE TIME OF HER PRESENTATION SHE ALSO HAD EPIDERMOLYSIS OF HER HANDS FEET AND PERIAREOLAR REGION EXAM WAS CONSISTENT WITH AN INFECTED BREAST IMPLANT THEREFORE THE IMPLANT WAS REMOVED IN THE OFFICE UNDER LOCAL ANESTHESIAS HER EPIDERMOLYSIS EVENTUALLY CLEARED AND THE INFECTION IMPROVED HOWEVER SHE DEVELOPED AN INFLAMMATORY ABSCESS IN THE INFRAMAMMARY PORTION OF THE RIGHT BREAST THAT REQUIRED OPERATIVE EXCISION AND DEBRIDEMENT UNDER ANESTHESIA THE TISSUE THAT WAS REMOVED AND SENT TO THE LABORATORY CAME BACK ANAPLASTIC LARGE CELL LYMPHOMA THE PT HAD A CONSULT FOR TREATMENT AND RECEIVED CHEMOTHERAPY SHE REQUESTED REMOVAL OF THE LEFT BREAST IMPLANT AS WELL WHICH WAS UNEVENTFUL BUT FOUND TO BE RUPTURED UPON REMOVAL THE PRODUCT WAS RETAINED AND IS AVAILABLE FOR EXAMINATION THE PT CONTINUED TO BE UNDER MY CARE AT THIS TIME|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/30/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2348477|62765167|D|1||HEALTHCARE PROFESSIONAL REPORTED A CASE OF ANAPLASTIC LARGE CELL LYMPHOMA WHICH WILL BE CAPTURED AS LYMPHOMA AS THERE IS NO PATHOLOGY REPORT AVAILABLE TO CONFIRM THE DIAGNOSIS OF ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/30/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2100509|21426777|D|1||PT REPORTED ON VOLUNTARY MW FORM THAT IN 2010 SHE WAS DIAGNOSED WITH ALCL ALK NEGATIVE POSSIBLY RELATED OR CAUSED BY BREAST IMPLANTS RECEIVED IN 2002 FOR AUGMENTATION LEFT BREAST CAPSULAR CONTRACTURE WAS NOTED PT HAD LEFT IMPLANT REPLACED IN 2008 STILL EXPERIENCING CAPSULAR CONTRACTURE AFTER REPLACEMENT IN 2010 A NEEDLE BIOPSY WAS PERFORMED AND THE DIAGNOSIS LYMPHOMA WAS MADE ALSO IN 2010 SURGICAL BIOPSY WAS PERFORMED AND A DIAGNOSIS OF ALCL WAS MADE THE PT IS PREPARING FOR STEM-CELL TRANSPLANT SCHEDULED IN 2011 WITHIN THE VOLUNTARY FORM THE IMPLANTING NOR EXPLANTING SURGEON INFO WAS NOT GIVEN AND THERE IS NO FURTHER INFO TO BE GATHERED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-380|05/16/2011|||DA|N|R||0HP|FWM|1.0|07/12/2006|nan||579142|||GOLETA|US|ALLERGAN||CA|||||True
2251798|20956603|D|1||PATIENT REPORTS VIA EMAIL A CASE OF LYMPHOMA SHE REPORTS THAT SHE IS AN AUGMENTATION PATIENT AND WAS IMPLANTED IN 2007 SHE STATES THAT SHE NOTICED HER IMPLANT GETTING HARD AND WENT TO SEE THE DOCTOR ON B6 2011 THE SURGEON CALLS IN TO PROVIDE ADDITIONAL INFORMATION ON THIS PATIENT HE PRESENTS HER HISTORY AS A RECONSTRUCTION PATIENT SHE WAS DIAGNOSED WITH RIGHT BREAST CANCER PRIOR TO IMPLANTATION RECONSTRUCTION SURGERY TOOK PLACE ON B6 2007 WITH THE LEFT SIDE BEING DONE FOR PROPHYLACTIC PURPOSES ON B6 2011 THE PRESENTED WITH CAPSULAR CONTRACTURE BAKER GRADE IV OF THE RIGHT BREAST AND WAS EXPLANTED THE DIAGNOSIS OF ALCL WAS MADE FROM THE RIGHT BREAST CAPSULE SAMPLE FROM THE B6 2011 SURGERY THE PATIENT IS SCHEDULED TO HAVE THE DEVICES REMOVED BILATERALLY B6 2011|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 115|09/13/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2341596|2363207|D|1||PT HAD BILATERAL SALINE BREAST IMPLANTS PLACED 10 YRS AGO IN B6 NOTED RIGHT BREAST SWELLING MAMMOGRAM SHOWED FLUID PT WAS NOT INFORMED PT CAME TO SEE ME THAT IS THE DATE OF THE EVENT I SENT HER FOR ULTRASOUND GUIDED ASPIRATION THE 200 CC SEROUS FLUID REMOVED CYTOLOGY CONFIRMS ALCL SHE HAS SINCE BEEN REFERRED TO EMORY FOR WORK UP ANTICIPATE REMOVAL OF IMPLANTS AND CAPSULES WHEN WORKUP BONE MARROW PET SCAN COMPLETED|UNKNOWN||11/10/2011||||N|||0|FWM|1.0||TEXTURED SALINE IMPLANTS. DO NOT KNOWN IF SILICONE||UNKNOWN|UNKNOWN||UNKNOWN||UNKNOWN|||||||True
2003941|1715828|D|1||ALCL CASE REPORT THE PT HAD BREAST AUGMENTATION IN B6 2001 THE PT PRESENTED WITH A 4 CM MASS IN THE 6 OCLOCK POSTERIOR POSITION IN THE LEFT BREAST ON B6 2003 THE PATHOLOGY WAS REVIEWED AS A CD30 POSITIVE T-CELL ALCL ALK NEGATIVE THE PT HAD LEFT BREAST IMPLANT REMOVED IN B6 2003 INITIAL THERAPY WAS CHOP BEGINNING IN B6 2003 AFTER AN INITIAL RESPONSE SHE PROGRESSED AFTER 3 CYCLES THE PT WAS THEN GIVEN DHAP THE LAST WEEK IN B6 2003 WITH A RESPONSE IMMEDIATELY AFTER DHAP SHE DEVELOPED AN INFECTIONABSCESS IN THE LEFT BREAST THE PT THEN HAD A LEFT TOTAL MASTECTOMY B6 2004 SHE EVENTUALLY COMPLETED 2 COURSES OF DHAP BY B6 2004 FOLLOWING PROGRESSION THE PT RECEIVED HYPER CVAD FOR ONE COURSE AT THE END OF B6 WITH PROGRESSION IN B6 2004 THE PT THEN STARTED AN INVESTIGATIONAL THERAPY WITH SGN 30 FOR WHICH SHE ACHIEVED A COMPLETE REMISSION WHICH HAS BEEN SUSTAINED AT THIS TIME THOUGH SHE DID HAVE XRT TO HER LEFT CHEST WALL IN B6 2004 AS A PREVENTATIVE METHOD|UNKNOWN||02/23/2011|||||||0|FTR|1.0||UNKNOWN||UNK|UNK||UNK||UNK|||||||True
1985458|1846143|D|1||ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA AFTER BREAST IMPLANTS FOR RECONSTRUCTION FROM BREAST CANCER DATES OF USE B6 2007 DIAGNOSIS OR REASON FOR USE REPLACING SALINE IMPLANTS 1 RUPTURE MENTOR SILICONE BREAST IMPLANTS PUT IN ON B6 2007 RIGHT BREAST REMOVED ON B6 2008 REPLACED SAME DAY WITH MENTOR SILICONE IMPLANT REMOVED BOTH ON B6 2008 VIA RADICAL MASTECTOMY FOUR WRONG DIAGNOSES OF BREAST CANCER MADE 9 WEEKS AFTER MASTECTOMY ALCL DIAGNOSIS MADE TREATED WITH VERY HIGH DOSING CHEMO SEVERAL KINDS STEM CELL TRANSPLANT ADDL CHEMO AND RADIATION EVENT ABATED AFTER USE NO EVENT REAPPEARED AFTER REINTRODUCTION YES|MENTOR||02/07/2011||||N|||0HP|FTR|1.0||SILICONE BREAST IMPLANTS|||||||MENTOR|||||||True
2111241|17147643|D|1||THE PT PRESENTED WITH A LEFT SEROMA AFTER PRESENTING TO THE EMERGENCY ROOM FOR WHAT WAS THOUGHT TO BE A DEFLATION A CALL WAS PLACED TO THE SURGEON OFFICE AND AFTER SPEAKING TO THE OFFICE STAFF SHE CONFIRMS A DIAGNOSIS OF ALCL THE PTS MED RECORDS WERE REQUESTED AND REVIEWED THE ACTUAL CYTOLOGY REPORT HOWEVER WAS NOT INCLUDED IN THE NOTES RECD THE PT HAS BEEN EXPLANTED BILATERALLY WITHOUT REPLACEMENT AND HAS SEEN AN ONCOLOGIST THERE IS NO PLAN FOR CHEMOTHERAPY AT THIS TIME THE TISSUE HAS BEEN SENT FOR FURTHER EVAL AND FINAL RESULTS ARE PENDING|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|05/16/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2119773|2014999|D|1||I HAD BILATERAL SILICONE BREAST IMPLANTS IMPLANTED IN B6 1990 I DEVELOPED SWELLING AND REDNESS OF THE RIGHT BREAST IN 2002 FOLLOWED BY ENLARGED LYMPH NODES AND SKIN NODULES I WAS DIAGNOSED WITH NODULAR SCLEROSING HODGKINS OF THE RIGHT AXILLA WHICH SPREAD TO THE SKIN SIX MONTHS LATER THIS WAS TREATED WITH CHEMO AND RADIATION HOWEVER TWO MONTHS LATER IT RECURRED I WAS TREATED WITH A STEM CELL TRANSPLANT AND WITHIN 60 DAYS DEVELOPED A 7 CM TUMOR OF THE CHEST WALL SURROUNDING THE RIGHT BREAST IMPLANT AND ENLARGED ANTERIOR MAXILLARY LYMPH NODES THIS WAS DIAGNOSED AS A RECURRENCE AND TREATED WITH MORE RADIATION FOUR MONTHS LATER I DEVELOPED MULTIPLE PAINFUL BLISTERING LESIONS OF THE RIGHT BREAST THESE WERE BIOPSIED AND DIAGNOSED AS ALCL THE ONCOLOGIST AND PATHOLOGIST SAID THERE WAS A STRONG POSSIBILITY THAT THE PREVIOUS DIAGNOSIS OF HODGKINS DISEASE WAS INCORRECT AND INDEED I COULD HAVE HAD SYSTEMIC ALCL ALL ALONG AFTER READING ABOUT THE ASSOCIATION BETWEEN ALCL AND BREAST IMPLANTS I WANT TO MAKE SURE THAT MY CASE IS INCLUDED FOR RESEARCH PURPOSES THERE WAS NO CORRELATION BETWEEN THE IMPLANT AND THE DISEASE AT THE TIME SO I DID NOT HAVE IT REMOVED UNTIL 2008 REASON FOR USE AESTHETIC|MCGHAN TEXTURED||06/03/2011||||N|||0LP|FTR|1.0||SILICONE BREAST IMPLANT|||||||MCGHAN|||||||True
2348522|61100522|D|1||HEALTHCARE PROFESSIONAL REPORTED VIA MEDWATCH LEFT SIDE GRADUAL ELEVATION OF THE IMPLANT LOCATION ADDITIONAL INFORMATION NOTED AS LEFT SIDE DEVICE RIGIDLY AFFIXED TO PATIENTS CHEST WALL NO PATHOLOGY REPORT PROVIDED TO CONFIRM THE DIAGNOSIS OF ALCL THEREFORE THE EVENT WILL BE CAPTURED AS LYMPHOMA|STYLE 68 SALINE FILLED BREAST IMPLANT|68-390|09/30/2011|||DA|N|R||0HP|FWM|1.0|07/30/2010|nan||1316501|||GOLETA|US|ALLERGAN||CA|||||True
2348522|2273259|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF ALCL AND RECURRENT CAPSULAR CONTRACTURE ON VIA VOLUNTARY MW B4 WITHIN THE REPORT THE SURGEON REPORTS THAT THE PT HAS A HISTORY OF LEFT SIDE BREAST CANCER DCIS WITH A LEFT SIDE MASTECTOMY THE PT HAD AN IMMEDIATE RECONSTRUCTION AND PLACEMENT OF TISSUE EXPANDER PLACED IN 1998 THE PT DID NOT HAVE CHEMOTHERAPY OR RADIATION TREATMENT POST RECONSTRUCTION THE PTS PAST MEDICAL HISTORY IS SIGNIFICANT FOR HYPOTHYROIDISM AND BLADDER PROLAPSE IN 1999 THE EXPANDER WAS REMOVED AND GELSALINE DEVICE STYLE 440 WAS PLACED THAT WAS MFG BY MCGHAN WITHIN A YR SHE DEVELOPED SIGNIFICANT HARDENING OF THE LEFT CHEST WALL THE DEVICE REMAINS IN PLACE UNTIL 2006 WHEN THE PT PRESENTED WITH COMPLAINTS OF PAIN AND CAPSULAR CONTRACTURE THE SURGEON THEN PERFORMED A CAPSULECTOMY AND DEVICE EXCHANGE FOR AN ALLERGAN B4 THE RECONSTRUCTION WAS SOFT FOR SEVERAL MONTHS BUT WITHIN A YR DEVELOPED TIGHTENING OF THE TISSUE AND DISCOMFORT IN THE LEFT CHEST WALL SHE WAS THEN EVALUATED IN 2009 BY ANOTHER SURGEON WHO RECOMMENDED THAT SHE CONSIDER A REVISION OF HER RECONSTRUCTION WITH AN ADDITION OF AN ACELLULAR DERMAL MATRIX IT WAS THEN RECOMMENDED THAT SHE HAVE AN AUTOLOGOUS FLAP PROCEDURE OR DIEP IN 2011 THE LEFT BREAST CAPSULE WAS OPENED AND CONTAINED CLOUDY YELLOW FLUID UNDER ENORMOUS PRESSURE THE FLUID SQUIRTED OUT OF THE CAPSULAR INCISION AND TRAVELED AT LEAST 56 INCHES THERE WAS A COLLECTION OF GELATINOUS MATERIAL WITHIN THE CAPSULE AS WELL AS AN INTACT SINGLE BREAST IMPLANT THE CAPSULE WAS THICKENED AND COVERED WITH PLAQUE-LIKE LESIONS INTERNALLY A TOTAL CAPSULECTOMY WAS PERFORMEDALL MATERIALS WERE SENT FOR PATHOLOGIC AND CYTOLOGICAL EVAL INCLUDING FROZEN SECTION THE FROZEN SECTION WAS CONSISTENT WITH ALCL|STYLE 68 SALINE FILLED BREAST IMPLANT|68-390|09/30/2011|||DA|N|R||0HP|FWM|1.0|07/30/2010|nan||1316501|||GOLETA|US|ALLERGAN||CA|||||True
2348522|61100521|N|1||MEDWATCH SUBMITTED TO THE FDA ON 07162015 ADVERSE EVENT OF ALCL WAS REPORTED PREVIOUSLY BUT AS THERE IS NO PATHOLOGY OR FOLLOW-UP CONFIRMING CD30+ OR ALK- THE EVENT WILL REMAIN REPORTABLE AS LYMPHOMA|STYLE 68 SALINE FILLED BREAST IMPLANT|68-390|09/30/2011|||DA|N|R||0HP|FWM|1.0|07/30/2010|nan||1316501|||GOLETA|US|ALLERGAN||CA|||||True
2140645|2119287|D|1||ALK NEGATIVE ALCL - ANAPLASTIC LARGE CELL LYMPHOMA POSSIBLY RELATED TO BREAST IMPLANTS HX OF HL - TREATED WITH MANTLE FIELD RADIATION THERAPY AND BREAST CANCER TREATED WITH SURGERY CHEMO AND TAMOXIFEN|BREAST IMPLANTS||06/22/2011||||N|||0|FWM|1.0||BREAST IMPLANTS|||||||nan|||||||True
2076644|2025896|D|1||SALES REPRESENTATIVE CALLED TO REPORT A CASE OF ALCL HE REPORTED THAT THE PATIENT HAD A HISTORY OF LEFT BREAST CANCER 17-18 YEARS AGO AND HAD UNDERGONE A BILATERAL MASTECTOMY THE RIGHT SIDE WAS FOR PROPHYLACTIC PURPOSES THE PATIENT HAD ALLERGAN TISSUE EXPANDERS PLACED AND ONCE EXPANSION WAS COMPLETE HAD 168 DEVICES IMPLANTED HOWEVER 3-4 YEARS AGO THE PATIENT HAD REMOVAL AND REPLACEMENT OF THE 168 TO A 68 DEVICE AT THIS TIME THE REASON FOR REPLACEMENT IS UNKNOWN IN B6 2011 THE PATIENT PRESENTED WITH RIGHT SIDE REDNESS AND EDEMA A DRAIN WAS PLACED AND FLUID WAS SENT TO THE LAB FOR ANALYSIS THE CYTOLOGY WAS ALCL+ THE SURGEON IS PLANNING ON A LYMPH NODE BIOPSY PENDING THE REMAINDER OF THE CYTOLOGY ADDITIONAL INFORMATION WAS THEN REQUESTED BY THE HEALTHCARE PROFESSIONAL FOR CLARIFICATION MEDICAL RECORDS WERE FORWARDED THAT DATE BACK TO B6 1987 WHEN THE PATIENT WAS ORIGINALLY DIAGNOSED WITH LEFT BREAST INTRADUCTAL CARINOMA THE PATIENT HAD IMPLANTED A DOW-CORNING TISSUE EXPANDER 500 CC DEVICE PLACED FILLED WITH 60 CC OF SALINE ON B6 1988 THE PATIENT RETURNED TO THE OPERATING ROOM FOR FIRST STAGE RECONSTRUCTION ON THE RIGHT SIDE A DOW-CORNING TISSUE EXPANDER 600CC TISSUE EXPANDER WAS PLACED AND FILLED TO 180CC ON B6 1988 BILATERAL SECOND STAGE RECONSTRUCTION WAS CARRIED OUT THE TISSUE EXPANDERS WERE REMOVED AND SURGITEK HIGH PROFILE RECONSTRUCTIVE IMPLANTS WERE PLACED CONTAINING 200CC OF GEL AND 50CC OF SALINE IN THE CENTRAL COLUMN THE TOTAL VOLUMES WERE 250CC ON THE RIGHT AND 270CC ON THE LEFT THE PATIENT WAS TAKEN BACK TO THE OPERATING ROOM ON B6 1994 FOR A RIGHT RUPTURED BREAST IMPLANT AFTER A RECENT MRI REVEALS BILATERAL IMPLANT ABNORMALITIES ONCE THE INCISION WAS MADE THE SILICONE WAS ENCOUNTERED IT SHOULD BE NOTED THAT WAS NOT TYPICAL COHESIVE GEL THE FLUID WAS THE CONSISTENCY OF HONEY OR AUTOMOBILE OIL IT FLOWED FREELY MCGHAN SALINE FILLED TEXTURED IMPLANTS 168 WERE EMPLOYED ON BOTH SIDES 27-168-271 B4 ON THE LEFT AND 27-168-241 B4 ON THE RIGHT ON B6 2011 THE PATIENT HAD A LEFT IMPLANT FAILURE A CAPSULECTOMY AND IMPLANT REMOVAL AND REPLACEMENT WAS PERFORMED DEVICE B4 27-168-271 WAS IMPLANTED ON THE LEFT SIDE THE PATIENT RETURNS IN B6 2011 WITH COMPLAINTS OF RIGHT SIDE SPONTANEOUS EXPANSION THAT BEGAN ABOUT ONE MONTH PRIOR SHE WAS AFEBRILE AND THERE WAS NO REDNESS PRESENT THIS REPRESENTED A SEROMA HOWEVER THIS HAS NOT RESOLVED TO ANY SIGNIFICANT DEGREE IN THE PAST FOUR WEEKS IT IS THEREFORE ELECTED AT THIS TIME TO EXPLORE THE AREA OBTAIN CYTOLOGY AND CULTURES AND PLACE A DRAIN THE CAPSULE WAS WINDOWED AND YELLOW FLUID WAS ENCOUNTERED IT WAS ASPIRATED FOR CYTOLOGY AEROBIC AND ANAEROBIC CULTURES WERE OBTAINED THE MCGHAN IMPLANT WAS ENCOUNTERED BUT NOT REMOVED FROM THE WOUND THERE WAS NO OVERT ABNORMALITY ON ITS SURFACE PATHOLOGY RETURNED CONFIRMS CD30+ CD45 SUBSET CD4 CD25 AND VIMENTIN ALK - |STYLE 168 SALINE FILLED BREAST IMPLANT|168-240|04/12/2011|||DA|N|R||0HP|FWM|1.0|09/01/1997|nan||2-507710|||GOLETA|US|ALLERGAN||CA|||||True
2338306|2365004|D|1||A REPORT OF LYMPHOMA OF THE BREAST CAPSULE IN SILICONE IMPLANT-RECONSTRUCTED PT PUBLISHED IN THE AMERICAN SURGEON SEPT 2010 VOL 76 PG 1030-31 WAS REVIEWED AND ADDL INFO HAS BEEN REQUESTED BY THE AUTHOR THE AUTHOR HAS NOT RESPONDED TO THIS DATE WITHIN THE ARTICLE THE AUTHOR NOTES A B6 WOMAN WITH A TISSUE DIAGNOSIS OF ADENOCARCINOMA OF THE LEFT BREAST UNDERWENT A LEFT MODIFIED RADICAL MASTECTOMY WITH PROPHYLACTIC RIGHT BREAST SIMPLE MASTECTOMY IN 1999 THIS WAS IMMEDIATELY FOLLOWED BY PRIMARY RECONSTRUCTION WITH SILICONE IMPLANTS THE LYMPH NODE BASIN WAS FREE OF DISEASE AND THE PT RECEIVED NO CHEMOTHERAPY OR RADIATION THERAPY SIX YEARS LATER SHE PRESENTED TO HER PRIMARY CARE WITH A LUMP IN HER RECONSTRUCTED RIGHT BREAST ON EXAMINATION SHE HAD A 3CM NON-TENDER MOBILE CYSTIC MASS IN THE RIGHT BREAST AT THE 9 OCLOCK POSITION COMPRESSION OF THE IMPLANT CAUSED ENLARGEMENT OF THE LESION SHE DID NOT REPORT NIPPLE DISCHARGE OR RETRACTION THE SKIN AND AREOLA COMPLEX WERE NORMAL AND THERE WERE NO PALPABLE LYMPH NODES HER PRIMARY CARE PHYSICIAN PERFORMED A NEEDLE ASPIRATION OF THE MASS WHICH WAS ORANGE IN COLOR WITH CYTOLOGIC FEATURES OF ADENOCARCINOMA SHE UNDERWENT BILATERAL IMPLANT REMOVAL EXCISION OF THE CYSTIC MASS AND BIOPSIES OF BOTH CAPSULES THE LEFT BREAST IMPLANT WAS INTACT AND THE CAPSULE WAS NORMAL IN APPEARANCE THE RIGHT BREAST IMPLANT WAS INTACT AS WELL HOWEVER THE ANTERIOR AND POSTERIOR WALLS OF THE CAPSULE WERE COATED WITH A NECROTIC HETEROGENEOUS MATERIAL INITIAL BIOPSIES OF THE RIGHT BREAST CAPSULE SHOWED POORLY DIFFERENTIATED ADENENOCARCINOMA IT WAS IMMUNOPOSITIVE FOR CD30 EMA AND T-CELL MARKERS CD45RO CD43 FINAL PATHOLOGY OF THE MASS AFTER REVIEW BY A SECOND PATHOLOGIST AT A UNIVERSITY HOSPITAL WAS ANAPLASTIC LARGE CELL LYMPHOMA ALK- T CELL PHENOTYPE THE POST OP RECOVER WAS UNEVENTFUL THE PT HAD A COURSE OF CHOP PROTOCOL OUR PTS LYMPHOMA WAS DISCOVERED AS A CYSTIC LESION INVOLVING THE RIGHT BREAST CAPSULE THE PRELIMINARY CYTOLOGIC FEATURE OF THE LESION WAS POORLY DIFFERENTIATED ADENENOCARCINOMA SIMILAR TO THE PRIOR DIAGNOSIS OF THE LEFT BREASTONLY AFTER IMMUNOHISTOCHEMISTRY OF THE SPECIMEN WAS SHE CORRECTLY DIAGNOSED WITH ALCL T-CELL LYMPHOMA AND TREATED WITH CHOP CHEMOTHERAPY PROTOCOL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|11/09/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2030915|1919205|D|1||ON B6 2010 DIAGNOSED WITH ANAPLASTIC LARGE CELL LYMPHOMA ALCL ALK-NEGATIVE POSSIBLY RELATED OR CAUSED BY BREAST IMPLANTS RECEIVED IN B6 2002 FOR AUGMENTATION EXPERIENCED COMPLICATIONS WITH LEFT IMPLANT DIAGNOSED AS CAPSULAR CONTRACTION IMPLANT REPLACED ON B6 2008 STILL EXPERIENCING CAPSULAR CONTRACTION AFTER REPLACEMENT B6 2010 - B6 2011 RECEIVED 12 DOSES OF CHEMOTHERAPY RECEIVED 20 DOSES OF RADIATION THERAPY PREPARING FOR STEM CELL TRANSPLANT SCHEDULED FOR B6 2011 B6 2010 NEEDLE BIOPSY - DIAGNOSIS LYMPHOMA B6 2010 SURGICAL BIOPSY - DIAGNOSIS ALCL B6 2010 SURGICAL BIOPSY - DIAGNOSIS ALCL|NATRELLE||03/17/2011||||N|||0HP|FWM|1.0||SALINE - FILLED BREAST IMPLANT||RIGHT: 579142|||IRVINE|US|ALLERGAN, INC.||CA|||STYLE # 468||True
2030915|1919205|D|1||ON B6 2010 DIAGNOSED WITH ANAPLASTIC LARGE CELL LYMPHOMA ALCL ALK-NEGATIVE POSSIBLY RELATED OR CAUSED BY BREAST IMPLANTS RECEIVED IN B6 2002 FOR AUGMENTATION EXPERIENCED COMPLICATIONS WITH LEFT IMPLANT DIAGNOSED AS CAPSULAR CONTRACTION IMPLANT REPLACED ON B6 2008 STILL EXPERIENCING CAPSULAR CONTRACTION AFTER REPLACEMENT B6 2010 - B6 2011 RECEIVED 12 DOSES OF CHEMOTHERAPY RECEIVED 20 DOSES OF RADIATION THERAPY PREPARING FOR STEM CELL TRANSPLANT SCHEDULED FOR B6 2011 B6 2010 NEEDLE BIOPSY - DIAGNOSIS LYMPHOMA B6 2010 SURGICAL BIOPSY - DIAGNOSIS ALCL B6 2010 SURGICAL BIOPSY - DIAGNOSIS ALCL|NATRELLE||03/17/2011||||N|||0HP|FWM|2.0||SALINE - FILLED BREAST IMPLANT|||||IRVINE|US|ALLERGAN, INC.||CA|||STYLE # 468||True
1976502|1898383|D|1||PATIENT WAS DIAGNOSED WITH ALCL - ANAPLASTIC LARGE CELL LYMPHOMA - AROUND HER RIGHT SALINE BREAST IMPLANT THE IMPLANTS WERE ORIGINALLY PLACED IN 1998 THE IMPLANTS HAVE BEEN REMOVED AND SHE HAS BEEN TREATED FOR HER LYMPHOMA|SALINE BREAST IMPLANT||01/26/2011||||N|||0LP|FWM|1.0||SALINE BREAST IMPLANT|||||||ALLERGAN|||||||True
2121010|2056222|D|1||RECEIVED VOLUNTARY B4 FROM THE FDA STATING PATIENT WAS DIAGNOSED WITH ALCL  ANAPLASTIC LARGE CELL LYMPHOMA - AROUND HER RIGHT SALINE BREAST IMPLANT A CALL WAS PLACED TO THE SURGEONS OFFICE TO GATHER ADDL INFO ABOUT THE DEVICE PT DEMOGRAPHICS AND PATHOLOGY THE DEVICE WAS PLACED IN 1998 THE DEVICES HAVE BEEN REMOVED AND SHE HAS BEEN TREATED FOR HER LYMPHOMA AT THE TIME OF THIS SUBMISSION THERE HAS BEEN NO ADDL INFO RECEIVED FROM THE OFFICE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|05/26/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2261241|2158948|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF ALCL PAIN AND SEROMA VIA VOLUNTARY FORM B4 ADDL INFO GATHERED FROM THE SURGEONS OFFICE THE PT PRESENTS WITH COMPLAINTS OF PAIN ITCHING AND SWELLING OF THE LEFT BREAST A MAMMOGRAMSONOGRAM REVEALED CIRCUMFERENTIAL FLUID COLLECTION SURROUNDING ENTIRE BREAST EXTENDING TO THE AXILLARY REGION ULTRASOUND GUIDED FLUID ASPIRATION PERFORMED 2011 REVEALED ATYPICAL LYMPHOID PROLIFERATION CONSISTENT WITH CD30+ ALK-ALCL EXPLANT SURGERY PERFORMED TO REMOVE IMPLANT ADDL TREATMENT IS UNK AT THIS TIME|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|09/21/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2292800|22097964|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF ALCL AND SEROMA ACCORDING TO THE CASE NOTES PROVIDED THE PT WAS AN AUGMENTATION PT IMPLANTED IN 2002 THE PT PRESENTED TO THE OFFICE WITH COMPLAINTS OF SWOLLEN TENDER LEFT BREAST THE PT ALSO HAD AN ULTRASOUND DONE THAT CONFIRMED A SEROMA EXPLANT SURGERY TOOK PLACE ON B6 2011 BILATERALLY AT WHICH TIME THE DIAGNOSIS WAS MADE ON THE LEFT SIDE THE DEVICES THAT WERE REMOVED WERE MCGHAN SALINE FILLED TEXTURED 390 CC IMPLANT THE PT HAS SEEN AN ONCOLOGIST BUT TREATMENT HAS NOT BEEN SCHEDULED AT THIS TIME A PET SCAN HAS BEEN DISCUSSED BUT NOT CARRIED OUT AS OF THIS DATE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|10/07/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
1999354|14966427|D|1||INITIALLY PT REPORTED RIGHT SIDE LYMPHOMA DEFLATION INFECTION IRRITATIONINFLAMMATION WITH RIGHT BREAST IMPLANT FU WITH THE IMPLANTING SURGEONS OFFICE NOTED THE PT WAS SEEN IN THE EMERGENCY ROOM FOR WHAT WAS THOUGHT TO BE A RIGHT BREAST ABSCESS OR AN INFECTION THE PT WAS THEN SENT TO SEE THE IMPLANTING SURGEON WHO PERFORMED AN ANTIBIOTIC WASH AND HAD THE PT HAVE AN ULTRASOUND AS WELL OPERATIVE NOTES WERE REQUESTED AND STATE ON THE RIGHT SIDE ONCE INCISED WE ENCOUNTERED A LARGE VOLUME OF PURULENT FLUID THIS WAS SENT FOR CULTURE WE FOUND A COMPLETELY DEFLATED SALINE IMPLANT THE CAPSULE WAS ANGRY AND INFLAMED THE PATHOLOGY FINAL DIAGNOSIS ALCL CD30+ ALK- INCLUDING CD45+ THE PT WAS TO SEE AN ONCOLOGIST AT A LATER DATE ADDITIONAL INFO PROVIDED BY THE SURGEONS OFFICES NOTES THAT THE PT WAS SEEN BY THE ONCOLOGIST AND BREAST IMPLANT THAT WAS REMOVED WAS DISCARDED|STYLE 168 SALINE FILLED BREAST IMPLANT|168-800|02/14/2011||||N|R||0HP|FWM|1.0|08/01/1997|nan||2-505392|||GOLETA|US|ALLERGAN||CA|||||True
1994929|1712741|D|1||ALCL REPORT CASE MY ILLNESS BEGAN SOMETIME IN LATE B6 2009 I HAD NOTICED A MASS UNDER AND NEAR MY RIGHT BREAST I WENT TO MY PRIMARY CARE PHYSICIAN DR B6 SHE HAD ME DO AN MRI AND THE TEST CAME BACK NEGATIVE I BEGAN TO FEEL VERY TIRED AND LAZY AROUND B6 OF 2009 I HAVE A HISTORY OF ASTHMA AND THOUGHT I MIGHT BE COMING DOWN WITH BRONCHITIS I WENT BACK TO HER LATE B6 AND SHE HAD GIVEN ME A STEROID SHOT WHICH HAD HELPED FOR AWHILE THE FIRST WEEK OF B6 2010 I BEGAN TO HAVE SHORTNESS OF BREATH AND FELT IT WAS MORE THAN JUST MY ASTHMA I ALSO HAD VERY BAD LOWER BACK AND STOMACH PAIN I WENT TO SEE DR B6 ABOUT MY SYMPTOMS ON B6 2010 HE HAD DONE A CHEST X-RAY AND DETERMINED I HAD PNEUMONIA SHOWING FLUID IN MY LEFT LUNG HE PUT ME ON ANTIBIOTICS TOOK ME OFF OF WORK AND GAVE ME A FOLLOW UP APPOINTMENT I REALLY NEVER FELT BETTER SO WENT BACK ABOUT 1 WEEK LATER AND HE NOTICED THE FLUID HAD GOTTEN WORSE HE CONTACTED A PULMONARY SPECIALIST AT B6 HOSPITAL IN B6 DR B6 I HAD THE FLUID REMOVED AND FELT MUCH BETTER FOR A COUPLE OF WEEKS MY WHITE BLOOD COUNTS WERE VERY HIGH 11000 TO 22000 DURING THIS TIME THE FLUID CAME BACK IN EARLY B6 AND I WAS SEEN AT B6 EMERGENCY ROOM AGAIN TO HAVE THE FLUID REMOVED AND TO BE ADMITTED THEY RAN MULTIPLE TESTS CT SCANS MRIS AND TOOK BIOPSIES OF MY LUNGS AND STOMACH I HAD A CHEST TUBE PUT IN FOR 7 TO 10 DAYS TO DRAIN THE FLUID I SPENT ABOUT 12 TO 14 DAYS HERE I WAS RELEASED TO DO IN-HOME ANTIBIOTICS BY PIC LINE AND FELT BETTER BUT VERY WEAK I ALSO CONTINUED TO HAVE VERY BAD BACK PAIN ALL TESTS DONE IN THE HOSPITAL CAME BACK NEGATIVE I SAW A DOCTOR IN B6 DR B6 HE WAS ABLE TO RELIEVE SOME PAIN BY DOING PAIN SHOTS IN MY BACK ASSUMING IT WAS IN THE SPINAL AREA THIS WAS NOT WORKING ANYMORE AND AS OF LATE B6 I WAS STILL OFF WORK DUE TO PAIN AND SWELLING OF MY STOMACH NOT SURE WHY THIS WAS OCCURRING I WENT BACK TO DR B6 AND SHE SUGGESTED I DO AN MRI ON MY BACK AREA IT WAS SUGGESTED THAT I SEE MY EMPLOYEES EXECUTIVE PHYSICAL DOCTOR AT B6 TO REVIEW SOME MEDICAL RECORDS FROM B6 RELATING TO AN ULTRA SOUND I HAD DONE THIS IS WHEN I SAW DR B6 I SAW HIM AROUND THE END OF B6 WHICH HE REVIEWED THE MEDICAL RECORDS AND THOUGHT THERE MIGHT BE A FOREIGN OBJECT LEFT IN MY STOMACH AREA FROM A PRIOR SURGERY THIS SURGERY WAS WHEN I HAD MY IMPLANTS PUT IN AND LIPO SUCTION DONE IN 1996 HE THEN REFERRED ME TO A PLASTIC SURGEON IN B6 NAMED DR B6 I SAW HIM THAT SAME AFTERNOON AND HE HAD AGREED WITH DR B6 ABOUT SEEING A FOREIGN OBJECT IN MY LOWER STOMACH AREA AND WANTED TO DO SURGERY TO REMOVE THIS THE FOLLOWING DAY I WAS IN SO MUCH PAIN I WAS OPEN TO ANYTHING HE SCHEDULED ME AT B6 MEDICAL CENTER THE FOLLOWING DAY B6 2010 B6 WHILE THERE I DID ANOTHER CT SCAN AND THEY NOTICED A SWOLLEN LYMPH NODE UNDER MY LEFT ARMPIT I WAS SCHEDULED AGAIN WITH DR B6 AND DR B6 TO REMOVE BOTH MY BREAST IMPLANTS AND THE LYMPH NODE B6 REFERRED ME TO DR B6 WHOM DID MY FIRST TREATMENT AT CEDARS THIS INCLUDED CHEMOTHERAPY RADIATION AND CHEMO SHOTS IN MY SPINE DR B6 DR B6 THEN REFERRED ME TO ANOTHER ONCOLOGY DOCTOR CLOSER TO HOME BY THE NAME OF DR B6 SHE FINISHED UP MY CHEMO TREATMENTS AND ALSO REFERRED ME TO THE B6 RELATING TO THE POSSIBILITY OF A BONE MARROW TRANSPLANT I AM CURRENTLY SEEING AND UNDERGOING A BONE MARROW TRANSPLANT WITH DR B6 MY BREAST IMPLANTS WERE PUT IN AROUND B6 1996 WITH DR B6 I HAVE REACHED OUT TO DR B6 REGARDING THE DETAILS RELATED TO MY IMPLANTS AND HAVE YET TO HEAR FROM HIM B6 PLASTIC SURGERY CENTER B6 THE NAME WAS SILIMED NOW SIENTRA|SILICON BREAST IMPLANTS||02/13/2011|||||||0|FTR|2.0||BREAST IMPLANTS|||||||nan|||||||True
1994929|1712741|D|1||ALCL REPORT CASE MY ILLNESS BEGAN SOMETIME IN LATE B6 2009 I HAD NOTICED A MASS UNDER AND NEAR MY RIGHT BREAST I WENT TO MY PRIMARY CARE PHYSICIAN DR B6 SHE HAD ME DO AN MRI AND THE TEST CAME BACK NEGATIVE I BEGAN TO FEEL VERY TIRED AND LAZY AROUND B6 OF 2009 I HAVE A HISTORY OF ASTHMA AND THOUGHT I MIGHT BE COMING DOWN WITH BRONCHITIS I WENT BACK TO HER LATE B6 AND SHE HAD GIVEN ME A STEROID SHOT WHICH HAD HELPED FOR AWHILE THE FIRST WEEK OF B6 2010 I BEGAN TO HAVE SHORTNESS OF BREATH AND FELT IT WAS MORE THAN JUST MY ASTHMA I ALSO HAD VERY BAD LOWER BACK AND STOMACH PAIN I WENT TO SEE DR B6 ABOUT MY SYMPTOMS ON B6 2010 HE HAD DONE A CHEST X-RAY AND DETERMINED I HAD PNEUMONIA SHOWING FLUID IN MY LEFT LUNG HE PUT ME ON ANTIBIOTICS TOOK ME OFF OF WORK AND GAVE ME A FOLLOW UP APPOINTMENT I REALLY NEVER FELT BETTER SO WENT BACK ABOUT 1 WEEK LATER AND HE NOTICED THE FLUID HAD GOTTEN WORSE HE CONTACTED A PULMONARY SPECIALIST AT B6 HOSPITAL IN B6 DR B6 I HAD THE FLUID REMOVED AND FELT MUCH BETTER FOR A COUPLE OF WEEKS MY WHITE BLOOD COUNTS WERE VERY HIGH 11000 TO 22000 DURING THIS TIME THE FLUID CAME BACK IN EARLY B6 AND I WAS SEEN AT B6 EMERGENCY ROOM AGAIN TO HAVE THE FLUID REMOVED AND TO BE ADMITTED THEY RAN MULTIPLE TESTS CT SCANS MRIS AND TOOK BIOPSIES OF MY LUNGS AND STOMACH I HAD A CHEST TUBE PUT IN FOR 7 TO 10 DAYS TO DRAIN THE FLUID I SPENT ABOUT 12 TO 14 DAYS HERE I WAS RELEASED TO DO IN-HOME ANTIBIOTICS BY PIC LINE AND FELT BETTER BUT VERY WEAK I ALSO CONTINUED TO HAVE VERY BAD BACK PAIN ALL TESTS DONE IN THE HOSPITAL CAME BACK NEGATIVE I SAW A DOCTOR IN B6 DR B6 HE WAS ABLE TO RELIEVE SOME PAIN BY DOING PAIN SHOTS IN MY BACK ASSUMING IT WAS IN THE SPINAL AREA THIS WAS NOT WORKING ANYMORE AND AS OF LATE B6 I WAS STILL OFF WORK DUE TO PAIN AND SWELLING OF MY STOMACH NOT SURE WHY THIS WAS OCCURRING I WENT BACK TO DR B6 AND SHE SUGGESTED I DO AN MRI ON MY BACK AREA IT WAS SUGGESTED THAT I SEE MY EMPLOYEES EXECUTIVE PHYSICAL DOCTOR AT B6 TO REVIEW SOME MEDICAL RECORDS FROM B6 RELATING TO AN ULTRA SOUND I HAD DONE THIS IS WHEN I SAW DR B6 I SAW HIM AROUND THE END OF B6 WHICH HE REVIEWED THE MEDICAL RECORDS AND THOUGHT THERE MIGHT BE A FOREIGN OBJECT LEFT IN MY STOMACH AREA FROM A PRIOR SURGERY THIS SURGERY WAS WHEN I HAD MY IMPLANTS PUT IN AND LIPO SUCTION DONE IN 1996 HE THEN REFERRED ME TO A PLASTIC SURGEON IN B6 NAMED DR B6 I SAW HIM THAT SAME AFTERNOON AND HE HAD AGREED WITH DR B6 ABOUT SEEING A FOREIGN OBJECT IN MY LOWER STOMACH AREA AND WANTED TO DO SURGERY TO REMOVE THIS THE FOLLOWING DAY I WAS IN SO MUCH PAIN I WAS OPEN TO ANYTHING HE SCHEDULED ME AT B6 MEDICAL CENTER THE FOLLOWING DAY B6 2010 B6 WHILE THERE I DID ANOTHER CT SCAN AND THEY NOTICED A SWOLLEN LYMPH NODE UNDER MY LEFT ARMPIT I WAS SCHEDULED AGAIN WITH DR B6 AND DR B6 TO REMOVE BOTH MY BREAST IMPLANTS AND THE LYMPH NODE B6 REFERRED ME TO DR B6 WHOM DID MY FIRST TREATMENT AT CEDARS THIS INCLUDED CHEMOTHERAPY RADIATION AND CHEMO SHOTS IN MY SPINE DR B6 DR B6 THEN REFERRED ME TO ANOTHER ONCOLOGY DOCTOR CLOSER TO HOME BY THE NAME OF DR B6 SHE FINISHED UP MY CHEMO TREATMENTS AND ALSO REFERRED ME TO THE B6 RELATING TO THE POSSIBILITY OF A BONE MARROW TRANSPLANT I AM CURRENTLY SEEING AND UNDERGOING A BONE MARROW TRANSPLANT WITH DR B6 MY BREAST IMPLANTS WERE PUT IN AROUND B6 1996 WITH DR B6 I HAVE REACHED OUT TO DR B6 REGARDING THE DETAILS RELATED TO MY IMPLANTS AND HAVE YET TO HEAR FROM HIM B6 PLASTIC SURGERY CENTER B6 THE NAME WAS SILIMED NOW SIENTRA|SILICON BREAST IMPLANTS||02/13/2011|||||||0|FTR|1.0||BREAST IMPLANTS||UNKNOWN|||||nan|||||||True
2210596|2193346|D|1||RECEIVED ABSTRACT ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA OF THE BREAST OCCURRING IN PATIENTS WITH SILICONE BREAST IMPLANTS WILL BE PUBLISHED IN THE FINAL ARTICLE ENTITLED LEUKEMIA AND LYMPHOMA AUG 20115281481-1487 WITHIN THE ARTICLE THIS PT IS IDENTIFIED AS PT 8 WHO WAS A COSMETIC AUGMENTATION CASE THIS PT PRESENTED WITH FLUID ACCUMULATION IN THE LEFT BREAST AFTER SECOND DRAINAGE OF A LARGE VOLUME OF FLUID WHILE WAITING FOR THE CYTOLOGY REPORT SHE HAD HER TEXTURED IMPLANTS REMOVED AND REPLACED WITH SMOOTH SALINE IMPLANTS A DIAGNOSIS ALCL ALK-WAS MADE AND CONFIRMED BY B4 T-CELL REARRANGEMENT STUDIES TREATMENT WITH CHOP WAS RECOMMENDED BUT SHE TREATED ELSEWHERE AND THE OUTCOME IS UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2452703|2538792|D|1||HEALTH PROFESSIONAL REPORTED A RIGHT SIDE PAIN SEROMA AND POSSIBLE LYMPHOMA ADDITIONAL INFORMATION NOTES THAT THE PATIENT PRESENTED WITH A COMPLAINT OF PAIN AND RIGHT BREAST SWELLING EXPLANT AND REPLACEMENT TOOK PLACE ON B6 2011 WITH SILICONE DEVICES PRELIMINARY RESULTS SHOW POSSIBLE ALCL OF THE CAPSULE THE PATIENT RETURNS TO THE OFFICE AND AFTER DISCUSSING THE RESULTS THE PATIENT AND THE SURGEON DECIDE ON BILATERAL EXPLANT SURGERY OF THE NEW DEVICES EXPLANT SURGERY TOOK PLACE ON B6 2011 FINAL DIAGNOSIS OF EXTRANODAL NK T CELL LYMPHOMA NASAL TYPE IS MADE USING CAPSULE FROM BLOCK SECTIONS THE PATHOLOGIST NOTES THIS IS NOT ALCL|STYLE 40 SILICONE GEL FILLED BREAST IMPLANT|40-400|02/09/2012|||DA|N|R||0HP|FTR|1.0|08/24/2007|nan||581167|||GOLETA|US|ALLERGAN||CA|||||True
2612780|2672263|D|1||HEALTHCARE PROFESSIONAL REPORTS VIA MAUDE REPORT A CASE OF LYMPHOMA AND SEROMA THE SURGEON REPORTS PT WITH BREAST IMPLANT FOR RECONSTRUCTION 11 YRS AGO PRESENTS WITH CHRONIC SEROMA ON THE LEFT SIDE PT WAS TAKEN TO THE OPERATING ROOM FOR EVAL OF SEROMAHEMATOMA INTRAOPERATIVELY FLUID LOOKED SUSPICIONS WITH A VERY THICK CAPSULE IMPLANT WAS TEXTURED SALINE IT WAS REMOVED WE PERFORMED A FULL COMPLETE CAPSULECTOMY FLUID WAS TAKEN TO PATHOLOGYCYTOLOGY FOR FROZEN AND PERMANENT CAPSULE WAS ALSO TAKEN FOR PATHOLOGY CONFIRMED ALCL ON PERMANENT PATHOLOGY PT HAD REPLACEMENT AT THE TIME WITH SMOOTH SILICONE SEVERAL CALLS HAVE BEEN MADE TO THE SURGEONS OFFICE TO TRY AND OBTAIN DEVICE INFO TO THIS DATE THIS INFO HAS NOT BEEN PROVIDED TO ALLERGAN AN ONGOING INVESTIGATION IS BEING CARRIED OUT ANY ADDL INFO REGARDING THESE EVENTS WILL BE UPDATED AND SUBMITTED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|05/31/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2842518|20004808|D|1||HEALTHCARE PROFESSIONAL REPORTED TO AN ALLERGAN EMPLOYEE THE EVENTS OF ALCL AND SEROMA THIS EVENT WAS REPORTED INITIALLY EASR B6 2009 B6 2011 AND B6 2011 BOTH AS A SUPPLEMENTAL REPORTS|STYLE 163 SALINE FILLED BREAST IMPLANT|163-655|11/15/2012|||DA|N|R||0HP|FWM|1.0|12/06/2003|nan||548191|||GOLETA|US|ALLERGAN|93117|CA|93117||||True
2675981|18977587|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF SUSPICIOUS OF SEROMA-ASSOCIATED ALCL IT IS NOT COMPLETELY CLEAR WHICH SIDE IS AFFECTED AT THIS TIME THE LYMPHOMA WILL BE REPRESENTED ON THE RIGHT SIDE AND THE LEFT SIDE IS NOTED AS A REMOVAL ONLY THERE IS NO DEVICE INFORMATION PATHOLOGY CYTOLOGY NOR IS THERE CLARIFICATION OF THE AFFECTED SIDE NOTED AT THIS TIME MULTIPLE ATTEMPTS HAVE BEEN MADE TO CONFIRM THE AFFECTED SIDE AND TO GATHER ANY ADDITIONAL INFORMATION ON THIS CASE ANY ADDITIONAL INFORMATION REGARDING THESE EVENTS WILL BE UPDATED IN THIS FILE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/26/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN|93117|CA|93117||||True
2517651|20917029|D|1||CASE OF ALCL ASSOCIATED WITH RUPTURED SILICONE BREAST IMPLANT PT PRESENTED WITH GROSS INFECTION IN R BREAST 30 YRS FOLLOWING BILATERAL MASTECTOMY RECONSTRUCTIONS WITH SILICONE BREAST PROSTHESES RUPTURED SILICONE IMPLANTS REMOVED SUCCESSFULLY ON BOTH SIDES GROSS INFECTION NOTED ON R EXCESS SKIN TRIMMED PATHOLOGY ON SKIN SHOWED ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED WITH BREAST IMPLANT PT IS DEMENTED DAUGHTER STATES SURGERY SOMETIME IN EARLY 1980S FURTHER DETAILS UNK PT MADE FULL RECOVERY FROM SURGERY NO PLANS FOR CHEMOTHERAPY BUT PTS FAMILY REPORTS WEIGHT LOSS OVER LAST YEAR AND QUESTION OF LESIONS SEEN IN SPLEENLIVER INCIDENTALLY ON CT SCAN IN LAST 2 YRS - I NEVER COULD LOCATE THE REPORT I HAVE PREOP PHOTOS AVAILABLE UNFORTUNATELY THE IMPLANT WAS DISCARDED AS FAR AS I KNOW IMPLANT WAS DISINTEGRATED|UNKNOWN|UNK|04/01/2012||||N|||0|FTR|1.0||SILICONE BREAST IMPLANT||UNK|UNK||UNK||UNK|||||UNK||True
2337179|2356522|D|1||RECEIVED A VOLUNTARY MEDWATCH FORM B4 WHERE THE PT REPORTED I HAD BILATERAL SILICONE IMPLANTS IMPLANTED IN 1990 I DEVELOPED SWELLING AND REDNESS OF THE RIGHT BREAST IN 2002 FOLLOWED BY ENLARGED LYMPH NODES AND SKIN NODULES I WAS DIAGNOSED WITH NODULAR SCLEROSIS HODGKINS OF THE RIGHT MAXILLARY WHICH SPREAD TO THE SKIN SIX MONTHS LATER THIS WAS TREATED WITH CHEMO AND RADIATION HOWEVER TWO MONTHS LATER IT RECURRED I WAS TREATED WITH STEM CELL TRANSPLANT AND WITHIN 60 DAYS DEVELOPED A 7CM TUMOR OF CHEST WALL SURROUNDING THE RIGHT BREAST IMPLANT AND ENLARGED ANTERIOR MAXILLARY LYMPH NODES THIS WAS DIAGNOSED AS A RECURRENCE AND TREATED WITH MORE RADIATION FOUR MONTHS LATER I DEVELOPED MULTIPLE PAINFUL BLISTERING LESIONS ON THE RIGHT BREAST THESE WERE MULTIPLE AND DIAGNOSED ALCL THE ONCOLOGIST AND PATHOLOGIST SAID THERE WAS A STRONG POSSIBILITY THAT THE PREVIOUS DIAGNOSIS OF HODGKINS DISEASE WAS INCORRECT AND INDEED I COULD HAVE HAD A SYSTEMIC ALCL ALL ALONG AFTER READING ABOUT THE ASSOCIATION BETWEEN ALCL AND BREAST IMPLANTS I WANTED TO MAKE SURE MY CASE IS INCLUDED FOR RESEARCH PURPOSES THERE WAS NO CORRELATION BETWEEN THE IMPLANT AND THE DISEASE AT THE TIME SO I DID NOT HAVE TO REMOVED UNTIL 2008 FU CALLS WERE MADE TO THE SURGEONS OFFICE TO GATHER ADDITIONAL INFO BUT THEY WERE UNABLE TO PROVIDE ANY DEVICE INFO THE SURGEON INFORMS PRODUCT SUPPORT THAT HE WAS NOT AWARE OF THE PTS DIAGNOSIS OF ALCL ANOTHER CALL WAS PLACED TO THE PT WHO WAS ABLE TO PROVIDE HER PATHOLOGY REPORT TO CONFIRM THE DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/26/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2444288|14886239|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF ALCL VIA MAUDE REPORT B6 FOLLOW UP INFO WAS NOT ABLE TO BE OBTAINED THE SURGEON DID NOT WANT TO SUPPLY ANY ADDL INFO AT THE TIME OF THIS REPORT|STYLE 168 SALINE FILLED BREAST IMPLANT|168-210|02/07/2012|||DA|N|R||0HP|FWM|1.0|05/05/2004|nan||553218|||GOLETA|US|ALLERGAN||CA|||||True
2718829|3055395|D|1||PT IS A B6 FEMALE WHO UNDERWENT LEFT MASTECTOMY IN 1996 FOR DUCTAL CARCINOMA IN SITU WITH TISSUE EXPANDER AND SALINE IMPLANT RECONSTRUCTION SHE PRESENTED IN B6 2010 WITH A PERI-IMPLANT HEMATOMA THOUGHT POSSIBLY POST-TRAUMATIC SHE UNDERWENT EVACUATION OF THE HEMATOMA AND CHANGE TO A SILICONE GEL IMPLANT ALL PATHOLOGY SPECIMENS WERE NEGATIVE FOR TUMOR SHE AGAIN PRESENTED IN B6 2012 WITH A SPONTANEOUS HEMATOMA AND AT SURGERY MULTIPLE BIOPSIES REVEALED ANAPLASTIC LARGE CELL LYMPHOMA ALCL LIMITED TO THE PERIPROSTHETIC CAPSULE AND HEMATOMA FLUID AFTER AN EXTENSIVE HEMATOLOGIC AND METASTATIC WORKUP WHICH WAS NEGATIVE SHE UNDERWENT REMOVAL OF THE IMPLANT AND TOTAL PERIPROSTHETIC CAPSULECTOMY CAPSULAR PATHOLOGY SHOWED ALCL|MENTOR SMOOTH ROUND HIGH PROFILE GEL, 450CC|350-4505BC|08/23/2012||||Y|||0HP|FTR|1.0||SILICONE GEL BREAST IMPLANT||6004844|||SANTA BARBARA|US|MENTOR CORP.||CA|||350-4505BC||True
2674766|2837807|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF ALCL ON AN UNK SIDE THE DEVICE INFO IS ALSO UNK AT THIS TIME MULTIPLE ATTEMPTS HAVE BEEN MADE TO GATHER INFO REGARDING THIS CASE TO THIS DATE THE INFO HAS NOT BEEN FORTHCOMING WHEN NEW INFO BECOMES AVAILABLE IT WILL BE UPDATED AND FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/24/2012|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
2674766|54676584|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF ALCL ON AN UNKNOWN SIDE THE DEVICE INFORMATION IS ALSO UNKNOWN AT THIS TIME MULTIPLE ATTEMPTS HAVE BEEN MADE TO GATHER INFORMATION REGARDING THIS CASE TO THIS DATE THE INFORMATION HAS NOT BEEN FORTHCOMING WHEN NEW INFORMATION BECOMES AVAILABLE IT WILL BE UPDATED AND FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/24/2012|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
2578247|2650283|D|1||ADDITIONAL INFORMATION PROVIDED RECEIVED FROM A LITERATURE ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA AND BREAST IMPLANTS FIVE B6 CASES PUBLISHED IN THE PLASTIC AND RECONSTRUCTIVE SURGERY B6 2012 B4 WITHIN THE ARTICLE THE AUTHOR DESCRIBES SEROMA WITHIN THE ARTICLE THE AUTHOR DESCRIBES A B6 WHO UNDERWENT A RIGHT MASTECTOMY AXILLARY DISSECTION AND IMMEDIATE BEAST RECONSTRUCTION WITH A LATISSIMUS DORSI FLAP AND TISSUE EXPANDER IN B6 1996 SHE DID NOT REQUIRE ADJUVANT THERAPY THE EXPANDER WAS REPLACED WITH A 390CC ROUND SMOOTH IMPLANT IN B6 1996 REVISION WAS PERFORMED ON THE RIGHT BREAST CAPSULE IN B6 1997 IN B6 1999 THE SALINE DEVICE WAS REPLACED WITH A TEXTURED SALINE IMPLANT B4 IN B6 2007 THE PATIENT DEVELOPED A SEROMA THE SEROMA WAS ASPIRATED AND REVEALED ALCL THE DEVICE WAS LEFT IN PLACE DURING CHEMOTHERAPY AS THE SEROMA RECURRED SHE THUS UNDERWENT TOTAL CAPSULECTOMY AND IMPLANT REMOVAL IN B6 2007 HER TREATMENT WAS COMPLETED WITH FURTHER CHEMOTHERAPY AND RADIATION SHE IS NOW DISEASE FREE THIS EVENT WAS ORIGINALLY REPORTED VIA EASR B6 2011|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|05/09/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2564353|2651879|D|1||ANAPLASTIC LARGE CELL LYMPHOMA AND BREAST IMPLANTS FIVE B6 CASES PUBLISHED IN THE PLASTIC AND RECONSTRUCTIVE SURGERY B6 2012 B4 WITHIN THE ARTICLE THE AUTHOR DESCRIBES A B6 WOMAN WHO PRESENTED IN 2011 WITH A RIGHT BREAST LUMP HER HISTORY NOTES A WIDE LOCAL EXCISION OF THE RIGHT BREAST FOR DUCTAL CARCINOMA IN SITU FOLLOWED BY RADIOTHERAPY IN 1995 IN 1998 SHE HAD A MASTECTOMY FOR RECURRENT DISEASE AND RECONSTRUCTION WITH A PEDICLED LATISSIMUS DORSI FLAP IN 2006 SHE HAD A REVISION WITH A RIGHT BREAST AUGMENTATION SUBPECTORALIS AND LATISSIMUS DORSI FLAP AND LEFT BREAST AUGMENTATION FOR SYMMETRY SUBFASCIAL WITH A TEXTURED MCGHAN IMPLANTS SHE UNDERWENT AN OPEN BIOPSY IN WHICH TWO MASSES WERE FOUND ONE MEDIAL AND ONE LATERAL THE MEDIAL MASS WAS FOUND TO HAVE THE IMPLANT WHICH HAD RUPTURED IMMEDIATELY UNDER IT THE IMPLANT WAS REMOVED A TOTAL CAPSULECTOMY WAS PERFORMED AND THE IMPLANT REPLACED THE ASSUMPTION THE MASS WAS A SILICOMA HISTOPATHOLOGIC ANALYSIS REVEALED BOTH MASSES TO BE ALK- ALCL CD30+ AND THE REMAINDER OF THE CAPSULE WAS NEGATIVE THE REMAINDER OF HER WOUND FAILED TO HEAL AND THE RIGHT BREAST IMPLANT WAS REMOVED CT SCAN AND PET SCAN WERE NORMAL AS WAS THE BONE MARROW SHE BEGAN CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE AND PREDNISONE AND IS AWAITING RADIATION SHE CURRENTLY HAS NO RECURRENCE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/01/2012|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2433975|2512555|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF LYMPHOMA VIA VOLUNTARY B4 FOLLOW UP INFORMATION FROM THE SURGEON NOTES THE PT HAD AN AUGMENTATION IN 1986 EXACT DATE UNK THE PT PRESENTED TO THE OFFICE B6 2006 FOR LEFT BREAST SEROMA AND CAPSULAR CONTRACTURE THE OFFICE NOTES THAT THE SEROMA WAS NEGATIVE FOR ALCL THE PT PRESENTS TO HAVE REMOVAL AND REPLACEMENT OF THE 168-650 DEVICE ON B6 2007 AND 15-575 DEVICES WERE PLACED THE POST-OP COURSE WAS UNREMARKABLE UNTIL SEP 2011 WHEN THE PT PRESENTS WITH RECURRENT SEROMA THAT HAD BEEN NOTICED THE MONTH PRIOR EXPLANT REMOVAL AND REPLACEMENT WAS CARRIED OUT WITH A COMPLETE CAPSULECTOMY ON B6 2011 ALLERGAN 15-575 WERE AGAIN IMPLANTED THERE WAS 30CC OF STRAW COLORED FLUID SENT TO CYTOLOGY THE DIAGNOSIS OF ALCL WAS MADE IN B6 2011|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-575|01/30/2012|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2800314|3086420|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF LYMPHOMA VIA VOLUNTARY REPORT B4 ALCL ASSOCIATED WITH A SALINE TYPE BREAST IMPLANT ABOUT 2 YEAR HISTORY OF RECURRENT EFFUSION SURROUNDING THE PROSTHESIS BEFORE REMOVAL LYMPHOMA CELLS CONFIRMED TO THE FIBRINOUS EFFUSION WITHOUT MEASURABLE MASS IMPLANT CAPSULE OR SOFT TISSUE INVASION OR LYMPHADENOPATHY PROGNOSIS IS FAVORABLE DATES OF USE 2 YEARS REASON FOR USE RECURRENT BREAST ABSCESS MULTIPLE ATTEMPTS HAVE BEEN MADE TO GATHER ADDITIONAL INFO REGARDING THIS CASE ANY ADDITIONAL INFO REGARDING THIS CASE WILL BE FORWARDED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|10/09/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2578281|2650718|D|1||ADDITIONAL INFORMATION RECEIVED FROM A LITERATURE ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA AND BREAST IMPLANTS FIVE AUSTRALIAN CASES PUBLISHED IN THE PLASTIC AND RECONSTRUCTIVE SURGERY APRIL 2012 PG 610E-617E WITHIN THE ARTICLE THE AUTHOR DESCRIBES A B6 AUGMENTATION PATIENT WHO HAD SURGERY 25 YEARS PRIOR SHE PRESENTED TO HER PRIMARY CARE PHYSICIAN FOR GENERAL MALAISE AND LETHARGY THE DETAILS WERE UNAVAILABLE TO THE AUTHOR HE NOTES HE HAD PERFORMED A HOST OF INVESTIGATIONS THE MAMMOGRAM AND ULTRASOUND SUGGEST RUPTURE WITH PERIPROSTHETIC FLUID COLLECTION AND A THICK CAPSULE SURGERY WAS SCHEDULED TO REMOVE AND REPLACE HER RUPTURED IMPLANTS AT THE TIME OF SURGERY HER IMPLANTS WERE FOUND TO BE INTACT THE CAPSULE HAD GRANULOMATOUS GROWTHS WITHIN IT AND A MODERATE AMOUNT OF SEROMA THAT WAS DRAINED NEW IMPLANTS WERE INSERTED AND CAPSULECTOMIES WERE PERFORMED THE OLD IMPLANTS WERE FOUND TO BE ROUND TEXTURED SILICONE GEL FILLED OF UNKNOWN MAKE HISTOLOGICAL ANALYSIS OF THE RIGHT BREAST CAPSULE WAS CONSISTENT WITH LOCALIZED SYSTEMIC ALCL ALK- HER SYMPTOMS OF LETHARGY AND MALAISE RESOLVED SHE WENT ON TO HAVE CHEMOTHERAPY BUT DECLINED RADIATION WHEN LAST SEEN SHE WAS DISEASE FREE THIS EVENT WAS ORIGINALLY SENT VIA B4 24JAN2011|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/09/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2888497|60334272|D|1||THROUGH MY RESEARCH REVIEW AS RN PRODUCT SUPPORT SPECIALIST THE FOLLOWING ARTICLE CAME TO MY ATTENTION RARE LYMPHOID MALIGNANCIES OF THE BREAST A REPORT OF TWO CASES ILLUSTRATING POTENTIAL DIAGNOSTIC PITFALLS CASE REPORT JOURNAL HEMATOPATHOLOGY 2009 2237-244 WITHIN THE ARTICLE THE AUTHOR DESCRIBES THE ALLEGED EVENTS OF SEMORA AND ALK NEG ALCL LYMPHOMA WITH A SALINE FILLED DEVICE IT IS UNCLEAR IF THE DEVICE IS AN ALLERGAN DEVICE OR NOT FURTHER INVESTIGATION IS CONTINUING|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/20/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2578282|2650719|D|1||HEALTH PROFESSIONAL REPORTED SEROMA AND RIGHT SIDE ALCL A CALL WAS PLACED THE SURGEONS WHERE ADDITIONAL INFORMATION WAS OBTAINED THEY PROVIDE THE FOLLOWING INFORMATION THE PATIENT WAS DIAGNOSED WITH RIGHT SIDE BREAST CANCER ON B6 2001 CARCINOMA IN SITU THE PATIENT UNDERWENT RECONSTRUCTION SURGERY ON B6 2001 WITH A B4 DEVICE ON B6 2004 SHE HAD A PROPHYLACTIC MASTECTOMY ON THE LEFT SIDE AND HAD AN ALLERGAN B4 PLACED ON B6 2004 THE PATIENT HAD ANOTHER REVISION SURGERY REPLACING THE ORIGINAL IMPLANT AND REMOVING THE TE SHE REPLACED WITH B4 RIGHT B4 LEFT B4 THE PATIENT PRESENT WITH RIGHT BREAST SWELLING MRI SHOWED MASSIVE AMOUNT OF FLUID AROUND THE RIGHT BREAST IMPLANT AND SMALL AMOUNT ON THE LEFT A PORTION OF THE MASTECTOMY SCAR WAS EXCISED AND SENT TO PATHOLOGY DISSECTION CARRIED DOWN TO THE MUSCLE A LARGE AMOUNT OF FLUID WAS ENCOUNTERED THIS WAS SENT FOR CYTOLOGY THE IMPLANT WAS REMOVED A PORTION OF THE CAPSULE WAS TAKEN AND SENT TO PATHOLOGY A STYLE B4 WAS THEN PLACED THE PATIENT WAS LAST SEEN B6 2012 AND WAS REFERRED TO SEE A MEDICAL ONCOLOGIST THE PATIENT IS SCHEDULED TO HAVE A PET SCAN AND A BONE MARROW ASPIRATION|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-360|05/09/2012|||DA|N|R||0HP|FTR|1.0||nan||334454|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2617539|20736854|D|1||ALCL INVOLVING BREAST IMPLANT PERIPROSTHETIC SEROMA THE PT IS A B6 FEMALE STATUS POST PLACEMENT OF BREAST IMPLANTS IN 1999 SHE DEVELOPED A RIGHT PERIPROSTHETIC SEROMA APPROX 5 MONTHS PRIOR TO SURGERY DUE TO PRESENCE OF A LATE SEROMA AND LACK OF CLINICAL SIGNS OF INFECTION THE PLASTIC SURGEON FOLLOWED RECOMMENDED MGMT ALGORITHMS - PLASTIC AND RECONSTRUCTIVE SURGERY B6 2011 VOL 128-1-PP-17-25 BOTH IMPLANTS WERE REMOVED ON B6 2012 PER THE OPERATIVE NOTE THE RIGHT IMPLANT WAS INTACT THE CAPSULE WAS SLIGHTLY THICKENED AND HAD ADHERENT WHITE DEBRIS ON THE INTERNAL SURFACE OVER 500 CC OF FLUID WAS ASPIRATED FROM THE PERIPROSTHETIC SEROMA THE FLUID WAS SUBMITTED FOR CULTURE FLOW CYTOMETRIC EVAL AND CYTOLOGIC EVAL THE LEFT IMPLANT CAPSULE WAS THIN AND SOMEWHAT EDEMATOUS THE LEFT IMPLANT WAS INTACT BOTH CAPSULES WERE SUBMITTED FOR PATHOLOGIC EXAMINATION REASON FOR USE BREAST AUGMENTATION|SILICONE BREAST IMPLANT 330 ML||06/11/2012||||N|||0HP|FWM|2.0||SILICONE BREAST IMPLANT 330 ML||40897|||||MCGHAN|||||||True
2617539|20736854|D|1||ALCL INVOLVING BREAST IMPLANT PERIPROSTHETIC SEROMA THE PT IS A B6 FEMALE STATUS POST PLACEMENT OF BREAST IMPLANTS IN 1999 SHE DEVELOPED A RIGHT PERIPROSTHETIC SEROMA APPROX 5 MONTHS PRIOR TO SURGERY DUE TO PRESENCE OF A LATE SEROMA AND LACK OF CLINICAL SIGNS OF INFECTION THE PLASTIC SURGEON FOLLOWED RECOMMENDED MGMT ALGORITHMS - PLASTIC AND RECONSTRUCTIVE SURGERY B6 2011 VOL 128-1-PP-17-25 BOTH IMPLANTS WERE REMOVED ON B6 2012 PER THE OPERATIVE NOTE THE RIGHT IMPLANT WAS INTACT THE CAPSULE WAS SLIGHTLY THICKENED AND HAD ADHERENT WHITE DEBRIS ON THE INTERNAL SURFACE OVER 500 CC OF FLUID WAS ASPIRATED FROM THE PERIPROSTHETIC SEROMA THE FLUID WAS SUBMITTED FOR CULTURE FLOW CYTOMETRIC EVAL AND CYTOLOGIC EVAL THE LEFT IMPLANT CAPSULE WAS THIN AND SOMEWHAT EDEMATOUS THE LEFT IMPLANT WAS INTACT BOTH CAPSULES WERE SUBMITTED FOR PATHOLOGIC EXAMINATION REASON FOR USE BREAST AUGMENTATION|SILICONE BREAST IMPLANT 330ML||06/11/2012||||N|||0HP|FWM|1.0||SILICON BREAST IMPLANT 330ML||40897|||||MCGHAN|||||||True
2935848|3235921|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF LYMPHOMA VIA INVOLUNTARY MW B4 PT HAD PRIOR BILATERAL IMPLANTS MCGHAN 390 ML IMPLANTS CURRENTLY KNOWN AS ALLERGAN INAMED SHE WAS EXPERIENCING BILATERAL CAPSULAR CONTRACTURE AND ENLARGING RIGHT BREAST SURGEON SUSPECTED SEVERE RIGHT BREAST IMPLANT RUPTURE WITH RADIOLOGICAL STUDIES SHE ELECTED TO REMOVE BOTH IMPLANTS NO REPLACEMENTS IMPLANTS WERE DONE THE PATHOLOGY REPORT AND SURGICAL FINDINGS INCLUDED RIGHT BREAST FOUND RESOLVING HEMATOMA WHICH WAS EXTRUDED THE IMPLANT APPEARED INTACT THE PATHOLOGY OF THE RIGHT BREAST IMPLANT CAPSULE REVEALED ALCL THE PT IS CURRENTLY RECEIVING TREATMENT FOR LYMPHOMA PATH REPORT ON B6 2012 LEFT BREAST IMPLANT CAPSULE EXCISION BENIGN FIBROUS PSEUDOCAPSULE AND BENIGN BREAST PARENCHYMA CONSISTENT WITH BREAST IMPLANT CAPSULE RIGHT BREAST IMPLANT CAPSULE EXCISION ALCL DURING THE INVESTIGATION THE SURGEON WAS ABLE TO BE LOCATED TO GATHER TO TRY AND GATHER MORE INFO REGARDING THE CASE TO DATE ALLERGAN HAS NOT BEEN ABLE TO GATHER ANY ADDL INFO REGARDING THIS CASE HOWEVER IF MORE INFO BECOMES AVAILABLE THIS REPORT WILL BE REVIEWED AND UPDATED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/22/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3139659|3524107|D|1||HEALTH PROFESSIONAL REPORTED A LEFT SIDE IMPLANT REMOVAL DUE TO A POSSIBLE ALCL NO FURTHER INFORMATION RECEIVED AT THIS TIME|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/29/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3487103|16685068|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF LYMPHOMA AND OTHER B-SYMPTOMS VIA MW B4 THE MW NOTES THAT THE REPORTER CALLED ON BEHALF OF A PT WHO WAS DIAGNOSED WITH ALCL THE PT PRESENTED WITH ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED IN 2013 HISTORY OF HODGKINS LYMPHOMA DIAGNOSED IN 2011 THESE TWO EVENTS CAME ABOUT AFTER THE PT UNDERWENT BREAST AUGMENTATION IN 1994 IN 2010 PT PRESENTED WITH AN ABNORMAL MAMMOGRAM PERFORMED IN 2010 BREAST PAIN SKIN COLOR CHANGE SKIN TEXTURE CHANGE AND INFLOWING DIFFUSION FORM THE RIGHT BREAST UP TO RIGHT NECK AND SHOULDER THE PT WAS RUNNING A FEVER THROUGHOUT THE ENTIRE PROCESS AFTER AN MRI AND SUBSEQUENT TEST THE PT WAS DIAGNOSED WITH HODGKINS LYMPHOMA AND UNDERWENT MANTLE RADIATION IN 2012 THE PT UNDERWENT SURGERY ESSENTIALLY FOR A BREAST MASS BUT THE PT ALSO DESIRED A MASTECTOMY FOR REMOVAL OF RIGHT AND LEFT IMPLANTS AND CAPSULES THE PATHOLOGY OF THE OPERATION SOON REPORTED THAT THE PT ALSO HAS ALCL THE MASS HAD COME FROM THE LYMPHOMA|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/07/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||BOLETA|US|ALLERGAN||CA|||||True
3165371|62390606|D|1||HEALTH PROFESSIONAL REPORTED  A SUBPECTORAL SALINE IMPLANT IS IDENTIFIED ON THE RIGHT CAPSULAR INFOLDING - CAPSULAR CONTRACTURES ARE IDENTIFIED A SMALL-MODERATE VOLUME OF FLUID IS SEEN AROUND THE IMPLANT ADDITIONALLY PATIENT REPORTS TO HEALTH PROFESSIONAL ITCHING OF THE RIGHT BREAST PATIENT HAD A MASTECTOMY TEN YEARS AGO POST OP PATIENT HAD A MILD INFECTION WHICH RESOLVED WITH ANTIBIOTICS PATIENT WAS RECENTLY DIAGNOSED WITH SUPRACLAVICULAR AND AXILLARY LYMPHADENOPATHY RECENT PET THAT SHOWED ENLARGED RIGHT EPITROCHLEAR LYMPH NODE THE BIOPSY SHOWED HODGKIN LYMPHOMA NODULAR SCLEROSIS BONE MARROW BIOPSY WAS NEGATIVE FOR LYMPHOMA PATIENT WAS TREATED WITH ABVD SUBSEQUENT SPECIMENS REVIEW HERE FROM PERI-PROSTHETIC FLUID OF THE RIGHT CHEST WAS REPORTED AS ATYPICAL LYMPHOID CELLS MOST CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA IN PERIPROSTHETIC FLUID AND SUBSEQUENT EXCISIONAL BIOPSY OF THE RIGHT BREAST CAPSULE IMMUNOHISTOCHEMICAL STAINS SHOW THAT THE ATYPICAL LYMPHOID CELLS ARE POSITIVE FOR CD15 AND CD30 THESE FINDINGS RAISE THE POSSIBILITY OF HODGKINS LYMPHOMA PATHOLOGICAL MARKERS DID NOT CONFIRM ALCL EVENT WILL BE CAPTURED AS LYMPHOMA DEVICE WAS REMOVED AND PATIENT HAD A PARTIAL CAPSULECTOMY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/07/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
3165371|62391233|D|1||HEALTH PROFESSIONAL REPORTED  Â¿A SUBPECTORAL SALINE IMPLANT IS IDENTIFIED ON THE RIGHT CAPSULAR INFOLDING Â¿ CAPSULAR CONTRACTURES ARE IDENTIFIED A SMALL-MODERATE VOLUME OF FLUID IS SEEN AROUND THE IMPLANTÂ¿ ADDITIONALLY PATIENT REPORTS TO HEALTH PROFESSIONAL Â¿ITCHING OF THE RIGHT BREASTÂ¿PATIENT HAD A MASTECTOMY TEN YEARS AGOÂ¿POST OP PATIENT HAD A MILD INFECTION WHICH RESOLVED WITH ANTIBIOTICSÂ¿ PATIENT WAS RECENTLY DIAGNOSED WITH SUPRACLAVICULAR AND AXILLARY LYMPHADENOPATHY Â¿RECENT PET THAT SHOWED Â¿ENLARGED RIGHT EPITROCHLEAR LYMPH NODEÂ¿ THE BIOPSY SHOWED Â¿HODGKIN LYMPHOMA NODULAR SCLEROSIS BONE MARROW BIOPSY WAS NEGATIVE FOR LYMPHOMA PATIENT WAS TREATED WITH ABVD SUBSEQUENT SPECIMENS REVIEW HERE FROM PERI-PROSTHETIC FLUID OF THE RIGHT CHEST WAS REPORTED AS ATYPICAL LYMPHOID CELLS MOST CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA IN PERIPROSTHETIC FLUID AND SUBSEQUENT EXCISIONAL BIOPSY OF THE RIGHT BREAST CAPSULE IMMUNOHISTOCHEMICAL STAINS SHOW THAT THE ATYPICAL LYMPHOID CELLS ARE POSITIVE FOR CD15 AND CD30 THESE FINDINGS RAISE THE POSSIBILITY OF HODGKINÂ¿S LYMPHOMAÂ¿ PATHOLOGICAL MARKERS DID NOT CONFIRM ALCL EVENT WILL BE CAPTURED AS LYMPHOMA DEVICE WAS REMOVED AND PATIENT HAD A PARTIAL CAPSULECTOMY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/07/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
3016526|3318828|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF ALCL AND SEROMA OF THIS PT WITH A HISTORY OF LEFT SIDE BREAST CANCER THE PT PRESENTS IN B6 2012 WITH LEFT SIDE BREAST SWELLING CT WAS PERFORMED AND CONFIRMS SEROMA IN B6 2012 SEROMA WAS ASPIRATED AND SENT FOR CULTURE ALCL WAS DIAGNOSED|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT||03/19/2013|||DA|N|R||0HP|FTR|1.0||nan||252664|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||153-360||True
3108566|16911202|D|1||HEALTHCARE PROFESSIONAL REPORTED A CASE OF SEROMA CAPSULAR CONTRACTURE BAKER GRADE IV AND LYMPHOMA PT HAD PRIMARY BILATERAL RECONSTRUCTION FOR RIGHT SIDE BREAST CANCER ON B6 2007 WITH TWO SUBSEQUENT SURGERIES SHE PRESENTED IN B6 2011 WITH SEROMA OF THE RIGHT BREAST THE BIOPSY WAS NEGATIVE THE CAPSULE BIOPSY WAS POSITIVE FOR ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|05/07/2013|||DA|N|R||0HP|FTR|1.0|02/22/2012|nan||1409894|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3487123|4026308|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF LYMPHOMA AND OTHER B-SYMPTOMS VIA MW B4 THE MW NOTES THAT THE REPORTER CALLED ON BEHALF OF PT WHO WAS DIAGNOSED WITH ALCL THE PT PRESENTED WITH ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED IN 2013 HISTORY OF HODGKINS LYMPHOMA DIAGNOSED IN 2011 THESE TWO EVENTS CAME ABOUT AFTER THE PT UNDERWENT BREAST AUGMENTATION IN 1994 IN 2010 PT PRESENTED WITH AN ABNORMAL MAMMOGRAM PERFORMED IN 2010 BREAST PAIN SKIN COLOR CHANGE SKIN TEXTURE CHANGE AND INFLOWING DIFFUSION FROM THE RIGHT BREAST UP TO RIGHT CHECK AND SHOULDER THE PT WAS RUNNING A FEVER THROUGHOUT THE ENTIRE PROCESS AFTER AN MRI AND SUBSEQUENT TESTS THE PT WAS DIAGNOSED WITH HODGKINS LYMPHOMA AND UNDERWENT MANTLE RADIATION IN 2012 THE PT UNDERWENT SURGERY ESSENTIALLY FOR A BREAST MASS BUT THE PT ALSO DESIRED A MASTECTOMY FOR REMOVAL OF RIGHT AND LEFT IMPLANTS AND CAPSULES THE PATHOLOGY OF THE OPERATION SOON REPORTED THAT THE PT ALSO HAS ALCL THE MASS HAD COME FROM THE LYMPHOMA|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/07/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3418292|3776961|D|1||HAD SILICONE MENTOR BREAST IMPLANTS IN 2006 GOT DIAGNOSED WITH RHEUMATOID ARTHRITIS 1 YEAR LATER ALSO HAVE HASHIMOTOS DISEASE CHRONIC FATIGUE BRAIN FOG POSSIBLE ALCL LYMPHOMA ACCORDING TO MY DOCTOR I AM GETTING THEM REMOVED NEXT MONTH AND WILL GIVE AN UPDATE AFTER REMOVAL SILICONE IMPLANTS SHOULD NOT BE ON THE MARKET|SILICONE BREAST IMPLANT||10/15/2013|||||||0HP|FTR|1.0||SILICONE BREAST IMPLANT|||||||MENTOR (J AND J)|||||||True
3405834|62723956|D|1||ADDITIONAL INFORMATION REPORTED FROM JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT A CASE REPORT AND REVIEW OF THE LITERATURE DETORRES ET AL  REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY 18 2013 DEVELOPED DURING THE FOLLOW UP AN AXILLARY LYMPH NODE THE EXCISIONAL BIOPSY OF THAT NODE SHOWED AN ALK NEGATIVE ALCL THE PET-TAC SHOWS A FOCAL INCREASED OF FDG UPTAKE AT LEFT AXILLAR REGION AND AT THE BREAST PROSTHETIC FLUID AREA WITH NO OTHER PATHOLOGICAL FINDINGS THE PATIENT RECEIVED 4 CYCLES OF CHOP CYCLOPHOSPHAMIDE DOXORUBICIN AND VINCRISTINE CHEMOTHERAPY THE PROSTHESES WAS REMOVED AND THEN THE PATIENT RECEIVED POSTOPERATIVE ADJUVANT RADIOTHERAPY ON THE CHEST WALL AND REGIONAL LYMPH NODES TO A TOTAL DOSE OF 36 GY NO PATHOLOGY OR FOLLOW-UP CONFIRMING CD30+ THEREFORE EVENT WILL REMAIN REPORTABLE AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|10/04/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
3405834|62724174|D|1||RECEIVED AN ARTICLE FROM PRODUCT WATCH ENTITLED ALCL ASSOCIATED BREAST IMPLANT A CASE REPORT AND REVIEW OF THE LITERATURE WRITTEN BY DETORRES ET AL WITHIN THE ARTICLE IT IS NOTED THE PATIENT HAD SEROMA AND LYMPHOMA THE MANUFACTURER OF THIS DEVICE IS UNKNOWN ADDITIONAL INFORMATION REPORTED FROM JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT A CASE REPORT AND REVIEW OF THE LITERATURE DETORRES ET AL REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY 18 2013 DEVELOPED DURING THE FOLLOW UP AN AXILLARY LYMPH NODE THE EXCISIONAL BIOPSY OF THAT NODE SHOWED AN ALK NEGATIVE ALCL THE PET-TAC SHOWS A FOCAL INCREASED OF FDG UPTAKE AT LEFT AXILLAR REGION AND AT THE BREAST PROSTHETIC FLUID AREA WITH NO OTHER PATHOLOGICAL FINDINGS THE PATIENT RECEIVED 4 CYCLES OF CHOP CYCLOPHOSPHAMIDE DOXORUBICIN AND VINCRISTINE CHEMOTHERAPY THE PROSTHESES WAS REMOVED AND THEN THE PATIENT RECEIVED POSTOPERATIVE ADJUVANT RADIOTHERAPY ON THE CHEST WALL AND REGIONAL LYMPH NODES TO A TOTAL DOSE OF 36 GY NO PATHOLOGY OR FOLLOW-UP CONFIRMING CD30+ THEREFORE EVENT WILL REMAIN REPORTABLE AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|10/04/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
3405834|3912734|D|1||RECD AN ARTICLE FROM PRODUCT WATCH ENTITLED ALCL ASSOCIATED BREAST IMPLANT A CASE REPORT AND REVIEW OF THE LITERATURE WRITTEN BY DE TORRES ET AL WITHIN THE ARTICLE IT IS NOTED THE PT HAD SEROMA AND LYMPHOMA THE MFR OF THIS DEVICE IS UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|10/04/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
3023802|10610793|N|1||B4 DEVICE LABELLING ADDRESSES SEROMA AND ALCL ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFO REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MFRS BREAST IMPLANTS YOU SHOULD CONSIDER POSSIBILITY OF ALCL WHEN YOU HAVE A PT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMENT FOR PERI-IMPLANT ALCL FOR MORE COMPLETE AND UP-TO-DATE INFO ON FDAS ANALYSIS AND REVIEW OF THE ALCL IN PTS WITH BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSAND PROSTHETICSBREASTIMPLANTSUCM239995HTM|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410360|03/26/2013|||DA|N|R||0HP|FTR|1.0|10/03/2012|nan||1507531|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3023802|3320091|D|1||ALLERGAN REP REPORTED PHYSICIAN REPORTS THAT A PT HAS BEEN DIAGNOSED WITH ALCL THE PT PRESENTED WITH A RIGHT SIDE SWOLLEN BREAST ASPIRATION PERFORMED THERE WAS FLUID BUT NO BLOOD|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410360|03/26/2013|||DA|N|R||0HP|FTR|1.0|10/03/2012|nan||1507531|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3031016|3257906|D|1||HEALTH PROFESSIONAL REPORTED LEFT SIDE PAIN ACCUMULATION OF FLUID AND DIAGNOSIS OF ALCL THIS EVENT WAS REPORTED VIA EPSR Q2 B6 2010|STYLE 10 SILICONE GEL FILLED BREAST IMPLANT|10-390|11/15/2012|||DA|N|R||0HP|FTR|1.0|10/15/2011|nan||1361759|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2926371|3122338|D|1||POSSIBLE ALCL SYMPTOMS|GEL-FILLED MAMMARY PROSTHESIS|354-4007|01/15/2013|||DA|N|R||0HP|FTR|1.0||BREAST IMPLANT||5744550|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR TEXAS, INC.|75038|TX|75038||||True
3378227|3752540|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF ALCL AND SEROMA VIA ALLERGAN LEGAL DEPARTMENT B4 THE PATIENT HAS A HISTORY OF BREAST CANCER THAT WAS DIAGNOSED B62004 SHE HAD A TOTAL MASTECTOMY WITH LYMPHNODE DISSECTION ON B6 2004 ON B6 2006 THE PATIENT UNDERWENT RECONSTRUCTION SURGERY WITH LATISSISMUS DORSI FLAP USING ALLERGAN 110-480 TEXTURED DEVICES IN B6 2003 THE PATIENT HAD SIX ROUNDS OF CHEMO BUT DID NOT REQUIRE RADIATION ON B6 2013 THE PATIENT PRESENTED TO HER SURGEON WITH LEFT BREAST BREAST SWELLING ON A REFERRAL FROM HER PCP AN ULTRASOUND WAS CARRIED OUT B6 2013 EXPLANT SURGERY WITH COMPLETE CAPSULECTOMY ON B6 2013 WAS PERFORMED THE SEROMA WAS SENT TO THE LAB ALONG WITH THE IMPLANT AND THE CAPSULE DURING THE SURGERY THE PATIENT WAS ALSO NOTED TO HAVE NODULES UNDER THE LEFT BREAST IMPLANT THE HISTOLOGY REPORT NOTES ALCL ALK-MARKER CD30+|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-480|09/17/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2933301|3225699|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED A LETTER REPORTING A PATIENT HAD BILATERAL BREAST AUGMENTATION WITH SILICONE BREAST IMPLANTS AND WAS DIAGNOSED WITH LYMPHOMA OF THE ANTERIOR MEDIASTINUM THERE IS LIMITED INFORMATION AVAILABLE FOR THIS CASE AFTER THE INITIAL INVESTIGATION AND THERE IS AN UNLIKELY CHANCE THAT THIS INFORMATION WILL BE OBTAINED HOWEVER IF THERE IS ADDITIONAL INFORMATION SUCH AS DEVICE INFORMATION IMPLANTINGEXPLANTING PHYSICIAN OR ANY LABS RELATED TO BUT NOT LIMITED TO ANY COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL THE FILE WILL BE REVIEWED AND UPDATED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 120|01/23/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3134127|10793581|N|1||B4 THE B4 LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA ALCL ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MFRS BREAST IMPLANT YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM R OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL FOR MORE COMPLETE AND UP-TO-DATE INFORMATION ON FDAS ANALYSIS AND REVIEW OF THE ALCL PTS WITH BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSETHETICSBREASTIMPLANTSUCM239995HTM THE 410 LABELING ADDRESSES CAPSULAR CONTRACTURE CAPSULAR CONTRACTURE - PTS SHOULD BE ADVISED THAT CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWING INFECTION HEMATOMA SEROMA AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME CAPSULAR CONTRACTURE OCCURS MORE COMMONLY IN REVISION PTS THAN IN PRIMARY AUGMENTATION OR RECONSTRUCTION PTS CAPSULAR CONTRACTURE IS ALSO A RISK FACTOR FOR IMPLANT RUPTURE AND IT IS ONE OF THE MOST COMMON REASONS FOR REOPERATION THE B4 LABELING ADDRESSES SEROMA ADDITIONAL COMPLICATIONS - AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME PAIN HEMATOMASEROMA CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3134127|3458905|D|1||ANAPLASTIC LARGE CELL LYMPHOMA OF THE BREAST ARISING AROUND MAMMARY IMPLANT CAPSULE A B6 REPORT WRITTEN IN B4 REPORTS ALCL SEROMA AND CAPSULAR CONTRACTURE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3134127|61102727|N|1||MEDWATCH SUBMITTED TO THE FDA ON 07162015 ADVERSE EVENT OF ALCL WAS REPORTED PREVIOUSLY BUT AS THERE IS NO PATHOLOGY OR FOLLOW-UP CONFIRMING CD30+ OR ALK- THE EVENT WILL REMAIN REPORTABLE AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3134124|18173802|N|1||B4 THE 410 DEVICE LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA ALCL ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MFRS BREAST IMPLANT YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM ER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL FOR MORE COMPLETE AND UP-TO-DATE INFORMATION ON FDAS ANALYSIS AND REVIEW OF THE ALCL PTS WITH BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICAL DEVICESPRODUCTSAND MEDICALPROCEDURESIMPLANTSANDPROSETHETICSBREASTIMPLANTSUCM239995HTM THE 410 LABELING ADDRESSES SEROMA AND PAIN ADDITIONAL COMPLICATIONS - AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME PAIN HEMATOMASEROMA CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3134124|17839593|D|1||ANAPLASTIC LARGE CELL LYMPHOMA OF THE BREAST ARISING AROUND MAMMARY IMPLANT CAPSULE AN B6 REPORT WRITTEN IN AESTHETIC PLASTIC SURGERY 2013 REPORTS ALCL SEROMA PAIN|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3031014|3257466|D|1||HEALTHCARE PROFESSIONAL REPORTS IN AN ARTICLE A CASE OF SEROMA AND ALCL THE LANCET 2012 380 1530 WITHIN THE ARTICLE THE AUTHOR REPORTS IN B4 2010 A PREVIOUSLY HEALTHY B6 WOMAN WITH TEXTURED SALINE BREAST IMPLANTS PLACED SUBPECTORALLY 8 YEARS AGO FOR AESTHETIC PURPOSES PRESENTED WITH 2-MONTH HISTORY OF A PAINLESS MASS UNDERNEATH HER LEFT ARM PHYSICAL EXAMINATION SHOWED A SYMMETRICAL BREASTS WITH NO OVERLYING SKIN OR NIPPLE CHANGES THERE WERE TWO LARGE MOBILE NODES PALPABLE IN THE LEFT AXILLA INITIAL BREAST MAMMOGRAPHY AND ULTRASONOGRAPHY CONFIRMED LEFT AXILLARY LYMPHADENOPATHY BUT DID NOT SHOW ANY PERI-IMPLANT FLUID COLLECTION BIOPSY OF THE LEFT AXILLARY MASS SHOWED FINDINGS CONSISTENT WITH CLASSIC HODGKINS LYMPHOMA NODULAR SCLEROSING TYPE IT LACKED TWO TYPICAL STAINS-CD15 AND PAX5 PET-CT SHOWED A 5-CM AREA OF PET-AVID LEFT AXILLARY LYMPHADENOPATHY HODGKINS LYMPHOMA STAGE IA WAS DIAGNOSED THE PT THEN HAD TWO CYCLES OF ADRIAMYCIN BLEOMYCIN VINBLASTINE AND DACARBAZINE ABVD AND 2000 GY OF FIELD RADIATION TO THE LEFT AXILLA HER INITIAL TREATMENT WAS COMPLETED IN B6 2011 FU CT SCAN IN B6 2011 SHOWED A DECREASE IN THE SIZE OF THE LEFT AXILLARY LYMPHADENOPATHY UNILATERAL FLUID COLLECTION HOWEVER WAS NOTED AROUND THE LEFT BREAST IMPLANT FIGURE THE FLUID INCREASED IN SIZE AND SHE PRESENTED 6 MONTHS ALTER WITH LEAKAGE OF SEROUS FLUID FROM HER LEFT BREAST CYTOLOGY OF THE PERI-IMPLANT FLUID SHOWED CD30+ LYMPHOMA CELLS OF INDETERMINATE LINEAGE DIFFERENT DIAGNOSIS INCLUDED RECURRENT HODGKINS LYMPHOMA OR IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMA REPEAT PET-CT SHOWED PET-AVID AREAS ON BILATERAL AXILLARY LYMPH NODES BOTH IMPLANTS WERE REMOVED WITH CAPSULECTOMIES IN B6 2011 SHE REPEAT PET-CT SHOWED PET-AVID AREAS IN BILATERAL AXILLARY LYMPH NODES BOTH IMPLANTS WERE REMOVED WITH CAPSULECTOMIES IN B6 2011 SHE WAS TREATED WITH FOUR CYCLES OF SALVAGE CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN FOR ASSUMED RECURRENT HODGKINS LYMPHOMA FU SONOGRAPHY OF THE LEFT BREAST 1 MONTH LATER SHOWED A HYPOECHOIC MASS BIOPSY OF THE MASS SHOWED SIMILAR CELLS FROM THE PERI-IMPLANT FLUID WHICH WERE CD30+ LYMPHOMA CELLS OF INDETERMINATE ORIGIN THE MASS WAS RESECTED IN B6 2012 AND PATHOLOGICAL TESTS SHOWED B6 SEROMA-ASSOCIATED LARGE-CELL LYMPHOMA ALK-NEGATIVE ALCL A RETROSPECTIVE REVIEW OF ALL SIDES SHOWED LARGE CELLS CHARACTERISTIC OF ALK-NEGATIVE ALCL SUBSTANTIAL OVERLAP IN MORPHOLOGY AND IMMUNOPHENOTYPE OF CELLS FROM THE INITIAL AXILLARY LYMPH NODE BIOPSY THE PERI-IMPLANT FLUID AND THE FINAL LEFT BREAST MASS BIOPSY SUGGESTED THE SAME MANIFESTATIONS OF THE ALCL THE PRESENTATION IS UNIQUE BECAUSE ALK-NEGATIVE ALCL PRESENTED WITH A PATHOLOGICAL AXILLARY LYMPH NODE INSTEAD OF THE TYPICAL PERI-IMPLANT SEROMA OUR PT COMPLETED BRENTUXIMAB THERAPY FOR TREATMENT OF ALK-NEGATIVE ALCL THE PT WAS LAST SEEN ON B6 2012 AND IS IN STABLE CONDITION|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/15/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3487125|4004895|D|1||HEALTHCARE PROFESSIONAL REPORTS VIA B4 A CASE OF LATE SEROMA AND LYMPHOMA THIS REPORT COMES FROM AN UNIDENTIFIED HEALTHCARE PROFESSIONAL THE B4 NOTES TO WHOM IT MAY CONCERN PURSUANT TO THE PARTNERSHIP BETWEEN THE FDA AND CONCERNING BREAST IMPLANT-ASSOCIATED ALCL WE ARE REPORTING A CASE OF ALCL ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED WITH A BREAST IMPLANT PT FIRST PRESENTED AFTER HAVING HAD BREAST AUGMENTATION SEVERAL YEARS PRIOR SHE HAD NOTICED SWELLING OF THE LEFT BREAST WHICH EVENTUALLY BECAME PAINFUL AND CAUSED HER TO SEEK TREATMENT WORKUP EVENTUALLY REVEALED SEROMA AROUND THE BREAST IMPLANT THE FLUID CAME BACK AS CD 30 POSITIVE ALK NEGATIVE CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA HER IMPLANTS WERE REMOVED BILATERALLY AND IT IS FELT THAT THIS IS ADEQUATE TREATMENT FOR THE PROBLEM SHE CONTINUES TO UNDERGO SURVEILLANCE BY US IN ADDITION TO THE HEMATOLOGYONCOLOGY TEAM OF NOTE SHE WAS FOUND TO HAVE NONRUPTURED 410 CC TEXTURED SILICONE IMPLANT MAY BE CUI NOT AVAILABLE IN THE UNITED STATES THE PTS CARE WAS COORDINATED BETWEEN THE PLASTIC SURGERY AND THE HEMATOLOGYONCOLOGY TEAMS BREAST IMPLANTS REMOVED NOT REPLACED PT WILL UNDERGO SURVEILLANCE WITH MRI AND ULTRASOUND|UNK CUI GEL|UNK CUI GEL|11/07/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3390404|3798157|D|1||BILATERAL SUBGLANDULAR TEXTURED SILICONE GEL BREAST IMPLANTS IMPLANTED 15 YEARS AGO WITH RECENT DEVELOPMENT OF 700 CC OF OPAQUE PERI-IMPLANT SEROMA AND CAPSULAR THICKENING INF LEFT BREAST STATUS POST BILATERAL IMPLANT EXPLANTATION AND BILATERAL CAPSULECTOMY WITH DIAGNOSIS OF LEFT BREAST IMPLANT- ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ALCL ON LEFT BREAST CAPSULECTOMY PATHOLOGICAL SPECIMEN AND L BREAST SEROMA FLUID POSITIVE FOR ALCL CELLS FOLLOWING REPEAT BILATERAL CAPSULECTOMY DIAGNOSIS BILATERAL BREAST AUGMENTATIONCOSMESIS|TEXTURED SILICONE GEL IMPLANT 220CC||10/02/2013||||N|||000|FTR|1.0||BREAST IMPLANTS|||||||MCGHAN/ALLERGAN|||||||True
3167435|3551128|D|1||THE PT UNDERWENT BREAST RECONSTRUCTION WITH MENTOR SILTEX GEL FILLED DEVICES THE PT UNDERWENT SURGERY 5 YRS LATER TO CORRECT A SYMMETRY ISSUE WHEN A LARGE SEROMA AND FIBRINOUS GELANTINOUS TISSUE WERE DISCOVERED UNDER THE IMPLANT THE TISSUE WAS SENT FOR CULTURE AND CAME BACK AS ALCL THE DEVICE WAS DISCARDED B4|MEMORYGEL MAMMARY PROSTHESIS|354-4450|06/05/2013||||N|R||0HP|FTR|1.0||BREAST IMPLANT||5769207|||IRVING|US|MENTOR WORLDWIDE LLC||TX|||||True
3208898|3579679|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF ALCL OF THE RIGHT BREAST ALONG WITH SEROMA THE PT HAD AN AUGMENTATION DATE OF SURGERY NOT PROVIDED AT THIS TIME THE PT PRESENTED WITH PAIN AND SWELLING ON B6 2013 AND HAD AN US THAT CONFIRMED SEROMA ON B6 2013 CYTOLOGY TAKEN AND SENT TO PATHOLOGY THE PT HAD BILATERAL REMOVAL WITH CAPSULECTOMY WITHOUT REPLACEMENT B6 2013 PET SCAN PERFORMED WHICH WAS NEGATIVE ONCOLOGY CONSULT TOOK PLACE HOWEVER THE NOTES ARE NOT AVAILABLE AT THIS TIME INFO PROVIDED CONFIRMS THAT THERE IS NOT A FAMILY HISTORY OF BREAST CANCER HOWEVER THERE IS A POSITIVE HISTORY FOR OVARIAN CANCER|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-507|07/02/2013|||DA|N|R||0HP|FTR|1.0|01/25/2013|nan||1559225|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3264883|3621903|D|1||ALCL SYMPTOMS|SILTEX CONTOUR PROFILE ROUND SPECTRUM|354-2515|07/26/2013|||||R||0HP|FWM|1.0||BREAST IMPLANT|||||IRVING|US|MENTOR||TX|||||True
3428755|21496558|D|1||ALCL CASE REPORT PT B6 PRESENTED WITH LATE SEROMA AND CAPSULAR CONTRACTURE PAIN IN RIGHT BREAST B6 2013 PT DELAYED SURGICAL INTERVENTION AS SEROMA WAS TEMPORARILY BETTER PHYSICIAN INSISTED ON INTERVENTION DEVICE REMOVED B6 2013 DIAGNOSIS B6 2013 RIGHT BREAST SEROMA FLUID - MALIGNANT CELLS PRESENT FLUID ONLY CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA NO LARGE CELLS NOTED OUTSIDE OF THE FIBROUS CAPSULE NO CAPSULAR INVASION OR EXTRACAPSULAR EXTENSION NOTED|SILICONE GEL - FILLED TEXTURED BREAST IMPLANT|20621-525U|10/18/2013|||DA|N|R||0HP|FTR|1.0|04/01/2008|nan|||11220 GRADER ST|STE 100|DALLAS|US|SILIMED, INC.|75238|TX|75238||20621||True
3170177|21675522|D|1||REPORTER CALLED ON BEHALF OF A PT WHO WAS DIAGNOSED WITH ALCL THE PT PRESENTED WITH ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED ON B6 2013 HISTORY OF HODGKINS LYMPHOMA DIAGNOSED B6 2011 THESE TWO EVENTS CAME ABOUT AFTER THE PT UNDERWENT BREAST AUGMENTATION IN 1994 THIS REPORT IS FILED IN RESPONSE TO THE FOLLOWING REPORT WWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTUCM239995HTM IN 2010 PT PRESENTED WITH AN ABNORMAL MAMMOGRAM DONE ON B6 2010 BREAST PAIN SKIN COLOR CHANGE SKIN TEXTURE CHANGE AND INFLOWING DIFFUSION FROM THE RIGHT BREAST UP TO RIGHT NECK AND SHOULDER THE PT WAS RUNNING A FEVER THROUGHOUT THE ENTIRE PROCESS AFTER AN MRI AND SUBSEQUENT TESTS THE PT WAS DIAGNOSED WITH HODGKINS LYMPHOMA AND UNDERWENT MANTLE RADIATION ON B6 2012 THE PT UNDERWENT SURGERY ESSENTIALLY FOR A BREAST MASS BUT THE PT ALSO DESIRED A MASTECTOMY FOR REMOVAL OF RIGHT AND LEFT IMPLANTS AND CAPSULES THE PATHOLOGY OF THE OPERATION SOON REPORTED THAT THE PT ALSO HAS ALCL THE MASS HAD COME FROM THE LYMPHOMA|MCGHAN 420 CC BREAST IMPLANTS (RIGHT & LEFT)||06/13/2013|||||||0|FWM|1.0||SALINE BREAST IMPLANT|||||||MCGHAN MED CORP|||||||True
3269181|3756340|D|1||SUDDEN ONSET OF SWELLING LATE SEROMA OF LEFT BREAST IMPLANT RECONSTRUCTION SHE PREVIOUSLY HAD 2-STAGE BREAST RECONSTRUCTION WITH PLACEMENT OF BILATERAL TISSUE EXPANDERS ON B6 2005 MCGHAN REF 67-133LV13 EXPANDERS WITH LEFT SN B4 LOT 623514 AND RIGHT SN B4 AND LOT 1030255 IMPLANTS WERE PLACED ON B6 2005 INAMED REF 27-FF125-375 WITH LEFT SN B4 AND LOT 335112 AND RIGHT SN B4 AND LOT 380839 PRESENTATION OF LATE SEROMA WAS ALMOST 8 YRS AFTER IMPLANT PLACEMENT SEROMA FLUID WAS ASPIRATED UNDER ULTRASOUND GUIDANCE AND WAS POSITIVE FOR MALIGNANT CELL ANAPLASTIC LARGE CELL LYMPHOMA ALCL INPATIENT SURGERY FOR REMOVAL OF BILATERAL BREAST IMPLANTS WITH TOTAL CAPSULECTOMIES WAS PERFORMED AND PATHOLOGY REVEALED ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING BUT NOT EXTENDING BEYOND THE LEFT CAPSULE THE CONTRALATERAL RIGHT SIDE HAD SEROMA FLUID AROUND IT AND AT THE TIME OF SURGERY THIS FLUID WAS SENT FOR CYTOLOGY AND ALSO FOUND TO BE POSITIVE FOR ANAPLASTIC LARGE CELL LYMPHOMA NO EVIDENCE OF DISTANT DISEASE TISSUE EXPANDERS WERE USED FOR 1ST STAGE BREAST RECONSTRUCTION PRIOR TO PLACEMENT OF THE IMPLANT EXPANDERS WERE PLACED ON B6 2005 AND REMOVED ON B6 2005 WHEN THE FINAL IMPLANTS WERE PLACED EXPANDERS WERE MCGHAN 133LV INAMED EXPANDERS WITH REFERENCECATALOG 76-133LV13 SERIAL NUMBERS AND LOT NUMBERS AS DESCRIBED IN INITIAL NARRATIVE OF EVENT REASON FOR USE 1 - POSTMASTECTOMY BREAST RECONSTRUCTION 2 - POSTMASTECTOMY BREAST RECONSTRUCTION EVENT ABATED AFTER USE STOPPED OR DOSE REDUCED 1 - YES 2 - YES|410FF BREAST IMPLANT LEFT|27-FF125-375|08/01/2013||||Y|||0LP|FWM|1.0||BREAST IMPLANT, HIGHLY-TEXTURED FORM-STABLE||335112|||||INAMED CORPORATION, NOW ALLERGAN|||||||True
3269181|3756340|D|1||SUDDEN ONSET OF SWELLING LATE SEROMA OF LEFT BREAST IMPLANT RECONSTRUCTION SHE PREVIOUSLY HAD 2-STAGE BREAST RECONSTRUCTION WITH PLACEMENT OF BILATERAL TISSUE EXPANDERS ON B6 2005 MCGHAN REF 67-133LV13 EXPANDERS WITH LEFT SN B4 LOT 623514 AND RIGHT SN B4 AND LOT 1030255 IMPLANTS WERE PLACED ON B6 2005 INAMED REF 27-FF125-375 WITH LEFT SN B4 AND LOT 335112 AND RIGHT SN B4 AND LOT 380839 PRESENTATION OF LATE SEROMA WAS ALMOST 8 YRS AFTER IMPLANT PLACEMENT SEROMA FLUID WAS ASPIRATED UNDER ULTRASOUND GUIDANCE AND WAS POSITIVE FOR MALIGNANT CELL ANAPLASTIC LARGE CELL LYMPHOMA ALCL INPATIENT SURGERY FOR REMOVAL OF BILATERAL BREAST IMPLANTS WITH TOTAL CAPSULECTOMIES WAS PERFORMED AND PATHOLOGY REVEALED ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING BUT NOT EXTENDING BEYOND THE LEFT CAPSULE THE CONTRALATERAL RIGHT SIDE HAD SEROMA FLUID AROUND IT AND AT THE TIME OF SURGERY THIS FLUID WAS SENT FOR CYTOLOGY AND ALSO FOUND TO BE POSITIVE FOR ANAPLASTIC LARGE CELL LYMPHOMA NO EVIDENCE OF DISTANT DISEASE TISSUE EXPANDERS WERE USED FOR 1ST STAGE BREAST RECONSTRUCTION PRIOR TO PLACEMENT OF THE IMPLANT EXPANDERS WERE PLACED ON B6 2005 AND REMOVED ON B6 2005 WHEN THE FINAL IMPLANTS WERE PLACED EXPANDERS WERE MCGHAN 133LV INAMED EXPANDERS WITH REFERENCECATALOG 76-133LV13 SERIAL NUMBERS AND LOT NUMBERS AS DESCRIBED IN INITIAL NARRATIVE OF EVENT REASON FOR USE 1 - POSTMASTECTOMY BREAST RECONSTRUCTION 2 - POSTMASTECTOMY BREAST RECONSTRUCTION EVENT ABATED AFTER USE STOPPED OR DOSE REDUCED 1 - YES 2 - YES|410FF BREAST IMPLANT RIGHT|27-FF125-375|08/01/2013||||Y|||0LP|FWM|2.0||BREAST IMPLANT, HIGHLY-TEXTURED FORM-STABLE||380839|||||INAMED CORPORATION, NOW ALLERGAN|||||||True
3269181|3756340|D|1||SUDDEN ONSET OF SWELLING LATE SEROMA OF LEFT BREAST IMPLANT RECONSTRUCTION SHE PREVIOUSLY HAD 2-STAGE BREAST RECONSTRUCTION WITH PLACEMENT OF BILATERAL TISSUE EXPANDERS ON B6 2005 MCGHAN REF 67-133LV13 EXPANDERS WITH LEFT SN B4 LOT 623514 AND RIGHT SN B4 AND LOT 1030255 IMPLANTS WERE PLACED ON B6 2005 INAMED REF 27-FF125-375 WITH LEFT SN B4 AND LOT 335112 AND RIGHT SN B4 AND LOT 380839 PRESENTATION OF LATE SEROMA WAS ALMOST 8 YRS AFTER IMPLANT PLACEMENT SEROMA FLUID WAS ASPIRATED UNDER ULTRASOUND GUIDANCE AND WAS POSITIVE FOR MALIGNANT CELL ANAPLASTIC LARGE CELL LYMPHOMA ALCL INPATIENT SURGERY FOR REMOVAL OF BILATERAL BREAST IMPLANTS WITH TOTAL CAPSULECTOMIES WAS PERFORMED AND PATHOLOGY REVEALED ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING BUT NOT EXTENDING BEYOND THE LEFT CAPSULE THE CONTRALATERAL RIGHT SIDE HAD SEROMA FLUID AROUND IT AND AT THE TIME OF SURGERY THIS FLUID WAS SENT FOR CYTOLOGY AND ALSO FOUND TO BE POSITIVE FOR ANAPLASTIC LARGE CELL LYMPHOMA NO EVIDENCE OF DISTANT DISEASE TISSUE EXPANDERS WERE USED FOR 1ST STAGE BREAST RECONSTRUCTION PRIOR TO PLACEMENT OF THE IMPLANT EXPANDERS WERE PLACED ON B6 2005 AND REMOVED ON B6 2005 WHEN THE FINAL IMPLANTS WERE PLACED EXPANDERS WERE MCGHAN 133LV INAMED EXPANDERS WITH REFERENCECATALOG 76-133LV13 SERIAL NUMBERS AND LOT NUMBERS AS DESCRIBED IN INITIAL NARRATIVE OF EVENT REASON FOR USE 1 - POSTMASTECTOMY BREAST RECONSTRUCTION 2 - POSTMASTECTOMY BREAST RECONSTRUCTION EVENT ABATED AFTER USE STOPPED OR DOSE REDUCED 1 - YES 2 - YES|MCGHAN BREAST IMPLANT RIGHT|67-133LV13|08/01/2013||||Y|||0LP|FWM|4.0||BREAST IMPLANT||1030255|||||MCGHAN MEDICAL CORP|||||||True
3269181|3756340|D|1||SUDDEN ONSET OF SWELLING LATE SEROMA OF LEFT BREAST IMPLANT RECONSTRUCTION SHE PREVIOUSLY HAD 2-STAGE BREAST RECONSTRUCTION WITH PLACEMENT OF BILATERAL TISSUE EXPANDERS ON B6 2005 MCGHAN REF 67-133LV13 EXPANDERS WITH LEFT SN B4 LOT 623514 AND RIGHT SN B4 AND LOT 1030255 IMPLANTS WERE PLACED ON B6 2005 INAMED REF 27-FF125-375 WITH LEFT SN B4 AND LOT 335112 AND RIGHT SN B4 AND LOT 380839 PRESENTATION OF LATE SEROMA WAS ALMOST 8 YRS AFTER IMPLANT PLACEMENT SEROMA FLUID WAS ASPIRATED UNDER ULTRASOUND GUIDANCE AND WAS POSITIVE FOR MALIGNANT CELL ANAPLASTIC LARGE CELL LYMPHOMA ALCL INPATIENT SURGERY FOR REMOVAL OF BILATERAL BREAST IMPLANTS WITH TOTAL CAPSULECTOMIES WAS PERFORMED AND PATHOLOGY REVEALED ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING BUT NOT EXTENDING BEYOND THE LEFT CAPSULE THE CONTRALATERAL RIGHT SIDE HAD SEROMA FLUID AROUND IT AND AT THE TIME OF SURGERY THIS FLUID WAS SENT FOR CYTOLOGY AND ALSO FOUND TO BE POSITIVE FOR ANAPLASTIC LARGE CELL LYMPHOMA NO EVIDENCE OF DISTANT DISEASE TISSUE EXPANDERS WERE USED FOR 1ST STAGE BREAST RECONSTRUCTION PRIOR TO PLACEMENT OF THE IMPLANT EXPANDERS WERE PLACED ON B6 2005 AND REMOVED ON B6 2005 WHEN THE FINAL IMPLANTS WERE PLACED EXPANDERS WERE MCGHAN 133LV INAMED EXPANDERS WITH REFERENCECATALOG 76-133LV13 SERIAL NUMBERS AND LOT NUMBERS AS DESCRIBED IN INITIAL NARRATIVE OF EVENT REASON FOR USE 1 - POSTMASTECTOMY BREAST RECONSTRUCTION 2 - POSTMASTECTOMY BREAST RECONSTRUCTION EVENT ABATED AFTER USE STOPPED OR DOSE REDUCED 1 - YES 2 - YES|MCGHAN BREAST IMPLANT LEFT|67-133LV13|08/01/2013||||Y|||0LP|FWM|3.0||BREAST IMPLANT||623514|||||MCGHAN MEDICAL CORP|||||||True
3530632|3971653|D|1||ALCL CASE REPORT RIGHT BREAST SEROMA ASSOCIATED ALCL HISTORY OF BILATERAL BREAST AUGMENTATION RIGHT BREAST WITH POLYURETHANE COVERED PROSTHESIS POLYTECH SILIMED 30645 290L DA 295ML|POLY-SILIMED BREAST IMPLANT 30645 290L DA 295ML||12/17/2013|||||||0|FTR|1.0||POLY-SILIMED BREAST IMPLANT||||||US|POLYTECH SILIMED|||||||True
3530618|20699147|D|1||ALCL CASE REPORT PATIENT WITH PERSONAL HISTORY OF LEFT BREAST CANCER IN 2005 UNDERWENT RADICAL MASTECTOMY AND RECONSTRUCTION WITH TISSUE EXPANDER IN 2006 SUBSTITUTION OF TISSUE EXPANDER WITH DEFINITIVE BREAST PROSTHESIS INAMED 410LX 625GR AND BREAST AUGMENTATION OF LEFT BREAST INAMED 410LX 625GR ON B6 2012 POSITIVE LYMPH NODE ON THE RIGHT AXILLARY SITE FOR ALCL ON B6 2012 SEROMA ASSOCIATED ALCL OF THE LEFT BREAST|410LX 625GR BREAST IMPLANT||12/17/2013|||||||0|FTR|1.0||BREAST PROSTHESIS|||||||INAMED|||||||True
3530645|4116958|D|1||ALCL CASE REPORT SEROMA ASSOCIATED PRIMARY ALCL OF THE RIGHT BREAST PATIENT WITH PERSONAL HISTORY OF RIGHT BREAST CANCER RIGHT MASTECTOMY AND IMMEDIATE RECONSTRUCTION WITH LATISSIMUS DORSI FLAP AND TEXTURED SILICONE PROSTHESIS MCGHAN ST-MX410 DA 445GR|TEXTURED 445GR SILICONE PROSTHESIS||12/17/2013|||||||0|FTR|1.0||BREAST IMPLANT|||||||MCGHAN|||||||True
3199749|3477268|D|1||COMPANY REP REPORTED RIGHT SIDE ANAPLASTIC LARGE-CELL LYMPHOMA AND SUBCUTANEOUS NODULES AND LYMPH NODES THE PT HAD A BILATERAL RECONSTRUCTION SEVEN YEARS AGO WITH STYLE 410 BREAST IMPLANT PLACED ON THE LEFT SIDE AND A STYLE 115 PLACED ON THE RIGHT SIDE THE PT HAD DONE WELL UNTIL SHE PRESENTED LAST WEEK WITH A PATHOLOGY REPORT FROM HER ONCOLOGIST STATING THAT SHE HAD ALCL THE PT STATED THAT SHE HAD NODULES ON THE RIGHT AXILLA A PET SCAN WAS CARRIED OUT THAT SHOWED METASTASIS IN THE LUNG AND BONE MARROW INVOLVEMENT NO SEROMA WAS NOTED THE ONCOLOGIST HAS DECIDED ON HER TREATMENT PLAN TO EXCLUDE RADIATION EXPLANT SURGERY WILL TAKE PLACE B6 2013|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-378|05/20/2013|||DA|N|R||0HP|FTR|1.0|04/24/2011|nan||1267625|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3199749|10822419|N|1||MEDWATCH SUBMITTED 05202013 ALLERGAN LABELING ADDRESSES THE EVENT OF BREAST LUMPS AS FOLLOWS BREAST SELF-EXAMINATIONS FOLLOWING BREAST AUGMENTATION YOU SHOULD CONTINUE TO PERFORM BREAST SELF-EXAMINATION MONTHLY THIS MAY BE MORE DIFFICULT WITH A BREAST IMPLANT IN PLACE TO CONTINUE TO PERFORM A MONTHLY BREAST SELF EXAMINATION EFFICIENTLY YOU SHOULD ASK YOUR SURGEON TO HELP YOU IDENTIFY THE DIFFERENCE BETWEEN THE IMPLANT AND YOUR BREAST TISSUE BEING ABLE TO IDENTIFY THE IMPLANT FROM BREAST TISSUE WILL DECREASE THE NECESSITY OF EXCESSIVE SQUEEZING OF THE IMPLANT DURING EXAMINATION ANY NEW LUMPS SHOULD BE EVALUATED WITH A BIOPSY AS APPROPRIATE IF A BIOPSY IS PERFORMED BE SURE TO INFORM THE MEDICAL PROFESSIONAL PERFORMING THE BIOPSY THAT YOU HAVE BREAST IMPLANTS SO THAT CARE WILL BE TAKEN TO AVOID INJURING THE IMPLANT THE 410 DEVICE LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA ALCL BASED ON INFO REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MANUFACTURERS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL FOR MORE COMPLETE AND UP-TO-DATE INFO ON FDAS ANALYSIS AND REVIEW OF THE ALCL IN PTS WITH BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-378|05/20/2013|||DA|N|R||0HP|FTR|1.0|04/24/2011|nan||1267625|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2933318|3225696|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED A LETTER REPORTING A PT HAD BILATERAL BREAST AUGMENTATION WITH MCGHAN SALINE IMPLANTS AND WAS DIAGNOSED WITH ANAPLASTIC LARGE CELL LYMPHOMA THERE IS LIMITED INFO AVAILABLE FOR THIS CASE AFTER THE INITIAL INVESTIGATION AND THERE IS AN UNLIKELY CHANCE THAT THIS INFO WILL BE OBTAINED HOWEVER IF THERE IS ADDL INFO SUCH AS DEVICE INFO IMPLANTINGEXPLANTING PHYSICIAN OR ANY LABS RELATED TO BUT NOT LIMITED TO ANY COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL THE FILE WILL BE REVIEWED AND UPDATED|CUI TEXTURED SALINE FILLED BREAST IMPLANT|UNK STYLE RTV|01/25/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2933317|17460937|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED A LETTER REPORTING A PATIENT UNDERWENT BREAST AUGMENTATION SURGERY WITH ALLERGAN SALINE FILLED BREAST IMPLANTS AND WAS DIAGNOSED WITH ANAPLASTIC LARGE CELL LYMPHOMA THERE IS LIMITED INFORMATION AVAILABLE FOR THIS CASE AFTER THE INITIAL INVESTIGATION AND THERE IS AN UNLIKELY CHANCE THAT THIS INFORMATION WILL BE OBTAINED HOWEVER IF THERE IS ADDITIONAL INFORMATION SUCH AS DEVICE INFORMATION IMPLANTINGEXPLANTING PHYSICIAN OR ANY LABS RELATED TO BUT NOT LIMITED TO ANY COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL THE FILE WILL BE REVIEWED AND UPDATED|STYLE 168 SALINE FILLED BREAST IMPLANT|UNK STYLE 168|01/23/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2973798|3169696|D|1||ALCL RIGHT BREAST PRESENTED WITH PERSISTENT SEROMAS THAT REQUIRED MULTIPLE ASPIRATIONS TEXTURED IMPLANT PLACED IN THE SUBFASCIAL PECTORAL PLANE SALT BASED TEXTURE FULL CAPSULECTOMY WITH REMOVAL OF IMPLANT DONE ON B6 2012 INTERCONSULTATION WITH MED  ONCOLOGY RECOMMENDED CHEMOTHERAPY THAT CURRENT IS RECEIVED|NATRELLE STYLE 110 REF #110-300|#110-300|02/13/2013||||N|||0HP|FWM|1.0||NONE||110-300|||||ALLERGAN|||||NATRELLE STYLE 110||True
2987556|3127805|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF LYMPHOMA AND SEROMA THERE IS LIMITED INFORMATION AVAILABLE FOR THIS CASE AFTER THE INITIAL INVESTIGATION AND THERE IS AN UNLIKELY CHANCE THAT THIS INFORMATION WILL BE OBTAINED HOWEVER IF THERE IS ADDITIONAL INFORMATION SUCH AS DEVICE INFORMATION IMPLANTINGEXPLANTING PHYSICIAN OR ANY LABS RELATED TO BUT NOT LIMITED TO ANY COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL THE FILE WILL BE REVIEWED AND UPDATED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/26/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3523590|17924822|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF LYMPHOMA AND SEROMA VIA B4 ALCL RIGHT BREAST PRESENTED WITH PERSISTENT SEROMAS THAT REQUIRED MULTIPLE ASPIRATIONS TEXTURED IMPLANT PLACED IN THE SUBFASCIAL PECTORAL PLANE SALT BASED TEXTURE FULL CAPSULECTOMY WITH REMOVAL OF IMPLANT DONE INTERCONSULTATION WITH MEDONCOLOGY RECOMMENDED CHEMOTHERAPY THAT CURRENT IS RECEIVED DURING THE INVESTIGATION THE OFFICE WAS ABLE TO PROVIDE MEDICAL RECORDS CLINICAL PATHOLOGY PROVIDED FOR THE CAPSULE AND THE SEROMA THE RIGHT BREAST CAPSULE WAS CONSISTENT WITH ALCL THE SEROMA NOTES ATYPICAL CELLS CONSISTENT WITH ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-330|11/15/2013|||DA|N|R||0HP|FTR|1.0|09/17/2011|nan||1338908|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3523596|16780284|D|1||HEALTHCARE PROFESSIONAL REPORTS VIA B4 A CASE OF LYMPHOMA AND SEROMA THE REPORT STATES BILATERAL SUBGLANDULAR TEXTURED SILICONE BREAST IMPLANTS IMPLANTED 15 YEARS AGO WITH RECENT DEVELOPMENT OF 700 CC OF OPAQUE PERI-IMPLANT SEROMA AND CAPSULAR THICKENING INF LEFT BREAST STATUS POST BILATERAL IMPLANT EXPLANTATION AND BILATERAL CAPSULECTOMY WITH DIAGNOSIS OF LEFT BREAST IMPLANT ASSOCIATED ALCL ON THE LEFT BREAST CAPSULECTOMY PATHOLOGICAL SPECIMEN AND LEFT BREAST SEROMA FLUID POSITIVE FOR ALCL CELLS FOLLOWING REPEAT BILATERAL CAPSULECTOMY DIAGNOSIS OF BILATERAL BREAST AUGMENTATIONCOSMESIS THERE IS NO DEVICE INFORMATION PROVIDED NOR CONTACT INFORMATION FOR THE HEALTH PROFESSIONAL TO OBTAIN FURTHER INFORMATION AT THIS TIME|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/05/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3523577|19486817|D|1||HEALTH PROFESSIONAL REPORTED A CASE OF ALCL APPROX B6 2013 THE PT COMPLAINED OF A LEFT SIDE DEFLATION ONCE EXAMINED IT WAS NOTED THAT IT WAS THE RIGHT BREAST THAT WAS ENLARGING IN REVIEWING A MAMMOGRAM PERFORMED IN B6 2013 FLUID WAS SEEN BEHIND THE CAPSULE THE PT WAS SENT FOR AN MRI WHICH SHOWED AN UPTAKE IN THE CAPSULE THE PT WAS ADMITTED FOR ELEVATED WHITE COUNT AND ABDOMINAL PAIN THE CT OF THE ABDOMEN WAS NEGATIVE AS WELL AS THE CXR THE DIAGNOSIS AT THE TIME OF ADMISSION WAS RIGHT BREAST MASS ASPIRATION WAS PERFORMED RESULTS WERE 5 ATYPICAL CELLS THE PATHOLOGIST PERFORMED A FLOWCYTOMETRY THE DIAGNOSIS OF ALCL WAS MADE WITH THE CAPSULE ALK- THE RESULTS WERE SENT TO THE NIH TO CONFIRM THE DIAGNOSIS A PET SCAN WAS PERFORMED REVEALING ONCE LYMPH NODE WHICH WAS POSITIVE THE SURGEON FEELS THAT THIS WAS DUE TO THE DYE FROM THE MRI AND HE WILL HAVE THE PT UNDERGO ANOTHER IN A FEW WEEKS THE PT HAS SEEN AN ONCOLOGIST THE RADIATION ONCOLOGIST IS DISCUSSING POSSIBLE TREATMENT WITH RADIATION THE SURGEON STATES HE FEELS THIS IS UNNECESSARY ADDL INFO WILL BE SENT IFWHEN IT BECOMES AVAILABLE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|12/02/2013|||DA|N|R||0HP|FWM|1.0|03/29/2008|nan||620705|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3001322|18848109|D|1||A COMPANY REP REPORTS A CASE OF ALCL DURING THE INVESTIGATION THE SURGEON REPORTS THE PT HAD AN MRI A COMPLETE CAPSULECTOMY WITH CYTOLOGY TAKEN THE CYTOLOGY REPORT WAS NEGATIVE AT THAT TIME HOWEVER TWO MONTHS LATER THE CAPSULE WAS REPORTED AS POSITIVE FOR ALCL THE PATHOLOGY HAS NOT BEEN RECEIVED TO ALLERGAN AT THIS TIME THE INVESTIGATION IS STILL ONGOING AND ANY NEW INFO WILL BE FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/08/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3516781|15024064|D|1||LEGAL DOCUMENTS RECEIVED BY ALLERGAN NOTE A CASE OF LYMPHOMA THE DOCUMENTS STATE THAT ON B6 2002 THE PATIENT WAS IMPLANTED WITH MCGHAN 468 IMPLANTS ON OR ABOUT B62011 THE PATIENT WAS DIAGNOSED WITH ABNORMAL T-CELL WHICH ARE LARGE IN SIZE AND CONSISTENT WITH T-CELL LYMPHOMA PARTICULARLY ALCL A RADIOLOGY SCHEDULING FORM PREPARED FOR EMORY HEALTHCARE ON B6 2011 DESCRIBES THE DIAGNOSIS AS T-CELL LYMPHOMA AND BREAST IMPLANTS AT THIS TIME FURTHER INVESTIGATION CANNOT TAKE PLACE DUE TO THE LACK OF INFORMATION PROVIDED IF ADDITIONAL INFORMATION IS OBTAINED IT WILL BE REVIEWED AND REPORTED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-495|11/22/2013|||DA|N|R||0HP|FWM|0.0||nan||NI|||GOLETA, NE||ALLERGAN||CA|||||True
3349460|3862832|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF POSSIBLE ALCL THIS WAS DISCOVERED AFTER THE PT PRESENTED WITH COMPLAINT OF SEROMA THERE HAVE BEEN NO LABS PRESENTED IN THIS CASE TO DATE|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|09/04/2013|||DA|N|R||0HP|FTR|1.0|11/15/2008|nan||249662|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2926387|15858134|D|1||POSSIBLE ALCL SYMPTOMS|GEL-FILLED MAMMARY PROSTHESIS|354-4007|01/15/2013||||N|R||0HP|FTR|1.0||BREAST IMPLANT||5627854|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR TEXAS, INC.|75038|TX|75038||||True
2903656|3063201|D|1||ALCL CASE REPORT DIAGNOSIS ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA CD30+ SP LEFT AXILLARY LN BIOPSY 52110 THE PT IS A B6 FEMALE WITH STAGE IV ALK NEGATIVE ANAPLASTIC LARGE-CELL LYMPHOMA THIS WAS DIAGNOSED ON B6 2010 SHE IS CURRENTLY UNDERGOING CHEMOTHERAPY AND IS FOLLOWED HERE IN ONCOLOGY SHE HAD BILATERAL BREAST AUGMENTATION WITH SILICONE IMPLANTS OVER 30 YEARS AGO SHE HAD A RUPTURE ON THE RIGHT SIDE AND HAD THE IMPLANTS REMOVED AND REPLACED IN 2005 BY A LOCAL PLASTIC SURGEON SHE STATES THEY ARE SUBPECTORAL THROUGH AN INFRAMAMMARY FOLD INCISION SHE BELIEVES THE RIGHT IMPLANT WAS 325 CC AND THE LEFT WAS 350 CC DURING ONE OF HER RECENT CT SCANS PERFORMED FOR LYMPHOMA STAGING THERE APPEARED TO BE EVIDENCE OF RUPTURE OF HER RIGHT BREAST IMPLANT I REMOVED BOTH IMPLANTS ON B6 2012 THEY WERE NOT REPLACED DUE TO THE POSSIBLE LINK BETWEEN BREAST IMPLANTS AND ALCL|INAMED||12/28/2012|||||||0HP|FTR|2.0||SILICONE BREAST IMPLANT||NONE|||IRVINE|US|ALLERGAN||CA|||STYLE 110|REF# 110-390|True
2903656|3063201|D|1||ALCL CASE REPORT DIAGNOSIS ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA CD30+ SP LEFT AXILLARY LN BIOPSY 52110 THE PT IS A B6 FEMALE WITH STAGE IV ALK NEGATIVE ANAPLASTIC LARGE-CELL LYMPHOMA THIS WAS DIAGNOSED ON B6 2010 SHE IS CURRENTLY UNDERGOING CHEMOTHERAPY AND IS FOLLOWED HERE IN ONCOLOGY SHE HAD BILATERAL BREAST AUGMENTATION WITH SILICONE IMPLANTS OVER 30 YEARS AGO SHE HAD A RUPTURE ON THE RIGHT SIDE AND HAD THE IMPLANTS REMOVED AND REPLACED IN 2005 BY A LOCAL PLASTIC SURGEON SHE STATES THEY ARE SUBPECTORAL THROUGH AN INFRAMAMMARY FOLD INCISION SHE BELIEVES THE RIGHT IMPLANT WAS 325 CC AND THE LEFT WAS 350 CC DURING ONE OF HER RECENT CT SCANS PERFORMED FOR LYMPHOMA STAGING THERE APPEARED TO BE EVIDENCE OF RUPTURE OF HER RIGHT BREAST IMPLANT I REMOVED BOTH IMPLANTS ON B6 2012 THEY WERE NOT REPLACED DUE TO THE POSSIBLE LINK BETWEEN BREAST IMPLANTS AND ALCL|INAMED||12/28/2012||10/01/2012||R|||0HP|FTR|1.0||SILICONE BREAST IMPLANT||NONE|||IRVINE|US|ALLERGAN||CA|||STYLE 110|REF# 110-420|True
2930345|17450111|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED A LETTER REPORTING A PATIENT WHO HAD BILATERAL BREAST AUGMENTATION WITH MCGHAN SILICONE GEL FILLED BREAST IMPLANTS AND DIAGNOSED WITH CB-30 POSITIVE ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA THERE IS LIMITED INFORMATION AVAILABLE FOR THIS CASE AFTER THE INITIAL INVESTIGATION AND HERE IS AN UNLIKELY CHANCE THAT HIS INFORMATION WILL BE OBTAINED HOWEVER IF THERE IS ADDITIONAL INFORMATION SUCH AS DEVICE INFORMATION IMPLANTINGEXPLANTING PHYSICIAN OR ANY LABS RELATED TO BUT NOT LIMITED TO ANY COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL THE FILE WILL BE REVIEWED AND UPDATED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|01/22/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA||||NI|True
3030996|20232348|D|1||HEALTH PROFESSIONAL REPORTED CAPSULAR CONTRACTURE BAKER GRADE IV AND POTENTIALLY ALCL THIS EVENT WAS SUBMITTED B6 B6 2010|STYLE 168 SALINE FILLED BREAST IMPLANT|168-240|11/15/2012||05/27/2010|DA|Y|Y||0HP|FWM|1.0|04/10/2003|nan||542534|||GOLETA|US|ALLERGAN||CA|||||True
3070387|3264818|D|1||TO WHOM IT MAY CONCERN PURSUANT TO THE PARTNERSHIP BETWEEN THE FDA AND B4 CONCERNING BREAST IMPLANT-ASSOCIATED ALCL WE ARE REPORTING A CASE OF ALCL ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED WITH A BREAST IMPLANT PT IS B6 FEMALE WHO FIRST PRESENTED LAST B6 AFTER HAVING HAD BREAST AUGMENTATION IN B6 SEVERAL YEARS PRIOR SHE HAD NOTICED SWELLING OF THE LEFT BREAST WHICH EVENTUALLY BECAME PAINFUL AND CAUSED HER TO SEEK TREATMENT WORKUP EVENTUALLY REVEALED SEROMA AROUND THE BREAST IMPLANT THE FLUID CAME BACK AS CD 30 POSITIVE ALK NEGATIVE CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA HER IMPLANTS WERE REMOVED BILATERALLY AND IT IS FELT THAT THIS IS ADEQUATE TREATMENT FOR THE PROBLEM SHE CONTINUES TO UNDERGO SURVEILLANCE BY US IN ADDITION TO THE HEMATOLOGYONCOLOGY TEAM OF NOTE SHE WAS FOUND TO HAVE NONRUPTURED 410 CC TEXTURED SILICONE IMPLANTS MADE BY CUI NOT AVAILABLE IN THE UNITED STATES THE PTS CARE WAS COORDINATED BETWEEN THE PLASTIC SURGERY AND THE HEMATOLOGYONCOLOGY TEAMS AT B6 BREAST IMPLANTS REMOVED NOT REPLACED PT WILL UNDERGO SURVEILLANCE WITH MRI AND ULTRASOUND|TEXTURED SILICONE BREAST IMPLANT||04/16/2013|||DA|N|||0HP|FTR|1.0||TESTURED SILICONE BREAST IMPLANT, 410 CC||UNK|||||CUI|||||||True
3530889|15813592|D|1||ALLERGAN LEGAL REPORTS A CASE OF LYMPHOMA ALCL MAMMOGRAM AND ULTRASOUND SHOWED DIFFUSE EXTRAVASATED FLUID NOTED AROUND THE RIGHT BREAST IMPLANT CONSISTENT WITH A LEAK NO SPECIFIC FINDINGS FOR MALIGNANCY SURGICAL CONSULTATION RECOMMENDED FOR LEAKAGE OF DEVICE CYTOLOGY REPORT FOR RIGHT SIDE ASPIRATES TAKEN NOTED POSITIVE FOR MALIGNANT CELLS ALCL PATHOLOGY REPORT FOR RIGHT SIDE CAPSULE SHOWED CHRONIC INFLAMMATION NO MALIGNANCY|STYLE 468 SALINE FILLED BREAST IMPLANT|468-495|12/17/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|71 SOUTH LOS CARNEROS ROAD||GOLETA|US|ALLERGAN|93117|CA|93117||||True
3519392|3961243|D|1||RECEIVED A REPORT OF ALCL VIA B4 THERE IS LIMITED INFORMATION NOTED ON THE FORM IT STATES ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED FROM THE LEFT BREAST THIS PATIENT HAD STYLE 468 TEXTURED SALINE BREAST IMPLANT FROM B6 NO CONTACT INFORMATION WAS PROVIDED THEREFORE NO INVESTIGATION IS ABLE TO BE PERFORMED AT THIS TIME|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|12/03/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3474013|15266478|D|1||IN 2010 I EXPERIENCED A HEMATOMA IN THE LOWER INSIDE OF MY LEFT BREAST ACCOMPANIED BY GREAT PAIN GRADUALLY THE BREAST DEVELOPED A PAINFUL CAPSULAR CONTRACTURE AND A MASS IN MY LEFT ARMPIT LYMPH NODES WHICH WAS TREATED BY THE B6 WITH AN ASTHMA MEDICATION THAT DID NOT WORK I THEN RECEIVED A LETTER ABOUT ALCL WHICH ALARMED ME EVEN FURTHER AND SAW SEVERAL DOCTORS OF WHICH NONE KNEW HOW TO TEST FOR ALCL I BEGAN EXPERIENCING A SENSATION IN MY CHEST THAT FELT LIKE AN ABSCESS THAT WAS SPREADING THROUGH MY RIBCAGE INTO MY LUNG WHICH MAKES IT INCREDIBLY HARD TO SLEEP AT NIGHT I AM IN CONSTANT PAIN RECENTLY MY OFFICE AT B4WAS CLOSED SO I WAS FORCED TO GO INTO A FIELD TECHNICIAN OR LINEMAN POSITION AS I HAVE PROGRESSED IN MY TRAINING FOR THE LAST 6 MONTHS I HAVE EXPERIENCED AN UNBELIEVABLE AMOUNT OF PAIN LACK OF SLEEP AND UBER FATIGUE I WENT TO THE B6 DID NOT AUTOMATICALLY PROVIDE INSURANCE THIS LAST YEAR AND ASKED FOR AN MRI I FINALLY GOT THE MRI AND THE RADIOLOGIST STATED THE IMPLANT WAS POSSIBLY RUPTURED AND THERE WAS EVIDENCE OF 2 LEAKS EXACT WORDING SUBJECT TO INTERPRETATION SINCE I RECEIVED THAT INFORMATION 2 WEEKS AGO I HAVE RESEARCHED THE INTERNET AND FOUND THAT B4 IS PROVIDING EXPLANT MONEY UNDER CERTAIN CONDITIONS UNFORTUNATELY THE CONDITIONS OR STIPULATIONS ARE EXTREMELY SUBJECTIVE FOR EXAMPLE THE EXPLANT MONEY IS ONLY ALLOTTED IF THE IMPLANT WAS NOT SUBJECT TO OR EXPOSED TO SOME SORT OF STRESS OR ACCIDENT ALSO THE LIFETIME WARRANTY IN SOME CASES WILL NOT BE APPLICABLE THIS BRINGS UP THE QUESTION OF WHEN THAT DETERMINATION WILL BE MADE IN MY OWN CASE IF THE IMPLANTS ARE NOT UNDER WARRANTY I WOULD CHOOSE NOT TO HAVE THEM REPLACED SO WHAT ARE THE DYNAMICS OF AN EXPLANT SURGERY WILL B4 PROVIDE BREAST IMPLANTS IN THE CASE THAT MY EXPLANT FITS INTO THEIR PERFECT LITTLE BOX THEY HAVE CREATED AND WILL MY SURGEON BE COMPELLED TO GO THROUGH THIS CHECKLIST IN THE MIDDLE OF SURGERY TO DET|SILIMED BREAST IMPLANT|UNK|11/13/2013|||||||0|FTR|1.0|11/25/2014|BREAST IMPLANT||UNK|||||SIENTRA|||||SILIMED|UNK|True
2933302|3232091|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED A LETTER REPORTING A PATIENT UNDERWENT BREAST AUGMENTATION SURGERY WITH IMPLANTATION OF A GEL FILLED IMPLANT AND WAS DIAGNOSED WITH SEROMA ASSOCIATED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA ADJACENT TO THE IMPLANT THERE IS LIMITED INFORMATION AVAILABLE FOR THIS CASE AFTER THE INITIAL INVESTIGATION AND THERE IS AN UNLIKELY CHANCE THAT THIS INFORMATION WILL BE OBTAINED HOWEVER IF THERE IS ADDITIONAL INFORMATION SUCH AS DEVICE INFORMATION IMPLANTINGEXPLANTING PHYSICIAN OR ANY LABS RELATED TO BUT NOT LIMITED TO ANY COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL THE FILE WILL BE REVIEWED AND UPDATED|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|01/23/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3031018|15024796|D|1||HEALTHCARE PROFESSIONAL REPORTED TO AN ALLERGAN EMPLOYEE ALCL AND SEROMA ALLERGAN WAS ABLE TO GATHER INFORMATION REGARDING THE DEVICE ALONG WITH PATIENT NOTES THIS MEDWATCH HAD BEEN SUBMITTED VIA B6 2011|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-390|11/15/2012|||DA|N|R||0HP|FTR|1.0|12/01/1995|nan||2-143391|||GOLETA, NE|US|ALLERGAN||CA|||||True
3378228|3720626|D|1||HEALTHCARE PROFESSIONAL REPORTS TO A COMPANY REP A CASE OF SEROMA AND POSSIBLE ALCL THE PT HAD AUGMENTATION SURGERY IN 1998 WITH SILICONE BREAST IMPLANTS THE PT PRESENTS WITH LEFT BREAST SWELLING EXPLANT SURGERY TOOK PLACE ON B6 2013 SEROMA SENT TO CYTOLOGY WHICH WAS POSITIVE FOR ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/17/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3370062|19556679|D|1||ALCL THE DOCTOR HAS RETIRED THE ONLY COMPLAINT INFORMATION WE HAVE IS WHAT HAS BEEN PROVIDED ON THIS MEDWATCH|nan||09/13/2013|||DA|N|R||0HP|FWM|1.0||BREAST IMPLANT|||||IRVING|US|MENTOR||TX|||||True
3533089|19299131|D|1||ALCL CASE REPORT THIS PT HAD BILATERAL BREAST AUGMENTATION PERFORMED IN 2005 SHE RECENTLY DEVELOPED A SEROMA THAT WAS ASPIRATED AND FOUND TO HAVE ATYPICAL T CELLS I PERFORMED BILATERAL IMPLANT REMOVAL AND TOTAL CAPSULECTOMY HER FINAL PATHOLOGY REVEALED ALCL OF THE LEFT BREAST|INAMED SALINE BREAST IMPLANT||10/22/2013||||N|||0HP|FWM|1.0||SALINE BREAST IMPLANT|||||||INAMED|||||||True
3896045|4542003|D|1||RECEIVED NOTIFICATION FROM MEDICAL AFFAIRS A CASE OF ALCL THE HEALTHCARE PROFESSIONAL REPORTS A B6 PT WHO RECEIVED COSMETIC AUGMENTATION IN 1969 WITH PERMANENT SILICONE IMPLANTS DUE TO CAPSULAR CONTRACTURE HAD EXCHANGED TO PERMANENT SALINE IMPLANTS IN 1997 IN B6 2013 DEVELOPED A DELAYED SEROMA IN THE LEFT BREAST FNA DEMONSTRATED BIA-ALCL UNDERWENT BILATERAL EXPLANTATION AND CAPSULECTOMIES IN B6 2013 THE PT WAS NOTED TO HAVE A MASS ON THE MEDIAL ASPECT OF THE LEFT CAPSULE POSTOPERATIVE PATHOLOGY CONFIRMED BIA-ALCL AND MARGINS WERE POSITIVE RETURNED TO THE OPERATING ROOM IN B6 2014 FOR BILATERAL COMPLETION CAPSULECTOMY NO RESIDUAL BIA-ALCL ON PATHOLOGY NOW REMAINS DISEASE FREE THE PT ALSO HAS A HISTORY OF RIGHT BREAST CANCER THAT WAS TREATED WITH MASTECTOMY AND NODAL DISSECTION PLACEMENT OF A TISSUE EXPANDER IMMEDIATELY IN 2003 SHE DID NOT GET CHEMOTHERAPY OR RADIATION AND SUBSEQUENTLY SHE WAS PLACED ON ENDOCRINE TREATMENT FOR 5 YEARS THE NOTIFICATION ALSO PROVIDED A DATE OF THE EXPLANTATION AND THE CAPSULECTOMY THAT TOOK PLACE ON THE B6 2014 IT NOTES 168-330 FILLED TO 325CC PLACED SUB-MUSCULARLY THE DATE OF THE DIAGNOSIS WAS B6 2014 IT PROVIDES THE LYMPHOMA CELLS ARE POSITIVE FOR CD30 DIFFUSE AND STRONG AND CD43 WEAK AND ARE NEGATIVE FOR CD3 CD20 CD45 ALK-1 CD68 E-CADHERIN MOC31 GATA3 ER PR AE1AE3 PAN-CK CK7 CAM52 MELANOMA COCKTAIL AND S-100 THE CD3 AND CD20 STAINS HIGHLIGHT BACKGROUND RARE SCATTERED SMALL T-CELLS AND B-CELLS RESPECTIVELY THE CD45 STAIN HIGHLIGHTS SCATTERED HEMATOPOIETIC CELLS CD68 INFO WAS NOT PROVIDED T25 ALSO NEGATIVE THE PATHOLOGY REPORT HAS BEEN REQUESTED BUT NOT PROVIDED IFTHEN THIS INFO IS PROVIDED IT WILL BE FORWARDED THE MEDICAL SAFETY TEAM HAS DETERMINED THAT COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL HOWEVER IF THERE IS ADDL INFO OR ANY LABS RELATED TO BUT NOT LIMITED TO ANY COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL THE FILE WILL BE REVIEWED AND UPDATED|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|06/12/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3738245|11860603|N|1||DEVICE LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA ALCL BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MANUFACTURERS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMAWHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF155-740|03/31/2014|||DA|N|R||0HP|FTR|1.0|02/15/2004|nan||47173|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3642248|4203744|D|1||LITERATURE REVIEW OF CHEMOTHERAPY-RESISTANT BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA MURALIDHARAN PARTHASARATHY ET AL BMJ CASE REP 2013 THE ARTICLE REPORTS A PT PRESENTING WITH SYMPTOMS OF DISCOMFORT AND HARDENING OF THE LEFT BREAST EXAM REVEALED A VAGUE MASS MEASURING ABOUT 5 CM IN THE UPPER OUTER QUADRANT OF THE LEFT BREAST TOGETHER WITH PALPABLE AXILLARY LYMPH NODES THREE YEARS PRIOR THE PT HAD BEEN TREATED FOR A SEROMA WHICH HAD BEEN DRAINED NO SEROMA WAS NOTED AT THIS TIME BILATERAL CAPSULAR CONTRACTURE WAS NOTED THE LEFT MORE THAN RIGHT DIAGNOSTICS CONFIRMED ALCL OF THE LEFT BREAST AFTER CHEMOTHERAPY TREATMENT CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE AND PREDNISONE THE PT WAS REASSESSED AND THE LEFT BREAST MASS WAS UNCHANGED SECOND LINE CHEMOTHERAPY WAS GIVEN CISPLATIN AND GEMCITABINE A REPEAT CORE BIOPSY CONFIRMED PERSISTENT ALK NEGATIVE ALCL THE PT HAD A LEFT MASTECTOMY WITH REMOVAL OF THE LEFT BREAST IMPLANT THIS WAS FOLLOWED BY RADIATION THERAPY THE PT HAS SINCE RECOVERED WITH NO SIGNS OF RECURRENCE ALTHOUGH THE MFR OF THE DEVICE IS UNK IT IS ALLERGANS APPROACH TO COMPLIANCE TO RESOLVE ALL DOUBT IN FAVOR OF REPORTING|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/31/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
3642248|55007799|D|1||LITERATURE REVIEW OF CHEMOTHERAPY-RESISTANT BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA MURALIDHARAN PARTHASARATHY ET AL BMJ CASE REP 2013 THE ARTICLE REPORTS A PATIENT PRESENTING WITH SYMPTOMS OF DISCOMFORT AND HARDENING OF THE LEFT BREAST EXAM REVEALED A VAGUE MASS MEASURING ABOUT 5 CM IN THE UPPER OUTER QUADRANT OF THE LEFT BREAST TOGETHER WITH PALPABLE AXILLARY LYMPH NODES THREE YEARS PRIOR THE PATIENT HAD BEEN TREATED FOR A SEROMA WHICH HAD BEEN DRAINED NO SEROMA WAS NOTED AT THIS TIME BILATERAL CAPSULAR CONTRACTURE WAS NOTED THE LEFT MORE THAN RIGHT DIAGNOSTICS CONFIRMED ALCL OF THE LEFT BREAST AFTER CHEMOTHERAPY TREATMENT CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE AND PREDNISONE THE PATIENT WAS REASSESSED AND THE LEFT BREAST MASS WAS UNCHANGED SECOND LINE CHEMOTHERAPY WAS GIVEN CISPLATIN AND GEMCITABINE A REPEAT CORE BIOPSY CONFIRMED PERSISTENT ALK NEGATIVE ALCL THE PATIENT HAD A LEFT MASTECTOMY WITH REMOVAL OF THE LEFT BREAST IMPLANT THIS WAS FOLLOWED BY RADIATION THERAPY THE PATIENT HAS SINCE RECOVERED WITH NO SIGNS OF RECURRENCE ALTHOUGH THE MANUFACTURER OF THE DEVICE IS UNKNOWN IT IS ALLERGANS APPROACH TO COMPLIANCE TO RESOLVE ALL DOUBT IN FAVOR OF REPORTING|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/31/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
4370907|20979164|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE DRAINAGE REDNESS TISSUE BREAK DOWN THROUGH THE INCISION AND INFECTION THE HEALTHCARE PROFESSIONAL ALSO REPORTED THAT WHEN THE DEVICE WAS REMOVED INSIDE THE CAPSULE THERE WERE BLACK GRANULES FURTHER SPECIFIED AS BLOOD CLOTS ADDITIONAL REPORT INCLUDES PT MAY HAVE ALCL WHICH WILL BE CAPTURED AS LYMPHOMA UNTIL CONFIRMED VIA DIAGNOSTICS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410640|12/23/2014|||DA|N|R||0HP|FTR|1.0||nan||2586316|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3896044|4422726|D|1||PT REPORTED A RIGHT SIDE LUMP AND ANAPLASTIC LARGE CELL LYMPHOMA THE MEDICAL SAFETY TEAM WAS DETERMINED THAT COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL CRITERIA WITH WHICH TO DIAGNOSE ALCL THERE IS LIMITED INFO AVAILABLE FOR THIS CASE AFTER THE INITIAL INVESTIGATION AND THERE IS AN UNLIKELY CHANCE THAT THIS INFO WILL BE OBTAINED HOWEVER IF THERE IS ADDL INFO SUCH AS DEVICE INFO IMPLANTINGEXPLANTING PHYSICIAN OR ANY LABS RELATED TO BUT NOT LIMITED TO ANY COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSED ALCL THE FILE WILL BE REVIEWED AND UPDATED|STYLE 168 SALINE FILLED BREAST IMPLANT|168-210|06/12/2014|||DA|N|R||0HP|FWM|1.0|07/27/2012|nan||1643163|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3946570|54659173|D|1||HEALTHCARE PROFESSIONAL REPORTS INCIDENCE OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL THAT APPEARS TO BE ASSOCIATED WITH THE USE OF TEXTURED BREAST IMPLANTS I HAVE ENCOUNTERED 3 CASES WITHIN THE PAST 3 YEARS OVER 130 CASES HAVE BEEN REPORTED WORLDWIDE AND TWO OF THESE WERE IN PATIENTS WHO HAD MCGHAN IMPLANTS IE THE SAME TEXTURING PROCESS THAT ALLERGAN CURRENTLY USE THE MEDICAL SAFETY TEAM HAS DETERMINED THAT COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL MULTIPLE ATTEMPTS HAVE BEEN MADE TO OBTAIN FURTHER INFORMATION INCLUDING CYTOLOGYPATHOLOGY REPORTS DEVICE INFORMATION ETC IFWHEN ADDITIONAL INFORMATION DOES BECOME AVAILABLE IT WILL BE FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
3946570|4604105|D|1||HEALTHCARE PROFESSIONAL REPORTS INCIDENCE OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL THAT APPEARS TO BE ASSOCIATED WITH THE USE OF TEXTURED BREAST IMPLANTS I HAVE ENCOUNTERED 3 CASES WITHIN THE PAST 3 YEARS OVER 130 CASES HAVE BEEN REPORTED WORLDWIDE AND TWO OF THESE WERE IN PTS WHO HAD MCGHAN IMPLANTS IE THE SAME TEXTURING PROCESS THAT ALLERGAN CURRENTLY USE THE MEDICAL SAFETY TEAM HAS DETERMINED THAT COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL MULTIPLE ATTEMPTS HAVE BEEN MADE TO OBTAIN FURTHER INFO INCLUDING CYTOLOGYPATHOLOGY REPORTS DEVICE INFO ETC IFWHEN ADDL INFO DOES BECOME AVAILABLE IT WILL BE FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
4020375|4878205|D|1||ON B6 2014 I RECEIVED AN ARTICLE THROUGH PRODUCT WATCH ENTITLED FLOW CYTOMETRY OF ALK- NEGATIVE ALCL OF BREAST IMPLANT ASSOCIATED EFFUSION AND CAPSULAR TISSUE WITHIN THE ARTICLE IT NOTES A CASE OF A B6 YEAR OLD PT WHO HAD A BREAST PROSTHETIC IMPLANT FOR 65 YEARS PRIOR TO CLINICAL PRESENTATION UPON PRESENTATION THE PT REPORTED SWELLING IN THE AREA WITHOUT PAIN OR ERYTHEMA A BILATERAL MAMMOGRAM AND BREAST ULTRA-SOUND WERE REPORTED AS NEGATIVE FOR MASS LESIONS NEVERTHELESS A LARGE AMOUNT OF FLUID WAS IDENTIFIED AROUND THE RIGHT IMPLANT INVOLVING THE ADJACENT CAPSULAR TISSUE ASPIRATION OF THIS FLUID 380 CC DEMONSTRATED HIGHLY ATYPICAL CELLS CT SCAN OF CHEST ABDOMEN AND PELVIS SHOWED NO EVIDENCE OF DISEASE RESULT OF IMMUNOHISTOCHEMICAL STAINING WERE POSITIVE FOR CD15 CD30 AND 45 NEGATIVE FOR ALK-1 PAX-5 CD3 CD20 PAN-CYTOKERATIN EMA THERE IS NO MENTION OF THE DEVICES USED FOR THIS PT THEREFORE AN EMAIL IS SENT TO THE AUTHOR TO TRY AND OBTAIN THIS MISSING INFO|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/31/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3895999|16446469|D|1||L BREAST IMPLANTED LARGE CELL LYMPHOMA SP L BREAST IMPLANT PLACEMENT IN 2003 IN 1998- AT B6 DIAGNOSED WITH L BREAST CA AND L LUMPECTOMY WITH RADIATION DONE IN 2002-L LATISSIMUS DORSI MYOCUTANEOUS FLAP RECONSTRUCTION WITH TISSUE EXPANDER MENTOR REFB4 LOT 248391 AND R SUBQ MASTECTOMY WITH IMMEDIATE RECONSTRUCTION WITH SALINE IMPLANT MENTOR REFB4 SILTEX CONTOUR PROFILE MAMM PROSTH LOT 251827 SN B4 ADDED 450ML TO IMPLANT PATH REPORT ON B6 2002 WAS NEGATIVE FOR CARCINOMA IN EITHER BREAST ON B62013 SECOND STAGE RECONSTRUCTION L BREAST EXPANDER REMOVED MCGHAN 163 SALINE IMPLANT PLACED REF B4 SN B4 LOT 582791 380CC PRESENTED TO DR B6 B6 2014 WITH PAIN AND SWELLING IN L BREAST-GRADE IV CAPSULE CONTRACTURE NOTED SHE DID NOT WISH TO SCHEDULE SURGERY AT THAT TIME SECOND CONSULTATION ON B6 2014 NEW LUMP IN L BREAST ULTRASOUND MRI AND L BREAST BIOPSY DONE ON B6 2014 REMOVED INTACT IMPLANT L BREAST MCGHAN STYLE 163 SALINE TEXTURED IMPLANT L TOTAL CAPSULECTOMY L BREAST PATH REPORT SHOWS ALCL ANAPLASTIC LARGE CELL LYMPHOMA|MCGHAN|27-163361|06/20/2014|||||||0HP|FWM|1.0||SALINE IMPLANT||582791|||SANTA BARBARA||INAMED|93111||93111||STYLE 163||True
3883642|4565748|D|1||ADDITIONAL INFO RECEIVED FROM A LITERATURE ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA AND BREAST IMPLANTS FIVE AUSTRALIAN CASES PUBLISHED IN THE PLASTIC AND RECONSTRUCTIVE SURGERY ON B6 2012 PG 610E-617E WITHIN THE ARTICLE THE AUTHOR DESCRIBES A B6 WHO UNDERWENT BILATERAL AUGMENTATION WITH 110-360 INAMED TEXTURED ROUND DEVICES VIA INFRAMAMMARY INTO A SUB GLANDULAR POCKET IN B6 2008 THE PT PRESENTED WITH SPONTANEOUS LEFT BREAST SWELLING ALTHOUGH SHE WAS WITH ON FEVER AND MILD DISCOMFORT THE LEFT BREAST WAS DIFFUSELY SWOLLEN THE PT HAD A NORMAL MAMMO IN 2008 AND IN 2009 ULTRASOUND REVEALED A SEROMA A CT SCAN SHOWED AN INFOLDING OF THE IMPLANT BETWEEN 7 AND 9 OCLOCK WITH AN APPARENT MASS WITH SLIGHTLY INCREASED DENSITY IN B6 2009 SURGERY WAS PLANNED TO REMOVE THE PRESUMED RUPTURED IMPLANT AT THE TIME OF SURGERY A STRAW COLORED SEROMA OF 200CC WAS FOUND THE IMPLANT WAS INTACT WITHIN THE CAPSULE THERE WERE TWO AREAS OF GRANULOMATOUS TISSUE AND THICK MASS INFEROMEDIALLY THE CAPSULE AND MASS WERE SENT TO MICROBIOLOGY CULTURE AND HISTOPATHOLOGY THE LYMPHOID CELLS WERE HIGHLY ATYPICAL SHOWING ENLARGED AND IRREGULARLY CONFIGURED NUCLEI IMMUNOHISTOCHEMICAL ANALYSIS SHOWED CD30 + ALK- B-CELL MARKER NEGATIVE AND T-CELL MARKER PARTIAL AND PATCHILY-POSITIVE CD3 CD43 CD45RO AND CD5 TISSUE THE FINDINGS WERE CONSISTENT WITH LOCALIZED FORM OF SYSTEMIC ALCL LARGE T-CELL LYMPHOMA THE BREAST HEALED BUT A RECURRENT MASS APPEARED WEEKS LATER STAGING CT OF CHEST ABD PELVIS AND PET SCAN SHOWED NO EVIDENCE OF DISEASE OUTSIDE THE BREAST SHE UNDERWENT CHEMO WITH CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE AND PREDNISONE IN B6 2009 THE MASS FAILED TO RESPOND AND PROGRESSED TO A WOUND THE LYMPHOMA METASTASIZED TO THE THORACOLUMBAR REGION AND THE RIGHT LUNG AS SEEN IN THE B6 2009 PET SCAN SHE WAS TREATED WITH RADIATION AND A SECOND ROUND OF CHEMO USING GEMCITABINE IFOSFAMIDE AND VINORELBINE SHE RESPONDED WELL AND UNDERWENT A BONE MARROW TRANSPLANT IN 122009 TWO YEARS AFTER DIAGNOSIS SHE REMAINS IN REMISSION THIS EVENT WAS ORIGINALLY SUBMITTED VIA B4 ON B4 2011|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110361|06/18/2014|||DA|N|R||0HP|FTR|1.0|09/30/2010|nan||1148082|||ARKLOW, COUNTY, WICKLOW|EI|ALLERGAN|||||||True
3676747|18791128|D|1||HEALTHCARE PROFESSIONAL REPORTS CAPSULAR CONTRACTURE SEROMA AND ALCL OF THIS LEFT SIDE DEVICE RECEIVED A CALL FROM THE HEALTHCARE PROFESSIONAL INDICATING THAT THEY DO HAVE THE INFO REGARDING THIS CASE BUT ARE WAITING ON THE SURGEON TO SIGN THE OP REPORT WE ARE ALSO INFORMED THAT THE ORIGINAL IMPLANTING SURGEON NO LONGER HAS THE PTS MEDICAL RECORDS BUT THAT THE PT WAS PART OF A B6 STUDY BUT HE DOESNT REMEMBER WHICH ONE IF AND WHEN FURTHER INFO IS OBTAINED FROM THE EXPLANTING PHYSICIAN IT WILL BE SUBMITTED THE DIRECTOR OF MEDICAL SAFETY HAS DETERMINED THAT COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|02/25/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3993362|11951948|N|1||DEVICE LABELING ADDRESS THE EVENT OF SEROMA AS FOR PRIMARY AUGMENTATION PTS SEROMA RATE = 16 PRIMARY RECONSTRUCTIONS PTS = 10 OTHER COMPLICATIONS SWELLING = 71 THERE WERE NO REPORTED EVENTS OF LYMPHOMAALCL FOR PTS IN THE B4 STUDY INCLUDED IN THE LABELING FOR SALINE BREAST IMPLANTS THE EXACT DEVICE INFO IS UNK HOWEVER IT DOES SPEAK TO A 168-330 AN ONGOING INVESTIGATION WILL BE CARRIED OUT ON THIS CASE THE MEDICAL SAFETY TEAM HAS DETERMINED THAT COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL THERE IS LIMITED INFO AVAILABLE FOR THIS CASE AFTER THE INITIAL INVESTIGATION AND THERE IS AN UNLIKELY CHANCE THAT THIS INFO WILL BE OBTAINED HOWEVER IF THERE IS ADDITIONAL INFO SUCH AS DEVICE INFO IMPLANTING PHYSICIAN OR ANY LABS RELATED TO BUT NOT LIMITED TO ANY COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL THE FILE WILL BE REVIEWED AND UPDATED|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|07/24/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
4012140|18368421|D|1||ON B6 2014 RECEIVED AN ARTICLE ENTITLED BREAST IMPLANT-ASSOCIATED ALCL REPORT OF 2 CASES AND REVIEW OF THE LITERATURE AESTHETIC SURGERY JOURNAL 06172014 WITHIN THE ARTICLE IT NOTES A CASE OF A B6 PT WHO PRESENTED WITH AN ACUTE ENLARGEMENT OF RIGHT BREAST SWELLING SIXTEEN YEARS EARLIER THE PT HAD A BILATERAL AUGMENTATION SURGERY 425CC TEXTURED ROUND IMPLANTS WERE PLACED SUBGLANDULARLY THE MFR OF THE IMPLANTS WAS NOT KNOWN THE PT DID NOT UNDERGO ANY ADDITIONAL BREAST SURGERY BEFORE PRESENTING TO THE OFFICE CLINICAL EXAM SHOWED SWELLING OF THE RIGHT BREAST BUT NO MASSES US SHOWED A FLUID COLLECTION AROUND THE RIGHT IMPLANT THAT WAS INTACT MRI CONFIRMED THE PRESENCE OF FLUID AND DID NOT REVEAL ANY MASSES US GUIDED ASPIRATION SHOWED CD30+ ALK-ALCL THE CELLS WERE ALSO POSITIVE FOR CD45 CD5 CD4 BUT FAILED TO EXPRESS CD34 CD20 CD68 OR CD10 THE PT UNDERWENT BILATERALLY CAPSULECTOMIES AND IMPLANT REMOVAL WITHOUT REPLACEMENT ON B6 2012 THERE WAS NO SILICONE FOUND IN THE CAPSULE THE PT WAS SENT TO ONCOLOGY THE PT DID NOT RECEIVE ANY ADDITIONAL TREATMENT AND HAS BEEN DISEASE FREE SINCE HER 15 MONTH FOLLOW-UP THE PT CONTINUES TO HAVE PAIN IN THE AFFECTED BREAST THIS REPRESENTS CASE 2|UNK SALINE IMPLANT|UNK SALINE IMPLANT|07/16/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA||||NI|True
4012140|55598047|D|1||ON 25JUN2014 RECEIVED AN ARTICLE ENTITLED BREAST IMPLANT-ASSOCIATED ALCL REPORT OF 2 CASES AND REVIEW OF THE LITERATURE AESTHETIC SURGERY JOURNAL 17JUN2014  WITHIN THE ARTICLE IT NOTES A CASE OF A B6 PATIENT WHO PRESENTED WITH AN ACUTE ENLARGEMENT OF RIGHT BREAST SWELLING SIXTEEN YEARS EARLIER THE PATIENT HAD A BILATERAL AUGMENTATION SURGERY 425CC TEXTURED ROUND IMPLANTS WERE PLACED SUBGLANDULARLY THE MANUFACTURER OF THE IMPLANTS WAS NOT KNOWN THE PATIENT DID NOT UNDERGO ANY ADDITIONAL BREAST SURGERY BEFORE PRESENTING TO THE OFFICE CLINICAL EXAM SHOWED SWELLING OF THE RIGHT BREAST BUT NO MASSES US SHOWED A FLUID COLLECTION AROUND THE RIGHT IMPLANT THAT WAS INTACT MRI CONFIRMED THE PRESENCE OF FLUID AND DID NOT REVEAL ANY MASSES US GUIDED ASPIRATION SHOWED CD30+ ALK-ALCL THE CELLS WERE ALSO POSITIVE FOR CD45 CD5 CD4 BUT FAILED TO EXPRESS CD34 CD20 CD68 OR CD10 THE PATIENT UNDERWENT BILATERALLY CAPSULECTOMIES AND IMPLANT REMOVAL WITHOUT REPLACEMENT ON B6 2012 THERE WAS NO SILICONE FOUND IN THE CAPSULE THE PATIENT WAS SENT TO ONCOLOGY THE PATIENT DID NOT RECEIVE ANY ADDITIONAL TREATMENT AND HAS BEEN DISEASE FREE SINCE 15 MONTH FOLLOW UP THE PATIENT CONTINUES TO HAVE PAIN IN THE AFFECTED BREAST THIS REPRESENTS CASE 2|UNK SALINE IMPLANT|UNK SALINE IMPLANT|07/16/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA||||NI|True
3611913|4170417|D|1||REPORTED EVENTS OF CUTANEOUS ALCL CASE 2 BREAST PRESENTATION MASS EFFECT FLUID AROUND IMPLANT AS STATED IN JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING THE BREAST ARCH PATHOLOGY LAB MEDICAL JOURNAL- VOLUME 133 SEPTEMBER 2009 ALTHOUGH THE MANUFACTURER OF THE DEVICE IS UNKNOWN IT IS ALLERGANS APPROACH TO COMPLIANCE TO RESOLVE ALL DOUBT IN FAVOR OR REPORTING|UNK SALINE IMPLANT|UNK SALINE IMPLANT|01/30/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA, NE||ALLERGAN||CA|||||True
3693307|11615224|N|1||THIS EVENT WAS INITIALLY SUBMITTED VIA EASR ON B6 2010 WITH THE ADVERSE EVENT TERM CODE OF CANCER NON BREAST AN UPDATE TO OUR SAFETY DATABASE FOR THIS REPORTED EVENT NOTES THAT THE TERM CODE HAS BEEN CHANGED FROM CANCER NONBREAST TO LYMPHOMA - ALCL DUE TO INCREASED SPECIFICITY DEVICE LABELING ADDRESSES THE FOLLOWING ADVERSE EVENTS AS PER FOUR STUDY TRIALS OF SALINE IMPLANTS IRRITATION THE FOLLOWING IS A LIST OF POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH BREAST IMPLANT SURGERY THE RISKS INCLUDE ADDITIONAL SURGERY IRRITATIONINFLAMMATION PER THE CORE STUDY OF SILICONE IMPLANT IRRITATION WAS REPORTED AT A RATE OF 0 DEVICE LABELING REVIEWED THERE WERE NO EVENTS FOR LYMPHOMA OR ANAPLASTIC LARGE CELL LYMPHOMA LISTED IN THE CORE STUDY FOR SILICONE OR THE STUDY TRIALS IN THE LABELING FOR SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/14/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3946569|4537478|D|1||HEALTHCARE PROFESSIONAL REPORTS INCIDENCE OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL THAT APPEARS TO BE ASSOCIATED WITH THE USE OF TEXTURED BREAST IMPLANTS I HAVE ENCOUNTERED 3 CASES WITHIN THE PAST 3 YEARS OVER 130 CASES HAVE BEEN REPORTED WORLDWIDE AND TWO OF THESE WERE IN PTS WHO HAD MCGHAN IMPLANTS IE THE SAME TEXTURING PROCESS THAT ALLERGAN CURRENTLY USE THE MEDICAL SAFETY TEAM HAS DETERMINED THAT COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WHICH TO DIAGNOSE ALCL MULTIPLE ATTEMPTS HAVE BEEN MADE TO OBTAIN FURTHER INFO INCLUDING CYTOLOGYPATHOLOGY REPORTS DEVICE INFO ETC IFWHEN ADDL INFO DOES BECOME AVAILABLE IT WILL BE FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3883653|4596671|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF ALCL PAIN SEROMA OF THIS LEFT SIDE DEVICE ON VOLUNTARY MW REPORT B4 THE HEALTH PROFESSIONAL REPORTS PT UNDERWENT BILATERAL BREAST IMPLANTS IN 1989 STARTING IN 2011 SHE DEVELOPED DISCOMFORT IN LEFT CHEST WALL A LARGE FLUID COLLECTION SURROUNDING THE LEFT IMPLANT WAS FOUND IN 2012 FLUID DRAINAGE SHOWED ALK NEGATIVE ALCL CELLS WITHOUT A MASS SHE UNDERWENT REMOVAL OF BILATERAL BREAST IMPLANTS ON B6 2012 EVENT ABATED AFTER USE STOPPED OR DOSE REDUCED EXPLANTING SURGEON PROVIDED MORE INFO INCLUDING PATHOLOGY OF CYTOLOGY REPORTS IF FURTHER INFO BECOMES AVAILABLE IT WILL BE FORWARDED ON|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|06/18/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3679657|17568717|D|1||HEALTHCARE PROFESSIONAL REPORTS VIA B6 A CASE OF SEROMA AND LYMPHOMA WITHIN THE REPORT IT STATES ALCL CASE REPORT THIS PT HAD BILATERAL BREAST AUGMENTATION PERFORMED IN 2005 SHE RECENTLY DEVELOPED A SEROMA THAT WAS ASPIRATED AND FOUND TO HAVE ATYPICAL T CELLS I PERFORMED BILATERAL IMPLANT REMOVAL AND TOTAL CAPSULECTOMY HER FINAL PATHOLOGY REVEALED ALCL OF THE LEFT BREAST SEVERAL ATTEMPTS HAVE BEEN MADE TO GATHER INFO REGARDING THIS CASE IN THE EVENT OF NEW INFO IT WILL BE FORWARDED ON|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/07/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
4081199|4894070|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF RIGHT SIDE LYMPHOMA ALCL|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|09/08/2014|||DA|N|R||0HP|FTR|1.0|10/15/2006|nan||120755|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3761522|62721912|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF LATE SEROMA AND DIAGNOSED ALCL  AS A PATHOLOGY REPORT CONFIRMED MARKERS FOR CD30 POSITIVE ALK NEG ANTIGEN AND OTHER MARKERS CD3 POS CD4 POS CD43 POS WITH HIGH PROLIFERATIVE INDEX OF KI-67 100|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-600|04/07/2014||07/24/2014|DA|Y|Y||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN|93117|CA|93117||||True
4296519|18889780|D|1||ALCL CASE REPORT - B6 FEMALE CAUCASIAN HISTORY OF BILATERAL BREAST AUGMENTATION IS 1996 AT AN OUTSIDE FACILITY PT WITH A 4 YEAR HX OF PAINFUL SWELLING OF LEFT BREAST AFTER A MAMMOGRAM SHE THEN HAD 2 YR HISTORY OF INDURATION AND ERYTHEMA OF INFERIOR PORTION OF LEFT BREAST IN 2012 THE PT UNDERWENT MRI AND SKIN BIOPSY OF THE INDURATED PORTION OF HER LEFT BREAST BY REPORT THE BIOPSY SHOWED INFLAMMATORY TISSUE BUT NO MALIGNANCY THE PT PRESENTED WITH INCREASED PAIN AND SWELLING OF HER LEFT BREAST HER LEFT BREAST WAS FIRM AND LARGER VOLUME THAN HER RIGHT BREAST SHE HAD AN AREA 5 X 8 CM OF ERYTHEMA ALONG THE INFERIOR ASPECT OF THE LEFT BREAST THE PT WAS TAKEN TO THE OPERATING ROOM ON B6 2014 SHE HAD DENSE FIBROSIS AND INDURATION OF THE SKIN AND UNDERLYING BREAST TISSUE ON THE LEFT FROZEN SECTION PATHOLOGY WAS CONSISTENT WITH PROBABLE INFLAMMATORY CARCINOMA ENTIRE CAPSULECTOMY PERFORMED BILATERALLY ON THE RIGHT THE CAPSULE WAS THIN AND THE IMPLANT WAS INTACT ON THE LEFT THE CAPSULE WAS THICK AND FIRM AND THE IMPLANT WAS COMPLETELY DEFLATED THE IMPLANT WAS SURROUNDED BY 250-300 CC OF CREAM MONOGENEOUS YELLOW FLUID THIS WAS SENT FOR CYTOLOGY PROCEDURE WAS BILATERAL CAPSULECTOMY WITH REMOVAL OF IMPLANTS AND CLOSURE OVER DRAINS THE IMPLANTS WERE MCGHAN TEXTURED SALINE IMPLANTS 270 CC APPEARED TO BE SHAPED IMPLANTS NO OTHER IDENTIFYING MARKS ON IMPLANTS PROCEDURE IN 1996 NO ADDL PROCEDURES ON HER BREASTS SINCE INITIAL IMPLANTATION|MCGHAN TEXTURED SALINE IMPLANT, 270CC||11/28/2014||||N|||0|FWM|1.0||SALINE IMPLANT|||||||MCGHAN|||||||True
4296519|18889780|D|1||ALCL CASE REPORT - B6 FEMALE CAUCASIAN HISTORY OF BILATERAL BREAST AUGMENTATION IS 1996 AT AN OUTSIDE FACILITY PT WITH A 4 YEAR HX OF PAINFUL SWELLING OF LEFT BREAST AFTER A MAMMOGRAM SHE THEN HAD 2 YR HISTORY OF INDURATION AND ERYTHEMA OF INFERIOR PORTION OF LEFT BREAST IN 2012 THE PT UNDERWENT MRI AND SKIN BIOPSY OF THE INDURATED PORTION OF HER LEFT BREAST BY REPORT THE BIOPSY SHOWED INFLAMMATORY TISSUE BUT NO MALIGNANCY THE PT PRESENTED WITH INCREASED PAIN AND SWELLING OF HER LEFT BREAST HER LEFT BREAST WAS FIRM AND LARGER VOLUME THAN HER RIGHT BREAST SHE HAD AN AREA 5 X 8 CM OF ERYTHEMA ALONG THE INFERIOR ASPECT OF THE LEFT BREAST THE PT WAS TAKEN TO THE OPERATING ROOM ON B6 2014 SHE HAD DENSE FIBROSIS AND INDURATION OF THE SKIN AND UNDERLYING BREAST TISSUE ON THE LEFT FROZEN SECTION PATHOLOGY WAS CONSISTENT WITH PROBABLE INFLAMMATORY CARCINOMA ENTIRE CAPSULECTOMY PERFORMED BILATERALLY ON THE RIGHT THE CAPSULE WAS THIN AND THE IMPLANT WAS INTACT ON THE LEFT THE CAPSULE WAS THICK AND FIRM AND THE IMPLANT WAS COMPLETELY DEFLATED THE IMPLANT WAS SURROUNDED BY 250-300 CC OF CREAM MONOGENEOUS YELLOW FLUID THIS WAS SENT FOR CYTOLOGY PROCEDURE WAS BILATERAL CAPSULECTOMY WITH REMOVAL OF IMPLANTS AND CLOSURE OVER DRAINS THE IMPLANTS WERE MCGHAN TEXTURED SALINE IMPLANTS 270 CC APPEARED TO BE SHAPED IMPLANTS NO OTHER IDENTIFYING MARKS ON IMPLANTS PROCEDURE IN 1996 NO ADDL PROCEDURES ON HER BREASTS SINCE INITIAL IMPLANTATION|MCGHAN TEXTURED SALINE IMPLANT, 270CC||11/28/2014||||N|||0|FWM|2.0||SALINE IMPLANT|||||||MCGHAN|||||||True
3962610|4605458|D|1||HEALTHCARE PROFESSIONAL CALLS TO REPORT LEFT SIDE ALCL PAIN AND CAPSULAR CONTRACTURE BAKER GRADE IV EXPLANT SURGERY TOOK PLACE IN B6 2014 AND THE DEVICE WILL BE RETURNED AT THE TIME OF THE CALL THE EXACT DEVICE INFORMATION IS UNKNOWN HOWEVER IT IS AN ALLERGAN SALINE STYLE 163 IMPLANT REGARDING CAPSULAR CONTRACTURE THE PATIENT DOES NOT HAVE AN INFECTION OR HEMATOMA THE PATIENT UNDERWENT RADIATION TREATMENT IN 1998 A CALL WAS PLACED TO THE OFFICE THE NURSE INFORMS ALLERGAN THAT THE PATIENT PRESENTED WITH CAPS GRADE IV PAIN AND A LUMP ALL LOCATED ON THE LEFT SIDE SURGERY TOOK PLACE ON B6 2014 WHERE A COMPLETE CAPSULECTOMY AND IMPLANT REMOVAL WITHOUT REPLACEMENT TOOK PLACE FLUID WAS NOTED AT THE TIME OF SURGERY THIS FLUID WAS ASPIRATED AND SUBMITTED THE PATIENT HAS A HISTORY OF BREAST CANCER WITH RECONSTRUCTION WITH A LATISSIMUS FLAP AND IMPLANT THE AFFECTED SIDE WAS NOTED AS LEFT PER THE OFFICE THE PATH REPORT NOTES POSITIVE CD30 CD2 CD4 CD43 AND CD45 THE TUMOR CELLS ARE NEGATIVE FOR CD20 CD3 CD5 CD7 CD8 TIA-1 ALKX2 AND CK-OSCAR|STYLE 163 SALINE FILLED BREAST IMPLANT|UNK STYLE 163|07/15/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA,|US|ALLERGAN||CA|||||True
4296470|15126609|D|1||ALCL CASE REPORT ASSOCIATED WITH BREAST CANCER RECONSTRUCTION IMPLANT|MCGHAN ALLERGAN||11/25/2014|||||||0HP|FWM|1.0||SALINE TEXTURED BREAST IMPLANT||1059645|||IRVINE||MCGHAN / ALLERGAN|92623||92623||27-363150LF||True
3876028|4461510|D|1||SALES REP REPORTED A CASE OF A POSSIBLE ALCL OCCURENCE DEVICE MFR IS UNK AN ONGOING INVESTIGATION IS BEING CARRIED OUT AS MULTIPLE ATTEMPTS HAVE BEEN MADE TO OBTAIN ADDL INFO ALLERGAN HAS NOT RECEIVED ANY FURTHER DETAILS REGARDING THIS REPORTED EVENT|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/30/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA, NE|US|ALLERGAN||CA|||||True
3883660|4593228|D|1||HEALTHCARE PROFESSIONAL REPORTED THIS CASE OF ALCL VIA ADJUNCT STUDY FORM THE PT WAS DIAGNOSED WITH LEFT BREAST CANCER IN 1995 RECONSTRUCTION SURGERY OCCURRED ON B6 2002 WITH A STYLE 153 IMPLANT SYMPTOMS OF AN ENLARGED LEFT BREAST AND CAPSULAR CONTRACTURE OCCURRED A LEFT SIDE SEROMA WAS TREATED WITH DRAINAGE THE SEROMA RECURRED AND SHE WAS EXPLANTED ON B6 2005 REPLACED WITH A MENTOR DEVICE STYLE UNK BIOPSY OF THE SEROMA FLUID AND OF THE LEFT BREAST CAPSULE WAS PERFORMED ON B6 2005 AND AT THAT TIME SHE WAS DIAGNOSED WITH ANAPLASTIC LARGE CELL T CELL LYMPHOMA RADIATION THERAPY BEGAN ON B6 2005 SHE WAS DOING FINE AT HER FOLLOW UP WITH THE PHYSICIAN IN 2007|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-630|06/18/2014|||DA|N|R||0HP|FTR|1.0||nan||569899|||GOLETA|US|ALLERGAN||CA|||||True
3874163|4506744|D|1||ANAPLASTIC LARGE CELL LYMPHOMA ALCL BREAST IMPLANT RELATED DISCOVERED UPON REMOVING BREAST IMPLANT CAPSULE AND SEROMA FLUID FROM RIGHT BREAST IN PT WHO HAD TEXTURED SALINE-FILLED ALLERGAN IMPLANTS PLACED FOR COSMETIC BREAST ENLARGEMENT IN B6 2009 PT NOTICED BREAST ASYMMETRY IN SUMMER OF 2013 WHICH PROGRESSED TO RIGHT BREAST NOTICEABLY LARGER THAN LEFT SIDE WITH ULTRASOUND STUDY DONE ON B6 2014 SHOWING WHAT APPEARED TO BE FLUID AROUND THE RIGHT IMPLANT - POSSIBLE DEFLATION THIS IMPLANT WAS INTACT UPON REMOVAL BUT HAD A LARGE SURROUNDING SEROMA BECAUSE OF SUSPICION FOR ALCL A RIGHT BREAST IMPLANT TOTAL CAPSULECTOMY AND IMPLANT REMOVAL WAS DONE CAPSULE AND SEROMA FLUID SPECIMENS SENT FOR HISTOLOGYPATHOLOGY EVALUATION|NATRELLE SALINE IMPLANT|168-330|06/11/2014|||||||0HP|FWM|1.0||SALINE IMPLANT|||||||ALLERGAN|||||168 NATRELLE SALINE- FILLED||True
3946563|19797996|D|1||HEALTHCARE PROFESSIONAL REPORTS INCIDENCE OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL THAT APPEARS TO BE ASSOCIATED WITH THE USE OF TEXTURED BREAST IMPLANTS I HAVE ENCOUNTERED 3 CASES WITHIN THE PAST 3 YEARS OVER 130 CASES HAVE BEEN REPORTED WORLDWIDE AND TWO OF THESE WERE IN PATIENTS WHO HAD MCGHAN IMPLANTS IE THE SAME TEXTURING PROCESS THAT ALLERGAN CURRENTLY USE THE MEDICAL SAFETY TEAM HAS DETERMINED THAT COMBINED RESULTS OF IMMUNE-CHEMICAL HISTOLOGICAL AND CYTOLOGICAL ANALYSIS OF SPECIMENS ARE SCIENTIFICALLY ACCEPTABLE CRITERIA WITH WHICH TO DIAGNOSE ALCL MULTIPLE ATTEMPTS HAVE BEEN MADE TO OBTAIN FURTHER INFO INCLUDING CYTOLOGYPATHOLOGY REPORTS DEVICE INFO ETC IFWHEN ADDITIONAL INFO DOES BECOME AVAILABLE IT WILL BE FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3642249|18155221|N|1||THE ADVERSE EVENT TERM CODES CANCER AND CANCER NONBREAST HAVE BEEN RETIRED FOR THE USE IN LYMPHOMA AND LYMPHOMA - ALCL CASES AS A RESULT OF THIS INCREASED SPECIFICITY THE SAFETY DATABASE TERM CODES OF LYMPHOMA OR LYMPHOMA - ALCL ARE TO BE USED RATHER THAN CANCER OR CANCER NONBREAST THIS EVENT WAS SUBMITTED VIA B4 B4 2011 WITH THE TERM CODES MFR UNK AND CANCER DEVICE LABELING REVIEWED THERE WERE NO REPORTED EVENTS OF LYMPHOMAALCL FOR PTS IN THE CORE STUDY IN THE LABELING FOR SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|02/05/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3986857|4822318|D|1||ALCL CASE REPORT LOCATION OF ALCL R BREASTAXILLA CLINICAL PRESENTATION RECURRENT FLUID COLLECTIONS MULTIPLE NEGATIVE BIOPSIES DATES OF USE 7 YEARS DIAGNOSIS OR REASON FOR USE BREAST AUGMENTATION|SILICONE BREAST IMPLANT||08/04/2014|||||||0|FTR|1.0||SILICONE BREAST IMPLANT|||||||nan|||||||True
3671970|19393472|N|1||THIS EVENT WAS INITIALLY SUBMITTED VIA B6 WITH THE TERM CODES SEROMA CANCER AND RUPTURE THE ADVERSE EVENT TERM CODE OF SEROMA WAS REMOVED AS MEDICAL RECORDS PROVIDED NO DIAGNOSIS OF SEROMA UPDATE TO OUR SAFETY DATA BASE NOTES THAT FOR THE REPORTED EVENT OF CANCER THE TERM CODE HAS BEEN CHANGED FROM CANCER TO LYMPHOMA DUE TO INCREASED SPECIFICITY DEVICE LABELING FOR SILICONE BREAST IMPLANTS ADDRESSES AS FOLLOWS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION DEVICE LABELING REVIEWED THERE WERE NO REPORTED EVENTS OF LYMPHOMA ALCL FOR PATIENTS IN THE CORE STUDY IN THE LABELING FOR SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|02/12/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN|93117|CA|93117||||True
4055803|4860628|D|1||I HAD SILICONE BREAST IMPLANTS REPLICON BY SURGITEK IN 1990 THE FDA APPROVED THIS PROCEDURE AND MY DOCTOR TOLD ME THEY WOULD LAST A LIFETIME AND THERE WERE NO HEALTH RISKS I WAS TOLD ONLY NEGATIVE ISSUE WAS THAT 1 OF PATIENTS HAD THE IMPLANTS BECOME HARD DUE TO ENCAPSULATION PROBLEMS I HAD THAT PROBLEM AFTER 2 YEARS I HAD A LEAK CONTAINED WITHIN THE ENCAPSULATED AREA ABOUT 5 YEARS LATER ON B6 2014 I HAD A MAMMOGRAM THAT SHOWS A PROGRESSIVE LEAK OUTSIDE THE ENCAPSULATION I HAD THIS TEST BECAUSE OF RECENT UNEXPLAINED HEALTH ISSUES PAIN AND WEIGHT LOSS FOR 20 YEARS I HAVE EXPERIENCED NUMEROUS AUTOIMMUNE DISORDERS AND OTHER HEALTH ISSUES WITH A DIAGNOSIS OF UNKNOWN ORIGIN I ALWAYS ASK MY DOCTORS IF IT COULD BE CAUSED FROM MY SILICONE IMPLANTS AND THEY ALWAYS SAID IT WAS NOT POSSIBLE I HAVE BEEN ON DISABILITY FOR FIBROMYALGIA FOR SEVERAL YEARS I AM SCHEDULED TO HAVE THESE TOXIC IMPLANTS REMOVED BUT IT WILL COST ME ALMOSTB6 WITH NO INSURANCE HELP I ORIGINALLY MADE THE DECISION TO HAVE IMPLANTS BECAUSE FDA AND MY DOCTORS SAID THEY WERE TOTALLY SAFE I HAVE NEVER SMOKED NOT EVEN ONE PUFF I EAT MY GARDEN RAISED WHOLE FOODS I AM B6 AND I TAKE NO MEDS AND HAVE NEVER DONE ANY DRUGS PEOPLE SMOKE AND OVER EAT KNOWING THEY RISK HEART DISEASE DIABETES CANCER ETC AND INSURANCE STILL PAYS FOR THEIR TREATMENT I AM NOW HAVING TO USE ALL THE MONEY I HAVE SAVED AND ARE SELLING FAMILY HEIRLOOMS TO PAY FOR THE TREATMENT I MUST HAVE BECAUSE I TRUSTED THE FDA I DONT UNDERSTAND WHY THE FDA RECOMMENDS REMOVING LEAKING SILICONE IMPLANTS IF THERE IS NO HEALTH PROBLEMS FROM SILICONE IMPLANTS I HAVE ALWAYS STRONGLY SUPPORTED MY WONDERFUL GOVERNMENT AND MY HEART IS BROKEN THAT I HAVE BEEN WRONG THE RESEARCH YOU AND OTHERS HAVE DONE ARE SO LIMITED AND FLAWED YOU HAVE CONVINCED DOCTORS THAT IMPLANT RELATED HEALTH ISSUES ARE NOT A PROBLEM AND SO THEREFORE WHEN WOMEN LIKE ME TRY TO GET OUR DOCTORS TO INVESTIGATE THE POSSIBILITY WE ARE DISMISSED AND TOLD OUR SYMPTOMS ARE EITHER IN OUR HEADS OR ARE CAUSED BY A VIRUS OR STRESS SO WE SHOULD JUST GO HOME AND RELAX THE LOSS OF CONFIDENCE AND TRUST IN MY GOVERNMENT IS ACTUALLY ONE OF THE WORST PROBLEM WITH THIS ISSUE I AM SO SAD AND DEPRESSED I DO UNDERSTAND WHY THERE IS SUCH A HIGH DEGREE OF SUICIDE BY WOMEN WITH IMPLANT PROBLEMS MY QUALITY OF LIFE IS AT ROCK BOTTOM AFTER 30 YEARS OF TEACHING SECONDARY EDUCATION IN THE PUBLIC SCHOOL SYSTEM AND LOOKING FORWARD TO MY RETIREMENT YEARS ALL MY RESOURCES WILL NOW HAVE TO BE USED TO PAY DOCTORS AND I JUST PRAY THAT THEY DO NOT FIND ALCL I JUST READ THAT INSURANCE WILL NOT PAY FOR THAT CANCER TREATMENT EITHER AND SO IF I HAVE IT I WILL JUST NOT BE ABLE TO GET TREATMENT THIS IS JUST WRONG THAT MY GOVERNMENT ALLOWS THIS TO HAPPEN TO WOMEN WHO HAD IMPLANTS DURING A TIME THAT WE WERE TOLD THEY WERE TOTALLY SAFE IN 1990 I DID THE RESEARCH AND I BELIEVED YOU FDA THAT I WAS MAKING A SAFE DECISION I JUST WANTED MY HUSBAND TO BE PROUD OF ME SO SAD AND HEART BROKEN WHAT IS THE TEST FOR THAT EVEN THOUGH I PAY MONTHLY INSURANCE PREMIUMS THEY WOULDNT PAY FOR THAT EITHER|REPLICON SILICONE BREAST IMPLANT||08/28/2014|||||||0|FTR|2.0||SILICONE BREAST IMPLANT|||||||SURGITEK|||||NOT KNOWN||True
4055803|4860628|D|1||I HAD SILICONE BREAST IMPLANTS REPLICON BY SURGITEK IN 1990 THE FDA APPROVED THIS PROCEDURE AND MY DOCTOR TOLD ME THEY WOULD LAST A LIFETIME AND THERE WERE NO HEALTH RISKS I WAS TOLD ONLY NEGATIVE ISSUE WAS THAT 1 OF PATIENTS HAD THE IMPLANTS BECOME HARD DUE TO ENCAPSULATION PROBLEMS I HAD THAT PROBLEM AFTER 2 YEARS I HAD A LEAK CONTAINED WITHIN THE ENCAPSULATED AREA ABOUT 5 YEARS LATER ON B6 2014 I HAD A MAMMOGRAM THAT SHOWS A PROGRESSIVE LEAK OUTSIDE THE ENCAPSULATION I HAD THIS TEST BECAUSE OF RECENT UNEXPLAINED HEALTH ISSUES PAIN AND WEIGHT LOSS FOR 20 YEARS I HAVE EXPERIENCED NUMEROUS AUTOIMMUNE DISORDERS AND OTHER HEALTH ISSUES WITH A DIAGNOSIS OF UNKNOWN ORIGIN I ALWAYS ASK MY DOCTORS IF IT COULD BE CAUSED FROM MY SILICONE IMPLANTS AND THEY ALWAYS SAID IT WAS NOT POSSIBLE I HAVE BEEN ON DISABILITY FOR FIBROMYALGIA FOR SEVERAL YEARS I AM SCHEDULED TO HAVE THESE TOXIC IMPLANTS REMOVED BUT IT WILL COST ME ALMOSTB6 WITH NO INSURANCE HELP I ORIGINALLY MADE THE DECISION TO HAVE IMPLANTS BECAUSE FDA AND MY DOCTORS SAID THEY WERE TOTALLY SAFE I HAVE NEVER SMOKED NOT EVEN ONE PUFF I EAT MY GARDEN RAISED WHOLE FOODS I AM B6 AND I TAKE NO MEDS AND HAVE NEVER DONE ANY DRUGS PEOPLE SMOKE AND OVER EAT KNOWING THEY RISK HEART DISEASE DIABETES CANCER ETC AND INSURANCE STILL PAYS FOR THEIR TREATMENT I AM NOW HAVING TO USE ALL THE MONEY I HAVE SAVED AND ARE SELLING FAMILY HEIRLOOMS TO PAY FOR THE TREATMENT I MUST HAVE BECAUSE I TRUSTED THE FDA I DONT UNDERSTAND WHY THE FDA RECOMMENDS REMOVING LEAKING SILICONE IMPLANTS IF THERE IS NO HEALTH PROBLEMS FROM SILICONE IMPLANTS I HAVE ALWAYS STRONGLY SUPPORTED MY WONDERFUL GOVERNMENT AND MY HEART IS BROKEN THAT I HAVE BEEN WRONG THE RESEARCH YOU AND OTHERS HAVE DONE ARE SO LIMITED AND FLAWED YOU HAVE CONVINCED DOCTORS THAT IMPLANT RELATED HEALTH ISSUES ARE NOT A PROBLEM AND SO THEREFORE WHEN WOMEN LIKE ME TRY TO GET OUR DOCTORS TO INVESTIGATE THE POSSIBILITY WE ARE DISMISSED AND TOLD OUR SYMPTOMS ARE EITHER IN OUR HEADS OR ARE CAUSED BY A VIRUS OR STRESS SO WE SHOULD JUST GO HOME AND RELAX THE LOSS OF CONFIDENCE AND TRUST IN MY GOVERNMENT IS ACTUALLY ONE OF THE WORST PROBLEM WITH THIS ISSUE I AM SO SAD AND DEPRESSED I DO UNDERSTAND WHY THERE IS SUCH A HIGH DEGREE OF SUICIDE BY WOMEN WITH IMPLANT PROBLEMS MY QUALITY OF LIFE IS AT ROCK BOTTOM AFTER 30 YEARS OF TEACHING SECONDARY EDUCATION IN THE PUBLIC SCHOOL SYSTEM AND LOOKING FORWARD TO MY RETIREMENT YEARS ALL MY RESOURCES WILL NOW HAVE TO BE USED TO PAY DOCTORS AND I JUST PRAY THAT THEY DO NOT FIND ALCL I JUST READ THAT INSURANCE WILL NOT PAY FOR THAT CANCER TREATMENT EITHER AND SO IF I HAVE IT I WILL JUST NOT BE ABLE TO GET TREATMENT THIS IS JUST WRONG THAT MY GOVERNMENT ALLOWS THIS TO HAPPEN TO WOMEN WHO HAD IMPLANTS DURING A TIME THAT WE WERE TOLD THEY WERE TOTALLY SAFE IN 1990 I DID THE RESEARCH AND I BELIEVED YOU FDA THAT I WAS MAKING A SAFE DECISION I JUST WANTED MY HUSBAND TO BE PROUD OF ME SO SAD AND HEART BROKEN WHAT IS THE TEST FOR THAT EVEN THOUGH I PAY MONTHLY INSURANCE PREMIUMS THEY WOULDNT PAY FOR THAT EITHER|REPLICON SILICONE BREAST IMPLANT||08/28/2014|||||||0|FTR|1.0||SILICONE BREAST IMPLANT|||||||SURGITEK|||||NOT KNOWN||True
3671971|18584358|N|1||THIS EVENT WAS INITIALLY SUBMITTED VIA B6 WITH THE TERM CODES RUPTURE SEROMA AND CANCER NON BREAST THE ADVERSE EVENT TERM CODES OF RUPTURE AND SEROMA WERE REMOVED AS MEDICAL REPORTS PROVIDED NO DIAGNOSIS OF SEROMA AND NEGATIVE FOR LEFT SIDE RUPTURE UPDATED OUR SAFETY DATA BASE NOTES THAT FOR THE REPORTED EVENT OF CANCER THE TERM CODE HAS BEEN CHANGED FROM CANCER TO LYMPHOMA DUE TO INCREASED SPECIFICITY DEVICE LABELING FOR SILICONE BREAST IMPLANTS ADDRESSES THE EVENTS AS FOLLOWS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE CAPSULAR CONTRACTURE REOPERATION DEVICE LABELING REVIEWED THERE WERE NO REPORTED EVENTS OF LYMPHOMA ALCL FOR PATIENTS IN THE CORE STUDY IN THE LABELING FOR SILICONE IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST|02/12/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
4317244|5130090|D|1||A B6 FEMALE PRESENTED WITH RIGHT LATERAL CHEST MELANOMA EXCISION AND FOUND TO HAVE AXILLARY LYMPHADENOPATHY BUT ULTRASOUND NORMAL PT ALSO APPEARED TO HAVE RIGHT BREAST FIRM GRADE IV CAPSULAR CONTRACTURE PT INITIALLY DECLINED TREATMENT THEN RETURNED DIAGNOSED WITH ALCL B6 2013|MCGHAN 240CC||12/10/2014|||DA||*||0HP|FWM|1.0||BREAST IMPLANT TYPE UNCLEAR|||||||MCGHAN|||||||True
3739115|16914969|D|1||THIS FILE WAS ORIGINALLY SENT IN MARCH UNDER MFR REPORT 1645337-2014-00019 WHICH IS A DUPLICATEALCL SYMPTOMS ALCL SYMPTOMS HAVE NOT BEEN CONFIRMED BY A RHEUMATOID PHYSICIAN|CONTOUR PROFILE HIGH GEL - LUMERA|354-1401|04/10/2014|||DA||R||0HP|FTR|1.0||BREAST IMPLANT||5591688|||IRVING|US|MENTOR||TX|||||True
3739116|4275183|D|1||THIS FILE WAS ORIGINALLY SENT IN MARCH UNDER MFR REPORT 1645337-2014-00019 WHICH IS A DUPLICATE ALCL SYMPTOMS HAVE NOT BEEN CONFIRMED BY A RHEUMATOID PHYSICIAN|COUNTOUR PROFILE HIGH GEL - LUMERA|354-1401|04/10/2014|||DA||R||0HP|FTR|1.0||BREAST IMPLANT||5591688|||IRVING|US|MENTOR||TX|||||True
3693305|4292884|D|1||RESEARCH ARTICLE PUBLISHED IN 2008 AMERICAN JOURNAL OF SURGICAL PATHOLOGY ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED WITH A BREAST IMPLANT CAPSULE A CASE REPORT AND REVIEW OF THE LITERATURE REPORTED A B6 PT WITH A HISTORY OF RIGHT SIDE BREAST CANCER AND RECONSTRUCTION WITH ALLERGAN SALINE TEXTURED BREAST IMPLANT IN B6 2005 THE PT PRESENTED WITH A SEROMA SUBSEQUENTLY SHE WAS DIAGNOSED WITH ALCL T CELL TYPE THIS CASE STUDY WAS REPORTED ORIGINALLY BY ANOTHER DOCTOR ET AL IN ANNALS OF PLASTIC SURGERY B6 2007|STYLE 363 SALINE FILLED BREAST IMPLANT|27-363651|03/14/2014|||DA|N|R||0HP|FWM|1.0||nan||532328|||GOLETA|US|ALLERGAN||CA|||||True
3693305|11615223|N|1||THIS EVENT WAS INITIALLY REPORTED VIA EASR ON B6 2010 WITH THE ADVERSE EVENT TERM CODE OF CANCER NON BREAST AN UPDATE TO OUR SAFETY DATA BASE FOR THIS REPORTED EVENT NOTES THAT THE TERM CODE HAS BEEN CHANGED FROM CANCER NONBREAST TO LYMPHOMA - ALCL DUE TO INCREASED SPECIFICITY DEVICE LABELING REVIEWED THERE WERE NO EVENTS FOR LYMPHOMA OR ANAPLASTIC LARGE CELL LYMPHOMA OR THE STUDY TRIALS IN THE LABELING FOR SALINE IMPLANTS|STYLE 363 SALINE FILLED BREAST IMPLANT|27-363651|03/14/2014|||DA|N|R||0HP|FWM|1.0||nan||532328|||GOLETA|US|ALLERGAN||CA|||||True
4012158|4705786|D|1||ON B6 2014 RECEIVED AN ARTICLE ENTITLED BREAST IMPLANT-ASSOCIATED ALCL REPORT OF 2 CASES AND REVIEW OF THE LITERATURE AESTHETIC SURGERY JOURNAL 17 JUNE 2014 WITHIN THE ARTICLE IT NOTES A CASE OF A B6 PATIENT WHO PRESENTED WITH A SIX WEEK HISTORY OF RIGHT BREAST SWELLING NINE YEARS EARLIER THE PATIENT HAD A BILATERAL SUBMUSCULAR AUGMENTATION WITH A 510CC ALLERGAN TEXTURED IMPLANT THERE WERE NO POST OP COMPLICATIONS PATIENT HAS FAMILY HISTORY OF BREAST CANCER AND A PERSONAL HISTORY OF CELIAC DISEASE UPON PRESENTATION THERE WERE NO MASSES FOUND JUST RIGHT BREAST ERYTHEMA AND SWELLING A MAMMOGRAM REVEALED FLUID SURROUNDING THE IMPLANT THAT WAS INTACT AN US ALSO SHOWS AN INTACT IMPLANT AND FLUID ADJACENT TO THE IMPLANT THAT WAS INDICATIVE OF AN INFLAMMATORY PROCESS OR SEROMA PERCUTANEOUS FLUID COLLECTION OF 200CC OF CLEAR FLUID DEMONSTRATED A POPULATION OF LARGE CELLS WITH THE EXPRESSION OF CD2 CD5 CD4 AND CD30 AND FAILED TO EXPRESS CD3 OR CD7 RESULTS OF IMMUNHISTOCHEMICAL STAINING WERE NEGATIVE FOR ALK-1 THE PATIENT ALSO HAD AN MRI OF THE BREAST CONFIRMING INTACT IMPLANTS SHE WAS SENT TO ONCOLOGY FOR STAGING AND TREATMENT A PET SCAN WAS NEGATIVE TREATMENT INCLUDED A CAPSULECTOMY AND IMPLANT REMOVAL BILATERALLY WITHOUT REPLACEMENT IN B6 2011 THERE WAS EVIDENCE OF SILICONE WITHIN THE CAPSULE THE PATIENT HAS BEEN DISEASE FREE SINCE B6 2013 THIS REPRESENTS CASE 1 WITHIN THE ARTICLE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|07/16/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3611928|11525621|N|1||THIS EVENT WAS INITIALLY SUBMITTED VIA B4 ON B4 2010 WITH THE TERM CODES CANCER LUMPNODULE AND MANUFACTURER UNK UPDATE TO OUR SAFETY DATA BASE NOTES THAT THE TERM CODE HAS BEEN CHANGED FROM LYMPHPOMA TO LYMPHOMA ALCL DEVICE LABELING REVIEWED THERE WERE NO REPORTED EVENTS OF LYMPHOMAALCL FOR PTS IN THE CORE STUDY IN THE LABELING FOR SILICONE IMPLANTS DEVICE LABELING ADDRESS THE EVENT OF SWELLING AS FOR PRIMARY AUGMENTATION PTS SWELLING RATE = 92 PERCENT PRIMARY RECONSTRUCTION PTS = 84 PERCENT SILICONE PT BROCHURE FOLLOWING BREAST AUGMENTATION YOU SHOULD CONTINUE TO PERFORM BREAST SELF-EXAMINATION MONTHLY THIS MAY BE MORE DIFFICULT WITH A BREAST IMPLANT IN PLACE TO CONTINUE TO PERFORM A MONTHLY BREAST SELF EXAMINATION EFFICIENTLY YOU SHOULD ASK YOUR SURGEON TO HELP YOU IDENTIFY THE DIFFERENCE BETWEEN THE IMPLANT AND YOUR BREAST TISSUE BEING ABLE TO IDENTIFY THE IMPLANT FROM BREAST TISSUE WILL DECREASE THE NECESSITY OF EXCESSIVE SQUEEZING OF THE IMPLANT DURING EXAMINATION ANY NEW LUMPS SHOULD BE EVALUATED WITH A BIOPSY AS APPROPRIATE IF A BIOPSY IS PERFORMED BE SURE TO INFORM THE MEDICAL PROFESSIONAL PERFORMING THE BIOPSY THAT YOU HAVE BREAST IMPLANTS SO THAT CARE WILL BE TAKEN TO AVOID INJURING THE IMPLANT|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/30/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3611928|4157112|D|1||REPORTED EVENTS OF ALK- ALCL CASE 3 BREAST PRESENTATION PAIN AND SWELLING SCAR NO FLUID AS STATED IN JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING THE BREAST ARCH PATHOLOGY LAB MEDICAL JOURNAL-VOL 133 SEP 2009 ALTHOUGH THE MFR OF THE DEVICE IS UNK IT IS ALLERGANS APPROACH TO COMPLIANCE TO RESOLVE ALL DOUBT IN FAVOR OR REPORTING|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/30/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3642247|11651516|N|1||THIS EVENT WAS INITIALLY SUBMITTED VIA B4 B4 2010 WITH THE TERM CODES SEROMA AND CANCER CORRECTED  UPDATE TO OUR SAFETY DATA BASE FOR THIS REPORTED EVENT NOTES THAT THE TERM CODE HAS BEEN CHANGED FROM CANCER TO LYMPHOMA - ALCL DUE TO INCREASED SPECIFICITY DEVICE LABELING REVIEWED THERE WERE NO REPORTED EVENTS OF LYMPHOMAALCL FOR PTS IN THE A95R95 STUDY INCLUDED IN THE LABELING FOR SALINE BREAST IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|02/07/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
5186386|29786531|D|1||HEALTH PROFESSIONAL REPORTED APPEARANCE OF PERI PROSTHETIC RECIDIVIST LIQUID WHICH AT THE HISTOLOGICAL EXAMINATION RESULTED TO BE COMPATIBLE WITH ANAPLASTIC LARGE CELL LYMPHOMA DEVICE WAS EXPLANTED AND A TOTAL CAPSULECTOMY WAS PERFORMED SIDE WAS UNSPECIFIED EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL PATHOLOGICAL MARKERS ARE RECEIVED TO CONFIRM ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX150-620|10/29/2015||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1325729|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5186386|29786530|N|1||DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX150-620|10/29/2015||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1325729|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5108565|26936205|D|1||HEALTH PROFESSIONAL REPORTED SPONTANEOUS RECURRENT SEROMA IN THE RIGHT BREAST POSITIVE CYTOLOGY ANAPLASTIC LYMPHOMA DEVICE WAS REMOVED AND THE CAPSULE WAS ANALYZED WITH RESULT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE OF DIAGNOSED CAPSULE WAS NOT SPECIFIED ALCL WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED SEE MFR  9617229-2015-00372 FOR THE LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1509947|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5108565|26936204|N|1|| DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1509947|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4377497|17379665|N|1||UNIQUE IDENTIFIER UDI  NA MEDWATCH SUBMITTED ON 12242014 ALLERGAN HAS NOT RECEIVED THE PRODUCT AT THIS TIME THEREFORE NO ANALYSIS OR TESTING HAS BEEN DONE IT IS UNLIKELY RHE PRODUCT WILL BE RETURNED DEATH IS A SURGICALPHYSIOLOGICAL COMPLICATION AND ANALYSIS OF DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING ADDRESSES THE REPORTED EVENT OF DEATH AS FOLLOWS AS WITH ANY SURGICAL PROCEDURE BREAST IMPLANTATION IS NOT WITHOUT RISKS BREAST IMPLANTATION IS AN ELECTIVE PROCEDURE AND THE PT MUST BE WELL COUNSELED AND UNDERSTAND THE RISKBENEFIT RELATIONSHIP DEVICE LABELING ADDRESSES ALCL THERE WERE NO REPORTED EVENTS OF LYMPHOMAALCL FOR PTS IN THE CORE STUDY IN THE LABELING FOR SILICONE IMPLANTS DEVICE LABELING ADDRESSES LUMPS PTS SHOULD PERFORM BREAST SELF-EXAMINATIONS MONTHLY AND BE SHOWN HOW TO DISTINGUISH THE IMPLANT FROM THEIR BREAST TISSUE THE PT SHOULD NOT MANIPULATE OR SQUEEZE THE IMPLANT EXCESSIVELY THE PT SHOULD BE TOLD THAT THE PRESENCE OF LUMPS PERSISTENT PAIN SWELLING HARDENING OR CHANGE IN THE IMPLANT SHAPE MAY BE SIGNS OF SYMPTOMATIC RUPTURE OF THE IMPLANT IF THE PT HAS ANY OF THESE SIGNS SHE SHOULD BE TOLD TO REPORT THEM AND POSSIBLY HAVE AN MRI EVALUATION TO SCREEN FOR RUPTURE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4377497|17294303|D|1||HEALTH PROFESSIONAL REPORTED PT FELT A LUMP IN THE LEFT BREAST UNDERWENT AN FNA OF THE MASS DIAGNOSED ALCL STAGE IE MASS WAS 4X3CM IN SIZE NO CUTANEOUS INVOLVEMENT OR SYSTEMIC DISEASE AT THIS POINT UNDERWENT CHOP CHEMOTHERAPY FOLLOWED BY REGIONAL RADIATION HOWEVER HAD RECURRENCE OF DISEASE WITHIN FOUR MONTHS OF ADJUNCTIVE TREATMENT DISEASE PROGRESSED TO CNS INVOLVEMENT WITH MENINGEAL DISEASE EXPIRED ON B6 1997|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4377497|55005828|D|1||HEALTH PROFESSIONAL REPORTED PATIENT FELT A LUMP IN THE LEFT BREAST UNDERWENT AN FNA OF THE MASS DIAGNOSED AS ALCL STAGE IE MASS WAS 4X3CM IN SIZE NO CUTANEOUS INVOLVEMENT OR SYSTEMIC DISEASE AT THIS POINT UNDERWENT CHOP CHEMOTHERAPY FOLLOWED BY REGIONAL RADIATION HOWEVER HAD RECURRENCE OF DISEASE WITHIN FOUR MONTHS OF ADJUNCTIVE TREATMENT DISEASE PROGRESSED TO CNS INVOLVEMENT WITH MENINGEAL DISEASE EXPIRED ON B6 1997|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
5067426|25380332|N|1||B4 DEVICE LABELING ADDRESSES ADDITIONAL COMPLICATIONS - AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME PAIN HEMATOMASEROMA CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS LYMPHOMAS INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL Â¿ INFORMATION FROM THE MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF 20 CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THIS DISEASE IS EXCEPTIONALLY RARE AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO IDENTIFY ALCL FROM OTHER CANCERS OF THE BREAST IT IS IMPORTANT TO NOTE THAT THESE FINDINGS ARE CONSIDERED PRELIMINARY THE MAJORITY OF THE CASES REPORTED IN PATIENTS WITH BREAST IMPLANTS PRESENT AS LATE OCCURRING SEROMAS AND HAVE AN INDOLENT CLINICAL COURSE INCLUDING SOME INVOLVING SPONTANEOUS REMISSION WITHOUT ADJUVANT THERAPY NO STUDY HAS CONCLUDED A CAUSE AND EFFECT RELATIONSHIP BETWEEN ALCL AND BREAST IMPLANTS ALL PERTINENT FINDINGS RESPECTING CASES ASSOCIATED WITH ALLERGAN DEVICES SHOULD BE REPORTED TO ALLERGAN EG TIME TO CLINICAL PRESENTATION SIGNS OR SYMPTOMS IMMUNOHISTOLOGICAL ANALYSIS TYPE OF IMPLANT TEXTURE PATIENT HISTORY WITH IMPLANTS PHYSICIANS SHOULD KEEP ABREAST OF ALCL IN THE LITERATURE AND PROVIDE APPROPRIATE THERAPY TO PATIENTS AS NEEDED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM120-280|09/10/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4791712|50521769|D|1||FU CONFIRMED WITH THE PHYSICIAN THAT THE PT DOES NOT HAVE LYMPHOMA OR ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084366|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN (COSTA RICA)|||||||True
4791712|22282406|N|1||B4 DEVICE LABELING ADDRESSES THE POSSIBILITY OF ADVERSE EVENTS AS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY DISCUSS WITH THE PT THE WARNINGS PRECAUTIONS IMPORTANT FACTORS TO CONSIDER POSSIBLE ADVERSE EVENTS AND ALLERGANS CORE CLINICAL STUDY RESULTS BASED ON INFO REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084366|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN (COSTA RICA)|||||||True
4791712|22243235|D|1||PT REPORTED RIGHT SIDE RUPTURE PT ADDITIONALLY REPORTED NAUSEA AND ALCL AND OTHER UNSPECIFIED SIDE EFFECTS ALCL WILL BE CAPTURED AS LYMPHOMA AS THIS EVENT CANNOT BE CONFIRMED BY THE PHYSICIAN SEE MFR 9617229-2015-00086|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084366|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN (COSTA RICA)|||||||True
4791712|50912363|D|1||PATIENT REPORTED RIGHT SIDE RUPTURE PATIENT ADDITIONALLY REPORTED NAUSEA AND ALCL AND OTHER UNSPECIFIED SIDE EFFECTS ALCL WILL BE CAPTURED AS LYMPHOMA AS THIS EVENT CANNOT BE CONFIRMED BY THE PHYSICIAN SEE MFR  9617229-2015-00086 FOR THE LEFT SIDE FOLLOW-UP CONFIRMED WITH THE PHYSICIAN THAT THE PATIENT DOES NOT HAVE LYMPHOMA OR ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084366|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN (COSTA RICA)|||||||True
5048951|24795080|N|1||DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY PUBLISHED STUDIES INDICATE THAT BREAST CANCER IS NO MORE COMMON IN WOMEN WITH IMPLANTS THAN THOSE WITHOUT IMPLANTS A LARGE LONG-TERM FOLLOW-UP FOUND NO SIGNIFICANT INCREASES IN THE RISK RATES FOR A WIDE VARIETY OF CANCERS INCLUDING STOMACH CANCER LEUKEMIA AND LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MANUFACTURERS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-270|09/02/2015||||N|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||540807|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5048951|24795081|D|1||HEALTH PROFESSIONAL REPORTED VIA VOLUNTARY MEDWATCH 5042321 PATIENT NOTED INCREASED SIZE OF THE LEFT BREAST AND A FIRM MASS MEDIALLY ALSO IN THE LEFT BREAST ULTRASONIC-GUIDED NEEDLE BIOPSY OF BOTH THE BREAST MASS WHICH PROVIDED TO BE RETRO-PECTORAL AND LEFT AXILLARY LYMPH NODES DONE SHOWED ANAPLASTIC LARGE CELL LYMPHOMA ALK NEG IN THE BREAST AND THE NODES PETCT SHOWED THE BREAST MASS TO BE HIGHLY HYPERMETABOLIC ENLARGED HYPERMETABOLIC LEFT AXILLARY NODES THE PATIENT RECEIVED CHEMOTHERAPY CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE ETOPOSIDE WITH GOOD RESPONSE BREAST IMPLANT REMOVAL HAS BEEN RECOMMENDED PER FOLLOW-UP HEALTH PROFESSIONAL ADDITIONALLY REPORTED THAT THE PATIENT HAS LEFT SIDE CAPSULAR CONTRACTURE AND HAD NOTED A BULGING ON THE LEFT SIDE BAKER GRADE WAS NOT PROVIDED HEALTH PROFESSIONAL CONFIRMED THAT THE LEFT SIDE DEVICE REMAINS IMPLANTED AND THAT THE PATIENT HAS DECLINED TO HAVE IT REMOVED THIS EVENT WILL BE CAPTURED AS LYMPHOMA AS CONFIRMATION OF ALCL HAS NOT BEEN RECEIVED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-270|09/02/2015||||N|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||540807|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4385755|16883770|D|1||HEALTH PROFESSIONAL REPORTED PT DEVELOPED AXILLARY PERICAPSULAR AND SUPRACLAVICULAR MASSES DIAGNOSED AS CD30+ ALK-ALCL AND SYNCHRONOUS HODGKINS LYMPHOMA TREATED WITH BILATERAL IMPLANT REMOVAL CAPSULECTOMIES CHEMOTHERAPY WITH CHOP X 3 ROUNDS AND RADIATION TO THE AXILLA FOLLOW UP IMAGING WITH CT SCAN NO RECURRENCE OF DISEASE REMAINS HEALTHY ALCL AFFECTED BREAST REPORTED AS UNILATERAL -LEFT HEALTH PROFESSIONAL ADDITIONALLY REPORTED CAPSULAR CONTRACTURE BAKER GRADE III|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385755|54780897|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED AXILLARY PERICAPSULAR AND SUPRACLAVICULAR MASSES DIAGNOSED AS CD30+ ALK- ALCL AND SYNCHRONOUS HODGKINS LYMPHOMA TREATED WITH BILATERAL IMPLANT REMOVAL CAPSULECTOMIES CHEMOTHERAPY WITH CHOP X 3 ROUNDS AND RADIATION TO THE AXILLA FOLLOW UP IMAGING WITH CT SCAN NO RECURRENCE OF DISEASE REMAINS HEALTHY ALCL AFFECTED BREAST REPORTED AS UNILATERAL - LEFT HEALTH PROFESSIONAL ADDITIONALLY REPORTED CAPSULAR CONTRACTURE BAKER GRADE III|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385755|17004785|N|1||THERE WERE NO REPORTED EVENTS OF LYMPHOMA ALCL FOR PTS IN THE B6 STUDY IN THE LABELING FOR SILICONE IMPLANTS DEVICE LABELING ADDRESSES LUMPS PTS SHOULD PERFORM BREAST SELF-EXAMINATIONS MONTHLY AND BE SHOWN HOW TO DISTINGUISH THE IMPLANT FROM THEIR BREAST TISSUE THE PT SHOULD NOT MANIPULATE OR SQUEEZE THE IMPLANT EXCESSIVELY THE PT SHOULD BE TOLD THAT THE PRESENCE OF LUMPS PERSISTENT PAIN SWELLING HARDENING OR CHANGE IN THE IMPLANT SHAPE MAY BE SIGNS OF SYMPTOMATIC RUPTURE OF THE IMPLANT IF THE PT HAS ANY OF THESE SIGNS SHE SHOULD BE TOLD TO REPORT THEM AND POSSIBLY HAVE MRI EVAL TO SCREEN FOR RUPTURE DEVICE LABELING ADDRESSES CAPSULAR CONTRACTURE PTS SHOULD BE ADVISED THAT CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWING INFECTION HEMATOMA AND SEROMA AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME CAPSULAR CONTRACTURE OCCURS MORE COMMONLY IN REVISION PTS THAN IN PRIMARY AUGMENTATION OR RECONSTRUCTION PTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
5286885|33230445|D|1||PHYSICIAN REPORTED RIGHT SIDE DEVICE REMOVAL WITH REPLACEMENT AND A DIAGNOSIS OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL AS PATHOLOGICAL MARKERS HAVE NOT BEEN PROVIDED THIS CASE WILL BE CAPTURED AS LYMPHOMA UNTIL CONFIRMATION HAS BEEN RECEIVED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|12/10/2015|||DA|N|R||0HP|FTR|1.0|10/21/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1157331|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5286885|36621596|D|1||ADDITIONAL INFORMATION RECEIVED REVEALS PATIENT EXPERIENCED VOLUME INCREASE AT RIGHT SIDE APPROXIMATELY EIGHT YEARS AFTER IMPLANTATION SUBSEQUENT MRI SHOWED A PERIPROSTHETIC SEROMA ON RIGHT SIDE THE SUBSEQUENT FINE-NEEDLE ASPIRATION CYTOLOGY SHOWS INFLAMMATION AND THE PATIENT IS TREATED WITH ANTI-INFLAMMATORY AND ANTIBIOTICS THE PATIENT AGAIN EXPERIENCED RIGHT BREAST VOLUME INCREASE APPROXIMATELY THREE MONTHS PRIOR TO DEVICE REMOVAL A TOTAL CAPSULECTOMY WAS PERFORMED WITH EXPLANT AND ALCL WAS DIAGNOSED AGAINST THE CAPSULE PATHOLOGICAL ANALYSIS PATHOLOGICAL MARKERS STILL NOT PROVIDED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|12/10/2015|||DA|N|R||0HP|FTR|1.0|10/21/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1157331|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5286885|33230384|N|1||DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MANUFACTURERS BREAST IMPLANTS  YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|12/10/2015|||DA|N|R||0HP|FTR|1.0|10/21/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1157331|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5270622|32776697|D|1||COMPANY REPRESENTATIVE REPORTED ON BEHALF OF HEALTH PROFESSIONAL A DELAYED SEROMA ALCL AND ON AND OFF SWELLING SIDE UNKNOWN EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL PATHOLOGICAL MARKERS ARE RECEIVED TO CONFIRM ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|12/07/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||565193|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5270622|36726551|D|1||COMPANY REPRESENTATIVE REPORTED ON BEHALF OF HEALTH PROFESSIONAL A DELAYED SEROMA ALCL AND ON AND OFF SWELLING SIDE UNKNOWN EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL PATHOLOGICAL MARKERS ARE RECEIVED TO CONFIRM ALCL HEALTH PROFESSIONAL ADDITIONALLY REPORTED ALCL CASE REPORT PATIENT UNDERWENT UNCOMPLICATED BILATERAL BREAST AUGMENTATION WITH MCGHAN STYLE 468 SALINE-FILLED BREAST IMPLANTS PATIENT DID VERY WELL UNTIL PATIENT NOTED INTERMITTENT SWELLING OF THE LEFT BREAST MAMMOGRAM AND ULTRASOUND OF THE LEFT BREAST ORDERED BY THE PCP CONFIRMED PERI-PROSTHETIC SEROMA WITHOUT ANY ABNORMAL BREAST TISSUE FINDINGS THE SWELLING BECAME MORE PERSISTENT AND PATIENT WAS SEEN IN THE OFFICE FOR EVAL AND WAS TAKEN EXPEDIENTLY TO THE OPERATING ROOM FOR SEROMA ASPIRATION CULTURES AND CAPSULE BIOPSY CONFIRMED ALCL CULTURES WERE NEGATIVE ONE WEEK LATER PATIENT UNDERWENT COMPLETE CAPSULECTOMY AND IMPLANT REMOVAL WITHOUT REPLACEMENT|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|12/07/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||565193|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5270622|33982741|D|1||COMPANY REPRESENTATIVE REPORTED ON BEHALF OF HEALTH PROFESSIONAL A DELAYED SEROMA ALCL AND ON AND OFF SWELLING SIDE UNKNOWN EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL PATHOLOGICAL MARKERS ARE RECEIVED TO CONFIRM ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|12/07/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||565193|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5270622|32776696|N|1||MEDWATCH SUBMITTED ON 12072015 DEVICE LABELING ADDRESSES PUBLISHED STUDIES INDICATE THAT BREAST CANCER IS NO MORE COMMON IN WOMEN WITH IMPLANTS THAN THOSE WITHOUT IMPLANTS A LARGE LONG-TERM FOLLOW-UP FOUND NO SIGNIFICANT INCREASES IN THE RISK RATES FOR A WIDE VARIETY OF CANCERS INCLUDING STOMACH CANCER LEUKEMIA AND LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|12/07/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||565193|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5088633|26204676|N|1||MEDWATCH SUBMITTED ON 09182015 DEVICE LABELING PUBLISHED STUDIES INDICATE THAT BREAST CANCER IS NO MORE COMMON IN WOMEN WITH IMPLANTS THAN THOSE WITHOUT IMPLANTS A LARGE LONG-TERM FOLLOW-UP FOUND NO SIGNIFICANT INCREASES IN THE RISK RATES FOR A WIDE VARIETY OF CANCERS INCLUDING STOMACH CANCER LEUKEMIA AND LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/18/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNKNOWN MANUFACTURER|||||||True
5088633|54646607|D|1||PHYSICIAN REPORTED A CASE OF BREAST IMPLANT ALCL ANAPLASTIC LARGE CELL LYMPHOMA AND A PATHOLOGY CONFIRMED EFFUSION SIDE IS UNKNOWN TREATMENT HAS NOT YET OCCURRED DEVICE REMAINS IMPLANTED MANUFACTURER OF DEVICE IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/18/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNKNOWN MANUFACTURER|||||||True
5088633|26204677|D|1||PHYSICIAN REPORTED A CASE OF BREAST IMPLANT ALCL ANAPLASTIC LARGE CELL LYMPHOMA AND A PATHOLOGY CONFIRMED EFFUSION SIDE IS UNKNOWN TREATMENT HAS NOT YET OCCURRED DEVICE REMAINS IMPLANTED MANUFACTURER OF DEVICE IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/18/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNKNOWN MANUFACTURER|||||||True
4407133|25949126|D|1||HEALTHCARE PROFESSIONAL REPORTED A LEFT SIDE IMPLANT HAD FOLDS WITH LIQUID  AROUND THE IMPLANT AND REMOTE POSSIBILITY OF ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-390|01/08/2015||07/30/2015|DA|R|Y||0HP|FTR|1.0|02/04/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1708168|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN (COSTA RICA)|||||||True
4407133|5301992|D|1||HEALTHCARE PROFESSIONAL REPORTED A LEFT SIDE IMPLANT HAD FOLDS WITH LIQUID AROUND THE IMPLANT AND REMOTE POSSIBILITY OF ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-390|01/08/2015||07/30/2015|DA|R|Y||0HP|FTR|1.0|02/04/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1708168|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN (COSTA RICA)|||||||True
5331748|39806228|D|1||COMPANY REPRESENTATIVE REPORTED A CASE OF ALCL FOLLOW-UP WITH HEALTH PROFESSIONAL FINDS PATIENT PRESENTED WITH EXPANDING SEROMA ONLY SPECIFIED AS LEFT BREAST THE SEROMA WAS DRAINED AND SENT FOR CYTOLOGY THERE WAS SEVERE CAPSULAR CONTRACTURE WHICH WAS LATER IDENTIFIED AS BAKER GRADE IV THIS WAS BIOPSIED DEVICE WAS EXPLANTED CAPSULECTOMY WAS PERFORMED PATIENT IS CURRENTLY Â¿SEEING HAEMATOLOGYONCOLOGYÂ¿ IMMUNOCHEMISTRY REPORTED RECEIVED NOTES POSITIVE FOR CD30Â¿NEGATIVE FOR ALK-1Â¿ DIAGNOSIS OF LYMPHOMA ALCL HAS BEEN CONFIRMED PATHOLOGY ADDITIONALLY STATES Â¿CHRONICALLY INFLAMED DENSE FIBROUS CONNECTIVE TISSUEÂ¿ AND Â¿CHRONIC INFLAMMATORY CELLSÂ¿|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FF130-425|12/29/2015|||DA|N|R||0HP|FTR|1.0|04/19/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1832218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5331748|34569574|N|1||MEDWATCH SUBMITTED ON 12292015 B4 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FF130-425|12/29/2015|||DA|N|R||0HP|FTR|1.0|04/19/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1832218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5331748|34569575|D|1||COMPANY REPRESENTATIVE REPORTED A CASE OF ALCL FOLLOW-UP WITH HEALTH PROFESSIONAL FINDS PATIENT PRESENTED WITH EXPANDING SEROMA ONLY SPECIFIED AS LEFT BREAST THE SEROMA WAS DRAINED AND SENT FOR CYTOLOGY THERE WAS SEVERE CAPSULAR CONTRACTURE WHICH WAS LATER IDENTIFIED AS BAKER GRADE IV THIS WAS BIOPSIED DEVICE WAS EXPLANTED CAPSULECTOMY WAS PERFORMED PATIENT IS CURRENTLY SEEING HAEMOTOLOGYONCOLOGYIMMUNOCHEMISTRY REPORTED RECEIVED NOTES POSITIVE FOR CD30NEGATIVE FOR ALK-1 DIAGNOSIS OF LYMPHOMA ALCL HAS BEEN CONFIRMED PATHOLOGY ADDITIONALLY STATES CHRONICALLY INFLAMED DENSE FIBROUS CONNECTIVE TISSUE AND CHRONIC INFLAMMATORY CELLS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FF130-425|12/29/2015|||DA|N|R||0HP|FTR|1.0|04/19/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1832218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4553413|59981182|D|1||PHYSICIAN REPORTS TUMEFACTION PAIN REDNESS AND LEFT PERI-PROSTHETIC EXTRAVASATION AT LEFT SIDE LEFT SIDE DEVICE WAS REMOVED AND REPLACED FURTHER REPORT STATES REDNESS PERIPROSTHETIC EFFUSION PAIN PECTORAL SIDE TUMEFACTION OF THE PERIPROSTHETIC CAPSULE TEAR IN THE PROSTHETIC SIDE OF THE PERIPROSTHETIC CAPSULE TREATMENT REPORTED AS EXCISION OF THE TUMEFACTION CAPSULECTOMY RE-IMPLANTATION STRICT MONITORING MARKERS OF ALCL DIAGNOSIS ON B6 2015 INCLUDE CD30+ALK-|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|02/25/2015|||DA|N|R||0HP|FTR|1.0|11/01/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1159047|900 PARKWAY GLOBAL PARK|ZONA FRANCA|ARKLOW, COUNTY WICKLOW|CS|ALLERGAN (COSTA RICA)|||||||True
4680690|13211132|N|1||B4 DEVICE LABELING UNDERGOING ANY TYPE OF SURGICAL PROCEDURE INVOLVES RISKS SUCH AS THE EFFECTS OF ANESTHESIA INFECTION SWELLING REDNESS BLEEDING PAIN AND EVEN DEATH SOME OF THESE RISKS ARE SERIOUS AND ALL OF THESE RISKS NEED TO BE BALANCED AGAINST THE BENEFITS OF THE SURGERY WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ANAPLASTIC LARGE CELL LYMPHOMA OR ALCL IN THE SCAR TISSUE AND FLUID ADJACENT TO THE IMPLANT ALCL IS NOT BREAST CANCER - IT IS A RARE TYPE OF NON-HODGKINS LYMPHOMA CANCER OF THE IMMUNE SYSTEM ALCL HAS BEEN REPORTED GLOBALLY IN PTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MANUFACTURERS BREAST IMPLANTS MOST PTS WERE DIAGNOSED WHEN THEY SOUGH MEDICAL TREATMENT FOR IMPLANT-RELATED SYMPTOMS SUCH AS PAIN LUMPS SWELLING OR ASYMMETRY THAT DEVELOPED AFTER THEIR INITIAL SURGICAL SITES WERE FULLY HEALED IN THE CASES REPORTED ALCL WAS TYPICALLY DIAGNOSED YEARS AFTER THE IMPLANT SURGERY ONE RECONSTRUCTION PT IN THE PIVOTAL STUDY WAS REPORTED WITH ALCL THROUGH 10 YEARS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF140-440|04/09/2015|||DA|N|R||0HP|FTR|1.0|03/20/2012|nan||1408999|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5285719|33288642|N|1||MEDWATCH SUBMITTED ON 12102015 DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-350|12/10/2015||01/08/2016|DA|R|Y||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5285719|35139726|D|1||COMPANY REPRESENTATIVE REPORTED PHYSICIAN STATED POSSIBLE ALCL NO OTHER SPECIFICS WERE GIVEN TO ME FOLLOW-UP WITH HEALTH PROFESSIONAL CONFIRMS THAT THE MANUFACTURER IS ALLERGAN AND THAT THE PATIENT PRESENTED WITH RIGHT BREAST VERY SWOLLEN AND RED FINE NEEDLE ASPIRATION REPORTS APPARENT TINY CALCIFICATIONS AND APPROXIMATELY ONE LITER OF YELLOW SLIGHTLY TURBID FLUID WAS OBTAINED IMPRESSION STATES THERE ARE AREAS OF SOFT TISSUE NODULARITY ALONG THE MARGINS OF THE FLUID COLLECTION WHICH ARE SUSPICIOUS FOR LYMPHOMA CYTOLOGY SHOWS MALIGNANCY CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY REPORT NOTES B4 POSITIVE AND ALK-1 NEGATIVE CAPSULECTOMY AND EXPLANTATION OCCURRED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-350|12/10/2015||01/08/2016|DA|R|Y||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5285719|33288643|D|1||COMPANY REPRESENTATIVE REPORTED PHYSICIAN STATED POSSIBLE ALCLNO OTHER SPECIFICS WERE GIVEN TO ME SIDE NOT SPECIFIED MANUFACTURER OF THE DEVICE IS UNKNOWN PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-350|12/10/2015||01/08/2016|DA|R|Y||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5054360|24980550|D|1||PATIENT REPORTED LEFT SIDE SEROMA AND ANAPLASTIC LYMPHOMA DEVICE WAS REMOVED PATIENT ADDITIONALLY REPORTED SAMPLE OF THE CAPSULE WAS TAKEN FROM THE LEFT SIDE AND CAME BACK POSITIVE FOR ANAPLASTIC LYMPHOMA DIAGNOSTIC MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED THIS EVENT WILL BE CAPTURED AS LYMPHOMA THESE EVENTS HAVE NOT BEEN CONFIRMED BY A HEALTH PROFESSIONAL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410580|09/03/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2429863|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5054360|24980549|N|1||DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT PLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY CASE-CONTROL STUDIES TO EVALUATE THE ASSOCIATION BETWEEN NATRELLEÂ® 410 BREAST IMPLANTS AND 5 RARE DISEASE OUTCOMES RARE CONNECTIVE TISSUE DISEASES NEUROLOGICAL DISEASES BRAIN CANCER CERVICALVULVAR CANCER AND LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MANUFACTURERS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410580|09/03/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2429863|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4385729|12634624|N|1||DEVICE LABELING ADDRESSES THE REPORTED EVENT OF ALCL AS FOLLOWS BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MFRS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REP PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AND INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL DEVICE LABELING ADDRESSES THE REPORTED EVENT OF SEROMA AS FOLLOWS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSISTWITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS DEVICE LABELING ADDRESSES THE REPORTED EVENT OF JUMPMASSCYST AS FOLLOWS IN THE B6 STUDY AT LEAST 1 REOPERATION WAS PERFORMED ON 315 PATIENTS 365 THROUGH 10 YEARS A TOTAL OF 424 REOPERATIONS WERE PERFORMED THE PRIMARY REASON FOR REOPERATION THROUGH 10 YEARS ON AUGMENTATION PATIENTS WAS IMPLANT DEFLATION AT 217 THE PERCENTAGE OF REOPERATIONS DUE TO LUMPMASSCYST INCREASED FROM 85 OF 293 REOPERATIONS THROUGH 5 YEARS TO 139 OF 424 REOPERATIONS THROUGH 10 YEARS THE OCCURRENCE OF LUMPS MASSES AND CYSTS CAN BE EXPECTED TO NATURALLY INCREASE AS PTS AGE AND COULD BE AN EXPLANATION FOR THE INCREASE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385750|20562037|N|1||DEVICE LABELING ADDRESSES THE REPORTED EVENT OF ALCL AS FOLLOWS BASED ON INFO REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MFRS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REP PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL DEVICE LABELING ADDRESSES THE REPORTED EVENT OF SEROMA AS FOLLOWS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385750|20374001|D|1||HEALTH PROFESSIONAL REPORTED PT DEVELOPED RAPID DELAYED SEROMA DIAGNOSED AS CD30+ ALK- ALCL OF MALIGNANT EFFUSION TREATED WITH BILATERAL IMPLANT REMOVAL CAPSULECTOMIES CHEMOTHERAPY WITH CHOP FU IMAGING WITH CT SCAN NO RECURRENCE OF DISEASE ALCL AFFECTED BREAST REPORTED AS UNILATERAL - RIGHT STAGE IE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385750|55048878|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED RAPID DELAYED SEROMA DIAGNOSED AS CD30+ ALK- ALCL OF MALIGNANT EFFUSION TREATED WITH BILATERAL IMPLANT REMOVAL CAPSULECTOMIES CHEMOTHERAPY WITH CHOP FOLLOW UP IMAGING WITH CT SCAN NO RECURRENCE OF DISEASE ALCL AFFECTED BREAST REPORTED AS UNILATERAL - RIGHT STAGE IE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4791713|50656531|D|1||FU CONFIRMED WITH THE PHYSICIAN THAT THE PT DOES NOT HAVE LYMPHOMA OR ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084729|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN (COSTA RICA)|||||||True
4791713|21083118|D|1||PATIENT REPORTED LEFT SIDE DISCOMFORT PATIENT ADDITIONALLY REPORTED STOMACH PAINS NAUSEA AND ALCL AND OTHER SIDE EFFECTS ALCL WILL BE CAPTURED AS LYMPHOMA AS THIS EVENT CANNOT BE CONFIRMED BY THE PHYSICIAN SEE MFR 9617229-2015-00085 FOR THE RIGHT SIDE|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084729|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN (COSTA RICA)|||||||True
4791713|50913116|D|1||PATIENT REPORTED LEFT SIDE DISCOMFORT PATIENT ADDITIONALLY REPORTED STOMACH PAINS NAUSEA AND ALCL AND OTHER SIDE EFFECTS ALCL WILL BE CAPTURED AS LYMPHOMA AS THIS EVENT CANNOT BE CONFIRMED BY THE PHYSICIAN SEE MFR  9617229-2015-00085 FOR THE RIGHT SIDE FOLLOW-UP CONFIRMED WITH THE PHYSICIAN THAT THE PATIENT DOES NOT HAVE LYMPHOMA OR ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084729|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN (COSTA RICA)|||||||True
4385811|55591407|D|1||HEALTH PROFESSIONAL REPORTED PATIENT RECEIVED BILATERAL MASTECTOMIES OF NOTE ON PATIENTS PATHOLOGY CD30+ ALK- ALCL STAGE IE WAS FOUND IN THE CONTRALATERAL RIGHT BREAST AT TIME OF MASTECTOMY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|NE||NE||||True
4627437|5593685|D|1||HEALTH PROFESSIONAL REPORTED VIA VOLUNTARY MW5039349 ALCL CASE REPORT HISTORY OF BILATERAL BREAST AUGMENTATION PT HAS HX OF PAINFUL SWELLING OF LEFT BREAST AFTER A MAMMOGRAM SHE THEN HAD INDURATION AND ERYTHEMA OF INFERIOR PORTION OF LEFT BREAST PT UNDERWENT MRI AND SKIN BIOPSY OF THE INDURATED PORTION OF THE LEFT BREAST BY REPORT THE BIOPSY SHOWED INFLAMMATORY TISSUE BUT NO MALIGNANCY THE PT PRESENTED WITH INCREASED PAIN AND SWELLING OF THE LEFT BREAST THE LEFT BREAST WAS FIRM AND LARGER VOLUME THAN THE RIGHT BREAST PATIENT HAD AN AREA 5 X 8 CM OF ERYTHEMA ALONG THE INFERIOR ASPECT OF THE LEFT BREAST UPON REMOVAL PATIENT HAD DENSE FIBROSIS AND INDURATION OF THE SKIN AND UNDERLYING BREAST TISSUE ON THE LEFT FROZEN SECTION PATHOLOGY WAS CONSISTENT WITH PROBABLE INFLAMMATORY CARCINOMA ENTIRE CAPSULECTOMY PERFORMED BILATERALLY ON THE LEFT THE CAPSULE WAS THICK AND FIRM AND THE IMPLANT WAS COMPLETELY DEFLATED THE IMPLANT WAS SURROUNDED BY 250-300CC OF CREAM MONOGENOUS YELLOW FLUID THIS WAS SENT FOR CYTOLOGY PROCEDURE WAS BILATERAL CAPSULECTOMY WITH REMOVAL OF IMPLANTS AND CLOSURE OVER DRAINS THE IMPLANTS WERE MCGHAN TEXTURED SALINE IMPLANTS 270CC APPEARED TO BE SHAPED IMPLANTS NO OTHER IDENTIFYING MARKS ON IMPLANTS LYMPHOMA WILL BE CAPTURED UNTIL CONFIRMATION OF ALCL CD30+ AND ALK- IS RECEIVED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/23/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5108543|32666145|D|1||HEALTH PROFESSIONAL REPORTED SEVERAL SPONTANEOUS SEROMA IN THE LEFT BREAST WITH NEGATIVE CYTOLOGY THEY WERE SPONTANEOUSLY RESOLVED DEVICE WAS REMOVED AND THE CAPSULE WAS ANALYZED WITH RESULT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE OF DIAGNOSED CAPSULE WAS NOT SPECIFIED ALCL WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED SEE MFR  9617229-2015-00373 FOR THE RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5108543|26936807|N|1||DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5108543|32280916|D|1||HEALTH PROFESSIONAL REPORTED SEVERAL SPONTANEOUS SEROMA IN THE LEFT BREAST WITH NEGATIVE CYTOLOGY THEY WERE SPONTANEOUSLY RESOLVED DEVICE WAS REMOVED AND THE CAPSULE WAS ANALYZED WITH RESULT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE OF DIAGNOSED CAPSULE WAS NOT SPECIFIED ALCL WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED SEE MFR  9617229-2015-00373 FOR THE RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5108543|49682505|D|1||HEALTH PROFESSIONAL REPORTED SEVERAL SPONTANEOUS SEROMA IN THE LEFT BREAST WITH NEGATIVE CYTOLOGY THEY WERE SPONTANEOUSLY RESOLVED DEVICE WAS REMOVED AND THE CAPSULE WAS ANALYZED WITH RESULT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE OF DIAGNOSED CAPSULE WAS NOT SPECIFIED ALCL WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED SEE MFR  9617229-2015-00373 FOR THE RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5108543|26936808|D|1||HEALTH PROFESSIONAL REPORTED SEVERAL SPONTANEOUS SEROMA IN THE LEFT BREAST WITH NEGATIVE CYTOLOGY THEY WERE SPONTANEOUSLY RESOLVED DEVICE WAS REMOVED AND THE CAPSULE WAS ANALYZED WITH RESULT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE OF DIAGNOSED CAPSULE WAS NOT SPECIFIED ALCL WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED SEE MFR  9617229-2015-00373 FOR THE RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4859987|5847605|D|1||HEALTH PROFESSIONAL REPORTED PT DEVELOPED A LARGE VOLUME LATE SEROMA AROUND THE RIGHT RECONSTRUCTIVE BREAST IMPLANT FLUID WAS ASPIRATED AND SENT TO CYTOLOGY THIS CONFIRMED ANAPLASTIC LARGE CELL LYMPHOMA ALK-1 NEGATIVE SUBSEQUENT PET SCAN - MILD ACTIVITY IN INTERNAL MAMMARY LYMPH NODES AWAITING FINAL HAEMATOLOGY REVIEW DEVICE WAS REMOVED FURTHER FOLLOW-UP REPORTED FINE NEEDLE ASPIRATION OF SEROMA FLUID AROUND RIGHT IMPLANT CONFIRMED THE DIAGNOSIS OF ALK-1 NEGATIVE ALCL THE ALCL WAS CONTAINED WITHIN THE CAPSULE IN THE PERIPROSTHETIC FLUID ONLY PATHOLOGY REPORT CONFIRMED  CD30 LARGE CELL POSITIVE  ALK-1 NEGATIVE AND OVERALL THESE FINDINGS ARE SUGGESTIVE OF ALK-1 NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA STAGE 1AE PET-CT SCAN REPORTS THERE ARE BILATERAL BORDERLINE ENLARGED INTERNAL MAMMARY LYMPH NODES WHICH SHOW MILDLY INCREASED METABOLIC ACTIVITY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FM-410500|06/19/2015|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4874726|31122635|D|1||PHYSICIAN REPORTED SUSPICION OF ALCL LYMPHOMA SIDE UNSPECIFIED MANUFACTURER OF THE DEVICE IS UNKNOWN PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED TO CONFIRM ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/26/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4874726|22249899|D|1||PHYSICIAN REPORTED SUSPICION OF ALCL LYMPHOMA SIDE UNSPECIFIED MFR OF THE DEVICE IS UNK PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED TO CONFIRM ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/26/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4874726|54538473|D|1||PHYSICIAN REPORTED SUSPICION OF ALCL LYMPHOMA SIDE UNSPECIFIED MANUFACTURER OF THE DEVICE IS UNKNOWN PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED TO CONFIRM ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/26/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385762|5263418|D|1||MEDICAL STAFF REPORTED EXPLANTATION OF THE PERIPROSTHETIC RIGHT SIDE ANAPLASTIC LARGE CELL LYMPHOMA T-CELL FORMED IN THE EXUDATE AND WITHOUT INFILTRATION OF THE TUMOR IN THE CAPSULE ALCL HAS NOT YET BEEN CONFIRMED VIA DIAGNOSTICS THEREFORE THE EVENT OF LYMPHOMA WILL BE REPORTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MF120-295|12/31/2014|||DA||R||0HP|FTR|1.0|02/08/2013|nan||1553196|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5078001|40431380|D|1||HEALTH PROFESSIONAL REPORTED A RIGHT SIDE DEFLATION HEALTH PROFESSIONAL ADDITIONALLY REPORTED ENLARGED RIGHT BREAST SEROMA RIGHT BREAST IMPLANT POCKET PATIENT WAS GIVEN SOME ANTIBIOTICS WITH SOME IMPROVEMENT BUT WITH RECURRENT SUDDENLY ENLARGING RIGHT BREASTÂ¿ AT THE TIME OF SURGERY A CLEAR STRAW COLORED FLUID APPROXIMATELY 450CC WAS REMOVED SOME PROTEINACEOUS EXUDATE WAS FOUND IN AND AROUND THE POCKET AND THE IMPLANTÂ¿ PATHOLOGY REPORT STATES DIAGNOSIS OF Â¿CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA ALK-NEGATIVE ALCL ASSOCIATED WITH BREAST IMPLANT NEOPLASTIC CELLS ARE CD30 CD4 AND CD43 POSITIVEÂ¿ PER ADDITIONAL INFORMATION HEALTH PROFESSIONAL NOTED SWELLING INVOLVING THE RIGHT BREAST WHICH WAS BELIEVED TO BE AN INFECTION TREATED WITH ANTIBIOTICS|STYLE 168 SALINE FILLED BREAST IMPLANT|168-420|09/15/2015||08/21/2015|DA|R|Y||0HP|FWM|1.0|05/01/2005|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||564274|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4385745|18292591|D|1||HEALTH PROFESSIONAL REPORTED PT DEVELOPED RAPID LATE SEROMA DIAGNOSED WITH BIA-ALCL RIGHT BREAST BY CAPSULE PATHOLOGY AT EXPLANTATION UNDERWENT BILATERAL CAPSULECTOMIES AND IMPLANT REMOVAL RECEIVED CHOP CHEMOTHERAPY BUT REFUSED RADIATION THERAPY FOLLOW UP IMAGING WITH PET NO RECURRENCE OF DISEASE REMAINS HEALTHY ALCL AFFECTED BREAST SPECIFIED AS UNILATERAL - LEFT STAGE IE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE DEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385745|18428752|N|1||DEVICE LABELING ADDRESSES THE REPORTED EVENT OF ALCL AS FOLLOWS BASED ON INFO REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MFRS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PTS PRESENTED WITH CAPSULAR CONTRACTURE OF MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL DEVICE LABELING ADDRESSES THE REPORTED EVENT OF SEROMA AS FOLLOWS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE DEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385745|75875876|D|1||HEALTH PROFESSIONAL REPORTED PATIENT RECEIVED ALCL DIAGNOSIS ON B6 2012 ALCL STAGE AT TIME OF DIAGNOSIS PROVIDED AS Â¿STAGE II HER II NEGATIVE BY FISH ALK NEGATIVEÂ¿ PATIENT EXPERIENCED Â¿DISCOMFORT IN LEFT BREAST 78 CM MASS ADJACENT TO IMPLANTÂ¿ HEALTH PROFESSIONAL CONFIRMED A PERI-IMPLANT SEROMA WAS NOT PRESENT BUT ONLY Â¿MASS ONLY 78 CM CAUSING PAINÂ¿|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE DEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385745|55222307|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED RAPID LATE SEROMA DIAGNOSED WITH BIA-ALCL RIGHT BREAST BY CAPSULE PATHOLOGY AT EXPLANTATION UNDERWENT BILATERAL CAPSULECTOMIES AND IMPLANT REMOVAL RECEIVED CHOP CHEMOTHERAPY BUT REFUSED RADIATION THERAPY FOLLOW UP IMAGING WITH PET NO RECURRENCE OF DISEASE REMAINS HEALTHY ALCL AFFECTED BREAST SPECIFIED AS UNILATERAL - LEFT STAGE IE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE DEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4648716|13098279|N|1||THE EVENT OF ANAPLASTIC LARGE CELL LYMPHOMA WAS INITIALLY REPORTED VIA B4 ON B4 2010 WITH THE ADVERSE EVENT TERM CODE OF CANCER THE EVENT WAS REPORTED AGAIN VIA B4 ON B4 2012 WITH THE ADVERSE EVENT TERM CODE OF LYMPHOMA AN UPDATE TO OUR SAFETY DATABASE FOR THIS REPORTED EVENT NOTES THAT THE TERM CODE HAS BEEN CHANGED TO LYMPHOMA ALCL DUE TO INCREASED SPECIFICITY B6 DEVICE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS POSTOPERATIVE HEMATOMA AND SEROMA MAY BE MINIMIZED BY METICULOUS ATTENTION TO HEMOSTASIS DURING SURGERY AND POSSIBLY ALSO BY POSTOPERATIVE USE OF A CLOSED DRAINAGE SYSTEM PERSISTENT EXCESSIVE BLEEDING MUST BE CONTROLLED BEFORE IMPLANTATION ANY POSTOPERATIVE EVACUATION OF HEMATOMA OR SEROMA MUST BE CONDUCTED WITH CARE TO AVOID BREAST IMPLANT CONTAMINATION OR DAMAGE FROM SHARP INSTRUMENTS USE CARE IN SUBSEQUENT PROCEDURES SUCH AS OPEN CAPSULOTOMY BREAST POCKET REVISION HEMATOMASEROMA ASPIRATION AND BIOPSYLUMPECTOMY TO AVOID DAMAGE TO THE IMPLANT THE B4 STUDY WILL CONTINUE TO EVALUATE THE LONG-TERM B4 SAFETY AND EFFECTIVENESS OF THESE PRODUCTS IN ADDITION ALLERGAN HAS INITIATED A SEPARATE B4 POST-APPROVAL STUDY B4 TO ADDRESS SPECIFIC ISSUES WHICH ALLERGANS CORE STUDY WAS NOT DESIGNED TO FULLY ANSWER AS WELL AS TO PROVIDE A REAL-WORLD ASSESSMENT OF SOME ENDPOINTS B4 ALLERGAN WILL UPDATE THEIR LABELING ON A REGULAR BASIS WITH THE RESULTS OF THESE TWO STUDIES B4 THERE WERE NO REPORTS OF OTHER CANCERS SUCH AS BRAIN RESPIRATORY OR CERVICALVULVAR IN PRIMARY RECONSTRUCTION OR REVISION-RECONSTRUCTION PATIENTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|03/31/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5105218|26823377|N|1||DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|09/25/2015||||N|R||0HP|FTR|1.0|11/04/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1671333|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5105218|26823378|D|1||MEDICAL STAFF REPORTED A SUSPECTED RUPTURED ON THE RIGHT SIDE ADDITIONAL REPORT FROM REGULATORY BODY VIA EXPLANTING PHYSICIAN INDICATES THAT THE PATIENT PRESENTED WITH AN INCREASE IN VOLUME OF THE RIGHT BREAST TESTING REVEALED A MAJOR RIGHT PERIPROSTHETIC FLUID EFFUSION THE DEVICE WAS REMOVED AND FOUND INTACT THE LIQUID AROUND THE RIGHT IMPLANT WAS FOUND TO BE HEMORRHAGIC LIQUID WITHOUT MALIGNANT CELLS RIGHT CAPSULECTOMY TESTING YIELDED THE PATHOLOGICAL RESULTS ALCL CD3+ ALK1- SEROMA ONSEQUENCES LISTED ASALCL CD30+ALK1- CONFIRMED BY LYMPHOPATH|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|09/25/2015||||N|R||0HP|FTR|1.0|11/04/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1671333|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4922480|6025362|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE DEVICE REMOVAL DUE TO SWELLING SUBCUTANEOUS MASSES AND ALCL THE EVENT OF LYMPHOMA-ALCL WAS CONFIRMED BY PATHOLOGY WHICH INDICATED CD30 ATYPICAL LYMPHOCYTE AND ALK1 NON REACTIVE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-500|07/16/2015|||DA|N|R||0HP|FTR|1.0|09/26/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE PEL-FILLED||2031914|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5285827|34095038|D|1||ALLERGAN SALES REPRESENTATIVE REPORTED A REVISION CASE ON A PATIENT THAT HAD ALLERGAN IMPLANTSTHERE WAS FLUID AROUND THE DEVICE AND THE OFFICE SENT THE FLUID OFF TO BE CULTURED THE CULTURED FLUID CAME BACK POSITIVE FOR BREAST IMPLANT ASSOCIATED ALCL SIDE WAS UNSPECIFIED FOLLOW-UP WITH HEALTH PROFESSIONAL CONFIRMED THAT THE REASON FOR SURGERY WAS THE LEFT BREAST KEPT GETTING LARGER AND LARGER SWELLING PATHOLOGY NOTED OPAQUE ORANGE FLUID AND CONFIRMED PRESENCE OF CD30+ AND ALK- PATHOLOGY ALSO NOTED CLINICAL HISTORY LEFT BREAST IMPLANT MALPOSITION ALCL HAS BEEN CONFIRMED|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|12/10/2015|||DA|N|R||0HP|FWM|1.0|12/04/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1375592|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5285827|33170547|D|1||ALLERGAN SALES REPRESENTATIVE REPORTED A REVISION CASE ON A PATIENT THAT HAD ALLERGAN IMPLANTSTHERE WAS FLUID AROUND THE DEVICE AND THE OFFICE SENT THE FLUID OFF TO BE CULTURED THE CULTURED FLUID CAME BACK POSITIVE FOR BREAST IMPLANT ASSOCIATED ALCL SIDE WAS UNSPECIFIED FOLLOW-UP WITH HEALTH PROFESSIONAL CONFIRMED THAT THE REASON FOR SURGERY WAS THE LEFT BREAST KEPT GETTING LARGER AND LARGER SWELLING PATHOLOGY NOTED OPAQUE ORANGE FLUID AND CONFIRMED PRESENCE OF CD30+ AND ALK- PATHOLOGY ALSO NOTED CLINICAL HISTORY LEFT BREAST IMPLANT MALPOSITION ALCL HAS BEEN CONFIRMED|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|12/10/2015|||DA|N|R||0HP|FWM|1.0|12/04/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1375592|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5285827|33170546|N|1||MEDWATCH SUBMITTED ON 12102015 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|12/10/2015|||DA|N|R||0HP|FWM|1.0|12/04/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1375592|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5061707|25188102|D|1||HEALTH PROFESSIONAL REPORTED HISTORY L BREAST SIZE INCREASE RO SEROMA - ATYPICAL LEUKOCYTES CD30+ ALK- TREATMENT REPORTED AS TOTAL CAPSULECTOMY  EXPLANTATION FOLLOW UP DIAGNOSTIC TESTS RECEIVED CONFIRMED PRESENCE OF SEROMA AND ALCL BREAST ULTRASOUND STATES 375ML OF MINIMALLY TURBID STRAW COLOURED FLUID WAS ASPIRATED CYTOPATHOLOGY OF THIS FLUID REPORTS SPECIMEN RECEIVED L BREAST 20 ML OF CLEAR YELLOW FLUID CONCLUSION RARE ATYPICAL LARGE CD30+ CELLS PRESENT HISTOPATHOLOGY REPORT STATES  MICROSCOPIC DESCRIPTION THE ATYPICAL CELLS ARE STRONGLY CD30 MEMBRANE EXPRESSING ALK-1 ARE NEGATIVE THE DIAGNOSES STATES BREAST IMPLANT-ASSOCIATED LARGE CELL LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX125-370|09/08/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1331894|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5061707|25188101|N|1||MEDWATCH SUBMITTED ON 09082015 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT PLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX125-370|09/08/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1331894|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4702227|13234344|N|1||B4 DEVICE LABELING BASED ON INFORMATION TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MANUFACTURERS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL THERE WERE 9 PRIMARY AUGMENTATION PATIENTS 19 WITH A NEW DIAGNOSIS OF BREAST CANCER THROUGH 10 YEARS IN THE ALLERGAN PIVOTAL STUDY IN PRIMARY AUGMENTATION PATIENTS THERE WAS 1 REPORT OF SKIN CANCER AND 1 REPORT OF RENAL CELL CANCER AND 1 PRIMARY AUGMENTATION PATIENT WHO WAS PREGNANT AT THE TIME OF IMPLANTATION GAVE BIRTH TO A CHILD WHO LATER DEVELOPED HISTIOCYTOSIS THERE WAS 1 REVISION-AUGMENTATION PATIENT 08 WITH A NEW DIAGNOSIS OF BREAST CANCER THROUGH 10 YEARS AND 1 PATIENT REPORT OF BLADDER CANCER AND 1 PATIENT REPORT OF MULTIPLE MYELOMA THERE WERE 17 RECONSTRUCTION PATIENTS 76 WITH RECURRENCE OF BREAST CANCER THROUGH 10 YEARS 1 REPORT OF NON-HODGKINS LYMPHOMA AND 1 REPORT OF UTERINE CANCER THERE WERE NO REVISION-RECONSTRUCTION PATIENTS WHO REPORTED A RECURRENCE OF BREAST CANCER THROUGH 10 YEARS AND NO REPORTS OF OTHER CANCERS IN REVISION-RECONSTRUCTION PATIENTS ONE RECONSTRUCTION PATIENT IN THE PIVOTAL STUDY WAS REPORTED WITH ALCL THROUGH 10 YEARS SOMETIMES THERE ARE SYMPTOMS ASSOCIATED WITH GEL IMPLANT RUPTURE THESE SYMPTOMS INCLUDE HARD KNOTS OR LUMPS SURROUNDING THE IMPLANT OR IN THE ARMPIT CHANGE OR LOSS OF SIZE OR SHAPE OF THE BREAST OR IMPLANT PAIN TINGLING SWELLING NUMBNESS BURNING AND HARDENING OF THE BREAST LITERATURE REPORTS HAVE ALSO BEEN MADE ASSOCIATING SILICONE BREAST IMPLANTS WITH VARIOUS RHEUMATOLOGICAL SIGNS AND SYMPTOMS SUCH AS FATIGUE EXHAUSTION JOINT PAIN AND SWELLING MUSCLE PAIN AND CRAMPING TINGLING NUMBNESS WEAKNESS AND SKIN RASHES|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410335|04/16/2015||02/25/2013|DA|Y|Y||0HP|FTR|1.0|02/02/2011|nan||1223847|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4702227|5724962|D|1||HEALTH PROFESSIONAL REPORTED ANAPLASTIC LARGE CELL LYMPHOMA AND PATIENT PRESENTED WITH RIGHT BREAST SWELLING EVENT OF ANAPLASTIC LARGE CELL LYMPHOMA WILL BY CAPTURED AS LYMPHOMA UNTIL DIAGNOSTIC TESTING CAN CONFIRM DIAGNOSIS OF ALCL DEVICE HAS BEEN REMOVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410335|04/16/2015||02/25/2013|DA|Y|Y||0HP|FTR|1.0|02/02/2011|nan||1223847|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5039249|24514426|D|1||I HAD BREAST AUGMENTATION IN 2007 MY IMPLANTS ARE THE GUMMY BEAR SILICONE UNDER THE MUSCLE I REALLY HADNT BEEN PAYING ATTENTION TO ANY CERTAIN SYMPTOM UNTIL IN EARLY B6 2014 I WAS EXERCISING AND NOTICED A SEVERE PAIN IN MY RIGHT CALF MUSCLE I THOUGHT I HAD TORN MY CALF BUT AFTER A WEEK IT WENT AWAY AS I CONTINUED TO EXERCISE I NOTICED EXTREME FATIGUE IN MY MUSCLES AND REALIZED THAT I COULD NOT LIFT MY RIGHT FOOT SEARCHING THE INTERNET I REALIZED I HAD FOOT DROP AT THE SAME TIME I HAD STARTED NOTICING MY MUSCLES TWITCHING I AM AN INTERNET RESEARCHER AND WHAT I WAS FINDING WAS INCREDIBLY SCARY IN ADDITION MY RIGHT BREAST HAD AN EPISODE OF SWELLING AND PAIN I SCHEDULED AN APPOINTMENT FOR THE BREAST THEY DID ULTRASOUND MAMMO AND THEN MRI FINDING FLUID UNDER THE IMPLANT THEY SCHEDULED A BIOPSY AND MENTIONED ALCL DURING THE APPOINTMENT FOR THE BIOPSY THE DOC COULD NOT FIND ENOUGH FLUID TO BIOPSY AND BECAUSE THE PAIN WAS GONE HE ABORTED THE PROCEDURE FAST FORWARD TO B6 2014 I SAW A GP FOR THE MUSCLE CRAMPS AND FOOT DROP SHE REFERRED ME TO A NEUROLOGIST I ASKED ALL DOCTORS IF MY IMPLANTS COULD BE THE RADIOLOGIST FOUND NO EVIDENCE OF RUPTURE RELATED AT ALL - ALL SAID OH BUT IM NO EXPERT NEUROLOGIST 1 DID A COUPLE OF TESTS OF MY BLOOD FOR COPPER AND AN EMG SAID I DEFINITELY HAD WEAKNESS AND UNEXPLAINED FOOT DROP SO I PROBABLY HAVE ALS SO MY WORLD HAS COME CRASHING DOWN WE GOT A SECOND OPINION FROM A NEUROLOGIST THAT SPECIALIZES IN ALS UPON FIRST MEETING HE SAID IT COULD BE SO MANY THINGS ORDERED ANOTHER EMG THAT DOC SAID THE TEST RESULTS DID NOT SEEM CONSISTENT WITH ALS BUT BECAUSE THERE IS NO TEST FOR ALS IT WOULD BE A WAIT AND SEE SITUATION ABOUT B6 IN BLOOD TESTS LATER FOR ANY ALS MARKERS OR ANYTHING ELSE NO CONCLUSION ANOTHER EMG WAS DONE AT THE SPECIALISTS OFFICE AND ONE TECH SAID SOME PARTS OF ME TESTED BETTER THAN LAST TIME AND THEN SOME AREAS LOOKED THE SAME OR MAYBE SLIGHTLY WORSE AT THIS POINT I HAD STOPPED FOCUSING ON MY BREAST BUT THE RIGHT SIDE STILL DOESNT FEEL RIGHT IT IS SLIGHTLY MORE RIGID I CAN FEEL RIPPLES IN THE IMPLANT MY NECK APPEARS SLIGHTLY SWOLLEN ON THE RIGHT SEARCHING BACK THE LAST 8 YEARS I STARTED REALIZING THAT MY MUSCLE WEAKNESSES PROBABLY BEGAN 3-4 YEARS AGO THE CRAMPS AT LEAST 3-4 YEARS IVE STRUGGLED WITH MILD FACIAL BREAK OUTS SMELLING URINE MORE EXTREME SYMPTOMS DURING CERTAIN DAYS OF THE MONTH TONGUE SWELLING ANXIETY FATIGUE ETC NOT WILLING TO SIT AROUND AND DO NOTHING I AM SEEING A NATUROPATH HE SAYS MY LYME TEST CAME BACK WITH A 5050 CHANCE OF ME HAVING LYME MY B12 IS LOW MY TESTOSTERONE LEVELS ARE BARELY EXISTENT AND ONE OTHER MICRONUTRIENT WAS LOW IVE SHARED ALL THIS WITH MY NEUROLOGIST AND HE SAYS THAT NONE OF THIS MEANS ANYTHING I AM GETTING SLIGHTLY WEAKER I WALK WITH A LIMP DUE TO THE FOOT DROP JOINT PAIN AND BACK PAIN COME AND GO FOOT DROP AND MUSCLE TWITCHES REMAIN MY GUT SAYS ITS THE IMPLANTS AND I KNOW THERE IS NO TEST TO DO FOR A DEFINITIVE ANSWER ON B6 2015 I WENT IN FOR EXPLANT IT WAS FOUND THAT MY RIGHT IMPLANT WAS RUPTURED AND THE SILICONE HAD SPILLED OUT INTO MY TISSUES THE DOCTOR PERFORMED AN EN BLOC CAPSULECTOMY AND REPLACED THE IMPLANTS WITH MENTOR SALINE IMPLANTS I AM 15 POST EXPLANT AND I NOTICE SOME MILD CHANGES IMPROVEMENTS HOWEVER MUSCLE TWITCHES AND FOOT DROP REMAIN I HAVE FOUND A B6 GROUP WITH OVER 300 WOMEN THAT ARE EXTREMELY ILL FROM THEIR IMPLANTS AND TRYING TO GET HELP AND GET HEALTHY I BELIEVE THAT I HAVE SOME SOFT OF SILICONE POISONING THAT IS NOT DETECTED BY MEDICAL TESTS I AM IN THE PROCESS OF TRYING TO DO SMALL THINGS TO DETOX EAT HEALTHY INFRARED SAUNA ETC BUT I AM JUST WAITING AND PRAYING FOR IMPROVEMENT|NATRELLE SILICONE|20-300|08/25/2015||||*|*||0LP|FTR|0.0||BREAST IMPLANT|||||||ALLERGAN|||||STYLE 20||True
4922479|6435381|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE DEVICE REMOVED DUE TO A SEROMA THAT SUDDENLY APPEARED WITH SWELLING OF MAMMARY FOR SEVERAL WEEKS DURING REMOVAL OF RIGHT SIDE IMPLANT A DOUBLE CAPSULE WAS FOUND PATHOLOGICAL TESTING OF THE SEROMA AND CAPSULE REVEALED PATHOLOGICAL MARKERS CD30+ AND ALK- AND FOCAL INFLAMMATORY CHRONIC REARRANGEMENTS THIS CONFIRMS DIAGNOSIS OF RIGHT SIDE ANAPLASTIC LARGE CELL LYMPHOMA ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF120-270|07/16/2015|||DA|N|R||0HP|FTR|1.0|08/25/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE, GEL-FILLED||1126779|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4385726|12614082|N|1||UNIQUE IDENTIFIER UDI NA DEVICE LABELING ADDRESSES ALCL THERE WERE NO REPORTED EVENTS OF LYMPHOMAALCL FOR PATIENTS IN THE CORE STUDY IN THE LABELING FOR SILICONE IMPLANTS DEVICE LABELING ADDRESSES SEROMA POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENUMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS DEVICE LABELING ADDRESSES LUMPS PATIENTS SHOULD PERFORM BREAST SELF-EXAMINATIONS MONTHLY AND BE SHOWN HOW TO DISTINGUISH THE IMPLANT FROM THEIR BREAST TISSUE THE PATIENT SHOULD NOT MANIPULATE OR SQUEEZE THE IMPLANT EXCESSIVELY THE PATIENT SHOULD BE TOLD THAT THE PRESENCE OF LUMPS PERSISTENT PAIN SWELLING HARDENING OR CHANGE IN THE IMPLANT SHAPE MAY BE SIGNS OF SYMPTOMATIC RUPTURE OF THE IMPLANT IF THE PATIENT HAS ANY OF THESE SIGNS SHE SHOULD BE TOLD TO REPORT THEM AND POSSIBLY HAVE AN MRI EVAL TO SCREEN FOR RUPTURE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|LA AURORA DE HEREDIA|||CS|UNKNOWN MANUFACTURER|||||||True
4702206|17934685|D|1||HEALTHCARE PROFESSIONAL REPORTED A DIAGNOSIS OF ALCL FROM SEROMA FLUID ASPIRATED FROM AROUND IMPLANTS SPECIMEN SENT TO B6 WHERE DX WAS MADE EVENT OF ALCL WILL BY CAPTURED AS LYMPHOMA UNTIL CONFIRMATION OF PATHOLOGY RESULTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/16/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA, NE|CS|UNKNOWN MANUFACTURER|||||||True
4702206|55589065|D|1||HEALTHCARE PROFESSIONAL REPORTED A DIAGNOSIS OF ALCL FROM SEROMA FLUID ASPIRATED FROM AROUND IMPLANTS SPECIMEN SENT TO UNIV OF VA PATH WHERE DX WAS MADE EVENT OF ALCL WILL BY CAPTURED AS LYMPHOMA UNTIL CONFIRMATION OF PATHOLOGY RESULTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/16/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA, NE|CS|UNKNOWN MANUFACTURER|||||||True
4849890|5944021|D|1||HEALTH PROFESSIONAL REPORTED THE PATIENT HAD A SMALL AMOUNT OF SEROMA AT THE OPERATING ROOM AND IT WAS FOUND TO BE ALCL CELLS IN THE CYTOLOGY FLUID NO PATHOLOGY RESULTS ARE AVAILABLE ALCL IS NOT CONFIRMED AND THEREFORE WILL BE REPORTED AS LYMPHOMA DEVICE HAS BEEN REMOVED|STYLE 410 OCHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF125-375|06/15/2015|||DA|N|R||0HP|FTR|1.0|02/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICON GEL-FILLED||380839|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4645849|5618617|D|1||REGULATORY AGENCY REPORTED THE FOLLOWING EVENTS IN VOLUNTARY REPORT NUMBER MW5039416 A PATIENT PRESENTED WITH RIGHT LATERAL CHEST MELANOMA EXCISION AND FOUND TO HAVE AXILLARY LYMPHADENOPATHY BUT ULTRASOUND NORMAL PT ALSO APPEARED TO HAVE RIGHT BREAST FIRM GRADE IV CAPSULAR CONTRACTURE PT INITIALLY DECLINED TREATMENT THEN RETURNED DIAGNOSED WITH ALCL PATHOLOGY RESULTS NOT PROVIDED THE REPORT OF ALCL IS CAPTURED AS LYMPHOMA UNLESS PATHOLOGY RESULTS ARE RECEIVED TREATMENT IS UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/30/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4432002|20460339|D|1||PHYSICIAN REPORTED ANAPLASTIC LYMPHOMA CLINICAL SIGNS EXTRAVASATION EXTRAVASATION WILL BE CODED AS RUPTURE SIDE NOT SPECIFIED ALLERGAN NURSE SPECIALIST CONFIRMED EVENT TO BE LYMPHOMA UNTIL THE REPORTED EVENT OF ALCL IS CONFIRMED BY CYTOLOGYIMMUNOCHEMISTRY MARKERS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/15/2015|||DA|N|R||0HP|FTR|1.0||FTR||NI|||LA AURORA DE HEREDIA, NE|CS|ALLERGAN|||||||True
5155756|28464643|N|0||DEVICE LABELING PUBLISHED STUDIES INDICATE THAT BREAST CANCER IS NO MORE COMMON IN WOMEN WITH IMPLANTS THAN THOSE WITHOUT IMPLANTS A LARGE LONG-TERM FOLLOW-UP FOUND NO SIGNIFICANT INCREASES IN THE RISK RATES FOR A WIDE VARIETY OF CANCERS INCLUDING STOMACH CANCER LEUKEMIA AND LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY DEFLATION Â¿ BREAST IMPLANTS ARE NOT LIFETIME DEVICES SALINE BREAST IMPLANTS DEFLATE WHEN THE SHELL DEVELOPS A TEAR OR HOLE DEFLATION CAN OCCUR AT ANY TIME AFTER IMPLANTATION BUT THEY ARE MORE LIKELY TO OCCUR THE LONGER THE IMPLANT IS IMPLANTED THE FOLLOWING THINGS MAY CAUSE IMPLANTS TO DEFLATE DAMAGE BY SURGICAL INSTRUMENTS FOLDING OR WRINKLING OF THE IMPLANT SHELL EXCESSIVE FORCE TO THE CHEST EG DURING CLOSED CAPSULOTOMY WHICH IS CONTRAINDICATED TRAUMA COMPRESSION DURING MAMMOGRAPHIC IMAGING AND SEVERE CAPSULAR CONTRACTURE BREAST IMPLANTS MAY ALSO SIMPLY WEAR OUT OVER TIME LABORATORY STUDIES HAVE IDENTIFIED SOME OF THE CAUSES OF DEFLATION FOR ALLERGANÂ¿S PRODUCT HOWEVER IT IS NOT CONCLUSIVELY KNOWN WHETHER THESE TESTS HAVE IDENTIFIED ALL CAUSES OF DEFLATION|STYLE 168 SALINE FILLED BREAST IMPLANT|168-420|10/16/2015||||N|R||0HP|FWM|1.0|05/01/1996|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2-163072|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5155756|28464644|D|0||LAW FIRM REPORTED A POSSIBLE LUMP BEHIND PATIENTS LEFT BREAST AND A LEFT IMPLANT RUPTURE ADDITIONAL INFORMATION PROVIDED REVEALS PATIENT PRESENTED WITH A SMALL MASS ON THE LEFT CHEST WALL MEDIAL TO HER RECONSTRUCTION THIS MASS HAS RAPIDLY GROWN IN SIZE AND NOW IS PUSHING IMPLANT LATERALLY IT HAS GOTTEN QUITE UNCOMFORTABLE PATIENT SAW PHYSICIAN WHO OBTAINED A CT DEMONSTRATING A LARGE MASS DEFORMING THE IMPLANT LOCATED SUB-PECTORALLY THE PATIENT WAS ULTIMATELY DIAGNOSED WITH A LEFT SUB-PECTORAL MASS IDENTIFIED AS LYMPHOMA A BIOPSY REVEALED THAT PATIENT HAD ALCL ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE CD30 RESULTS AND PATHOLOGY TESTS HAVE NOT BEEN PROVIDED THIS UNCONFIRMED REPORT OF ALCL WILL BE CAPTURED AS LYMPHOMA AT THIS TIME TREATMENT INCLUDED MULTIPLE HOSPITALIZATIONS LEFT SIDE DEVICE REMOVAL AND 16 ROUNDS OF CHEMOTHERAPY AND MULTIPLE SURGERIES ADDITIONAL NOTES INCLUDE BASAL CELL CARCINOMA MALIGNANT MELANOMA AND HERPES ZOSTER SIDE NOT SPECIFIED MELANOMA IS NOT RELATED TO THE DEVICE AS IT WAS FIRST DIAGNOSED PRIOR TO IMPLANTATION THIS RECORD IS FOR THE LEFT SIDE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-420|10/16/2015||||N|R||0HP|FWM|1.0|05/01/1996|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2-163072|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4859975|54646975|D|1||HEALTH PROFESSIONAL REPORTED A CASE OF ALCL SIDE UNSPECIFIED MANUFACTURER OF THE DEVICE IS UNKNOWN PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN PROVIDED THEREFORE THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/19/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|LA AURORA DE HEREDIA||NE|CS|UNKNOWN MANUFACTURER|||||||True
4859975|5810930|D|1||HEALTH PROFESSIONAL REPORTED A CASE OF ALCL SIDE UNSPECIFIED MANUFACTURER OF THE DEVICE IS UNK PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN PROVIDED THEREFORE THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/19/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|LA AURORA DE HEREDIA||NE|CS|UNKNOWN MANUFACTURER|||||||True
5286834|33227133|N|1||DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/10/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5286834|33227134|D|1||HEALTH PROFESSIONAL REPORTED A PERIPROSTHETIC OEDEMA LEADING TO A PARTIAL CAPSULECTOMY ON THE CAPSULECTOMY LEFT SIDE PATIENT WAS DIAGNOSED WITH ALCL ANAPLASTIC LARGE CELL LYMPHOMA CD30+ ALK-|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/10/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4385769|19013900|N|1||UDI NA DEVICE LABELING ADDRESSES THE REPORTED EVENT OF ALCL AS FOLLOWS BASED ON THE INFO REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MANUFACTURERS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REP PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOU PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALLER NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL DEVICE LABELING ADDRESSES THE REPORTED EVENT OF SEROMA AS FOLLOWS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN THE NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY AFTER A BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA, NE|CS|UNKNOWN MANUFACTURER|||||||True
4957654|19502324|D|1||HEALTH PROFESSIONAL REPORTED CALCIFICATION IN CAPSULE AND ANAPLASTIC LARGE CELL LYMPHOMA ALCL PATHOLOGY IN THE REMOVED LEFT BREAST CAPSULECTOMY SPECIMEN WITH EXCHANGE OF IMPLANT ALCL HAS NOT BEEN CONFIRMED AS PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA AT THIS TIME|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4957654|55248981|D|1||ADDITIONAL INFORMATION PROVIDED BY HEALTHCARE PROFESSIONAL NOTES DIAGNOSTIC INFORMATION REPORTED CD30+ AND ALK- PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE BEEN RECEIVED PATIENT HAS SINCE RECEIVED B4 ROUNDS OF CHOEP TREATMENT B6 2015-B6 2016 B4 ROUNDS OF GDP TREATMENT B6 2016-B6 2016 AND B4 ROUNDS OF BRENTUXIMAB STARTING B6 2016 UNTIL PRESENT A STEM CELL TRANSPLANT IS PLANNED FOR B6 2016|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4957654|26958644|D|1||FOLLOW-UP WITH PHYSICIAN REVEALS THE FOLLOWING LEFT SIDE EVENTS CAPSULAR CONTRACTURE BAKER IIIIV NOTED REACTIVE AXILLARY LYMPH NODES EDEMA SUSPECTED AND PAIN PATHOLOGICAL TESTING OF THE LEFT BREAST CAPSULE HAD FEATURES CONSISTENT WITH BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA THE DESCRIPTION OF THE CAPSULE INCLUDED THREE ADJACENT BUT SEPARATE HARD WHITE NODULES MEASURING 50 CM 55 CM AND 60 CM IN MAXIMUM DIAMETER AS TESTING FOR ALK RESULTS WERE NOT PERFORMED ON THE PROVIDED PATHOLOGY TESTS ALCL CANNOT BE CONFIRMED AND WILL CONTINUE TO BE CAPTURED AS LYMPHOMA|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4957654|55248980|N|1||THE EVENT OF LYMPHOMA ALCL IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4943508|6632766|D|1||ALCL DIAGNOSIS|SILTEX CONTOUR PROFILE LUMERA MODERATE GEL|324-1307|07/17/2015|||DA||R||0HP|FTR|1.0||CONTOUR PROFILE GEL||5713687|||IRVING|US|MENTOR WORLDWIDE LLC||TX|||||True
4702205|15310134|D|1||HEALTH PROFESSIONAL REPORTED TO REGULATORY AGENCY VIA VOLUNTARY MW5039346 ALCL CASE REPORT ASSOCIATED WITH BREAST CANCER RECONSTRUCTION PATIENT FOLLOW-UP REVEALS THAT PATIENT HAS A HISTORY OF LEFT BREAST DUCTAL CARCINOMA IN SITU PRIOR TO BREAST IMPLANTS THE PATIENT PRESENTED WITH SWELLING AND PAIN PRIMARY DIAGNOSIS OF ALCL WAS DIAGNOSED AGAINST THE RIGHT SIDE IN THE PERI IMPLANT FLUID AND 1 X 23 CM MASS AT MEDIANINFERIOR EDGE OF IMPLANT THE SEROMA WAS NOTED AS SEVERE PATIENT WAS TREATED WITH CHEMOTHERAPY AND THE RIGHT SIDE DEVICE WAS EXPLANTED PATHOLOGY RESULTS CONFIRM THE DIAGNOSIS SHOULD READ AS BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IMMUNOSTAINS SHOW TUMOR CELLS ARE POSITIVE FOR CD30 CD2 AND CD4 THEY ARE NEGATIVE FOR ER PR HER2 AND CYTOKERATIN S100 CD45 MPO CD3 CD20 AND ALK1|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|04/16/2015|||DA|N|R||0HP|FWM|1.0|12/05/2008|nan||1059645|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4600131|5470590|D|1||PHYSICIAN REPORTED TO REGULATORY AGENCY AS 2 SUICIDE ATTEMPTS FIBROMYALGIA RUPTURE OF THE ROTATOR CUFF LEFT B6 TWO PHLEBITIS A DYSTHYROIDEA IRON DEFICIENCY ANEMIA GASTRITIS WITH ESOPHAGITIS ARTHRITIS REQUIRING IMPLANTATION OF KNEE PROSTHESIS CLINICAL CONSEQUENCE ANAPLASTIC LARGE CELL LYMPHOMA ALCL ALK1 - CD30 LAGC SIDE IS UNKNOWN TREATMENT IS UNKNOWN|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|03/11/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4600131|12978182|N|1||DEVICE LABELING ADDRESSES ALCL ANAPLASTIC LARGE CELL LYMPHOMA ALCL - WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ANAPLASTIC LARGE CELL LYMPHOMA OR ALCL IN THE SCAR TISSUE AND FLUID ADJACENT TO THE IMPLANT ALCL IS NOT BREAST CANCER - IT IS A RARE TYPE OF NON-HODGKINS LYMPHOMA CANCER OF THE IMMUNE SYSTEM ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MANUFACTURERS BREAST IMPLANTS MOST PATIENTS WERE DIAGNOSED WHEN THEY SOUGHT MEDICAL TREATMENT FOR IMPLANT RELATED SYMPTOMS SUCH AS PAIN LUMPS SWELLING OR ASYMMETRY THAT DEVELOPED AFTER THEIR INITIAL SURGICAL SITES WERE FULLY HEALED IN THE CASES REPORTED ALCL WAS TYPICALLY DIAGNOSED YEARS AFTER THAT IMPLANT SURGERY DEVICE LABELING ADDRESSES ARTHRITIS AND FIBROMYALGIA CONNECTIVE TISSUE DISEASES INCLUDE DISEASES SUCH AS LUPUS SCLERODERMA RHEUMATOID ARTHRITIS AND FIBROMYALGIA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|03/11/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5098529|26591653|N|1||DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL THE PATIENT SHOULD BE TOLD THAT THE PRESENCE OF LUMPS PERSISTENT PAIN SWELLING HARDENING OR CHANGE IN THE IMPLANT SHAPE MAY BE SIGNS OF SYMPTOMATIC RUPTURE OF THE IMPLANT IF THE PATIENT HAS ANY OF THESE SIGNS SHE SHOULD BE TOLD TO REPORT THEM AND POSSIBLY HAVE AN MRI EVALUATION TO SCREEN FOR RUPTURE LITERATURE REPORTS HAVE ALSO BEEN MADE ASSOCIATING SILICONE BREAST IMPLANTS WITH VARIOUS RHEUMATOLOGICAL SIGNS AND SYMPTOMS SUCH AS FATIGUE EXHAUSTION JOINT PAIN AND SWELLING MUSCLE PAIN AND CRAMPING TINGLING NUMBNESS WEAKNESS AND SKIN RASHES|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/23/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||nan|||||||True
4385749|15814629|D|1||HEALTH PROFESSIONAL REPORTED DIAGNOSIS OF ANAPLASTIC LYMPHOMA LINKED TO BREAST PROSTHESIS PLACED FOR BREAST RECONSTRUCTION DIAGNOSTIC TESTS NOT PROVIDED TO CONFIRM ALCL THE EVENT OF LYMPHOMA WILL BE REPORTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX115-315|12/24/2014|||DA|N|R||0HP|FTR|1.0|08/25/2012|nan||1474756|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4943532|6632764|D|1||ALCL DIAGNOSIS|SILTEX CONTOUR PROFILE LUMERA MODERATE GEL|324-1257|07/17/2015|||DA||R||0HP|FTR|1.0||CONTOUR PROFILE GEL||5681120|||IRVING|US|MENTOR WORLDWIDE LLC||TX|||||True
4819204|5927912|D|1||AFTER 10 YEARS OF HAVING IMPLANTS JUST DISCOVERED HAVE ALCL ALK-|BREAST IMPLANT|*|05/29/2015|||||||0HP|FWM|1.0||BREAST IMPLANT||*|*||*|*|*|||||*|*|True
4922455|6051210|D|1||PHYSICIAN REPORTED A PT WHO HAS DEVELOPED A FULMINANT ALCL DUE TO AN ALLERGAN IMPLANT AND HAS A SEVERE DISEASE WITH A PRIMARY TUMOR IN THE BREAST AND INGROWTH IN THE THORACIC MUSCLES AND IN THE RIBS ALCL WILL BE CAPTURED AS LYMPHOMA AS REPORT OF PATHOLOGICAL TESTING HAS NOT BEEN PROVIDED SIDE IS UNK TREATMENT IS UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/16/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL SALINE||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4922455|14212221|N|1||BASED ON THE INFO REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MFRS BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/16/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL SALINE||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5230911|31447414|N|1||DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|11/17/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4553419|19634012|N|1||UNIQUE IDENTIFIER UDI  B4 DEVICE LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALAL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MANUFACTURERS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410470|02/25/2015|||DA|N|R||0HP|FTR|1.0|01/15/2011|nan||1210806|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4553419|19316035|D|1||HEALTH PROFESSIONAL REPORTED LYMPHOMA ALCL DEVICE WAS REMOVED PATHOLOGY REPORT DIAGNOSIS STATES ALK-NEGATIVE ANPLASTIC LARGE CELL LYMPHOMA INVOLVING CAPSULE AND IMMUNOSTAINS SHOW THAT THE TUMOR CELLS ARE POSITIVE FOR CD30|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410470|02/25/2015|||DA|N|R||0HP|FTR|1.0|01/15/2011|nan||1210806|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5222818|31178939|N|1||B4 DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL IN THE PASS STUDY AT LEAST 1 REOPERATION WAS PERFORMED ON 315 PATIENTS 365 THROUGH 10 YEARS A TOTAL OF 424 REOPERATIONS WERE PERFORMED THE PRIMARY REASON FOR REOPERATION THROUGH 10 YEARS ON AUGMENTATION PATIENTS WAS IMPLANT DEFLATION AT 217 THE PERCENTAGE OF REOPERATIONS DUE TO LUMPMASSCYST INCREASED FROM 85 OF 293 REOPERATIONS THROUGH 5 YEARS TO 139 OF 424 REOPERATIONS THROUGH 10 YEARS THE OCCURRENCE OF LUMPS MASSES AND CYSTS CAN BE EXPECTED TO NATURALLY INCREASE AS PATIENTS AGE AND COULD BE AN EXPLANATION FOR THE INCREASE POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY CAPSULAR CONTRACTURE Â¿ PATIENTS SHOULD BE ADVISED THAT CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWING INFECTION HEMATOMA AND SEROMA AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME CAPSULAR CONTRACTURE OCCURS MORE COMMONLY IN REVISION PATIENTS THAN IN PRIMARY AUGMENTATION OR RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE IS ALSO A RISK FACTOR FOR IMPLANT DEFLATION AND IT IS ONE OF THE MOST COMMON REASONS FOR REOPERATION OF THE 237 PATIENTS IN THE R95 STUDY AT LEAST 1 REOPERATION WAS PERFORMED ON 99 PATIENTS 42 FOR A TOTAL OF 125 REOPERATIONS THROUGH 5 YEARS THE PRIMARY REASON FOR REOPERATION THROUGH 5 YEARS WAS CAPSULAR CONTRACTURE AT 256 OF THE 237 RECONSTRUCTION PATIENTS IN R95 THERE WERE 62 PATIENTS 262 WHO HAD 70 IMPLANTS REMOVED THROUGH 5 YEARS OF THE 70 RECONSTRUCTION IMPLANTS REMOVED THROUGH 5 YEARS 70 WERE REPLACED THE MOST COMMON REASON FOR IMPLANT REMOVAL WAS CAPSULAR CONTRACTURE 314 THROUGH 10 YEARS THERE WERE 104 IMPLANTS REMOVED FROM 85 PATIENTS THE MOST COMMON REASON FOR IMPLANT REMOVAL WAS IMPLANT LEAKAGEDEFLATION 327|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-410|11/13/2015||||N|R||0HP|FWM|1.0|10/09/2005|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||569053|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5222818|31178940|D|1||PHYSICIAN REPORTED VIA VOLUNTARY MW5055722 THAT THE PATIENT CAME WITH A SKIN LESION ON THE CHEST A BIOPSY ON THE LESION CAME BACK AS ALCL ANAPLASTIC LARGE CELL LYMPHOMA PHYSICIAN ADDITIONALLY NOTED THAT THE RIGHT SIDE DEVICE AND RIGHT SIDE CAPSULE WERE REMOVED AND FLUID WAS SENT FOR CYTOLOGY PHYSICIAN SPECIFIED THAT THE RIGHT BREAST WAS FILLED WITH A THICK RED COLOREDBROWN COLORED FLUID THIS REPORT IS FOR THE RIGHT SIDE FOLLOW-UP REVEALS PATHOLOGY WAS INITIALLY ASSESSED ON AN ABDOMINAL LESION BIOPSY RESULTS ON LESION WERE UPPER ABDOMEN - CD30 POSITIVE LYMPHOMA CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA AND LARGE CELLS ARE ALSO NEGATIVE FOR EBER AND ALK-1 WHEN THE IMPLANTS WERE REMOVED PATHOLOGY INDICATED THAT THE RIGHT BREAST CAPSULE WAS DIAGNOSED WITH ALCL ALK NEGATIVE PATHOLOGY REPORT ADDITIONALLY INDICATES THAT A SINGLE 15 CM NODULE WAS IDENTIFIED AND LOCATED NEAR AN IDENTICAL LESION IN THE RIGHT BREAST CAPSULE THE NODULE TESTED POSITIVE FOR CD30 AND NEGATIVE FOR ALK IT IS ALSO NOTED THAT THE IMPLANT IS RECEIVED WITH MINIMAL AMOUNTS OF ATTACHED BLOOD CLOT AND TISSUE PHYSICIAN ADDITIONALLY REPORTED RIGHT SIDE GRADE IV CAPSULAR CONTRACTURE PHYSICIAN NOTED THAT THE PATIENT REFUSED CHEMOTHERAPY AND RADIOTHERAPY|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-410|11/13/2015||||N|R||0HP|FWM|1.0|10/09/2005|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||569053|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4902572|55597680|D|1||A REPORT OF NULL-TYPE ANAPLASTIC LARGE CELL LYMPHOMA ARISING IN A SILICONE BREAST IMPLANT CAPSULE WRITTEN IN PLASTIC AND RECONSTRUCTIVE SURGERY JUNE 2011 VOL 127 NUMBER 6 REPORTS PATIENT PRESENTED WITH A PAINFUL RIGHT BREAST AND BAKER GRADE III CAPSULAR CONTRACTUREIMPLANT WAS REMOVED AND THE SUBMUSCULAR POUCH WAS EXPLORED WITH DRAINAGE OF A SEROUS-HEMATIC FLUID SURROUNDING THE RIGHT PROSTHESIS CAPSULECTOMY WAS PERFORMED AND THE REMOVED FIBROUS TISSUE ANALYZED BECAUSE OF ITS ALTERED ASPECT THE PATHOLOGY FINDINGS WERE CONSISTENT WITH A DIAGNOSIS OF NULL-TYPE ANAPLASTIC LYMPHOMA KINASE-NEGATIVE NON-HODGKINS ANAPLASTIC LARGE CELL LYMPHOMA ALCL DEVICE HAS BEEN REMOVED MANUFACTURER OF THE DEVICE IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/08/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4902572|14225628|N|1||UNIQUE IDENTIFIER UDI  NA MEDWATCH SUBMITTED TO THE FDA ON 07082015 DEVICE LABELING POTENTIAL ADVERSE EVENT THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFO REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MFRS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBLY OF ALCL WHEN YOU HAVE A PT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REP PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WITH DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS PTS SHOULD BE ADVISED THAT CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWING INFECTION HEMATOMA AND SEROMA AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME CAPSULAR CONTRACTURE OCCURS MORE COMMONLY IN REVISION PTS THAN IN PRIMARY AUGMENTATION OR RECONSTRUCTION PTS CAPSULAR CONTRACTURE IS ALSO A RISK FACTOR FOR IMPLANT DEFLATION AND IT IS ONE OF THE MOST COMMON REASONS FOR REOPERATION PTS SHOULD ALSO BE ADVISED THAT ADDL SURGERY MAY BE NEEDED IN CASES WHERE PAIN ANDOR FIRMNESS ARE SEVERE THIS SURGERY RANGES FROM REMOVAL OF THE IMPLANT CAPSULE TISSUE TO REMOVAL AND POSSIBLE REPLACEMENT OF THE IMPLANT ITSELF THIS SURGERY MAY RESULT IN LOSS OF BREAST TISSUE CAPSULAR CONTRACTURE MAY HAPPEN AGAIN AFTER THESE ADDL SURGERIES CAPSULAR CONTRACTURE MAY INCREASE THE RISK OF DEFLATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/08/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4902572|6067684|D|1||A REPORT OF NULL-TYPE ANAPLASTIC LARGE CELL LYMPHOMA ARISING IN A SILICONE BREAST IMPLANT CAPSULE WRITTEN IN PLASTIC AND RECONSTRUCTIVE SURGERY JUNE 2011 VOL 127 NUMBER 6 REPORTS PT PRESENTED WITH A PAINFUL RIGHT BREAST AND BAKER GRADE III CAPSULAR CONTRACTUREIMPLANT WAS REMOVED AND THE SUBMUSCULAR POUCH WAS EXPLORED WITH DRAINAGE OF A SEROUS-HEMATIC FLUID SURROUNDING THE RIGHT PROSTHESIS CAPSULECTOMY WAS PERFORMED AND THE REMOVED FIBROUS TISSUE ANALYZED BECAUSE OF ITS ALTERED ASPECT THE PATHOLOGY FINDINGS WERE CONSISTENT WITH A DIAGNOSIS OF NULL-TYPE ANAPLASTIC LYMPHOMA KINASE-NEGATIVE NON-HODGKINS ANAPLASTIC LARGE CELL LYMPHOMA ALCL DEVICE HAS BEEN REMOVED MFR OF THE DEVICE IS UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/08/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
5138318|27896968|D|1||ALLERGAN REPRESENTATIVE REPORTED A CASE OF ALCL RECEIVED FROM A PHYSICIAN IN WHICH THE PATIENT PRESENTED WITH SEROMA DRAINED SEROMA AND PROCEEDED TO SURGERY DID COMPLETE CAPSULECTOMY AND SEND CAPSULE TO PATHOLOGY PATHOLOGY CONFERRED CD30+ SIDE WAS UNSPECIFIED FOLLOW-UP WITH HEALTH PROFESSIONAL FOUND EXPANDING RIGHT BREAST CATEGORIZED AS SIGNIFICANT SEROMA THERE WAS CAPSULAR CONTRACTURE BUT THE BAKER GRADE WAS DIFFICULT TO DETERMINE DUE TO TENSION CAUSED BY SEROMA DEVICE WAS REMOVED AND INTRAOPERATIVELY NOTED MATERIAL INTRACAPSULE THAT APPEARED OLD HEMATOMA PATIENT HAS NOT YET HAD CHEMOTHERAPY OR RADIOTHERAPY IMMUNOHISTOCHEMISTRY ON THE MALIGNANT APPEARING TUMOR CELLS REVEALS THAT CELLS ARE NEGATIVE FOR CK7 AE1AE3 CD68 CK19 CK20 ER CD20 AND EMA TUMOR CELLS ARE POSITIVE FOR CD3 CD30 AND CD45 IMMUNOHISTOCHEMISTRY SUPPORTS DIAGNOSIS OF ANAPLASTIC LARGE CELL LYMPHOMA T CELL LYMPHOMA ALK- MARKER NOT CONFIRMED THIS EVENT WILL BE CAPTURED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX155-685|10/08/2015||||N|R||0HP|FTR|1.0|11/28/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1172190|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5138318|27896967|N|1||B4 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX155-685|10/08/2015||||N|R||0HP|FTR|1.0|11/28/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1172190|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5286954|40348295|N|1||MEDWATCH SENT TO FDA ON 3142016 THE PHYSICIAN DID NOT CONFIRM WHETHER THE DEVICE WAS EXPLANTED BUT DID CONFIRM THAT THE DEVICE WOULD NOT BE RETURNED THEREFORE NO ANALYSIS OR TESTING WILL BE DONE THESE EVENTS ARE BEING REPORTED BECAUSE MEDICAL INTERVENTION WAS REQUIRED ALTHOUGH DEVICE-RELATEDNESS HAS NOT BEEN ESTABLISHED THE EVENTS OF SEROMA GRANULOMATOUS REACTION AND LIPOPHAGIC NECROSIS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL -- INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF THE REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION INFLAMMATORY REACTION STUDIES EVALUATING THE CAPSULES AROUND TEXTURED IMPLANTS HAVE REPORTED POSSIBLE SILICONE PARTICLES WITHIN GIANT CELLS INDICATIVE OF A LOCAL AND NONSPECIFIC FOREIGN BODY REACTION AND SILICONE GRANULOMA FORMATION IN CASE OF AN INFLAMMATORY REACTION THE SURGEON IS ADVISED TO REMOVE THE DEVICE FROM THE PATIENTS BODY AND TO SECURE ANY EVIDENCE ON THE POSSIBLE CAUSE OF THE INFLAMMATORY REACTION AND TO TREAT THE PATIENT CORRESPONDINGLY IT IS ADVISED NOT TO REPLACE THE IMPLANT UNTIL THE INFLAMMATORY REACTION HAS PASSED COMPLETELY AND ITS CAUSE HAS BEEN ELIMINATED NECROSIS NECROSIS MAY INHIBIT WOUND HEALING AND REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION PERMANENT SCAR DEFORMITY MAY OCCUR AS A RESULT OF NECROSIS DO NOT USE MICROWAVE DIATHERMY IN PATIENTS WITH BEAST IMPLANTS MICROWAVE DIATHERMY HAS BEEN REPORTED TO CAUSE TISSUE NECROSIS SKIN EROSION AND IMPLANT EXTRUSION|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM240|12/10/2015|||DA|N|R||0HP|FTR|1.0|06/17/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2131883|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5286954|33227537|D|1||PHYSICIAN REPORTS PATIENT WITH A BREAST IMPLANT AND HAS BEEN DIAGNOSED WITH ANAPLASTIC LARGE CELL LYMPHOMA ALCL AT THE RIGHT BREAST AS PATHOLOGICAL MARKERS HAVE NOT BEEN PROVIDED THIS CASE WILL BE CAPTURED AS LYMPHOMA UNTIL DIAGNOSTIC CONFIRMATION IS RECEIVED TREATMENT IS UNKNOWN|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM240|12/10/2015|||DA|N|R||0HP|FTR|1.0|06/17/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2131883|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5286954|33227536|N|1||DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM240|12/10/2015|||DA|N|R||0HP|FTR|1.0|06/17/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2131883|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5286954|40348296|D|1||FOLLOW-UP REVEALS PATIENT EXPERIENCED A SEVERE RIGHT SIDE PERIPROSTHETIC SEROMA APPROXIMATELY TWO AND A HALF YEARS AFTER REVISION AUGMENTATION PATHOLOGY TESTS WERE PERFORMED ON THE RIGHT BREAST CAPSULECTOMY AND APPROXIMATELY 30 ML OF A RELATIVELY THICK LIQUID YELLOWISH AND OPAQUE FROM WHICH A 10 ML FRESH SAMPLE IS TAKEN THE CAPSULE REVEALS A GRANULOMATOUS REACTION AND LIPHOPHAGIC NECROSIS THE RIGHT SIDE SEROMA CELLS ARE ALL POSITIVE FOR CD30 ALK MARKERS WERE NOT TESTED FOR THIS REMAINS A SUSPECTED CASE OF ALCL A TOTAL CAPSULECTOMY WAS PERFORMED AS TREATMENT IT IS UNCLEAR IF EXPLANT OCCURRED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM240|12/10/2015|||DA|N|R||0HP|FTR|1.0|06/17/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2131883|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4374378|5118989|D|1||THE PT UNDERWENT BREAST AUGMENTATION WITH MENTOR SILTEX GEL FILLED MAMMARY PROSTHESES IN B6 2007 UB B6 2014 THE PT WAS DIAGNOSED WITH ALCL THE DEVICES WERE REMOVED IN B6 2014|MEMORYGEL SILTEX ROUND MODERATE PLUS PROFILE|354-4001|12/18/2014||||N|R||0HP|FTR|1.0||BREAST IMPLANT||5703499|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR WORLDWIDE, LLC|75038|TX|75038||||True
4623194|18636183|D|1||HEALTH PROFESSIONAL REPORTED NEW CASE OF ALCL AGAINST A NATRELLE IMPLANT SIDE UNSPECIFIED EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL ALCL CAN BE CONFIRMED VIA PATHOLOGY|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/20/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5098467|26589688|N|1||B4 BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL THE PATIENT SHOULD BE TOLD THAT THE PRESENCE OF LUMPS PERSISTENT PAIN SWELLING HARDENING OR CHANGE IN THE IMPLANT SHAPE MAY BE SIGNS OF SYMPTOMATIC RUPTURE OF THE IMPLANT IF THE PATIENT HAS ANY OF THESE SIGNS SHE SHOULD BE TOLD TO REPORT THEM AND POSSIBLY HAVE AN MRI EVALUATION TO SCREEN FOR RUPTURE LITERATURE REPORTS HAVE ALSO BEEN MADE ASSOCIATING SILICONE BREAST IMPLANTS WITH VARIOUS RHEUMATOLOGICAL SIGNS AND SYMPTOMS SUCH AS FATIGUE EXHAUSTION JOINT PAIN AND SWELLING MUSCLE PAIN AND CRAMPING TINGLING NUMBNESS WEAKNESS AND SKIN RASHES|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/23/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4974939|14087432|N|1||DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTEDLY GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MANUFACTURERS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/04/2015|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4623212|5575786|D|1||HEALTH PROFESSIONAL REPORTED NEW CASE OF ALCL AGAINST A NATRELLE IMPLANT SIDE UNSPECIFIED EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL ALCL CAN BE CONFIRMED VIA PATHOLOGY|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/20/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4626734|5586914|D|1||ALCL SYMPTOMS REF FDA REPORT MW5040065|BREAST IMPLANT|NI|03/17/2015|||DA|R|R||0HP|FTR|1.0||MENTOR MOULDED TEARDROP BREAST IMPLANT||NI|||IRVING|US|MENTOR WORLDWIDE||TX|||NI||True
4739846|5823824|D|1||HEALTH PROFESSIONAL REPORTED RECURRENT PERI PROSTHETIC LYMPHOCELE VERY ERYTHEMATOUS SKIN TOTAL CAPSULECTOMY WAS PERFORMED LEFT PROSTHESIS WAS REMOVED ROTATION OF PROSTHESIS A DOUBLE CAPSULE WAS FOUND AND SEROMA SEVERAL NODES OF TISSUE WERE FOUND AT UPPER BANK OF THE MASTECTOMY ALCL LYMPHOMA DIAGNOSED ADDITIONAL REPORT STATES RELAPSING PERIPROSTHETIC LYMPHOCELE ERYTHEMA NODULES AROUND THE BORDERS OF THE MASTECTOMY DOUBLE CAPSULE REARRANGEMENT OF TCRG AND TCRB LOCI TREATMENT INCLUDED IMPLANT ABLATION TOTAL CAPSULECTOMY CHANGE IN PROSTHESIS BY POLYTECH ADJUVANT TREATMENT ALCL DIAGNOSED VIA MARKERS OF CD30+ALK-|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410375|04/29/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4665224|5729407|D|1||REPORTED AS LYMPHADENOPATHYEXTRAVASATION ADDITIONAL REPORT STATES LEVY MICROBIOLOGY OF LEFT BREAST AND ANAPATH ON EXERESE OF LEFT DEVICE BREAST CAPSULE PERIPROSTHETIC BREAST CAPSULE HAVING ON ITS SIDE INTRACAPSULAR INFILTRATION BY CD30 + ALCL EMA + AS PATHOLOGY HAS NOT BEEN RECEIVED TO CONFIRM ALCL THIS EVENT WILL REMAIN REPORTABLE AS LYMPHOMA|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120341|04/06/2015||07/14/2014|DA|Y|Y||0HP|FTR|1.0|12/09/2010|NONE||1178535|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4665224|13168503|N|1||DEVICE LABELING ADDRESSES LYMPHOMA LYMPHOMAS INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - DOCUMENTATION MEDICAL SUGGESTS THAT THERE IS A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSALITY BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THIS DISEASE IS EXTREMELY RARE AND OCCURS IN WOMEN WITH OR WITHOUT BREAST IMPLANTS DEVICE LABELING ADDRESSES RUPTURE RUPTURE - PTS SHOULD BE INFORMED THAT THE FILLED BREAST IMPLANTS SILICONE GEL DOES NOT LAST A LIFETIME AND THAT IMPLANT RUPTURE IS A POSSIBILITY TO CONSIDER THE DECISION TO REMOVE A RUPTURED IMPLANT OR IS SUSPECTED TO BE TO BE TAKEN AFTER REVIEWING ALL CLINICAL DATA AVAILABLE AND AFTER CAREFUL THOUGHT ABOUT YOUR PT HOWEVER IF IMPLANT RUPTURE IS DIAGNOSED IT IS RECOMMENDED TO REMOVE THE IMPLANT DEVICE LABELING ADDRESSES LYMPHADENOPATHY ADDITIONAL COMPLICATIONS - AFTER A BREAST IMPLANT SURGERY THE FOLLOWING SITUATIONS MAY ARISE AND PERSIST AND TO VARY IN INTENSITY AND DURATION PAIN HEMATOMASEROMA CHANGES IN SENSATION IN NIPPLE AND BREAST EXTRUSION NECROSIS DELAYED WOUND HEALING TISSUE ATROPHY BREAST AND DEFORMITIES OF THE CHEST CALCIUM DEPOSITS FORM SOMETIMES IN THE CAPSULE TISSUE SURROUNDING THE IMPLANT WHICH IS MANIFESTED BY SYMPTOMS SUCH AS PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120341|04/06/2015||07/14/2014|DA|Y|Y||0HP|FTR|1.0|12/09/2010|NONE||1178535|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5303162|33710388|D|1||ALCL CASE REPORT A B6 OTHERWISE HEALTHY WHITE FEMALE WHO UNDERWENT UNCOMPLICATED BILATERAL BREAST AUGMENTATION WITH MCGHAN STYLE 468 SALINE-FILLED BREAST IMPLANTS ON B6 2002 SHE DID VERY WELL UNTIL B6 2015 WHEN SHE NOTED INTERMITTENT SWELLING OF HER LEFT BREAST WITH NO CHANGE IN HER RIGHT BREAST SHE DENIES ANY OTHER SYMPTOMS OTHER THAN MILD PRESSURE SENSATION IN THE LEFT BREAST MAMMOGRAM AND ULTRASOUND OF THE LEFT BREAST ORDERED BY HER PCP ON B6 2015 CONFIRMED PERI-PROSTHETIC SEROMA WITHOUT ANY ABNORMAL BREAST TISSUE FINDINGS THE SWELLING BECAME MORE PERSISTENT AND SHE WAS SEEN IN THE OFFICE FOR EVAL AND WAS TAKEN EXPEDIENTLY TO THE OPERATING ROOM FOR SEROMA ASPIRATION CULTURES AND CAPSULE BIOPSY WHICH CONFIRMED ALCL CULTURES WERE NEGATIVE ONE WEEK LATER SHE UNDERWENT BILATERAL COMPLETE CAPSULECTOMY AND BILATERAL IMPLANT REMOVAL WITHOUT REPLACEMENT|STYLE 468 SALINE IMPLANT|27-468301|12/11/2015||||*|*||I|FWM|2.0||SALINE BREAST IMPALNT||565193||||US|MCGHAN|||||468||True
5303162|33710388|D|1||ALCL CASE REPORT A B6 OTHERWISE HEALTHY WHITE FEMALE WHO UNDERWENT UNCOMPLICATED BILATERAL BREAST AUGMENTATION WITH MCGHAN STYLE 468 SALINE-FILLED BREAST IMPLANTS ON B6 2002 SHE DID VERY WELL UNTIL B6 2015 WHEN SHE NOTED INTERMITTENT SWELLING OF HER LEFT BREAST WITH NO CHANGE IN HER RIGHT BREAST SHE DENIES ANY OTHER SYMPTOMS OTHER THAN MILD PRESSURE SENSATION IN THE LEFT BREAST MAMMOGRAM AND ULTRASOUND OF THE LEFT BREAST ORDERED BY HER PCP ON B6 2015 CONFIRMED PERI-PROSTHETIC SEROMA WITHOUT ANY ABNORMAL BREAST TISSUE FINDINGS THE SWELLING BECAME MORE PERSISTENT AND SHE WAS SEEN IN THE OFFICE FOR EVAL AND WAS TAKEN EXPEDIENTLY TO THE OPERATING ROOM FOR SEROMA ASPIRATION CULTURES AND CAPSULE BIOPSY WHICH CONFIRMED ALCL CULTURES WERE NEGATIVE ONE WEEK LATER SHE UNDERWENT BILATERAL COMPLETE CAPSULECTOMY AND BILATERAL IMPLANT REMOVAL WITHOUT REPLACEMENT|STYLE 468 SALINE IMPLANT|27-468301|12/11/2015||||*|*||I|FWM|1.0||SALINE BREAST IMPLANT||565193||||US|MCGHAN|||||468||True
4399502|19805106|D|1||I WAS ONE OF THE RARE CASES OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL CAUSED BY BREAST IMPLANTS I HAD A CAPSULECTOMY OF BOTH BREASTS AND HAVE SINCE HAD RECONSTRUCTION USING DIFFERENT MAKETYPE OF PROSTHESIS SINCE FIRST DIAGNOSED IN 2009 I HAVE NOT BEEN ABLE TO OBTAIN ANY FURTHER INFORMATION ON WHAT WAS DETERMINED FROM CASES LIKE MINE OR WHAT IF ANY RECOMMENDATIONS WERE GIVEN TO PATIENTS AT THE TIME I DISCOVERED THAT MY FIRST COUSIN ALSO SUFFERED THE CONDITION ALSO CAUSED BY IMPLANTS I WAS ALSO TOLD THAT I WAS CAUGHT EARLY ENOUGH AS TO NOT REQUIRE ANY TREATMENT OTHER THAN REMOVAL ALL OF THIS HAPPENED IN MY BIRTH COUNTRY OF B6 MY PLASTIC SURGEON WAS B6 OF B6 WHO PERFORMED MY ORIGINAL BREAST AUGMENTATION IN 2006 I HAVE RECENTLY STARTED RESEARCHING MY PREVIOUS CONDITION BUT CANNOT FIND ANY DETAILS OR CONTACT INFORMATION IN MY OWN COUNTRY I WAS HOPING THAT THE AMERICAN FDA MAY HAVE SOME CURRENT INFORMATION TO GIVE ME|MOULDED TEARDROP BREAST IMPLANT||01/05/2015|||DA||*||0|FTR|1.0||MOULDED TEARDROP BREAST IMPLANT|||||||MENTOR|||||||True
4399502|19805106|D|1||I WAS ONE OF THE RARE CASES OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL CAUSED BY BREAST IMPLANTS I HAD A CAPSULECTOMY OF BOTH BREASTS AND HAVE SINCE HAD RECONSTRUCTION USING DIFFERENT MAKETYPE OF PROSTHESIS SINCE FIRST DIAGNOSED IN 2009 I HAVE NOT BEEN ABLE TO OBTAIN ANY FURTHER INFORMATION ON WHAT WAS DETERMINED FROM CASES LIKE MINE OR WHAT IF ANY RECOMMENDATIONS WERE GIVEN TO PATIENTS AT THE TIME I DISCOVERED THAT MY FIRST COUSIN ALSO SUFFERED THE CONDITION ALSO CAUSED BY IMPLANTS I WAS ALSO TOLD THAT I WAS CAUGHT EARLY ENOUGH AS TO NOT REQUIRE ANY TREATMENT OTHER THAN REMOVAL ALL OF THIS HAPPENED IN MY BIRTH COUNTRY OF B6 MY PLASTIC SURGEON WAS B6 OF B6 WHO PERFORMED MY ORIGINAL BREAST AUGMENTATION IN 2006 I HAVE RECENTLY STARTED RESEARCHING MY PREVIOUS CONDITION BUT CANNOT FIND ANY DETAILS OR CONTACT INFORMATION IN MY OWN COUNTRY I WAS HOPING THAT THE AMERICAN FDA MAY HAVE SOME CURRENT INFORMATION TO GIVE ME|MOULDED TEARDROP BREAST IMPLANT||01/05/2015|||||*||0|FTR|2.0||MOULDED TEARDROP BREAST IMPLANT|||||||MENTOR|||||||True
4794812|17626734|D|1||HEALTHCARE PROFESSIONAL REPORTS ALCL CASE REPORT SEROMA ASSOCIATED PRIMARY ALCL OF THE RIGHT BREAST PATIENT WITH PERSONAL HISTORY OF RIGHT BREAST CANCER RIGHT MASTECTOMY AND IMMEDIATE RECONSTRUCTION WITH LATISSIMUS DORSI FLAP AND TEXTURED SILICONE PROSTHESIS VIA MW 5033512 ALCL HAS NOT BEEN CONFIRMED VIA PATHOLOGY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MX-410445|05/22/2015|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4672656|13207851|N|1||B4 THE EVENT OF ANAPLASTIC LARGE CELL LYMPHOMA WAS INITIALLY REPORTED VIA EASR ON B6 2010 WITH THE ADVERSE EVENT TERM CODE OF CANCER AN UPDATE TO OUR SAFETY DATABASE FOR THIS REPORTED EVENT NOTES THAT THE TERM CODE HAS BEEN CHANGED FROM CANCER TO LYMPHOMA-ALCL DUE TO INCREASED SPECIFICITY SEROMA WAS REPORTED AT THAT TIME ALSO DEVICE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS BASED ON INFO REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MANUFACTURERS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MUFTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL USE CARE IN SUBSEQUENT PROCEDURES SUCH AS OPEN CAPSULOTOMY BREAST POCKET REVISION HEMATOMASEROMA ASPIRATION AND BIOPSYLUMPECTOMY TO AVOID DAMAGE TO THE IMPLANT SHELL OR VALVE ANY POSTOPERATIVE EVACUATION OF HEMATOMA OR SEROMA MUST BE CONDUCTED WITH CARE TO AVOID BREAST IMPLANT CONTAMINATION OR DAMAGE FROM SHARP INSTRUMENTS THE USE OF MICROWAVE DIATHERMY IN PATIENTS WITH BREAST IMPLANTS IS NOT RECOMMENDED AS IT HAS BEEN REPORTED TO CAUSE TISSUE NECROSIS SKIN EROSION AND EXTRUSION OF THE IMPLANT ALLERGAN HAS NOT TESTED THE IN VIVO EFFECTS OF RADIATION THERAPY IN PATIENTS WHO HAVE BREAST IMPLANTS THE LITERATURE SUGGESTS THAT RADIATION THERAPY MAY INCREASE THE LIKELIHOOD OF CAPSULAR CONTRACTURE NECROSIS AND IMPLANT EXTRUSION PATIENTS SHOULD BE INFORMED THAT DISSATISFACTION WITH COSMETIC RESULTS RELATED TO SUCH THINGS AS SCAR DEFORMITY HYPERTROPHIC SCARRING CAPSULAR CONTRACTURE ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION INCORRECT SIZE AND IMPLANT PALPABILITYVISIBILITY MAY OCCUR CAREFUL SURGICAL PLANNING AND TECHNIQUE CAN MINIMIZE BUT NOT PRECLUDE THE RISK OF SUCH RESULTS PRE-EXISTING ASYMMETRY MAY NOT BE ENTIRELY CORRECTABLE REVISION SURGERY MAY BE INDICATED TO MAINTAIN PATIENT SATISFACTION BUT CARRIES ADDITIONAL CONSIDERATIONS AND RISKS RECONSTRUCTION MAIN REASONS FOR REOPERATION THROUGH 5 AND 10 YEARS IMPLANT MALPOSITION YEAR 5 RATE= 32 IMPLANT MALPOSITION YEAR 10 RATE= 38|STYLE 163 SALINE FILLED BREAST IMPLANT|163-530|04/08/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4720409|16988108|D|1||HEALTH PROFESSIONAL REPORTED LATE SEROMA - ASPIRATION WAS POSITIVE FOR ALCL SPECIFIED AS THE RIGHT SIDE CYTOLOGY CONFIRMS THE TUMOUR CELLS EXPRESS THE PAN LYMPHOID MARKER CD45 CD3 AND CD30 THERE ARE VERY FEW B CELLS EXPRESSING CD20 THERE IS NO STAINING WITH ALK1CONCLUSION MALIGNANT BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX130-450|04/21/2015|||DA|N|R||0HP|FTR|1.0|06/14/2015|nan||1850087|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4688919|5687161|D|1||REPORT OF AGGRESSIVE PRESENTATION OF BREAST IMPLANT ASSOCIATED ALK-1 NEGATIVE ALCL WITH BILATERAL AXILLARY LYMPH NODE INVOLVEMENT IN AN ARTICLE BY DR GOVIND BHAGAT REPRINTED IN INFORMA HEALTHCARE 2009 JOURNAL STATES FOLLOWING RECONSTRUCTION THE PT DEVELOPED RIGHT AXILLARY LYMPHADENOPATHY  RIGHT AXILLARY LN BIOPSY SHOWED A LARGE CELL NEOPLASM INFILTRATING AND EXPANDING THE SINUSES AN EXHAUSTIVE STAINING PANEL LED TO THE DIAGNOSIS OF AN ALK-1 NEGATIVE ALCL THE GROSSLY INTACT IMPLANT WAS REMOVED WITH CAPSULECTOMY RESULTS SHOW CD30+|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/13/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4688919|13145475|N|1||THE EVENT OF ANAPLASTIC LARGE CELL LYMPHOMA WAS INITIALLY REPORTED VIA EASR ON B6 2011 WITH THE ADVERSE EVENT TERM CODE OF CANCER AN UPDATE TO OUR SAFETY DATABASE FOR THIS REPORTED EVENT NOTES THAT THE TERM CODE HAS BEEN CHANGED TO LYMPHOMA - ALCL DUE TO INCREASED SPECIFICITY PATIENT IDENTIFIER B6 RELATES TO PATIENTS RECORD PREVIOUSLY EXISTING IN B6 DATABASE CURRENT DATABASE PATIENT IDENTIFIER IS PR B6 DEVICE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS THE NATRELLE CORE STUDY WILL CONTINUE TO EVALUATE THE LONG-TERM 10 YEARS SAFETY AND EFFECTIVENESS OF THESE PRODUCTS IN ADDITION ALLERGAN HAS INITIATED A SEPARATE LARGE 10-YEAR POST-APPROVAL STUDY THE BREAST IMPLANT FOLLOW-UP STUDIES OR BIFS TO ADDRESS SPECIFIC ISSUES WHICH ALLERGANS CORE STUDY WAS NOT DESIGNED TO FULLY ANSWER AS WELL AS TO PROVIDE A REAL-WORLD ASSESSMENT OF SOME ENDPOINTS THE ENDPOINTS IN THE BIFS LARGE POST-APPROVAL STUDY INCLUDE LONG-TERM LOCAL COMPLICATIONS CONNECTIVE TISSUE DISEASE CTD CTD SIGNS AND SYMPTOMS NEUROLOGICAL DISEASE NEUROLOGICAL SIGNS AND SYMPTOMS OFFSPRING ISSUES REPRODUCTIVE ISSUES LACTATION ISSUES CANCER SUICIDE MAMMOGRAPHY ISSUES AND MRI COMPLIANCE AND RESULTS ALLERGAN WILL UPDATE THEIR LABELING ON A REGULAR BASIS WITH THE RESULTS OF THESE TWO STUDIES THERE WAS 1 PRIMARY AUGMENTATION PATIENT WITH A NEW DIAGNOSIS OF BREAST CANCER THROUGH 7 YEARS IN THE CORE STUDY THERE WAS A 13 BENIGN BREAST DISEASE RATE AND A 1 MALIGNANT BREAST DISEASE RATE FOR REVISION-AUGMENTATION PATIENTS THERE WAS 1 PATIENT WITH A NEW DIAGNOSIS OF BREAST CANCER THERE WAS A 15 BENIGN BREAST DISEASE RATE AND A 1 MALIGNANT BREAST DISEASE RATE THROUGH 7 YEARS IN PRIMARY AUGMENTATION PATIENTS THERE WAS 1 REPORT OF THYROID CANCER AND 1 REPORT OF BRAIN CANCER THERE WERE NO REPORTS OF OTHER CANCERS SUCH AS RESPIRATORY OR CERVICALVULVAR IN REVISION-AUGMENTATION PATIENTS THERE WERE 8 PRIMARY RECONSTRUCTION PATIENTS 8 WITH NEW REPORTS OF BREAST CANCER THROUGH 7 YEARS IN THE CORE STUDY THERE WAS A 17 BENIGN BREAST DISEASE RATE AND A 10 MALIGNANT BREAST DISEASE RATE THROUGH 7 YEARS FOR REVISION RECONSTRUCTION PATIENTS THERE WERE NO REPORTS OF NEW DIAGNOSES OR REOCCURRENCE OF BREAST CANCER THERE WAS A 7 BENIGN BREAST DISEASE RATE THROUGH 7 YEARS THERE WERE NO REPORTS OF OTHER CANCERS SUCH AS BRAIN RESPIRATORY OR CERVICALVULVAR IN PRIMARY RECONSTRUCTION OR REVISION-RECONSTRUCTION PATIENTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/13/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4730396|17824636|N|1||THE EVENT OF ANAPLASTIC LARGE CELL LYMPHOMA WAS INITIALLY REPORTED VIA EASR ON JULY 28 2010 WITH THE ADVERSE EVENT TERM CODE OF CANCER AN UPDATE TO OUR SAFETY DATABASE FOR THIS REPORTED EVENT NOTES THAT THE TERM CODE HAS BEEN CHANGED FROM CANCER TO LYMPHOMA - ALCL DUE TO INCREASED SPECIFICITY B6|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/24/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|LA AURORA DE HEREDIA|||CS|ALLERGAN|||||||True
5092043|26351217|N|1||DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/21/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5092043|26351218|D|1||EXPLANTING PHYSICIAN REPORTED CAPSULE CONFINED ALCL SPECIFIED AS RIGHT SIDE DEVICE HAS BEEN EXPLANTED NO POSTOPERATIVE COMPLICATIONS EVENT CAPTURED AS LYMPHOMA UNTIL PATHOLOGICAL MARKERS TO CONFIRM ALCL ARE RECEIVED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/21/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5029322|24060408|D|1||THE PATIENT CAME WITH A SKIN LESION ON THE CHEST AFTER BILATERAL BREAST RECONSTRUCTION AFTER MASTECTOMY WITH IMPLANTS 13 YEARS AGO A BIOPSY ON THE LESION CAME BACK AS ALCL I REMOVED THE IMPLANTS AND CAPSULES AND SENT FLUID FOR CYTOLOGY THE R BREAST WAS FILLED WITH A THICK RED COLOREDBROWN COLORED FLUID THE IMPLANTS WERE ALLERGAN 410 SHAPED SILICONE IMPLANTS BIOPSY PROVEN ALCL IN SKIN LESION BREAST CANCER AND TISSUE EXPANDERIMPLANT RECONSTRUCTION DATES OF USE 13 YEARS REASON FOR USE BREAST RECONSTRUCTION|410 SHAPED SILICONE IMPLANT||08/19/2015||||Y|*||0HP|FTR|1.0||ALLERGAN 410 SHAPED SILICONE IMPLANT|||||IRVINE|US|ALLERGAN|92623|CA|92623||410 SHAPED IMPLANT||True
4739847|20018445|D|1||PHYSICIAN REPORTS LEFT SIDE DEVICE REMOVAL AND REPLACEMENT OF PT WITH HISTORY OF BREAST CANCER DUE TO SEROMA AND AS CONFIRMED BY HISTOLOGY ALCL ANAPLASTIC LARGE CELL LYMPHOMA ALCL HAS NOT BEEN CONFIRMED AS TEST RESULTS HAVE NEITHER BEEN PROVIDED OR REPORTED THIS EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL TEST RESULTS ARE RECEIVED|UK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/29/2015|||DA|N|R||0HP|FWM|1.0||nan|||||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4541872|16628904|D|1||THE PT IS A B6 FEMALE WITH A HISTORY OF DCIS OF THE LEFT BREAST DIAGNOSED IN 1989 SHE UNDERWENT LUMPECTOMY AND RADIATION THERAPY SHE WAS FOUND TO HAVE RECURRENCE IN 2006 AT THAT TIME SHE UNDERWENT LEFT MASTECTOMY AND SENTINEL LYMPH NODE BIOPSY IN 2006 WITH NO RECONSTRUCTION IN B6 2007 SHE UNDERWENT DELAYED PLACEMENT OF A MENTOR TEXTURED SILTEXT MEDIUM HEIGHT TISSUE EXPANDER REFERENCE 3584-6215 LOT 5725412 SERIAL NUMBER B4 650CC VOLUME INTRAOPERATIVE FILL 180CC SALINE AND LATISSIMUS DORSI FLAP TO THE LEFT SIDE SHE UNDERWENT TISSUE EXPANSION AND SUBSEQUENTLY IN B6 2007 UNDERWENT EXCHANGE OF THE TISSUE EXPANDER FOR A PERMANENT SILICONE TEXTURED MENTOR CPG IMPLANT CONCURRENTLY SHE UNDERWENT RIGHT MASTOPEXY AND AUGMENTATION OF SYMMETRY THE PTS RECORDS FROM DR B6 WERE REVIEWED AND THE PT HAD A MENTOR CPG 323 SILICONE GEL IMPLANT 685 CC ON THE LEFT REF 334-1452G AND MENTOR CPG 323 GEL IMPLANT SIZE 350CC ON THE RIGHT REF 350-3501BC IN B6 2014 SHE NOTICED THAT HER LEFT BREAST WAS SUDDENLY OVER 1-2 WEEKS LARGER THAN THE RIGHT THE FLUID COLLECTION WAS FOUND ON PHYSICAL EXAM SHE UNDERWENT ASPIRATION OF THE FLUID COLLECTION WHICH TOTALED 400 CUBIC CENTIMETERS AND WAS CLEAR YELLOW IN OUTPUT WAS SENT TO PATHOLOGY AND DEMONSTRATED CD30 POSITIVE ALK NEGATIVE ANAPLASTIC LARGE-CELL LYMPHOMA ALCL CONSISTENT WITH BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ON B6 2014 SHE UNDERWENT BILATERAL BREAST EXPLANTATION WAS WELL AS BILATERAL TOTAL CAPSULECTOMIES WITH EXTENSIVE CAPSULECTOMY ON THE LEFT SIDE MARGINS WERE NEGATIVE PER THE PTS REPORT THERE WAS NO SUSPICIOUS LYMPHADENOPATHY THIS WAS DONE BY B6 WHO ALSO DID THE PTS BREAST RECONSTRUCTION THERE WAS NO MASS ONLY ALCL LOCATED WITHIN THE IMPLANT CAPSULE THE PTS SURGICAL ONCOLOGIST WAS DR B6 THE PT HAS BEEN SEEN BY THE LYMPHOMA SERVICE AND PLASTIC SURGERY AT B4 FOR SURVEILLANCE AND RECONSTRUCTION|CPG MEMORY SHAPE GEL BREAST IMPLANT|334-1452G|02/19/2015|||DA|N|R||0HP|FTR|1.0||BREAST IMPLANT||5719721|||IRVING|US|MENTOR||TX|||||True
6177062|62452555|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL SEROMA BREAST LUMPS AND ERYTHEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR AS A NORMAL RESPONSE TO EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6177062|62452556|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 OLD PATIENT WHO WAS IMPLANTED WITH A LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN THE ARTICLE ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED MASS SEROMA AND ERYTHEMATOUS SKIN ERUPTION  TREATMENT REPORTED AS IMPLANT REMOVAL AND CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE AND PREDNISONE 6 CURES CHOP OR CHOP-LIKE FOLLOW-UP FOUND NO EVIDENCE OF DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5445101|38528419|D|1||I HAD MCGHAN STYLE 120 TEXTURED IMPLANTS BY MCGHAN - NOW ALLERGAN INSERTED BILATERALLY ON B6 2004 ON B6 I HAD EXCESS FLUID IN THE RIGHT BREAST AND HAD THIS DRAINED IT WAS TESTED AND WAS NOT CANCEROUS I BECAME SICK AGAIN IN B6 2015 AND HAD MANY BLOOD TESTS BY B6 2015 MY RIGHT BREAST WAS SWOLLEN AGAIN ON B6 2015 I WAS TOLD I HAD ALCL OF THE RIGHT BREAST FROM THE FLUID ON B6 I HAD BOTH IMPLANTS REMOVED WITH CAPSULES AND SCAR TISSUE REMOVED THEY HOPE THAT BY REMOVAL MY LYMPHOMA SHOULD CLEAR FURTHER TESTING OF B  T CELLS CONFIRMED A T CELL LYMPHOPROLIFERATIVE DISORDER I WILL CONTINUE TO BE MONITORED FOR THE NEXT FEW YEARS|MCGHAN STYLE 120 GEL, HIGH ROUND TEXTURED||02/12/2016||||*|*||0LP|FTR|1.0||MCGHAN STYLE 120 GEL, HIGH ROUND TEXTURED|||||||ALLERGAN (INAMED CORP)|||||STYLE 120|27-120301|True
6145451|61448261|D|1||PHYSICIAN REPORTED A PATIENT WITH A LATE SEROMA ON THE RIGHT SIDE CYTOLOGICAL EXAMINATION RESULTED IN ALCL DIAGNOSIS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM120-280|12/05/2016||||N|R||0HP|FTR|1.0|06/13/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1287540|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145451|61448260|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED FOR DEVICE RETURN IF DEVICE IS RETURNED ANALYSIS WILL BE PERFORMED AND RESULTS REPORTED IN A SUPPLEMENTAL REPORT THE EVENTS OF LATE SEROMA AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE HISTORY RECORD DHR WAS PERFORMED AND DID NOT IDENTIFY ANY DEVIATIONS ERRORS OR OMISSIONS DURING MANUFACTURING PROCESS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM THIS WORK ORDER WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM120-280|12/05/2016||||N|R||0HP|FTR|1.0|06/13/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1287540|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145512|63919661|D|1||RECEIVED ADDITIONAL INFORMATION FROM PHYSICIAN REPORTING IN IMMUNOHISTOCHEMISTRY THESE TUMOR CELLS WHICH ARE STRICTLY LIMITED IN THE FIBRIN COATING ARE CD30+ AND ALK- THIS EVENT HAS BEEN CONFIRMED AS ALCL DIAGNOSIS OF ALCL OCCURRED ON B6 2016 PHYSICIAN ADDITIONALLY REPORTED INFLAMMATORY DERMAL CONNECTIVE TISSUE IN THE RIGHT SIDE RIGHT SIDE PAIN AND CAPSULAR CONTRACTURE BAKER GRADE II THIS MEDWATCH IS FOR THE RIGHT SIDE DEVICE SEE MANUFACTURER REPORT  9617229-2016-00173 FOR LEFT SIDE REPORT|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/03/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013309|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145512|63919660|N|1||B4 DEVICE WAS ANALYZED AT ALLERGAN B4 VISUAL ANALYSIS OF THE RETURNED DEVICE IDENTIFIED BROWN PARTICLES DELAMINATION OF THE PLUG STRAP LEAK TEST WAS PERFORMED AND NOT FOUND LEAKAGE A MICROSCOPIC ANALYSIS WAS PERFORMED WHICH IDENTIFY DELAMINATION OF THE PLUG STRAP DISK SHELL THE FILL TEST INSPECTION WAS PERFORMED THE RESULT IS NO BLOCKAGE BASED ON THE DEVICE ANALYSIS THE FINAL ASSESSMENT IS DELAMINATION OF THE PLUG STRAP DISK SHELL ASSESSED AS ADHESIVE FAILURE DEVICE HISTORY RECORD DHR DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM THIS WORK ORDER WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS THE EVENTS OF LYMPHOMA-ALCL CAPSULAR CONTRACTURE INFLAMMATION AND PAIN ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST FORMATION OF FIBROUS TISSUE AROUND AN IMPLANTED DEVICE IS A NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS A COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY AND IS ONE OF THE MOST COMMON REASONS FOR REOPERATION THE CAUSE OF CAPSULAR CONTRACTURE IS UNKNOWN HOWEVER IT IS MOST LIKELY MULTIFACTORIAL AND MAY BE MORE COMMON FOLLOWING INFECTION HAEMATOMA AND SEROMA CONTRACTURE DEVELOPS TO VARYING DEGREES UNILATERALLY OR BILATERALLY AND MAY OCCUR WITHIN WEEKS TO YEARS AFTER SURGERY CONTRACTURE OF THE FIBROUS CAPSULAR TISSUE SURROUNDING THE IMPLANT MAY CAUSE A RANGE OF SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES ARE CONSIDERED THE MOST CLINICALLY SIGNIFICANT AND MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT TO CORRECTIVE SURGICAL PROCEDURES DO NOT TREAT CAPSULAR CONTRACTURE BY EXTERNAL COMPRESSION OR MASSAGE WHICH MAY RESULT IN IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA Â¿AS EXPECTED FOLLOWING ANY INVASIVE SURGICAL PROCEDURE PAIN OF VARYING INTENSITY AND DURATION MAY OCCUR FOLLOWING IMPLANTATION IN ADDITION IMPROPER PLACEMENT SURGICAL TECHNIQUE OR CAPSULAR CONTRACTURE MAY RESULT IN PAIN ASSOCIATED WITH NERVE ENTRAPMENT OR INTERFERENCE WITH MUSCLE MOTION UNEXPLAINED PAIN MUST BE PROMPTLY INVESTIGATEDÂ¿|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/03/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013309|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145512|61450145|N|1||THE DEVICE IS CURRENTLY BEING RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LATE SEROMA AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/03/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013309|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5691027|51422386|D|1||PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410215|06/01/2016|||DA|N|R||0HP|FTR|1.0|06/02/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1620541|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5691027|46273891|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE REMOVAL AND REPLACEMENT DUE TO LATE SEROMA COMPANY REPRESENTATIVE REPORTED ON BEHALF OF PHYSICIAN SENT SEROMA FLUID AND CAPSULE TISSUE TO PATHOLOGY TO TEST FOR ALCL AND THE DOCTOR REPORTED THE TEST CAME BACK POSITIVE COMPANY REPRESENTATIVE ADDITIONALLY REPORTED ON BEHALF OF PHYSICIAN DISEASE SHOWED ON PATHOLOGY IN SEROMA FLUID AND IN CAPSULE PARTIAL CAPSULECTOMY WAS DONE INTRAOP AND IMPLANT WAS REPLACED PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT YET BEEN RECEIVED EVENT WILL BE CAPTURED AS LYMPHOMA AT THIS TIME|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410215|06/01/2016|||DA|N|R||0HP|FTR|1.0|06/02/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1620541|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5691027|46273890|N|1||MEDWATCH SENT TO FDA ON 06012016 THE EVENTS OF SEROMA AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE WILL NOT BE RETURNED AND IS THEREFORE UNAVAILABLE FOR ANALYSIS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410215|06/01/2016|||DA|N|R||0HP|FTR|1.0|06/02/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1620541|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5644586|48310176|D|1||HEALTH PROFESSIONAL REPORTED ONE OF THE ALCL PATIENTS HAD FURTHER SURGERY TO REMOVE THEIR REPLACEMENT IMPLANT AND THE NEW CAPSULE THUS HAS COME BACK POSITIVE FOR ALCL SPECIFIED AS RIGHT SIDE THIS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSF365|05/10/2016||04/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2740658|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5644586|44853450|D|1||HEALTH PROFESSIONAL REPORTED ONE OF THE ALCL PATIENTS HAD FURTHER SURGERY TO REMOVE THEIR REPLACEMENT IMPLANT AND THE NEW CAPSULE THUS HAS COME BACK POSITIVE FOR ALCL SPECIFIED AS RIGHT SIDE THIS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSF365|05/10/2016||04/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2740658|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5644586|47903123|D|1||HEALTH PROFESSIONAL REPORTED ONE OF THE ALCL PATIENTS HAD FURTHER SURGERY TO REMOVE THEIR REPLACEMENT IMPLANT AND THE NEW CAPSULE THUS HAS COME BACK POSITIVE FOR ALCL SPECIFIED AS RIGHT SIDE THIS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSF365|05/10/2016||04/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2740658|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5644586|44853449|N|1||MEDWATCH SENT TO FDA ON 05102016 THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE OF THE EVENT DEVICE HAS NOT YET BEEN RECEIVED DEVICE HISTORY RECORD REVIEWED RESULTS STATE REVIEW OF DHR FOR B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT FROM SAP WAS VERIFIED AND THERE WAS NOT ANY SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS IN ADDITION DHR FOR SHELL RUN NUMBER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING SHELL FABRICATION PROCESS ALL SHELLS WERE REVIEWED AS PART OF THE SHELL FABRICATION OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT FABRICATION MET THE REQUIRED SPECIFICATIONS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL Â¿ INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF THE REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSF365|05/10/2016||04/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2740658|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6177002|62447627|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 PATIENT WHO WAS IMPLANTED WITH A RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN THE ARTICLE ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED SEROMA AND Â¿DISRUPTED IMPLANTÂ¿ TREATMENT REPORTED AS IMPLANT REMOVAL AND CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE AND PREDNISONE 6 CURES CHOP OR CHOP-LIKE FOLLOW-UP FOUND Â¿NO EVIDENCE OF DISEASEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6177002|62447626|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5415036|38228122|N|1||IDEAL IMPLANT DID NOT SUBMIT THIS WITHIN 30 DAYS OF BECOMING AWARE OF THE INCIDENT FOR THE FOLLOWING REASONS PER THE FDA REGULATIONS FOR REPORTABLE EVENTS A SERIOUS INJURY IS ONE THAT 1 IS LIFE THREATENING 2 RESULTS IN PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE OR 3 NECESSITATES MEDICAL OR SURGICAL INTERVENTION TO PRECLUDE PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE PER THE DEFINITION NOTED ABOVE IDEAL IMPLANT INCORPORATED UNDERSTOOD THAT A COMMON SALINE BREAST IMPLANT DEFLATION WOULD NOT FALL WITHIN THE DEFINITION OF SERIOUS INJURY AND WOULD THEREFORE NOT BE CONSIDERED REPORTABLE ALTHOUGH SURGICAL INTERVENTION MAY BE PERFORMED TO REMOVE ANDOR REPLACE THE BREAST IMPLANT IT IS NOT MEDICALLY REQUIRED TO PRECLUDE PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE IMPLANTS ARE FILLED WITH NORMAL SALINE WHICH IS HARMLESSLY ABSORBED BY THE BODY A DEFLATION POSES MINIMAL RISK TO THE PATIENT AND IS NOT CONSIDERED SERIOUS IN THE ABSENCE OF AN ADDITIONAL SERIOUS CONDITION SUCH AS EXTRUSION TISSUE NECROSIS SEPSIS LYMPHOMA ALCL NEUROLOGIC PROBLEM BREAST MASS POSSIBLE AFFECT ON FETUS ETC BECAUSE A DEFLATION ABSENT OF AN ADDITIONAL SERIOUS PATIENT CONDITION DOES NOT POSE RISK TO THE PATIENT OF DEATH OR SERIOUS INJURY IDEAL IMPLANT DID NOT CONSIDER DEFLATION OR SURGERY TO REMOVE A DEFLATED IMPLANT TO BE A SURGICAL INTERVENTION TO PRECLUDE PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE A DEFLATION OR OTHER TYPE OF DEVICE MALFUNCTION IN WHICH A SERIOUS INJURY SERIOUS CONDITION OR DEATH IS REPORTED AS A CONSEQUENCE WOULD BE CONSIDERED REPORTABLE HOWEVER DURING A RECENT FDA INSPECTION PERFORMED B6 2016 AN OBSERVATION WAS MADE THAT THIS DEFLATION SHOULD HAVE BEEN REPORTED TO THE FDA UPON LEARNING THAT FDA CONSIDERS ANY DEFLATION THAT WAS EXPLANTED TO BE REPORTABLE IDEAL IMPLANT BEGAN SUBMITTING REPORTS FOR PAST DEFLATIONS AND WILL CONTINUE TO REPORT ALL INSTANCES OF EXPLANTED DEFLATIONS IN THE FUTURE|IDEAL IMPLANT STRUCTURED BREAST IMPLANT|370|02/06/2016||11/30/2015||R|Y||0HP|FWM|1.0||SALINE-FILLED BREAST IMPLANT||61048|5005 LYNDON B JOHNSON FREEWAY|SUITE 900|DALLAS|US|IDEAL IMPLANT|75244|TX|75244||37001||True
5488699|39950189|D|1||COMPANY REPRESENTATIVE REPORTED REMOVAL OF AN ALLERGAN TEXTURED ROUND IMPLANT SIDE UNKNOWN DUE TO ALCL FOLLOW-UP WITH HEALTH PROFESSIONAL CONFIRMED A RIGHT SIDE ALCL DIAGNOSIS STAINS FOR CD30 ARE STRONGLY POSITIVE WITHIN ABNORMAL CELLS WHILE STAIN FOR ALK IS NEGATIVE ADDITIONAL INFORMATION NOTED THE PATIENT RECENTLY HAD SOME CHANGES IN THE APPEARANCE AND CONTOUR OF THE BREAST AREAIS PLANNING TO UNDER MRI FOR EVALUATION OF THE PATIENTS RATHER CYSTIC BREAST DISEASE PATIENT HAS AN ENCAPSULATED IMPLANT ON THE RIGHT SIDE WHICH IS HIGHER THAN THE CONTRALATERAL LEFT SIDE AND APPEARS TO A BIT MORE ANTERIOR OPERATIVE REPORT STATED THERE WAS SIGNIFICANT ADHESION TO THE CHEST WALL THERE WAS PRESENCE OF CAPSULAR CONTRACTURE BAKER GRADE NOT SPECIFIED TREATMENT INCLUDED REMOVAL OF IMPLANT AND CAPSULE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|03/09/2016|||DA|N|R||0HP|FWM|1.0|04/12/2008|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||621428|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5488699|39950188|N|1||MEDWATCH SUBMITTED ON 03092016 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|03/09/2016|||DA|N|R||0HP|FWM|1.0|04/12/2008|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||621428|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5488699|41343378|D|1||COMPANY REPRESENTATIVE REPORTED REMOVAL OF AN ALLERGAN TEXTURED ROUND IMPLANT SIDE UNKNOWN DUE TO ALCL FOLLOW-UP WITH HEALTH PROFESSIONAL CONFIRMED A RIGHT SIDE ALCL DIAGNOSIS STAINS FOR CD30 ARE STRONGLY POSITIVE WITHIN ABNORMAL CELLS WHILE STAIN FOR ALK IS NEGATIVE ADDITIONAL INFORMATION NOTED THE PATIENT RECENTLY HAD SOME CHANGES IN THE APPEARANCE AND CONTOUR OF THE BREAST AREA IS PLANNING TO UNDER MRI FOR EVALUATION OF THE PATIENTS RATHER CYSTIC BREAST DISEASE PATIENT HAS AN ENCAPSULATED IMPLANT ON THE RIGHT SIDE WHICH IS HIGHER THAN THE CONTRALATERAL LEFT SIDE AND APPEARS TO A BIT MORE ANTERIOR OPERATIVE REPORT STATED THERE WAS SIGNIFICANT ADHESION TO THE CHEST WALL HERE WAS PRESENCE OF CAPSULAR CONTRACTURE BAKER GRADE NOT SPECIFIED TREATMENT INCLUDED REMOVAL OF IMPLANT AND CAPSULE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|03/09/2016|||DA|N|R||0HP|FWM|1.0|04/12/2008|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||621428|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5597717|43315362|N|1||MEDWATCH SUBMITTED TO THE FDA ON 04222016 B4  THE DEVICE WILL NOT BE RETURNED THESE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLY CAUSE FOR THIS EVENT DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|07/12/2001|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||530498|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5597717|49979645|D|1||COMPANY REPRESENTATIVE REPORTED ON BEHALF OF A HEALTH PROFESSIONAL A CASE OF ALCL PATIENT INITIALLY PRESENTED WITH A SEROMA AND WAS SIGNIFICANTLY SWOLLEN HEALTH PROFESSIONAL SUGGESTED REMOVAL AND CAPSULECTOMY HOWEVER THE PATIENT CHOSE NOT TO MOVE FORWARD WITH SURGERY PATIENT PASSED AWAY FURTHER FOLLOW-UP WITH HEALTH PROFESSIONAL REPORTED RIGHT SIDE CAPSULAR CONTRACTURE BAKER GRADE III THICKENING OF THE CAPSULE CAPSULITIS PATHOLOGY NOTES THE SPECIMENS AS LEFT AXILLARY LYMPH NODES BIOPSY AND RIGHT PECTORALIS MUSCLE BIOPSY PATIENT HAS ENLARGED LEFT AXILLARY LYMPH NODES PATHOLOGY NOTES BOTH SPECIMENS ARE ALK NEGATIVE AND WEAKLY POSITIVE FOR CD30 MICROSCOPIC DESCRIPTION NOTES NECROTIC DEBRIS IN REGARD TO THE LYMPH NODE BIOPSY AND THE MUSCLE BIOPSY ADDITIONAL PATHOLOGY RESULTS PROVIDED FOR RIGHT AXILLA SKIN BIOPSY AND RIGHT THORACENTESIS 50 ML OF CLEAR YELLOW FLUID FINDINGS INDICATE LYMPHOMA ALCL DIAGNOSIS HAS BEEN CONFIRMED VIA PATHOLOGY PATIENT WAS TREATED WITH CHEMOTHERAPY THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2016-00033 FOR THE LEFT SIDE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|07/12/2001|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||530498|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5597717|43315363|D|1||COMPANY REPRESENTATIVE REPORTED ON BEHALF OF A HEALTH PROFESSIONAL A CASE OF ALCL PATIENT INITIALLY PRESENTED WITH A SEROMA AND WAS SIGNIFICANTLY SWOLLEN HEALTH PROFESSIONAL SUGGESTED REMOVAL AND CAPSULECTOMY HOWEVER THE PATIENT CHOSE NOT TO MOVE FORWARD WITH SURGERY PATIENT PASSED AWAY FURTHER FOLLOW-UP WITH HEALTH PROFESSIONAL REPORTED RIGHT SIDE CAPSULAR CONTRACTURE BAKER GRADE III THICKENING OF THE CAPSULE CAPSULITIS PATHOLOGY NOTES THE SPECIMENS AS Â¿LEFT AXILLARY LYMPH NODES BIOPSYÂ¿ AND Â¿RIGHT PECTORALIS MUSCLE BIOPSYÂ¿ PATIENT HAS Â¿ENLARGED LEFT AXILLARY LYMPH NODESÂ¿ PATHOLOGY NOTES BOTH SPECIMENS ARE Â¿ALK NEGATIVEÂ¿ AND Â¿WEAKLY POSITIVE FOR CD30Â¿ MICROSCOPIC DESCRIPTION NOTES Â¿NECROTIC DEBRISÂ¿ IN REGARD TO THE LYMPH NODE BIOPSY AND THE MUSCLE BIOPSY ADDITIONAL PATHOLOGY RESULTS PROVIDED FOR Â¿RIGHT AXILLA SKIN BIOPSYÂ¿ AND Â¿RIGHT THORACENTESIS 50 ML OF CLEAR YELLOW FLUIDÂ¿ FINDINGS INDICATE LYMPHOMA ALCL DIAGNOSIS HAS BEEN CONFIRMED VIA PATHOLOGY PATIENT WAS TREATED WITH CHEMOTHERAPY THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2016-00033 FOR THE LEFT SIDE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|07/12/2001|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||530498|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5597737|43319693|N|1||MEDWATCH SUBMITTED TO THE FDA ON 04222016 B4 THE DEVICE WILL NOT BE RETURNED THESE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLY CAUSE FOR THIS EVENT DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|01/20/2002|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||533743|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5597737|49978503|D|1||COMPANY REPRESENTATIVE REPORTED ON BEHALF OF A HEALTH PROFESSIONAL PATIENT PASSED AWAY FURTHER FOLLOW-UP WITH HEALTH PROFESSIONAL REPORTED LEFT SIDE CAPSULAR CONTRACTURE BAKER GRADE IV PATHOLOGY NOTES THE SPECIMENS AS LEFT AXILLARY LYMPH NODES BIOPSY AND RIGHT PECTORALIS MUSCLE BIOPSY PATIENT HAS ENLARGED LEFT AXILLARY LYMPH NODES PATHOLOGY NOTES BOTH SPECIMENS ARE ALK NEGATIVE AND WEAKLY POSITIVE FOR CD30 MICROSCOPIC DESCRIPTION NOTES NECROTIC DEBRIS IN REGARD TO THE LYMPH NODE BIOPSY AND THE MUSCLE BIOPSY ADDITIONAL PATHOLOGY RESULTS PROVIDED FOR RIGHT AXILLA SKIN BIOPSY AND RIGHT THORACENTESIS 50 ML OF CLEAR YELLOW FLUID FINDINGS INDICATE LYMPHOMA ALCL DIAGNOSIS HAS BEEN CONFIRMED VIA PATHOLOGY ALCL HAS BEEN CAPTURED BILATERALLY AS THIS CASE APPEARS TO BE SYSTEMIC PATIENT WAS TREATED WITH CHEMOTHERAPY THIS MEDWATCH REPRESENTS THE LEFT SIDE SEE MFR  9617229-2016-00031 FOR THE RIGHT SIDE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|01/20/2002|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||533743|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5597737|43319694|D|1||COMPANY REPRESENTATIVE REPORTED ON BEHALF OF A HEALTH PROFESSIONAL PATIENT PASSED AWAY FURTHER FOLLOW-UP WITH HEALTH PROFESSIONAL REPORTED LEFT SIDE CAPSULAR CONTRACTURE BAKER GRADE IV PATHOLOGY NOTES THE SPECIMENS AS Â¿LEFT AXILLARY LYMPH NODES BIOPSYÂ¿ AND Â¿RIGHT PECTORALIS MUSCLE BIOPSYÂ¿ PATIENT HAS Â¿ENLARGED LEFT AXILLARY LYMPH NODESÂ¿ PATHOLOGY NOTES BOTH SPECIMENS ARE Â¿ALK NEGATIVEÂ¿ AND Â¿WEAKLY POSITIVE FOR CD30Â¿ MICROSCOPIC DESCRIPTION NOTES Â¿NECROTIC DEBRISÂ¿ IN REGARD TO THE LYMPH NODE BIOPSY AND THE MUSCLE BIOPSY ADDITIONAL PATHOLOGY RESULTS PROVIDED FOR Â¿RIGHT AXILLA SKIN BIOPSYÂ¿ AND Â¿RIGHT THORACENTESIS 50 ML OF CLEAR YELLOW FLUIDÂ¿ FINDINGS INDICATE LYMPHOMA ALCL DIAGNOSIS HAS BEEN CONFIRMED VIA PATHOLOGY ALCL HAS BEEN CAPTURED BILATERALLY AS THIS CASE APPEARS TO BE SYSTEMIC PATIENT WAS TREATED WITH CHEMOTHERAPY THIS MEDWATCH REPRESENTS THE LEFT SIDE SEE MFR  9617229-2016-00031 FOR THE RIGHT SIDE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|01/20/2002|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||533743|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6037732|57779754|D|1||ALLERGAN PRODUCT SURVEILLANCE RECEIVED A REPORT FROM THE THERAPEUTIC GOODS ADMINISTRATION TGA TGA REPORTED SWELLING OF BREAST AND LYMPHOMA ALCL SIDE UNKNOWN DEVICE HAS BEEN EXPLANTED AND A CAPSULECTOMY WAS PERFORMED PATIENT IS CURRENTLY RECEIVING CHEMOTHERAPY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/18/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6037732|57779753|N|1||THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/18/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5922918|58726651|D|1||ADDITIONAL INFORMATION HEALTHCARE PROFESSIONAL REPORTED PATIENT WAS IMPLANTED ON THE LEFT SIDE IN 1998 WITH A SALINE TEXTURED MCGHAN DEVICE NO SERIAL NUMBER AVAILABLE IN B6 OF 2016 PATIENT PRESENTED WITH Â¿RAPID SWELLING IN LEFT BREASTÂ¿ Â¿PERI-IMPLANT SEROMAÂ¿ AND SEVERE CAPSULAR CONTRACTURE BAKER GRADE III PATHOLOGY REPORT NOTES Â¿CHRONIC INFLAMMATIONÂ¿ Â¿NECROTIC TISSUE FRAGMENTSÂ¿ AND Â¿RED-BROWN MURKY FLUIDÂ¿ THE PATIENT RECEIVED ALCL DIAGNOSIS ON B6 2016 PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL HAVE BEEN RECEIVED THE DEVICE WAS EXPLANTED AND A CAPSULECTOMY WAS PERFORMED PETMRI HAS NOT BEEN PERFORMED DUE TO PATIENT ANXIETY THE EXPLANTED DEVICE WILL NOT BE RETURNED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|09/01/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5922918|53782148|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING PATIENT INFORMATION DEVICE INFORMATION SIDE EXPERIENCING POSSIBLE ALCL PATHOLOGY REPORT AND DEVICE RETURN HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|09/01/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5922918|53782149|D|1||HEALTHCARE PROFESSIONAL REPORTED A PATIENT THAT HAS ANAPLASTIC LARGE CELL LYMPHOMA ALCL EXPLANT SURGERY OCCURRED 3 WEEKS AGO PATHOLOGICAL MARKERS HAS NOT BEEN RECEIVED CONFIRMING ALCL THE EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL MARKERS ARE RECEIVED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|09/01/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5896408|52758840|N|1||MEDWATCH SENT TO FDA ON 08232016 DEVICE HAS BEEN RETURNED DEVICE ANALYSIS IS NOT COMPLETE FINDINGS WILL BE SENT IN FOLLOW-UP REPORT THE EVENTS OF INFLAMMATION LYMPHOMA AND SWELLING ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING PRODUCT INFORMATION HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES THE REPORTED EVENTS AS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|08/23/2016||08/23/2016|DA|R|Y||0HP|FTR|1.0|02/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||384466|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6106201|65086177|D|1||PHYSICIAN REPORTS PATIENT WITH SWELLING IN LEFT BREAST LEFT SIDE SEROMA FLUID AND CD30+ LYMPHOMA TREATED AS BIA-ALCL TOTAL CAPSULECTOMY AND EXPLANT REPORTED AT THIS TIME ALCL HAS NOT BEEN CONFIRMED BY THE PATHOLOGICAL MARKER ALK- UNTIL ALLERGAN RECEIVES CONFIRMATION OF THE MARKERS THIS WILL BE TERM CODED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|11/16/2016||12/14/2016|DA|R|Y||0HP|FTR|1.0|07/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||225212|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6106201|60020511|D|1||PHYSICIAN REPORTS PATIENT WITH SWELLING IN LEFT BREAST LEFT SIDE SEROMA FLUID AND CD30+ LYMPHOMA TREATED AS BIA-ALCL TOTAL CAPSULECTOMY AND EXPLANT REPORTED AT THIS TIME ALCL HAS NOT BEEN CONFIRMED BY THE PATHOLOGICAL MARKER ALK- UNTIL ALLERGAN RECEIVES CONFIRMATION OF THE MARKERS THIS WILL BE TERM CODED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|11/16/2016||12/14/2016|DA|R|Y||0HP|FTR|1.0|07/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||225212|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6106201|60020510|N|1||FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RECEIVED LAB ANALYSIS WILL BE PERFORMED AND THE RESULTS WILL BE REPORTED IN A SUPPLEMENTAL REPORT THE EVENTS OF SEROMA AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING ADDRESSES THE REPORTED EVENTS AS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION DEVICE HISTORY RECORD DHR REVIEW SUMMARY REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS IN ADDITION DHR FOR SHELL RUN NUMBER 8070302 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING SHELL FABRICATION PROCESS ALL SHELLS WERE REVIEWED AS PART OF THE SHELL FABRICATION OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT FABRICATION MET THE REQUIRED SPECIFICATIONS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|11/16/2016||12/14/2016|DA|R|Y||0HP|FTR|1.0|07/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||225212|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
5708570|46882993|N|1||MEDWATCH SENT TO FDA ON 06092016 IN RESPONSE TO FDA REPORT NUMBER MW5061580 B4 THESE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE SERIALLOT NUMBER AND PATIENT INFORMATION WERE NOT PROVIDED DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-400|06/09/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5708570|46882994|D|1||HEALTH PROFESSIONAL REPORTED ALCL ASSOCIATED WITH SILICONE BREAST IMPLANT SIDE UNSPECIFIED FURTHER FOLLOW-UP REPORTED AS PATIENT DEVELOPED A MASS AND A SEROMA ON THE LEFT SIDE AN INITIAL BIOPSY WAS TAKEN OF THE MASS AND IT WAS DIAGNOSED AS FAT NECROSIS THE MASS AND THE SEROMA WERE CONFIRMED TO BE SEPARATE EVENTS THE DEVICE HAS NOT YET BEEN REMOVED AS THEY ARE PROCEEDING WITH CHEMOTHERAPY CURRENTLY THE PATIENT WILL HAVE IMPLANT REMOVAL AND CAPSULECTOMY PENDING THE SUCCESS OF CHEMOTHERAPY HEALTH PROFESSIONAL CONFIRMED VERBALLY THAT PATHOLOGY REPORTS STATED MARKERS WERE CD30+  ATYPICAL LYMPHOID INFILTRATE AND ALK-1|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-400|06/09/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5596175|43273717|N|1||B4 THE DEVICE WILL NOT BE RETURNED THESE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLY CAUSE FOR THIS EVENT DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NONHODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-500|04/21/2016|||DA|N|R||0HP|FTR|1.0|01/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1204889|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6011867|56822654|D|1||THROUGH ALLERGANÂ¿S LITERATURE REVIEW OF RECENT JOURNAL ARTICLES WE RECEIVED THE FOLLOWING ARTICLE FROM MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN AUSTRALIA AND NEW ZEALAND Â¿ HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGYÂ¿ THE ARTICLEÂ¿S PURPOSE IS TO CAPTURE ALL REPORTED BIA-ALCL IN AUSTRALIA AND NEW ZEALAND AND TO STUDY THE ASSOCIATION AND RISK OF DIFFERENT IMPLANT SURFACES AND INCIDENCE OF BIA-ALCL A TOTAL OF 46 PATIENTS WERE IDENTIFIED BETWEEN 2007 AND AUGUST 2016 FIVE WOMEN HAD MULTIPLE IMPLANTS WHILE THE REMAINING 41 HAD A SINGLE IMPLANT HISTORY WITH A TOTAL OF 56 IMPLANT PAIRS ARTICLE STATES Â¿ALL PATIENTS WERE EXPOSED TO TEXTURED IMPLANTS AT SOME POINT IN THEIR IMPLANT HISTORYÂ¿ ARTICLE CLARIFIES Â¿THERE WERE A TOTAL OF 46 IMPLANTS THAT WERE PLACED IN AUSTRALIA AND 8 IMPLANTS PLACED IN NEW ZEALAND IN TWO PATIENTS THE IMPLANT WAS PLACED OUTSIDE OF AUSTRALIA AND NEW ZEALAND 1 MEXICO AND 1 THAILANDÂ¿ MANUFACTURER COULD NOT BE SPECIFIED AND ARTICLE STATES Â¿BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED FOR 571 OF IMPLANTS IN THIS SERIESÂ¿ THE ARTICLE DOES NOT PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL OR LOT INFORMATION OR SIDES OF ALCL DIAGNOSIS ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY AND REMOVAL OF IMPLANTS BOTH ON DISEASED AND NON-DISEASED SIDE ALL TUMORS WERE CD30 POSITIVE AND ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6011867|56822653|N|1||MEDWATCH SENT TO FDA ON 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN AUSTRALIA AND NEW ZEALAND Â¿ HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGYÂ¿ A LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS M MAGNUSSON T PAPADOPOULOS T CONNELL J LOFTS M LOCKE I HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA THE EVENT OF LYMPHOMA ALCL IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5670826|58278251|D|1||PHYSICIAN REPORTED TUMOUR CELLS EXPRESS CD3 CD30 CD15 P63 FOCAL AND VERY WEAK AND ARE NEGATIVE TO PAX5 CD20 ALK AND EBV EBER DIAGNOSIS ALK-NEGATIVE ANAPLASTIC LARGE CELL T LYMPHOMA ASSOCIATED WITH BREAST IMPLANTS EVENT OF ALCL HAS BEEN CONFIRMED AT THIS TIME PHYSICIAN ADDITIONALLY REPORTED THAT SMALL POST-BIOPSY HEMATOMA OBSERVED WITH PROBABLE THROMBOSIS IN THE ADJACENT VESSEL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MM125-320|05/20/2016|||DA|N|R||0HP|FTR|1.0|02/03/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2073435|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5670826|45647377|D|1||PHYSICIAN REPORTED THAT APPROXIMATELY FIVE YEARS AFTER IMPLANTATION THE PATIENT CONSULTED A DOCTOR AFTER DISCOVERING THROUGH A SELF-EXAM TEN DAYS EARLIER INFRACLAVICULAR C11 LUMPS IN THE PATIENTS LEFT BREAST AND LEFT AXILLARY ADENOPATHY ULTRASOUND-GUIDED BAG ACCORDING TO BI-RADS ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA ALCL AS CD30 RESULTS HAVE NOT BEEN PROVIDED THIS REPORT OF ALCL IS NOT YET CONFIRMED AND IS CURRENTLY CAPTURED AS LYMPHOMA DEVICE WAS EXPLANTED AND THE PATIENT IS BEING STUDIED FOR CHEMOTHERAPY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MM125-320|05/20/2016|||DA|N|R||0HP|FTR|1.0|02/03/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2073435|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5670826|45647376|N|1||THE REPORTER OF THE EVENT WAS ASKED TO RETURN THE PRODUCT FOR ANALYSIS ALLERGAN HAS NOT RECEIVED THE PRODUCT AT THIS TIME THEREFORE NO ANALYSIS OR TESTING HAS BEEN DONE THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE HISTORY REVIEW REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS DHR FOR WORK ORDER B4 INDICATES THAT THERE WAS A REPROCESS ON THE PRIMARY PACKAGING OPERATION HOWEVER THIS WAS COMPLETED ON A DIFFERENT SERIAL NUMBER UNIT AND THIS HAS NO RELATION NEITHER CAN CAUSE THE REPORTED EVENT THE DHR ASSEMBLY REPORT WAS VERIFIED AND THERE WAS NOT ANY SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE IN CONFORMANCE DURING MANUFACTURING PROCESS IN ADDITION DHR FOR SHELL RUNS NUMBER 10009114 AND 10009114 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING SHELL FABRICATION PROCESS ALL SHELLS WERE REVIEWED AS PART OF THE SHELL FABRICATION OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT FABRICATION MET THE REQUIRED SPECIFICATIONS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURANCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF THE REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MM125-320|05/20/2016|||DA|N|R||0HP|FTR|1.0|02/03/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2073435|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6146400|61491852|N|1||B4 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT AND PRODUCT HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA AND NECROSIS PUBLISHED STUDIES INDICATE THAT BREAST CANCER IS NO MORE COMMON IN WOMEN WITH IMPLANTS THAN THOSE WITHOUT IMPLANTS A LARGE LONG-TERM FOLLOW-UP FOUND NO SIGNIFICANT INCREASES IN THE RISK RATES FOR A WIDE VARIETY OF CANCERS INCLUDING STOMACH CANCER LEUKEMIA AND LYMPHOMA ARTICLE CITATION Â¿CLASSICAL HODGKIN LYMPHOMA ARISING ADJACENT TO A BREAST IMPLANTÂ¿ CIARA RYAN MB MRCSI FRCPATH1 YASSER GED MB1 FIONA QUINN PHD1 JAN WALKER BSC1 JOHN KENNEDY MB FRCPI1 CHARLES GILLHAM MB MRCP FRCR1 STEFANIA PITTALUGA MD PHD2 RONAN MCDERMOTT MB MRCPI FRCR FFRRCSI1 ELISABETH VANDENBERGHE MB PHD MRCPI MRCPATH1 CLIONA GRANT MB MRCPI1 AND RICHARD FLAVIN MD PHD FRCPATH1 INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY 2016 VOL 245 448Â¿455|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/05/2016|||DA|*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5880065|52274646|N|1||MEDWATCH SENT TO FDA ON 08162016 THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FOLLOW UP HAS BEEN PERFORMED TO DETERMINE THE DEVICE MANUFACTURER SERIAL NUMBER LOT NUMBER IMPLANT DATE PATIENT NAME PATIENT DATE OF BIRTH PATHOLOGICAL TESTING RESULTS EXPLANT DATE AND DEVICE RELATIONSHIP OF THE REPORTED EVENT DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/16/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNKNOWN MANUFACTURER|||||||True
5880065|52274647|D|1||ALLERGAN REPRESENTATIVE REPORTED VIA EMAIL HAVING RECEIVED A POSTER ABOUT A LEFT SIDE ALCL COMPLAINT DEVICE MANUFACTURER UNKNOWN EMAIL STATES 61524 HOSPITAL  THERE WAS A POSTER RECENTLY PRESENTED BY HEALTHCARE PROFESSIONAL THE POSTER IS ABOUT A ALCL COMPLAINT BUT IT DOES NOT SPECIFY IF DEVICE MANUFACTURE COMPANY HEALTHCARE PROFESSIONAL REFUSES TO PROVIDE ANY INFORMATION BECAUSE THAT HOSPITAL DOES NOT AUTHORIZE TO PROVIDE IT WITHOUT SUBJECT CONSENT|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/16/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNKNOWN MANUFACTURER|||||||True
5936530|54204593|D|1||HEALTHCARE PROFESSIONAL REPORTED UNKNOWN SIDE LYMPHOMA ALCL PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED THEREFORE THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/08/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5936530|54204592|N|1||MEDWATCH SENT TO FDA ON 09082016 THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING SERIAL NUMBER DATE OF IMPLANTEXPLANT IMPLANTING PHYSICIAN PATIENT INFORMATION AND THE RETURN OF PATHOLOGICAL MARKERS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/08/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6176674|62457390|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA-ALCL SEROMA AND MASS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176674|62457391|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 PATIENT WHO WAS IMPLANTED WITH A LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN THE ARTICLE ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED MASS AND SEROMA TREATMENT REPORTED AS IMPLANT REMOVAL AND CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE AND PREDNISONE 6 CURES CHOP OR CHOP-LIKE FOLLOW-UP FOUND NO EVIDENCE OF DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6142978|61395222|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL AND DEATH ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6153182|61700300|N|1||B4 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHADENOPATHY AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5940718|69962842|N|1||THE EVENTS OF INFLAMMATION LUMPNODULE AND LYMPHOMA ALCL ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS IN SOME CASES PATIENTS PRESENTED WITH MASSES ADJACENT TO THE BREAST IMPLANT IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/09/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5940718|69962843|D|1||HEALTHCARE PROFESSIONAL ADDITIONALLY REPORTED LEFT SIDE MASS AND INFLAMMATION PATHOLOGICAL MARKERS CD30+ AND ALK- HAVE BEEN RECEIVED THEREFORE LYMPHOMA ALCL HAS BEEN CONFIRMED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/09/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5940718|54394902|N|1||MEDWATCH SENT TO FDA ON 09092016 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/09/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5940718|54394903|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE PATIENT PRESENTED WITH LARGE SEROMA AND RECEIVED ALCL DIAGNOSIS ON B6 2014 A TOTAL CAPSULECTOMY WAS PERFORMED ON B6 2014 WITH IMPLANT REMOVAL AND NO REPLACEMENT PATIENT REMAINS DISEASE FREE AS OF B6 2016 PATIENT WAS TREATED WITH SURGERY CHEMO THERAPY CHOP RADIATION AS PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/09/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5644581|44885546|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE OF THE EVENT IT IS NOT KNOWN IF THE DEVICE WILL BE RETURNED MISSING INFORMATION INCLUDES DEVICE SERIAL NUMBER IMPLANT DATE DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL  INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF THE REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/10/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||nan|||||||True
5644581|44885547|D|1||HEALTH PROFESSIONAL REPORTED A RIGHT SIDE DEVICE REMOVAL AND TOTAL CAPSULECTOMY FOLLOWING SEROMA AND DIAGNOSIS OF ALCL MANUFACTURER OF THE DEVICE IS UNKNOWN THIS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/10/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||nan|||||||True
6199283|63133499|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM130-360|12/22/2016|||DA|N|R||0HP|FTR|1.0|11/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||352966|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6023404|72695628|D|1||PHYSICIAN REPORTS PATIENT WITH SUDDEN ONSET OF SEROMA ON RIGHT SIDE PHYSICIAN REPORTED IMPLANT WAS REMOVED AS PART OF TOTAL CAPSULECTOMY AND DIAGNOSIS OF IA LCAL WAS MADE ON CYTOLOGY OF THE ASPIRATED SEROMA FLUID EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FX155-775|10/12/2016||03/02/2017|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2379964|900 PARKWAY GLOBAL PARK|ZONA FRANCA|ARKLOW, COUNTY WICKLOW|CS|ALLERGAN (COSTA RICA)|||||||True
6023404|57191543|D|1||PHYSICIAN REPORTS PATIENT WITH SUDDEN ONSET OF SEROMA ON RIGHT SIDE PHYSICIAN REPORTED IMPLANT WAS REMOVED AS PART OF TOTAL CAPSULECTOMY AND DIAGNOSIS OF IA LCAL WAS MADE ON CYTOLOGY OF THE ASPIRATED SEROMA FLUID EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FX155-775|10/12/2016||03/02/2017|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2379964|900 PARKWAY GLOBAL PARK|ZONA FRANCA|ARKLOW, COUNTY WICKLOW|CS|ALLERGAN (COSTA RICA)|||||||True
6023404|57191542|N|1||FOLLOW-UP IS BEING PERFORMED FOR DEVICE RETURN THE EVENTS OF LYMPHOMA AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT AND PRODUCT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES THE REPORTED EVENTS AS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FX155-775|10/12/2016||03/02/2017|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2379964|900 PARKWAY GLOBAL PARK|ZONA FRANCA|ARKLOW, COUNTY WICKLOW|CS|ALLERGAN (COSTA RICA)|||||||True
5415044|38160022|N|1||IDEAL IMPLANT DID NOT SUBMIT THIS MDR WITHIN 30 DAYS OF BECOMING AWARE OF THE INCIDENT FOR THE FOLLOWING REASONS PER THE FDA REGULATIONS FOR REPORTABLE EVENTS A SERIOUS INJURY IS ONE THAT IS LIFE THREATENING RESULTS IN PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE OR NECESSITATES MEDICAL OR SURGICAL INTERVENTION TO PRECLUDE PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE PER THE DEFINITION NOTED ABOVE IDEAL IMPLANT INCORPORATED UNDERSTOOD THAT A COMMON SALINE BREAST IMPLANT DEFLATION WOULD NOT FALL WITHIN THE DEFINITION OF SERIOUS INJURY AND WOULD THEREFORE NOT BE CONSIDERED REPORTABLE ALTHOUGH SURGICAL INTERVENTION MAY BE PERFORMED TO REMOVE ANDOR REPLACE THE BREAST IMPLANT IT IS NOT MEDICALLY REQUIRED TO PRECLUDE PERMANENT IMPAIREMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE IMPLANTS ARE FILLED WITH NORMAL SALINE WHICH IS HARMLESSLY ABSORBED BY THE BODY A DEFLATION POSES MINIMAL RISK TO THE PATIENT AND IS NOT CONSIDERED SERIOUS IN THE ABSENCE OF AN ADDITIONAL SERIOUS CONDITION SUCH AS EXTRUSION TISSUE NECROSIS SEPSIS LYMPHOMA ALCL NEUROLOGIC PROBLEM BREAST MASS POSSIBLE AFFECT ON FETUS ETC BECAUSE A DEFLATION ABSENT OF AN ADDITIONAL SERIOUS PATIENT CONDITION DOES NOT POSE RISK TO THE PATIENT OF DEATH OR SERIOUS INJURY IDEAL IMPLANT DID NOT CONSIDER DEFLATION OR SURGERY TO REMOVE A DEFLATED IMPLANT TO BE A SURGICAL INTERVENTION TO PRECLUDE PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE A DEFLATION OR OTHER TYPE OF DEVICE MALFUNCTION IN WHICH A SERIOUS INJURY SERIOUS CONDITION OR DEATH IS REPORTED AS A CONSEQUENCE WOULD BE CONSIDERED REPORTABLE HOWEVER DURING A RECENT FDA INSPECTION PERFORMED 2116-2316 AN OBSERVATION WAS MADE THAT THIS DEFLATION SHOULD HAVE BEEN REPORTED TO THE FDA UPON LEARNING THAT FDA CONSIDERS ANY DEFLATION THAT WAS EXPLANTED TO BE REPORTABLE IDEAL IMPLANT BEGAN SUBMITTING REPORTS FOR PAST DEFLATIONS AND WILL CONTINUE TO REPORT ALL INSTANCES OF EXPLANTED DEFLATIONS IN THE FUTURE|IDEAL IMPLANT STRUCTURED BREAST IMPLANT|405|02/06/2016||10/28/2015|DA|R|Y||0HP|FWM|1.0||SALINE-FILLED BREAST IMPLANT||61030|5005 LYNDON B JOHNSON FREEWAY|SUITE 900|DALLAS|US|IDEAL IMPLANT|75244|TX|75244||40501||True
6153188|61710211|N|1||THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ 137 6 1659-1669 BY HONGHUA HU PHD KHALID JOHANI AHMAD ALMATROUDI KAREN VICKERY PHD BVSC BRUCE VAN NATTA MD MARSHALL E KADIN MD GARRY BRODY MD MARK CLEMENS MD CHAN YOON CHEAH MD STEPHEN LADE MD PREETI AVINASH JOSHI MDPHD H MILES PRINCE MDPHD ANAND K DEVA BSCMED MBBS MS PUBLISHED JUNE 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6153188|61710212|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS TABLE 1Â¿ ARTICLE GOES ON TO STATE Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG OF TISSUE CAPSULE 49 Ã 106 CELLSMG OF TISSUE ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS P  005 IN CONTRAST SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED ACCORDING TO TABLE 1 Â¿CLINICAL SUMMARY OF BREAST IMPLANTÂ¿ASSOCIATED ALCL PATIENTSÂ¿ THERE WERE 3 CASES OF ALCL WHERE THE PRESENTATION IS Â¿NOT KNOWNÂ¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE OR TESTED NEGATIVE FOR BACTERIAL INFECTION THIS REPORT WILL CAPTURE 3 CASES OF ALCL WHERE THE PRESENTATION IS Â¿NOT KNOWNÂ¿|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5659740|45309561|N|1||MEDWATCH SENT TO FDA ON 05172016 B4 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT THE DEVICE WILL NOT BE RETURNED SERIAL NUMBER IS NOT AVAILABLE DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY PUBLISHED STUDIES INDICATE THAT BREAST CANCER IS NO MORE COMMON IN WOMEN WITH IMPLANTS THAN THOSE WITHOUT IMPLANTS A LARGE LONG-TERM FOLLOW-UP FOUND NO SIGNIFICANT INCREASES IN THE RISK RATES FOR A WIDE VARIETY OF CANCERS INCLUDING STOMACH CANCER LEUKEMIA AND LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|UNK STYLE 168|05/17/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5894468|52721867|D|1||COMPANY REPRESENTATIVE REPORTED ON BEHALF OF HEALTH PROFESSIONAL LATE SEROMA THAT TESTED POSITIVE FOR CD30 OPERATIVE REPORT REFERENCES A SURGERY ON B6 2008 IN WHICH THE PATIENT HAD BILATERAL NEOSUBMUSCULAR POCKET WITH REPOSITIONING OF THE EXISTING BREAST IMPLANTS OPERATIVE REPORT ADDITIONALLY NOTES BOTTOMING OUT BREAST IMPLANT BREAST ASYMMETRY CHEST WALL DEFORMITY AND CONSTRICTED BREASTÂ¿ IN ADDITION TO Â¿THE BREAST IMPLANT WAS WIPED OFF WITH ANTIBIOTIC LAP PAD AND THEN REINSERTED INTO THE POCKETÂ¿ IN B6 2015 PATIENT NOTICED THAT THEIR BREAST IMPLANTS WERE ASYMMETRIC AND WAS EVALUATED BY HER PLASTIC SURGEON WHO HAD SUSPECTED CAPSULAR CONTRACTION PHYSICIAN NOTES CLARIFY Â¿ON PHYSICAL EXAMINATION HER LEFT BREAST IS ALMOST TWICE THE SIZE OF THE RIGHT BREAST THERE IS SOME EDEMA OF THE LEFT BREAST SKIN ULTRASOUND LATER CONFIRMED A LEFT SIDE RUPTURE WITH FLUID SURROUNDING THE IMPLANT HER LEFT BREAST LATER BECAME MORE ENGORGED AS SHE DEVELOPED SEROMA WHICH WAS ASPIRATED IN B6 2016 AND FOUND TO BE POSITIVE FOR CD30 ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY DATED B6 2016 STATES Â¿LYMPHOID CELLS POSITIVE FOR CD3 AND CD30Â¿THE FINDINGS SUGGEST POSSIBLE BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ EXAM DATED B6 2016 STATES Â¿DIAGNOSIS OF ALCL BREAST WITH PALPABLE LEFT BREAST MASSÂ¿ THE PATIENT HAD SURGERY ON B6 2016 AND HAD A REPLACEMENT AT THAT TIME THE DEVICE IS AVAILABLE FOR RETURN TO ALLERGAN AS OF B6 2016 PATIENT HAS NO EVIDENCE OF ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-354|08/22/2016|||DA|N|R||0HP|FTR|1.0|01/13/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1393696|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5894468|52721866|N|1||B4 THE EVENTS OF LYMPHOMA ALCL SEROMA LATE EDEMA AND VISIBILITYPALPABILITY ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE REOPERATION IMPLANT REMOVAL ASYMMETRY IMPLANT MISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY HEMATOMASEROMA AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-354|08/22/2016|||DA|N|R||0HP|FTR|1.0|01/13/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1393696|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5894468|54359677|D|1||COMPANY REPRESENTATIVE REPORTED ON BEHALF OF HEALTH PROFESSIONAL LATE SEROMA THAT TESTED POSITIVE FOR CD30 OPERATIVE REPORT REFERENCES A SURGERY ON B6 2008 IN WHICH THE PATIENT HAD BILATERAL NEOSUBMUSCULAR POCKET WITH REPOSITIONING OF THE EXISTING BREAST IMPLANTS OPERATIVE REPORT ADDITIONALLY NOTES BOTTOMING OUT BREAST IMPLANT BREAST ASYMMETRY CHEST WALL DEFORMITY AND CONSTRICTED BREASTÂ¿ IN ADDITION TO Â¿THE BREAST IMPLANT WAS WIPED OFF WITH ANTIBIOTIC LAP PAD AND THEN REINSERTED INTO THE POCKETÂ¿ IN B6 2015 PATIENT NOTICED THAT THEIR BREAST IMPLANTS WERE ASYMMETRIC AND WAS EVALUATED BY HER PLASTIC SURGEON WHO HAD SUSPECTED CAPSULAR CONTRACTION PHYSICIAN NOTES CLARIFY Â¿ON PHYSICAL EXAMINATION HER LEFT BREAST IS ALMOST TWICE THE SIZE OF THE RIGHT BREAST THERE IS SOME EDEMA OF THE LEFT BREAST SKIN ULTRASOUND LATER CONFIRMED A LEFT SIDE RUPTURE WITH FLUID SURROUNDING THE IMPLANT HER LEFT BREAST LATER BECAME MORE ENGORGED AS SHE DEVELOPED SEROMA WHICH WAS ASPIRATED IN B6 2016 AND FOUND TO BE POSITIVE FOR CD30 ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY DATED B6 2016 STATES Â¿LYMPHOID CELLS POSITIVE FOR CD3 AND CD30Â¿THE FINDINGS SUGGEST POSSIBLE BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ EXAM DATED B6 2016 STATES Â¿DIAGNOSIS OF ALCL BREAST WITH PALPABLE LEFT BREAST MASSÂ¿ THE PATIENT HAD SURGERY ON 06132016 AND HAD A REPLACEMENT AT THAT TIME THE DEVICE IS AVAILABLE FOR RETURN TO ALLERGAN AS OF B6 2016 PATIENT HAS NO EVIDENCE OF ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-354|08/22/2016|||DA|N|R||0HP|FTR|1.0|01/13/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1393696|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5935521|56208704|D|1||HEALTHCARE PROFESSIONAL REPORTED PATIENT PRESENTED WITH RIGHT SIDE LARGE SEROMA AND LARGE PALPABLE MASS A TOTAL CAPSULECTOMY WAS PERFORMED ON B6 2016 WITH IMPLANT REMOVAL AND NO REPLACEMENT PATIENT DIAGNOSED WITH RIGHT SIDE ALCL ON B6 2016 AS COMPLETE PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED THE EVENT WILL BE REPORTED AS LYMPHOMA PATIENT IS CURRENTLY RECEIVING CHEMOTHERAPY CHOP THERAPY|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|09/08/2016|||DA|N|R||0HP|FWM|1.0|05/05/2011|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1440846|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5935521|54162317|N|1||MEDWATCH SENT TO FDA ON 09082016 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|09/08/2016|||DA|N|R||0HP|FWM|1.0|05/05/2011|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1440846|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5935521|54162318|D|1||HEALTHCARE PROFESSIONAL REPORTED PATIENT PRESENTED WITH RIGHT SIDE LARGE SEROMA AND LARGE PALPABLE MASS A TOTAL CAPSULECTOMY WAS PERFORMED ON B6 2016 WITH IMPLANT REMOVAL AND NO REPLACEMENT PATIENT DIAGNOSED WITH RIGHT SIDE ALCL ON B6 2016 AS COMPLETE PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED THE EVENT WILL BE REPORTED AS LYMPHOMA PATIENT IS CURRENTLY RECEIVING CHEMOTHERAPY CHOP THERAPY|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|09/08/2016|||DA|N|R||0HP|FWM|1.0|05/05/2011|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1440846|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5904549|53036936|N|1||MEDWATCH SENT TO FDA ON 08252016 IN RESPONSE TO FDA REPORT NUMBER MW5063635 B4 DEVICE HAS BEEN CONFIRMED AS AVAILABLE FOR RETURN BUT HAS NOT YET BEEN RECEIVED THE EVENTS OF LYMPHOMA EDEMA VISIBILITYPALPABILITY SENSATION INCREASE AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES THE REPORTED EVENTS AS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION SENSATION IN THE NIPPLE AND BREAST CAN INCREASE OR DECREASE AFTER IMPLANT SURGERY IS TYPICALLY LOST AFTER COMPLETE MASTECTOMY WHERE THE NIPPLE ITSELF IS REMOVED AND CAN BE SEVERELY LESSENED BY PARTIAL MASTECTOMY|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
5904549|58060034|D|1||PHYSICIAN REPORTED THE RIGHT BREAST WAS SWOLLEN FIRM AND SENSITIVE TO DEEP PALPATION PHYSICIAN ALSO STATED AN ANAPLASTIC LARGE CELL LYMPHOMA WAS FOUND IN THE PERI PROSTHETIC FLUID AND FIBRINOID DEPOSITS WITHIN THE PERIPROSTHETIC CAPSULE OF THE RIGHT BREAST PHYSICIAN ALSO STATED THE PT UNDERWENT BILATERAL TOTAL CAPSULECTOMY AND IMPLANT REMOVAL NOW MORE THAN A YEAR AFTER THE PT IS DISEASE FREE CT PET SCANS INCLUDING A RECENT SCAN DO NOT SHOW ANY SIGNS OF THE LYMPHOMA EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
5904549|53036937|D|1||PHYSICIAN REPORTED THE RIGHT BREAST WAS SWOLLEN FIRM AND SENSITIVE TO DEEP PALPATION PHYSICIAN ALSO STATED AN ANAPLASTIC LARGE CELL LYMPHOMA WAS FOUND IN THE PERI PROSTHETIC FLUID AND FIBRINOID DEPOSITS WITHIN THE PERIPROSTHETIC CAPSULE OF THE RIGHT BREAST PHYSICIAN ALSO STATED THE PT UNDERWENT BILATERAL TOTAL CAPSULECTOMY AND IMPLANT REMOVAL NOW MORE THAN A YEAR AFTER THE PT IS DISEASE FREE CT PET SCANS INCLUDING A RECENT SCAN DO NOT SHOW ANY SIGNS OF THE LYMPHOMA EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
5904549|59237866|D|1||ADDITIONAL INFORMATION PATHOLOGY REPORTS SPECIFIES THAT THE FIBRINOID MATERIAL NEXT TO THE PROSTHESIS TESTED CD30+ AND ALK- THIS IS NOW A CONFIRMED CASE OF ALCL AND HAS BEEN CAPTURED AS LYMPHOMA-ALCL|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
5884313|52381107|D|1||REPORTED EVENTS FOUND WITHIN THE FOLLOWING ARTICLE CANCER RISK OF BREAST IMPLANTS 10 TIMES HIGHER THAN FIRST FEARED SHOCK WARNING FROM SURGEONS  AS ONE BRITISH SURVIVOR RELIVES ORDEAL PATIENT REPORTED DISCOVERED A LUMP THE SIZE OF A 5P PIECE AT THE TOP OF RIGHT BREAST NEAR THE CLEAVAGE PATIENT REPORTED DIAGNOSIS OF ALCL VIA ULTRASOUND SCAN AND NEEDLE BIOPSY PATIENT RECEIVED CHEMOTHERAPY TREATMENT PATIENT ALSO REPORTED MY RIGHT BREAST WAS SWOLLEN FELT BURNING HOT AND I HAD DEVELOPED A RED ITCHY RASH I BECAME UNABLE TO RAISE MY RIGHT ARM TO BRUSH MY HAIR OR TEETH AND COULD NO LONGER COOK OR DRIVE PATIENT RECEIVED SEVEN CYCLES OF BRENTUXIMAB DEVICE WAS THEN REMOVED PATIENT HAS BEEN TOLD THERE IS NO REMAINING CANCER EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/17/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5884313|52381106|N|1||FOLLOW-UP IS NOT POSSIBLE IN THIS CASE NO DEVICE HISTORY RECORD WAS REQUESTED AS DEVICE INFORMATION IS UNKNOWN DEVICE LABELING ADDRESSES THE REPORTED EVENTS AS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST ERYTHEMA MAY ALSO OCCUR AS A NORMAL RESPONSE TO EXPANSION THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/17/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5991152|58278327|D|1||GOVERNING BODY REPORTED RIGHT SIDE Â¿CLINICAL SIGNS SIGNS ON MRI AND ON ULTRASOUND ENLARGEMENT OF LYMPH NODES ANAPLASTIC LARGE CELL LYMPHOMA ALK- FURTHER SPECIFIED AS DISCOVERING OF ANAPLASTIC LYMPHOMA ON AXILLARY LYMPHADENOPATHY ALCL DIAGNOSIS RECEIVED IN MAY OF 2016 TREATMENT INCLUDES EXPLANTATION OF BREAST PROSTHESIS AND CAPSULECTOMY WAS PERFORMED ANATOMOPATHOLOGIC RESULT OF MATERIAL WAS KEPT PATIENT WILL RECEIVE A SPECIFIC TREATMENT BY CHEMOTHERAPY AFTER APPROVAL OF COLLEGIAL DECISION DURING A MULTIDISCIPLINARY MEETING|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF135-420|09/30/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2334015|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5991152|56059751|N|1||MEDWATCH SENT TO FDA ON 09302016 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE HISTORY REVIEW DHR SUMMARY REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT FROM SAP WAS VERIFIED AND THREE DEVICES WERE SCRAPPED DURING THE ASSEMBLY PROCESS WHICH ARE NOT RELATED TO THE REPORTED EVENT  IN ADDITION DHR FOR SHELL RUNS NUMBER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING SHELL FABRICATION PROCESS ALL SHELLS WERE REVIEWED AS PART OF THE SHELL FABRICATION OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT FABRICATION MET THE REQUIRED SPECIFICATIONS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF135-420|09/30/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2334015|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5991152|56059752|D|1||GOVERNING BODY REPORTED RIGHT SIDE CLINICAL SIGNS SIGNS ON MRI AND ON ULTRASOUND ENLARGEMENT OF LYMPH NODES ANAPLASTIC LARGE CELL LYMPHOMA ALK- FURTHER SPECIFIED AS DISCOVERING OF ANAPLASTIC LYMPHOMA ON AXILLARY LYMPHADENOPATHY ALCL DIAGNOSIS RECEIVED IN B6 2016 TREATMENT INCLUDES EXPLANTATION OF BREAST PROSTHESIS AND CAPSULECTOMY WAS PERFORMED ANATOMOPATHOLOGIC RESULT OF MATERIAL WAS KEPT PATIENT WILL RECEIVE A SPECIFIC TREATMENT BY CHEMOTHERAPY AFTER APPROVAL OF COLLEGIAL DECISION DURING A MULTIDISCIPLINARY MEETING|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF135-420|09/30/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2334015|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5595588|43273265|D|1||HEALTH PROFESSIONAL REPORTED PATIENT PRESENTED WITH LATE ONSET SEROMA WHICH TESTED POSITIVE FOR ALCL PATIENT HAS HAD IMPLANT REMOVED AND TOTAL CAPSULECTOMY OF THE RIGHT SIDE IMPLANT AND CAPSULE HAS BEEN SENT FOR HISTOLOGY PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT YET BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF140-535|04/21/2016||||N|R||0HP|FTR|1.0|09/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||165721|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5595588|43273124|N|1||THE EVENTS OF SEROMA-LATE AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLY CAUSE FOR THIS EVENT THE DEVICE WILL NOT BE RETURNED DEVICE LABELING ADDRESSES LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF THE REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF140-535|04/21/2016||||N|R||0HP|FTR|1.0|09/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||165721|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191866|64757804|N|1||THE EVENTS OF ALCL LYMPHOMA CAPSULAR CONTRACTURE AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVALHEMATOMASEROMA AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA PATIENTS SHOULD BE ADVISED THAT CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWINGSEROMA AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME CAPSULAR CONTRACTURE OCCURS MORE COMMONLY IN REVISION PATIENTS THAN IN PRIMARY AUGMENTATION OR RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE IS ALSO A RISK FACTOR FOR IMPLANT RUPTURE AND IT IS ONE OF THE MOST COMMON REASONS FOR REOPERATION|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191866|64757845|D|1||ADDITIONAL INFORMATION RECEIVED FROM THE HEALTHCARE PROFESSIONAL STATED PATIENT Â¿PRESENTED WITH LATE ONSET SEROMA LEFT BREAST ASPIRATE CONFIRMED ATYPICAL CELLS STRONGLY POSITIVE FOR CD30 T CELLS ALK NEGATIVE EMA POSITIVE THE DEVICE WAS EXPLANTED AND A CAPSULECTOMY WAS PERFORMED THE LEFT SIDE SHOWED SMALL CLUSTERS OF ATYPICAL CELLS IN SURFACE MATERIAL ON CAPSULE POSITIVE FOR CD30 EMA CD4 BUT NO INVASION EFFUSION ASSOCIATED ALCLÂ¿ PATHOLOGICAL MARKERS HAVE BEEN RECEIVED CONFIRMING ALCL PATIENT ADDITIONALLY EXPERIENCED CAPSULAR CONTRACTURE BAKER GRADE III THIS MEDWATCH REPRESENTS THE LEFT SIDE SEE MFR  9617229-2016-00248 FOR THE RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191866|62906213|D|1||HEALTHCARE PROFESSIONAL REPORTED BREAST IMPLANTS REMOVED TODAY DUE TO ALCL SIDE WAS NOT SPECIFIED THIS MEDWATCH REPRESENTS THE LEFT SIDE SEE MFR  9617229-2016-00248 FOR THE RIGHT SIDE AS PATHOLOGICAL MARKERS CONFIRMING ALK- AND CD30+ HAVE NOT BEEN RECEIVED THE EVENT OF Â¿DUE TO ALCLÂ¿ WILL BE REPORTED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191866|62906212|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191866|67358311|D|1||HEALTHCARE PROFESSIONAL REPORTED BREAST IMPLANTS REMOVED TODAY DUE TO ALCL SIDE WAS NOT SPECIFIED AS PATHOLOGICAL MARKERS CONFIRMING ALK- AND CD30+ HAVE NOT BEEN RECEIVED THE EVENT OF Â¿DUE TO ALCLÂ¿ WILL BE REPORTED AS LYMPHOMA ADDITIONAL INFORMATION RECEIVED FROM THE HEALTHCARE PROFESSIONAL STATED PATIENT Â¿PRESENTED WITH LATE ONSET SEROMA LEFT BREAST ASPIRATE CONFIRMED ATYPICAL CELLS STRONGLY POSITIVE FOR CD30 T CELLS ALK NEGATIVE EMA POSITIVE THE DEVICE WAS EXPLANTED AND A CAPSULECTOMY WAS PERFORMED THE LEFT SIDE SHOWED SMALL CLUSTERS OF ATYPICAL CELLS IN SURFACE MATERIAL ON CAPSULE POSITIVE FOR CD30 EMA CD4 BUT NO INVASION EFFUSION ASSOCIATED ALCLÂ¿ PATHOLOGICAL MARKERS HAVE BEEN RECEIVED CONFIRMING ALCL PATIENT ADDITIONALLY EXPERIENCED CAPSULAR CONTRACTURE BAKER GRADE III THIS MEDWATCH REPRESENTS THE LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191882|62905365|D|1||HEALTHCARE PROFESSIONAL REPORTED BREAST IMPLANTS REMOVED TODAY DUE TO ALCL SIDE WAS NOT SPECIFIED THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2016-00212 FOR THE LEFT SIDE AS PATHOLOGICAL MARKERS CONFIRMING ALK- AND CD30+ HAVE NOT BEEN RECEIVED THE EVENT OF Â¿DUE TO ALCLÂ¿ WILL BE REPORTED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF145-490|12/20/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191882|65043306|N|1||CLARIFICATION TO THE REPORTED EVENT THERE IS NO COMPLAINT AGAINST THE RIGHT SIDE DEVICE IN THE INITIAL REPORT ALCL AFFECTED SIDE WAS NOT PROVIDED HEALTHCARE PROFESSIONAL HAS CLARIFIED THAT THE RIGHT SIDE WAS UNAFFECTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF145-490|12/20/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191882|65043307|D|1||ADDITIONAL INFORMATION RECEIVED FROM THE HEALTHCARE PROFESSIONAL THAT Â¿THE CONTRALATERAL IMPLANT WAS ALSO REMOVED IN LINE WITH THE PATIENTÂ¿S WISHES AND AS PER GUIDANCE ON THE MANAGEMENT OF ALCL IN THIS CIRCUMSTANCE THIS SIDE THE RIGHT SIDE WAS HOWEVER UNAFFECTED AND THE DEVICE WAS DISPOSEDÂ¿ THERE IS NO COMPLAINT AGAINST THE RIGHT SIDE DEVICE THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2016-00212 FOR THE LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF145-490|12/20/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191882|62905244|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF145-490|12/20/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5896385|52760206|N|1||MEDWATCH SENT TO FDA ON 08232016 DEVICE HAS BEEN RETURNED DEVICE ANALYSIS IS NOT COMPLETE FINDINGS WILL BE SENT IN FOLLOW-UP REPORT THE EVENTS OF INFLAMMATION LYMPHOMA AND SWELLING ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING PRODUCT INFORMATION HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES THE REPORTED EVENTS AS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|08/23/2016||08/23/2016|DA|R|Y||0HP|FTR|1.0|02/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||384466|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5719833|47208525|D|1||PATIENT REPORTED SEROMA RIGHT BREAST PARTIAL CAPSULECTOMY  CAPSULOTOMY WITH EXCHANGE WAS PERFORMED SURGICAL LOG REPORTS THERE WAS 600 CC SEROUS FLUID UNDER PRESENT ON RIGHT SEROLOGY PENDING PATHOLOGY + ALCL PETCT SCAN STATES ONLY FAINT ACTIVITY IS AFFILIATED WITH RIGHT AXILLARY NODES OF RELATIVELY LESS CONCERN AND POTENTIALLY INFLAMMATORYREACTIVE CYTOLOGY REPORT STATES RIGHT BREAST FLUID HIGHLY ATYPICAL LYMPHOCYTES PRESENT CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE COMMENT THE HIGHLY ATYPICAL LYMPHOCYTES DEMONSTRATES STAINING WITH CD30 NEGATIVE FOR ALK-1 THE IMMUNOHISTOCHEMISTRY PROFILE IS CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/13/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2594775|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5719833|47208524|N|1||MEDWATCH SENT TO FDA ON 06132016 THESE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS IT IS NOT KNOWN IF THE DEVICE WILL BE RETURNED PATIENT DECLINED PERMISSION TO CONTACT THE HEALTH PROFESSIONAL AT THIS TIME DEVICE HISTORY RECORD REPORTS REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT FROM SAP WAS VERIFIED AND THERE WAS NOT ANY SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS IN ADDITION DHR FOR SHELL RUNS NUMBER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING SHELL FABRICATION PROCESS ALL SHELLS WERE REVIEWED AS PART OF THE SHELL FABRICATION OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT FABRICATION MET THE REQUIRED SPECIFICATIONS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/13/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2594775|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145514|64146442|N|1||B4 DEVICE WAS ANALYZED AT ALLERGAN B4 VISUAL ANALYSIS OF THE RETURNED DEVICE IDENTIFIED FLAT CREASES WHITE PARTICLES IN DEVICE OUTER SURFACE AND ONE CURVED OPENING IN THE POSTERIOR A LEAK TEST WAS PERFORMED WHICH IDENTIFIED OPENING A MICROSCOPIC ANALYSIS WAS PERFORMED WHICH IDENTIFY ONE OPENING STRIATED CURVED ASSESSED AS SURGICAL DAMAGE AND PARTIAL DELAMINATION OF PLUG STRAP DISK SHELL DUE TO ADHESIVE FAILURE FILL INSPECTION WAS PERFORMED AND IDENTIFIED NO BLOCKAGE IN THE VALVE BASED ON THE DEVICE ANALYSIS THE FINAL ASSESSMENT IS ONE OPENING STRIATED CURVED ASSESSED AS SURGICAL DAMAGE PARTIAL DELAMINATION OF PLUG STRAP DISK SHELL DUE TO ADHESIVE FAILURE DEVICE HISTORY RECORD DHR DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM THIS WORK ORDER WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS THE EVENTS OF LYMPHOMA-ALCL CAPSULAR CONTRACTURE INFLAMMATION AND PAIN ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST FORMATION OF FIBROUS TISSUE AROUND AN IMPLANTED DEVICE IS A NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS A COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY AND IS ONE OF THE MOST COMMON REASONS FOR REOPERATION THE CAUSE OF CAPSULAR CONTRACTURE IS UNKNOWN HOWEVER IT IS MOST LIKELY MULTIFACTORIAL AND MAY BE MORE COMMON FOLLOWING INFECTION HAEMATOMA AND SEROMA CONTRACTURE DEVELOPS TO VARYING DEGREES UNILATERALLY OR BILATERALLY AND MAY OCCUR WITHIN WEEKS TO YEARS AFTER SURGERY CONTRACTURE OF THE FIBROUS CAPSULAR TISSUE SURROUNDING THE IMPLANT MAY CAUSE A RANGE OF SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES ARE CONSIDERED THE MOST CLINICALLY SIGNIFICANT AND MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT TO CORRECTIVE SURGICAL PROCEDURES DO NOT TREAT CAPSULAR CONTRACTURE BY EXTERNAL COMPRESSION OR MASSAGE WHICH MAY RESULT IN IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA Â¿AS EXPECTED FOLLOWING ANY INVASIVE SURGICAL PROCEDURE PAIN OF VARYING INTENSITY AND DURATION MAY OCCUR FOLLOWING IMPLANTATION IN ADDITION IMPROPER PLACEMENT SURGICAL TECHNIQUE OR CAPSULAR CONTRACTURE MAY RESULT IN PAIN ASSOCIATED WITH NERVE ENTRAPMENT OR INTERFERENCE WITH MUSCLE MOTION UNEXPLAINED PAIN MUST BE PROMPTLY INVESTIGATEDÂ¿|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/09/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013310|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145514|64146443|D|1||PHYSICIAN REPORTED FIRST LEFT BREAST SEROMA OCCURRING ON B6 2014 AND A SECOND LEFT BREAST SEROMA OCCURRING ON B6 2016 RECEIVED ADDITIONAL INFORMATION FROM PHYSICIAN REPORTING ANALYSIS OF SLIGHTLY CLOUDY ORANGE FLUID RESULTED IN LARGE CELLS TESTING CD30+ AND ALK- PHYSICIAN ADDITIONALLY REPORTED IN IMMUNOHISTOCHEMISTRY THESE TUMOR CELLS WHICH ARE STRICTLY LIMITED IN THE FIBRIN COATING ARE CD30+ AND ALK- THIS EVENT HAS BEEN CONFIRMED AS ALCL DIAGNOSIS OF ALCL OCCURRED ON B6 2016 PHYSICIAN ADDITIONALLY REPORTED INFLAMMATORY COMPONENTS IN THE LEFT SIDE LEFT SIDE PAIN AND CAPSULAR CONTRACTURE BAKER GRADE II THIS MEDWATCH IS FOR THE LEFT SIDE DEVICE SEE MANUFACTURER REPORT  9617229-2016-00174 FOR RIGHT SIDE REPORT|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/09/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013310|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145514|61451047|N|1||THE DEVICE IS CURRENTLY BEING RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LATE SEROMA AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/09/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013310|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5531532|41335749|N|1||DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-550|03/29/2016||04/13/2016|DA|R|Y||0HP|FTR|1.0|02/20/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1235003|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5690994|49507692|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DIAGNOSED WITH ALCL DISEASE ASSOCIATED TO BREAST DEVICE SIDE UNSPECIFIED EXPLANT AND CAPSULECTOMY PERFORMED THE EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110391|06/01/2016|||DA|N|R||0HP|FTR|1.0|03/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||201218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5690994|46271112|N|1||MEDWATCH SENT TO FDA ON 06012016 THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE OF THIS EVENT IT IS NOT KNOWN IF THE DEVICE WILL BE RETURNED PATIENT INFORMATION WAS NOT PROVIDED DEVICE LABELING ADDRESSES LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF THE REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110391|06/01/2016|||DA|N|R||0HP|FTR|1.0|03/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||201218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5690994|46271113|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DIAGNOSED WITH ALCL DISEASE ASSOCIATED TO BREAST DEVICE SIDE UNSPECIFIED EXPLANT AND CAPSULECTOMY PERFORMED THE EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110391|06/01/2016|||DA|N|R||0HP|FTR|1.0|03/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||201218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5956972|54992703|D|1||PHYSICIAN REPORTS PATIENT UNDERWENT DELAYED RECONSTRUCTION NO PROBLEMS UNTIL 2015 WHEN PATIENT DEVELOPED A SPONTANEOUS HEAMO-SEROUS FLUID COLLECTION AROUND THE IMPLANT THIS FILE IS FOR THE LEFT SIDE DEVICE WAS REMOVED AND REPLACED FURTHER REPORT STATES IMPLANT APPEARED PREDOMINANTLY INTACT BUT TINY IRREGULARITY IDENTIFIED AND IMPLANT WAS THEREFORE REPLACED LARGE BLOOD STAINED FLUID COLLECTION RECURRED IN 2016 LEADING TO FURTHER EXPLORATION AND FIBRINOUS TISSUE WAS REMOVED AND SENT FOR HISTOLOGY DIAGNOSIS OF ALCL CONFIRMED BY EXPERT HAEMATOLOGY PANEL PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED THEREFORE THIS EVENT WILL BE CAPTURED AS LYMPHOMA|STYLE 150 EXPANDABLE BREAST IMPLANT|27-150496|09/16/2016|||DA|N|R||0HP|FTR|1.0|02/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1205583|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5956972|61427645|D|1||THERE IS NO COMPLAINT AGAINST THIS DEVICE EVENTS OF SEROMA AND ALCL HAVE BEEN REPORTED AGAINST A SUBSEQUENT DEVICE IN MANUFACTURER REPORT  9617229-2016-00170|STYLE 150 EXPANDABLE BREAST IMPLANT|27-150496|09/16/2016|||DA|N|R||0HP|FTR|1.0|02/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1205583|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5956972|54992702|N|1||THE EVENTS OF LYMPHOMA AND SEROMA-LATE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE OF THE EVENTS THE DEVICE WILL NOT BE RETURNED AS IT WAS DISCARDED DEVICE LABELING ADDRESSES LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF THE REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST DEVICE HISTORY RECORD STATES REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS  ALL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT FROM ORACLE WAS VERIFIED AND THERE WAS NO SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS IN ADDITION DHR FOR SHELL RUNS NUMBER B4 DID NOT IDENTIFY ANY ERRORS OMISSIONS OR NON-CONFORMANCES DURING SHELL FABRICATION PROCESS ALL SHELLS WERE REVIEWED AS PART OF THE SHELL FABRICATION OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT FABRICATION MET THE REQUIRED SPECIFICATIONS ERIR NUMBER B4 WAS REFERENCED IN DHR RECORD FOR SHELL RUN NUMBER B4 THIS ER IS RELATED TO TAPERING PROCESS HOWEVER THERE IS NO IMPACT TO THE DEVICES BASED ON THE REGULATORY REQUIREMENTS ERIR NUMBER B4 WAS REFERENCED IN DHR RECORD FOR SHELL RUN NUMBER B4 THIS ER IS RELATED TO TAPERING PROCESS HOWEVER THERE IS NO IMPACT TO THE DEVICES BASED ON THE REGULATORY REQUIREMENTS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS|STYLE 150 EXPANDABLE BREAST IMPLANT|27-150496|09/16/2016|||DA|N|R||0HP|FTR|1.0|02/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1205583|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6180550|62543961|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF LYMPHOMA IS PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/16/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6180550|62543962|D|1||PHYSICIAN REPORTED A PATIENT EXPERIENCED COMPLICATIONS 11 YEARS AFTER BREAST IMPLANTATION PHYSICIAN EXPLANTED DEVICE AND SENT A SAMPLE FOR TESTING SAMPLE TESTED POSITIVE FOR ALCL SIDE IS UNKNOWN AT THIS TIME ALCL HAS NOT BEEN CONFIRMED BY THE PATHOLOGICAL MARKERS CD30+ AND ALK- UNTIL ALLERGAN RECEIVES CONFIRMATION OF THE MARKERS THIS WILL BE REPRESENTED BY TERM CODE LYMPHOMA|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/16/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6177211|62456167|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL SEROMA LUMP AND ERYTHEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR AS A NORMAL RESPONSE TO EXPANSION GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6177211|62456168|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 OLD PATIENT WHO WAS IMPLANTED WITH A LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN THE CHART ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED A LEFT MASS SEROMA AND Â¿DISRUPTED IMPLANTÂ¿ ARTICLE ADDITIONALLY REPORTS ERYTHEMATOUS SKIN ERUPTION AGAINST THIS CASE TREATMENT REPORTED AS CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE AND PREDNISONE 6 CURES CHOP OR CHOP-LIKE EXPLANT NOT REPORTED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5708519|46870798|D|1||AUTHORS REPORTED THE CASE OF ONE PATIENT IN THE FOLLOWING JOURNAL ARTICLE BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA A CASE REPORT AND LITERATURE REVIEW AUTHORS REPORTED  A PATIENT PRESENTED WITH PAIN AND FIRMNESS IN PATIENTS RIGHT BREAST FOR SEVERAL WEEKS THE PATIENT HAD UNDERGONE BREAST AUGMENTATION WITH SALINE IMPLANTS 16 YEARS PRIOR TO PRESENTATION ROUTINE LABORATORY WORK REVEALED NO ABNORMALITIES THE PATIENT WAS REFERRED BY THE PATIENTS PRIMARY CARE PHYSICIAN FOR MRI OF THE RIGHT BREAST MRI DEMONSTRATED A LARGE FLUID COLLECTION SURROUNDING THE RIGHT BREAST IMPLANT WITH NO ASSOCIATED SIGNIFICANT ENHANCEMENT THERE WAS NO SUSPICIOUS MASS LESION AND NO AXILLARY ADENOPATHY THE IMPLANT WAS INTACT AN ULTRASOUND WAS PERFORMED AND DEMONSTRATED A SIMPLE FLUID COLLECTION SURROUNDING THE IMPLANT AGAIN NO MASS WAS IDENTIFIED ULTRASOUND-GUIDED FLUID ASPIRATION WAS PERFORMED WHICH YIELDED APPROXIMATELY 20 CUBIC CENTIMETERS OF YELLOW SEROUS FLUID PATHOLOGY DEMONSTRATED A SEROMA-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA OF THE RIGHT BREAST ANAPLASTIC LYMPHOMA KINASE ALK GENE TESTING WAS NEGATIVE THE PATIENT UNDERWENT PETCT WHICH REVEALED NO METASTATIC DISEASE THE PATIENT WAS TAKEN TO SURGERY AND BOTH IMPLANTS WERE REMOVED THE PATIENT DID NOT RECEIVE NEOADJUVANT OR ADJUVANT CHEMOTHERAPY OR RADIATION THERAPY THE PATIENT HAS NOW BEEN DISEASE-FREE WITH NO EVIDENCE OF DISEASE RECURRENCE FOR THREE YEARS CD30 RESULTS NOT PROVIDED THEREFORE THIS REPORTED CASE OF ALCL IS CONSIDERED TO BE A SUSPECTED CASE AND IS CAPTURED AS LYMPHOMA MANUFACTURER OF THE DEVICE IS UNKNOWN|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5708519|46870797|N|1||MEDWATCH SENT TO THE FDA ON 06092016 FULL CITATION OF ARTICLE LETTER H ROP B EDISON M N ET AL MARCH 26 2016 BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA A CASE REPORT AND LITERATURE REVIEW  CUREUS 83 E546 DOI 107759CUREUS546 A REQUEST FOR FURTHER INFORMATION REGARDING EVENT DATES PRODUCT INFORMATION PRODUCT RETURN AND PATIENT DETAILS HAVE BEEN MADE ALLERGAN HAS RECEIVED NO RESPONSE FROM THE CORRESPONDING AUTHOR ADDITIONAL ATTEMPTS WILL BE MADE B4 THE EVENTS OF SEROMA FIRMNESS AND ALCL ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT THE REPORTER OF THE EVENT WAS ASKED TO RETURN THE PRODUCT FOR ANALYSIS ALLERGAN HAS NOT RECEIVED THE PRODUCT AT THIS TIME THEREFORE NO ANALYSIS OR TESTING HAS BEEN DONE IF THE DEVICE IN QUESTION WAS MANUFACTURED BY ALLERGAN THE FOLLOWING DEVICE LABELING WOULD APPLY PUBLISHED STUDIES INDICATE THAT BREAST CANCER IS NO MORE COMMON IN WOMEN WITH IMPLANTS THAN THOSE WITHOUT IMPLANTS A LARGE LONG-TERM FOLLOW-UP FOUND NO SIGNIFICANT INCREASES IN THE RISK RATES FOR A WIDE VARIETY OF CANCERS INCLUDING STOMACH CANCER LEUKEMIA AND LYMPHOMA BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5788476|49361321|N|1||THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT IMPLANT DATE AND DEVICE RETURN STATUS ARE NOT KNOWN AT THIS TIME FOLLOW-UP WILL BE CONDUCTED DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5788476|53800763|D|1||HEALTH PROFESSIONAL REPORTED BREAST VOLUME INCREASE 5 YEARS AFTER REPLACEMENT AS PART OF MAMMARY MASTECTOMY PERIPROSTHETIC EXTRAVASATION REMOVAL OF PROSTHESIS + TOTAL CAPSULECTOMY ANAPATH RESULTS ALCL CONFIRMED SIDE WAS NOT SPECIFIED FURTHER INFORMATION RECEIVED REPORTS INCREASE OF THE VOLUME OF THE LEFT BREAST WITH EFFUSION DISCOVERED VIA MRI WITHOUT PROSTHETIC LEAK WITHOUT REDNESS NO PAIN OR FEVER IMPLANT REMOVAL AND TOTAL CAPSULECTOMY THE IMPLANT WAS FOUND INTACT A SAMPLE IS TAKEN AND DIAGNOSIS OF ALCL AIM CD30+ ALK- WILL BE DONE BY HISTOLOGICAL ANALYSIS CONFIRMED BY THE NETWORK LYMPHOPATH PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5788476|51513752|D|1||FURTHER INFORMATION RECEIVED REPORTS INCREASE OF THE VOLUME OF THE LEFT BREAST WITH EFFUSION DISCOVERED VIA MRI WITHOUT PROSTHETIC LEAK WITHOUT REDNESS NO PAIN OR FEVER IMPLANT REMOVAL AND TOTAL CAPSULECTOMIE THE IMPLANT WAS FOUND INTACT A SAMPLE IS TAKEN AND DIAGNOSIS OF ALCL AIM CD30+ ALK- WILL BE DONE BY HISTOLOGICAL ANALYSIS CONFIRMED BY THE NETWORK LYMPHOPATH PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5788476|49361322|D|1||HEALTH PROFESSIONAL REPORTED BREAST VOLUME INCREASE 5 YEARS AFTER REPLACEMENT AS PART OF MAMMARY MASTECTOMY PERIPROSTHETIC EXTRAVASATION REMOVAL OF PROSTHESIS + TOTAL CAPSULECTOMY ANAPATH RESULTS ALCL CONFIRMED SIDE WAS NOT SPECIFIED PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5620649|49979256|D|1||EXPLANTING PHYSICIAN REPORTED THAT THE PATIENT WAS TREATED FOR A LATE SEROMA AND ANAPLASTIC LARGE CELL LYMPHOMA ALCL ON THE CONTRALATERAL SIDE FINE NEEDLE ASPIRATION BIOPSY ON THE CONTRALATERAL SIDE REVEALED THE FOLLOWING ADDITIONAL DIAGNOSIS CYTOLOGIC FINDINGS COMPATIBLE WITH LYMPH NODE INVOLVEMENT BY LYMPHOPROLIFERATIVE PROCESS B4-B6 PROBABLY HODGKINS LYMPHOMA AS HODGKINS LYMPHOMA IS A SYSTEMIC DISEASE IT IS NOT A SIDE-SPECIFIC EVENT DIAGNOSTIC TESTING REVEALED NON SIDE-SPECIFIC EVENTS OF GOITER AND LUNG PARENCHYMA WITH MODERATE PARASEPTAL AND CENTRILOBULAR EMPHYSEMA IN THE MIDDLE AND UPPER FIELDS AND LAMINAR ATELECTASIS APPROXIMATELY ONE MONTH AFTER THE LEFT SIDE ALCL DIAGNOSIS THE PATIENTS RIGHT SIDE DEVICE WAS REMOVED PHYSICIAN NOTED AFTER SURGERY IS OBSERVED CLINICAL WORSENING OF THE PATIENT RESPIRATORY FAILURE SECONDARY TO LEFT PLEURAL EFFUSION RESULTING IN ADMISSION IN THE ICU AND THORACIC DRAINAGE THROUGH RECURRENT CHEST TUBE DRAINAGE WAS REQUIRED ON 3 OCCASIONS AFTER THE PATIENTS FIRST STAY IN THE ICU THE PATIENT GOES TO THE FIRST FLOOR AND RECEIVES THE FIRST CYCLE OF CHEMOTHERAPY SHOWING GRADE IV NEUTROPENIA AND DIARRHOEA AFTER THE SECOND CHEMOTHERAPY THE PATIENT SHOWS MARKED CLINICAL DETERIORATION WITH SUSPICIOUS OF TUMOUR LYSIS SYNDROME METABOLIC ACIDOSIS AND RENAL FAILURE THIS RESULTS IN A SECOND ADMISSION IN THE ICU THE PATIENT DIED APPROXIMATELY FIVE WEEKS AFTER IMPLANT REMOVAL THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2016-00035 FOR THE LEFT SIDE|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|04/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||396184|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5620649|44064473|D|1||EXPLANTING PHYSICIAN REPORTED THAT THE PATIENT WAS TREATED FOR A LATE SEROMA AND ANAPLASTIC LARGE CELL LYMPHOMA ALCL ON THE CONTRALATERAL SIDE FINE NEEDLE ASPIRATION BIOPSY ON THE CONTRALATERAL SIDE REVEALED THE FOLLOWING ADDITIONAL DIAGNOSIS CYTOLOGIC FINDINGS COMPATIBLE WITH LYMPH NODE INVOLVEMENT BY LYMPHOPROLIFERATIVE PROCESS CD30-POSITIVE PROBABLY HODGKINS LYMPHOMA AS HODGKINS LYMPHOMA IS A SYSTEMIC DISEASE IT IS NOT A SIDE-SPECIFIC EVENT DIAGNOSTIC TESTING REVEALED NON SIDE-SPECIFIC EVENTS OF GOITER AND Â¿LUNG PARENCHYMA WITH MODERATE PARASEPTAL AND CENTRILOLOBULAR EMPHYSEMA IN THE MIDDLE AND UPPER FIELDSÂ¿ AND Â¿LAMINAR ATELECTASISÂ¿ APPROXIMATELY ONE MONTH AFTER THE LEFT SIDE ALCL DIAGNOSIS THE PATIENTS RIGHT SIDE DEVICE WAS REMOVED PHYSICIAN NOTED AFTER SURGERY IS OBSERVED CLINICAL WORSENING OF THE PATIENT RESPIRATORY FAILURE SECONDARY TO LEFT PLEURAL EFFUSION RESULTING IN ADMISSION IN THE ICU AND THORACIC DRAINAGE THROUGH RECURRENT CHEST TUBE DRAINAGE WAS REQUIRED ON 3 OCCASIONS AFTER THE PATIENTS FIRST STAY IN THE ICU THE PATIENT GOES TO THE FIRST FLOOR AND RECEIVES THE FIRST CYCLE OF CHEMOTHERAPY SHOWING GRADE IV NEUTROPENIA AND DIARRHOEA AFTER THE SECOND CHEMOTHERAPY THE PATIENT SHOWS MARKED CLINICAL DETERIORATION WITH SUSPICIOUS OF TUMOUR LYSIS SYNDROME METABOLIC ACIDOSIS AND RENAL FAILURE THIS RESULTS IN A SECOND ADMISSION IN THE ICU THE PATIENT DIED APPROXIMATELY FIVE WEEKS AFTER IMPLANT REMOVAL THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2016-00035 FOR THE LEFT SIDE|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|04/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||396184|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6176804|62446183|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 PATIENT WHO WAS IMPLANTED WITH A LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN THE ARTICLE ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED SEROMA TREATMENT REPORTED AS IMPLANT REMOVAL FOLLOW-UP FOUND NO EVIDENCE OF DISEASE THIS MEDWATCH IS FOR THE LEFT SIDE MFR 9617229-2016-00241 REPRESENTS THE RIGHT SIDE DEVICE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176804|62446182|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6064624|62738626|D|1||HEALTHCARE PROFESSIONAL REPORTED Â¿PATIENT CAME INTO CLINIC ON B6 2016 WITH RIGHT-SIDE SEROMA FINE NEEDLE ASPIRATION FNA ON B6 2016 FOR FLOW CYTOMETRY TO RULE OUT BIA-ALCL INADEQUATE SAMPLE B6 2016 FNA REPEATED IN B6 2016 CYTOLOGY ON FNA WAS POSITIVE FOR ALCLÂ¿ EVENTS INVOLVE NATRELLE IMPLANT AS PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL HAVE NOT BEEN RECEIVED THE EVENT OF CYTOLOGY ON FNA WAS POSITIVE FOR ALCL WILL BE CAPTURED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX140-520|10/28/2016|||DA|*|*||0HP|FTR|1.0|01/29/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1699897|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6064624|58710791|N|1||THE EVENTS OF LYMPHOMA AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT AND PRODUCT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX140-520|10/28/2016|||DA|*|*||0HP|FTR|1.0|01/29/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1699897|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6064624|58710792|D|1||HEALTHCARE PROFESSIONAL REPORTED PATIENT CAME INTO CLINIC ON B6 2016 WITH RIGHT-SIDE SEROMA FINE NEEDLE ASPIRATION FNA ON B6 2016 FOR FLOW CYTOMETRY TO RULE OUT BIA-ALCL INADEQUATE SAMPLE FNA REPEATED ON MONTH B6 2016 CYTOLOGY ON FNA WAS POSITIVE FOR ALCL EVENTS INVOLVE NATRELLE IMPLANT AS PATHOLOGICAL MARKERS CONFIRMING LYMPHOMA ALCL HAVE NOT BEEN RECEIVED THE EVENT OF CYTOLOGY ON FNA WAS POSITIVE FOR ALCL WILL BE CAPTURED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX140-520|10/28/2016|||DA|*|*||0HP|FTR|1.0|01/29/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1699897|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6135580|61143723|N|1||THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT AND PRODUCT HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-700|11/30/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6135580|61143724|D|1||HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE METASTATIC BIA ALCL AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE REPORTED AS LYMPHOMA|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-700|11/30/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6148888|61547076|D|1||REVIEWED JOURNAL ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN A PATIENT WITH LI-FRAUMENI SYNDROMEÂ¿ Â¿WE REPORT A UNIQUE CASE OF BIA-ALCL ARISING IN A PATIENT WITH LIÂ¿FRAUMENI SYNDROME AND GERMLINE MUTATIONS IN TP53 THE CASE IS NOTABLE FOR THE SHORT INTERVAL OF ONLY 3 YEARS BETWEEN THE PLACEMENT OF THE IMPLANTS AND THE DEVELOPMENT OF ALCL AFTER CAPSULECTOMY AND IMPLANT REMOVAL THE PATIENT HAD NO RECURRENCE OF BIA-ALCL WITH CLINICAL FOLLOW-UP OF 7 YEARSÂ¿ ARTICLE FURTHER STATES Â¿THE PATIENT NOTED ASYMMETRIC SWELLING OF THE RIGHT BREAST A FINE NEEDLE ASPIRATION OF A BREAST SEROMA WAS PERFORMED LEADING TO THE DIAGNOSIS OF BIAALCLÂ¿ SAMPLE WAS POSITIVE FOR CD30 AND NEGATIVE FOR ALK ARTICLE ALSO STATES DURING SUBSEQUENT YEARS THE PATIENT WAS DIAGNOSED WITH ADRENOCORTICAL CARCINOMASUBSEQUENTLY DEVELOPED METASTATIC ADRENOCORTICAL CARCINOMA TO LIVER AND LUNG MANUFACTURER OF THE DEVICE IS UNKNOWN THIS MEDWATCH IS FOR THE RIGHT SIDE DEVICE SEE MANUFACTURER REPORT  9617229-2016-00207 FOR LEFT SIDE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/06/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6148888|61547075|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN A PATIENT WITH LI-FRAUMENI SYNDROMEÂ¿ BY YI-SHAN LEE ARMANDO FILIE DIANE ARTHUR ANTONIO T FOJO AND ELAINE S JAFFE PUBLISHED IN HISTOPATHOLOGY 67 923Â¿935 IN 2015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LATE SEROMA CANCER AND LYMPHOMA-ALCL ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/06/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5820703|50386638|N|1||MEDWATCH SENT TO FDA ON 07252016 B4 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FOLLOW UP IS BEING PERFORMED TO OBTAIN DEVICE MANUFACTURER SERIAL NUMBER LOT NUMBER IMPLANT EXPLANT DATE IMPLANTINGEXPLANTING PHYSICIAN PATIENT NAME PATIENT DATE OF BIRTH DEVICE RETURN STATUS AND DEVICE RELATIONSHIP OF THE REPORTED EVENTS DEVICE HISTORY RECORD UNAVAILABLE AS DEVICE INFORMATION IS UNKNOWN DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MX-410520|07/25/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5820703|50386639|D|1||FOLLOWING CASE RECEIVED IN AN ARTICLE TITLED SKIN INVOLVEMENT AS THE FIRST MANIFESTATION OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ARTICLE STATES WE PRESENT A NEW CASE OF BREAST IMPLANT-ASSOCIATED ALCL WITH CUTANEOUS LESIONS MIMICKING CUTANEOUS METASTASES FROM A POORLY DIFFERENTIATED BREAST ADENOCARCINOMA DETAILS INCLUDE SEVERAL CUTANEOUS NODULES OF 2 MONTHSÂ¿ DURATION ON THE RIGHT BREASTÂ¿RADIOGRAPHIC FOLLOW-UP REVEALED A RIGHT SUPRACLAVICULAR MASS AND MULTIPLE ENLARGED LYMPH NODES PATIENT UNDERWENT A CORE NEEDLE BIOPSY OF THE MASS THAT REVEALED EXTENSIVE NECROSIS PATIENT WAS TREATED WITH CHEMOTHERAPY AND RADIATION THERAPY BUT NO IMPROVEMENTS WERE NOTED A SECOND ROUND OF CHEMOTHERAPY WAS PRESCRIBED BUT THE DISEASE PROGRESSED Â¿WITH PROGRESSIVE HARDENING OF THE RIGHT BREAST AND APPEARANCE OF SEVERAL CUTANEOUS LESIONSTHERE WERE ALSO SEVERAL POORLY CIRCUMSCRIBED ERYTHEMATOUS INDURATED PAPULESÂ¿THE PATIENT REPORTED MODERATE PAINÂ¿THE CT SCAN SHOWED A LARGE AMOUNT OF PERI-IMPLANT FLUIDÂ¿ TESTED CELLS Â¿WERE CD15 AND CD30 POSITIVE AND ALK-1 NEGATIVEÂ¿ PATIENT WAS DIAGNOSED WITH ALCL ASSOCIATED WITH A BREAST IMPLANT CAPSULE Â¿PATIENT WAS STARTED ON CHOP THERAPY AND THE BREAST IMPLANT WAS REMOVED PATIENT PRESENTED FEBRILE NEUTROPENIA DURING THE TREATMENT AND FINALLY PATIENT DIED FROM SEPTIC SHOCKÂ¿ AUTOPSY WAS REQUESTED BUT THE FAMILY REFUSED MANUFACTURER OF THE DEVICE IS UNKNOWN THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2016-00093 FOR THE LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MX-410520|07/25/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5820703|55107988|D|1||FOLLOWING CASE RECEIVED IN AN ARTICLE TITLED SKIN INVOLVEMENT AS THE FIRST MANIFESTATION OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ARTICLE STATES WE PRESENT A NEW CASE OF BREAST IMPLANT-ASSOCIATED ALCL WITH CUTANEOUS LESIONS MIMICKING CUTANEOUS METASTASES FROM A POORLY DIFFERENTIATED BREAST ADENOCARCINOMA DETAILS INCLUDE SEVERAL CUTANEOUS NODULES OF 2 MONTHSÂ¿ DURATION ON THE RIGHT BREASTÂ¿RADIOGRAPHIC FOLLOW-UP REVEALED A RIGHT SUPRACLAVICULAR MASS AND MULTIPLE ENLARGED LYMPH NODES PATIENT UNDERWENT A CORE NEEDLE BIOPSY OF THE MASS THAT REVEALED EXTENSIVE NECROSIS PATIENT WAS TREATED WITH CHEMOTHERAPY AND RADIATION THERAPY BUT NO IMPROVEMENTS WERE NOTED A SECOND ROUND OF CHEMOTHERAPY WAS PRESCRIBED BUT THE DISEASE PROGRESSED Â¿WITH PROGRESSIVE HARDENING OF THE RIGHT BREAST AND APPEARANCE OF SEVERAL CUTANEOUS LESIONSTHERE WERE ALSO SEVERAL POORLY CIRCUMSCRIBED ERYTHEMATOUS INDURATED PAPULESÂ¿THE PATIENT REPORTED MODERATE PAINÂ¿THE CT SCAN SHOWED A LARGE AMOUNT OF PERI-IMPLANT FLUIDÂ¿  TESTED CELLS Â¿WERE CD15 AND CD30 POSITIVE AND ALK-1 NEGATIVEÂ¿ PATIENT WAS DIAGNOSED WITH ALCL ASSOCIATED WITH A BREAST IMPLANT CAPSULE Â¿PATIENT WAS STARTED ON CHOP THERAPY AND THE BREAST IMPLANT WAS REMOVED PATIENT PRESENTED FEBRILE NEUTROPENIA DURING THE TREATMENT AND FINALLY PATIENT DIED FROM SEPTIC SHOCKÂ¿ AUTOPSY WAS REQUESTED BUT THE FAMILY REFUSED MANUFACTURER OF THE DEVICE IS UNKNOWN THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2016-00093 FOR THE LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MX-410520|07/25/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5820703|57630105|D|1||ADDITIONAL INFORMATION IN B6 2003 PATIENT WAS IMPLANTED WITH A NATRELLE BREAST IMPLANT 410MX 140-520 GEL TEXTURED SIZE UNKNOWN IMPLANTATION SITE UNKNOWN PATIENT EXPERIENCED AN ENLARGED RIGHT BREAST PATIENT WAS DIAGNOSED WITH RIGHT SIDE ALCL ON B6 2014 PATIENT RECEIVED FIRST CHOP CYCLE WITHOUT RESPONSE IN B6 2014 ASHAP CHEMOTHERAPY BETWEEN B6 2014 X 3 CYCLES THE DEVICE WAS EXPLANTED ON B6 2014 IMPLANT WAS PRESENT FOR 10 YEARS AND 9 MONTHS ETOPOSIDE + CISPLATIN BETWEEN B6 2014 X 3 CYCLES TREATMENT SUSPENDED DUE TO NEUTROPENIA ON B6 2014 PATIENT RECEIVED 1 CYCLE OF BRENTUXIMAB PATIENT THEN EXPERIENCED MULTI-ORGAN FAILURE AND DIED B6 2014 THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2016-00093 FOR THE LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MX-410520|07/25/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5761253|48540699|D|1||I WAS DIAGNOSED WITH BREAST CANCER IN MY RIGHT BREAST IN B6 2010 I CONTACTED A BREAST CANCER SURGEON AND SHE TOLD ME I NEEDED TO HAVE A MASTECTOMY SINCE THERE WERE 2 TUMORS IN DIFFERENT AREAS OF MY BREAST I ALSO CONTACTED A RECONSTRUCTIVEPLASTIC SURGEON I AGREED TO HAVE AN IMPLANT PUT IN AT THE SAME TIME AS MY SURGERY THE PLASTIC SURGEON PUT IN A TISSUE EXPANDER FOR THREE MONTHS AND ON B6 2011 I HAD AN ALLERGAN TEXTURED BREAST IMPLANT PUT IN THE STYLE OF THE IMPLANT HAD NOT BEEN APPROVED BY THE FDA YET SO I SIGNED A CONSENT FORM TO BE PART OF A STUDY I READ THE AGREEMENT THOROUGHLY AND THERE WERE ONLY TWO POSSIBLE RISKS INFECTION OR COMPARTMENT CONTRACTURE THERE WAS NO MENTION OF LYMPHOMA CANCER APPROXIMATELY 2 YEARS LATER THE FDA APPROVED THIS STYLE IMPLANT AND THE STUDY WAS ENDED ON B6 2016 MY RIGHT BREAST BECAME TIGHT AND HARD IN THE NEXT FEW DAYS IT BECAME LARGER AND LARGER I CONTACTED MY PLASTIC SURGEON AND SHE ASKED ME TO TAKE A PICTURE OF MY BREAST AND SEND TO HER SINCE I WAS OUT OF TOWN AT THE TIME SHE ORDERED AN ANTIBIOTIC AND MADE AN APPOINTMENT FOR ME TO SEE HER THE FOLLOWING WEEK I WENT TO SEE HER AND SHE TOOK MORE PICTURES AND TOLD ME IT WAS PROBABLY AN INFECTION AND I SHOULD CONTINUE ANTIBIOTIC MY BREAST GOT BIGGER AND BIGGER AND MY SURGEON DECIDED TO REMOVE MY IMPLANT DURING THE SURGERY SHE TOOK A TISSUE SAMPLE AND THEN PUT IN A NEW TEXTURED IMPLANT AND CLOSED UP INCISION ON B6 THE PATHOLOGY REPORT CAME BACK WITH THE DIAGNOSIS OF ALCL IT WAS CONFIRMED BY A PET CT SCAN MY SURGEON SAID THAT SHE KNEW THE DOCTOR WHO SPECIALIZED IN ALCL AND THAT HE WAS AT THE B6 MY HUSBAND AND I FLEW TO B6 TO HAVE IMPLANT AND SURROUNDING SCAR TISSUE REMOVED BY THE SURGEONS WHO ARE THE AUTHORITY ON THIS DISEASE ALSO THE RESEARCH ON THIS DISEASE IS BEING DONE BY A TEAM THERE THEY HAVE SEEN MOST OF THE DIAGNOSED CASES IN THE US I HAD OTHER TESTS DONE THERE AN ULTRASOUND AND A CHEST X-RAY I SPOKE WITH THE DOCTOR AND HE TOLD ME THAT THE LYMPHOMA WAS ONLY IN THE FLUID SURROUNDING THE IMPLANT AND NOT IN THE SCAR TISSUE CAPSULE OR IN MY LYMPH NODES I HAD THE SURGERY ON B6 2016 AND WAS INFORMED THAT ALL OF THE CANCER CELLS WERE REMOVED AND I WAS NOW CANCER FREE I DECIDED TO HAVE A SMOOTH SILICONE IMPLANT PUT IN DURING THE SURGERY RATHER THAN COME BACK LATER FOR ADDITIONAL RECONSTRUCTION THE DOCTOR TOLD ME THAT NONE OF THE ALCL CASES HAD EVER INVOLVED A SMOOTH IMPLANT I ALSO AGREED TO HAVE A PET CT SCAN EVERY 6 MONTHS TO BE SURE THERE WERE NO NEW CANCER CELLS|NATRELLE TEXTURED BREAST IMPLANT||06/27/2016||||N|*||I|FTR|1.0||BREAST IMPLANT|||||||ALLERGAN|||||||True
6176705|62451142|N|1||B4 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176705|62451143|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 PATIENT WHO WAS IMPLANTED WITH A LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN THE ARTICLE ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED SEROMA AND DISRUPTED IMPLANT TREATMENT REPORTED AS IMPLANT REMOVAL AND RADIOTHERAPY B6 FOLLOW-UP FOUND NO EVIDENCE OF DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176730|62445769|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176730|62445770|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 YEAR-OLD PATIENT WHO WAS IMPLANTED WITH A RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN THE ARTICLE ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED SEROMA TREATMENT REPORTED AS IMPLANT REMOVAL FOLLOW-UP FOUND NO EVIDENCE OF DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176886|62453117|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 OLD PATIENT WHO WAS IMPLANTED WITH A RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN THE ARTICLE ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED MASS SEROMA AND DISRUPTED IMPLANT TREATMENT REPORTED AS IMPLANT REMOVAL AND CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE AND PREDNISONE 6 CURES CHOP OR CHOP-LIKE FOLLOW-UP FOUND NO EVIDENCE OF DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176886|62453116|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA SEROMA AND MASS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6146425|61492492|N|1||THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA ARTICLE CITATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA A CASE REPORT AND LITERATURE REVIEW LETTER HALEY ROP BAIYWO EDISON MICHELE N TURNER PATRICIA CUREUS 2016 VOL 8 NO 3 PP E546 ELECTRONIC PUBLICATION DATE 26 MAR 2016 JOURNAL CODE 101596737 B4|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/05/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6146425|61492493|D|1||JOURNAL ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA A CASE REPORT AND LITERATURE REVIEWÂ¿ ABSTRACT STATES Â¿PATIENT PRESENTED WITH SEVERAL WEEKS OF PAIN AND FIRMNESS IN PATIENT RIGHT BREAST MRI AND ULTRASOUND DEMONSTRATED A PERI-IMPLANT FLUID COLLECTION ULTRASOUND-GUIDED ASPIRATION REVEALED ANAPLASTIC LARGE CELL LYMPHOMA THE PATIENT WAS TREATED WITH IMPLANT REMOVAL ALONE AND HAS NOW BEEN IN REMISSION FOR 3 YEARSÂ¿ PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT YET BEEN RECEIVED THEREFORE THE EVENT WILL BE REPORTED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/05/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6176855|62446706|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6176855|62446707|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 PATIENT WHO WAS IMPLANTED WITH A LEFT SIDE TEXTURED SALINE IMPLANT DEVICE MANUFACTURER UNKNOWN THE ARTICLE ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED SEROMA TREATMENT REPORTED AS IMPLANT REMOVAL FOLLOW-UP FOUND NO EVIDENCE OF DISEASE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6176798|62453768|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176798|62453769|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 PATIENT WHO WAS IMPLANTED WITH A RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN THE ARTICLE ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED SEROMA TREATMENT REPORTED AS IMPLANT REMOVAL FOLLOW-UP FOUND NO EVIDENCE OF DISEASE THIS MEDWATCH IS FOR THE RIGHT SIDE MFR 9617229-2016-00240 REPRESENTS THE LEFT SIDE DEVICE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6153200|61697779|D|1||LITERATURE ARTICLE Â¿COMPLETE SURGICAL EXCISION IS ESSENTIAL FOR THE MANAGEMENT OF PATIENTS WITH BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿87 PATIENTS WITH BI-ALCL INCLUDING 50 PREVIOUSLY REPORTED IN THE LITERATURE AND 37 UNREPORTEDÂ¿ ARTICLE CONTINUES TO STATE Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMA BI-ALCL IS A RARE TYPE OF T-CELL LYMPHOMA THAT ARISES AROUND BREAST IMPLANTS THE OPTIMAL MANAGEMENT OF THIS DISEASE HAS NOT BEEN ESTABLISHED THE GOAL OF THIS STUDY IS TO EVALUATE THE EFFICACY OF DIFFERENT THERAPIES USED IN PATIENTS WITH BI-ALCL TO DETERMINE AN OPTIMAL TREATMENT APPROACHÂ¿ Â¿THE MEDIAN AND MEAN FOLLOW-UP TIMESWERE 45 AND 30 MONTHS RESPECTIVELY RANGE 3 TO 217 MONTHS THE MEDIAN OVERALL SURVIVAL OS TIME AFTER DIAGNOSIS OF BI-ALCL WAS 13 YEARS AND THE OS RATE WAS 93AND 89AT 3 AND 5 YEARS RESPECTIVELY PATIENTS WITH LYMPHOMA CONFINED BY THE FIBROUS CAPSULE SURROUNDING THE IMPLANT HAD BETTER EVENT-FREE SURVIVAL EFS AND OS THAN DID PATIENTS WITH LYMPHOMA THAT HAD SPREAD BEYOND THE CAPSULE P = 03 PATIENTS WHO UNDERWENT A COMPLETE SURGICAL EXCISION THAT CONSISTED OF TOTAL CAPSULECTOMY WITH BREAST IMPLANT REMOVAL HAD BETTER OSP = 022 AND EFSP = 014 THAN DID PATIENTS WHO RECEIVED PARTIAL CAPSULECTOMY SYSTEMIC CHEMOTHERAPY OR RADIATION THERAPYÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH THERAPIES OR DEVICE TYPE THIS REPORT WILL CAPTURE 37 UNREPORTED CASES OF ALCL  LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6153200|61697778|N|1||THE EVENT OF LYMPHOMA ALCL IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL Â¿COMPLETE SURGICAL EXCISION IS ESSENTIAL FOR THE MANAGEMENT OF PATIENTS WITH BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ MARK W CLEMENS L JEFFREY MEDEIROS CHARLES E BUTLER KELLY K HUNT MICHELLE A FANALE STEVEN HORWITZ DENNIS D WEISENBURGER JUN LIU ELIZABETH A MORGAN RASHMI KANAGAL-SHAMANNA VINITA PARKASH JING NING ALIYAH R SOHANI JUDITH A FERRY NEHA MEHTA-SHAH AHMED DOGAN HUI LIU NORA THORMANN ARIANNA DI NAPOLI STEPHEN LADE JORGE PICCOLINI RUBEN REYES TRAVIS WILLIAMS COLLEEN M MCCARTHY SUMMER E HANSON LORETTA J NASTOUPIL RAKESH GAUR YASUHIRO OKI KEN H YOUNG AND ROBERTO N MIRANDA JOURNAL OF CLINICAL ONCOLOGY VOLUME 34 NUMBER 2 JANUARY 10 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6011951|56916914|D|1||THROUGH ALLERGANS LITERATURE REVIEW OF RECENT JOURNAL ARTICLES WE RECEIVED THE FOLLOWING ARTICLE FROM MEDICAL SAFETY BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN B6 HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGY TABLE 4 PRESENTATION OF BIA-ALCL N=46 IN THE ARTICLE REPORTS THE FOLLOWING 2 CASES OF SEROMA AND CAPSULAR CONTRACTURE CONTRALATERAL THIS RECORD HAS BEEN CREATED THE CAPTURE THE 2 EVENTS OF CAPSULAR CONTRACTURE CONTRALATERAL EVENT OF SEROMA HAS BEEN CAPTURED IN MDR  9617229-2016-00142 THE ARTICLE DOES NOT PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL OR LOT INFORMATION OR SIDES OF ALCL DIAGNOSIS MANUFACTURER COULD NOT BE SPECIFIED AND ARTICLE STATES BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED FOR 571 OF IMPLANTS IN THIS SERIES ARTICLE STATES ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY AND REMOVAL OF IMPLANTS BOTH ON DISEASED AND NON-DISEASED SIDE ALL TUMORS WERE CD30 POSITIVE AND ALK NEGATIVE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5864951|51736729|N|1||MEDWATCH SENT TO FDA ON 08102016 B4 CONCOMITANT MEDICAL PRODUCTS FOLIC ACID D3 VITAMIN CALCIUM CARBONATE OMEGA 3 PAST MEDICAL HISTORY OF HYDROXYCHLOROQUINE THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL PATIENTS SHOULD BE ADVISED THAT CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWING INFECTION HEMATOMA AND SEROMA AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL CHANGES BREAST SENSATION HEMATOMASEROMA AND LYMPHADENOPATHY|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|N-27-120181|08/10/2016|||DA|N|R||0HP|FTR|1.0|02/20/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2243522|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5864951|51736730|D|1||ENGLISH PRODUCT FIELD NOTE PFN RECEIVED VIA EMAIL REPORTS LEFT SIDE THE PATIENT HAS ALLERGAN PROSTHESIS AND WAS DIAGNOSED WITH ALCL ANAPLASTIC LARGE CELL LYMPHOMA ADENOPATHY AXILLARY ENCAPSULATION WITH INFLAMMATORY PROCESS AND SUPERIOR INTERIOR INTRACAPSULAR LIQUID PATHOLOGIC DIAGNOSTIC OF NON-HODGKIN LYMPHOMA ALK NEGATIVE ANAPLASTIC LYMPHOMA ALK NEGATIVE CD 30+ ASSOCIATED TO BREAST PROSTHESIS CLINICAL STATUS II E  PATIENT HAS A MEDICAL HISTORY OF PRIMARY SJOGREN SYNDROME ON B6 2015 MRI FOUND BIGGER VOLUME OF THE LEFT BREAST AND EDEMA ON SUBCUTANEOUS LAYER PERIPROSTHETIC LIQUID WAS ALSO NOTED PATIENT PRESENTED PAIN NOT RELATED TO THE DEVICE ONE WEEK AFTER THE MRI ON B6 2015 IT WAS NOTED CAPSULAR CONTRACTURE ON B6 2015 A MRI DETECTED A MASS ON THE SUPERIOR AREA OF THE LEFT BREAST BIOPSY OF THE INJURY CAME NEGATIVE ON B6 2016 PATIENT PALPATED LEFT AXILLARY ADENOPATHY ON B6 2016 DURING CONSULTATION IT WAS NOTED NO SIGNALS OF RUPTURE SMALL MASS ON SUPERIOR LEFT PROSTHESIS ON CONSULTATION WITH HEALTHCARE PROFESSIONAL BIOPSY WAS PERFORMED WHICH CONFIRMED LYMPHOMA OF ANAPLASTIC T CELLS ALK - PERIPROSTHETIC LIQUID WAS ALSO NOTED EXPLANT DATE PROVIDED AS B6 2016 IMPLANT WAS NOT REPLACED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|N-27-120181|08/10/2016|||DA|N|R||0HP|FTR|1.0|02/20/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2243522|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5864951|63818637|D|1||ENGLISH PRODUCT FIELD NOTE PFN RECEIVED VIA EMAIL REPORTS Â¿LEFT SIDE THE PATIENT HAS ALLERGAN PROSTHESIS AND WAS DIAGNOSED WITH ALCL ANAPLASTIC LARGE CELL LYMPHOMA ADENOPATHY AXILLARY ENCAPSULATION WITH INFLAMMATORY PROCESS AND SUPERIOR INTERIOR INTRACAPSULAR LIQUID PATHOLOGIC DIAGNOSTIC OF NON-HODGKIN LYMPHOMA ALK NEGATIVE ANAPLASTIC LYMPHOMA ALK NEGATIVE CD 30+ ASSOCIATED TO BREAST PROSTHESIS CLINICAL STATUS II EÂ¿ PATIENT HAS A MEDICAL HISTORY OF PRIMARY SJOGREN SYNDROME ON B6 2015 MRI FOUND BIGGER VOLUME OF THE LEFT BREAST AND EDEMA ON SUBCUTANEOUS LAYER PERIPROSTHETIC LIQUID WAS ALSO NOTED PATIENT PRESENTED PAIN NOT RELATED TO THE DEVICE ONE WEEK AFTER THE MRI ON B6 2015 IT WAS NOTED CAPSULAR CONTRACTURE ON B6 2015 A MRI DETECTED A MASS ON THE SUPERIOR AREA OF THE LEFT BREAST BIOPSY OF THE INJURY CAME NEGATIVE ON B6 2016 PATIENT PALPATED LEFT AXILLARY ADENOPATHY ON B6 2016 DURING CONSULTATION IT WAS NOTED NO SIGNALS OF RUPTURE SMALL MASS ON SUPERIOR LEFT PROSTHESIS ON CONSULTATION WITH HEALTHCARE PROFESSIONAL BIOPSY WAS PERFORMED WHICH CONFIRMED LYMPHOMA OF ANAPLASTIC T CELLS ALK - PERIPROSTHETIC LIQUID WAS ALSO NOTED EXPLANT DATE PROVIDED AS B6 2016 IMPLANT WAS NOT REPLACED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|N-27-120181|08/10/2016|||DA|N|R||0HP|FTR|1.0|02/20/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2243522|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5864951|60014363|D|1||B4 PRODUCT FIELD NOTE PFN RECEIVED VIA EMAIL REPORTS LEFT SIDE THE PATIENT HAS ALLERGAN PROSTHESIS AND WAS DIAGNOSED WITH ALCL ANAPLASTIC LARGE CELL LYMPHOMA ADENOPATHY AXILLARY ENCAPSULATION WITH INFLAMMATORY PROCESS AND SUPERIOR INTERIOR INTRACAPSULAR LIQUID PATHOLOGIC DIAGNOSTIC OF NON-HODGKIN LYMPHOMA ALK NEGATIVE ANAPLASTIC LYMPHOMA ALK NEGATIVE CD 30+ ASSOCIATED TO BREAST PROSTHESIS CLINICAL STATUS II E  PATIENT HAS A MEDICAL HISTORY OF PRIMARY SJOGREN SYNDROME ON B6 2015 MRI FOUND BIGGER VOLUME OF THE LEFT BREAST AND EDEMA ON SUBCUTANEOUS LAYER PERIPROSTHESTIC LIQUID WAS ALSO NOTED PATIENT PRESENTED PAIN NOT RELATED TO THE DEVICE ONE WEEK AFTER THE MRI ON B6 2015 IT WAS NOTED CAPSULAR CONTRACTURE ON B6 2015 A MRI DETECTED A MASS ON THE SUPERIOR AREA OF THE LEFT BREAST BIOPSY OF THE INJURY CAME NEGATIVE ON B6 2016 PATIENT PALPATED LEFT AXILLARY ADENOPATHY ON B6 2016 DURING CONSULTATION IT WAS NOTED NO SIGNALS OF RUPTURE SMALL MASS ON SUPERIOR LEFT PROSTHESIS ON CONSULTATION WITH HEALTHCARE PROFESSIONAL BIOPSY WAS PERFORMED WHICH CONFIRMED LYMPHOMA OF ANAPLASTIC T CELLS ALK - PERIPROSTHESTIC LIQUID WAS ALSO NOTED EXPLANT DATE PROVIDED AS B6 2016 IMPLANT WAS NOT REPLACED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|N-27-120181|08/10/2016|||DA|N|R||0HP|FTR|1.0|02/20/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2243522|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6037704|57781488|D|1||HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE SPONTANEOUS SEROMA AND LYMPHOMA ALCL ON B6 2016 A COMPLETE CAPSULECTOMY AND EXPLANT OCCURRED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSX525|10/18/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2433989|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6037704|57781486|N|1||THE EVENTS OF SEROMA AND LYMPHOMA ALCL ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE HISTORY REVIEW DHR SUMMARY REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS DHR FOR WORK ORDER B4 INDICATES THAT THERE WAS A REPROCESS ON THE PRIMARY PACKAGING OPERATION IN WHICH THE REPORTED DEVICE WAS REPROCESSED HOWEVER REVIEW OF THE REPROCESS OF WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES THAT MAY BE ASSOCIATED WITH THE REPORTED DEVICE EVENT THE DHR ASSEMBLY REPORT FROM SAP WAS VERIFIED AND THERE WAS NOT ANY SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS IN ADDITION DHR FOR SHELL RUN NUMBER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING SHELL FABRICATION PROCESS ALL SHELLS WERE REVIEWED AS PART OF THE SHELL FABRICATION OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT FABRICATION MET THE REQUIRED SPECIFICATIONS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSX525|10/18/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2433989|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6153112|61699206|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS TABLE 1Â¿ ARTICLE GOES ON TO STATE Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG OF TISSUE CAPSULE 49 Ã 106 CELLSMG OF TISSUE ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS P  005 IN CONTRAST SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED ARTICLE FURTHER STATES Â¿NONTUMOR CAPSULE SPECIMENS FROM 62 PATIENTS UNDERGOING REVISION SURGERY FOR HIGH-GRADE CAPSULAR CONTRACTUREÂ¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE THIS REPORT WILL CAPTURE 62 CASES OF NONTUMOR NON ALCL CAPSULAR CONTRACTURE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5343961|35063341|N|1||B4 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-630|01/05/2016||03/17/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||339918|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5488680|39947737|N|1||DEVICE LABELING ADDRESSES LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF THE REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST STUDIES EVALUATING THE CAPSULES AROUND TEXTURED EXPANDERS HAVE REPORTED POSSIBLE SILICONE PARTICLES WITH GIANT CELLS INDICATIVE OF LOCAL AND NON SPECIFIC FOREIGN BODY REACTION AND SILICONE GRANULOMA FORMATION|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|03/09/2016|||DA|N|R||0HP|FTR|1.0|02/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||276452|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5488680|39947738|D|1||PATIENT REPORTED DIAGNOSED WITH BREAST IMPLANT ASSOCIATED ALCL PATIENT SOUGHT CONSULT AFTER EXPERIENCING A LOT OF SWELLING THE IMPLANT WAS REMOVED AND PATHOLOGY RESULTS CONFIRMED ALCL FURTHER FOLLOW-UP PROVIDED INDICATED IT WAS THE RIGHT BREAST CYTOPATHOLOGY REPORT STATES FINE NEEDLE ASPIRATION RIGHT BREAST Â¿ 5 ML OF CLOUDY ORANGE FLUID Â¿ BREAST ASPIRATE FROM IMPLANT CAPSULE FOLLOWED BY Â¿POSITIVE ANTIBODIES CD30 STRONGÂ¿ AND Â¿NEGATIVE ANTIBODIES ALK1 CONCLUSIONS REPORTED AS Â¿THIS IMMUNOPHENOTYPE IS TYPICAL OF THAT SEEN IN BREAST-IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ ADDITIONALLY PHYSICIAN NOTES RECEIVED DOCUMENTED A PRIOR 4 X 7 MM SIMPLE CYST AT 1100 OÂ¿CLOCK IN THE RIGHT BREAST HISTOPATHOLOGY REPORT NOTED CAPSULE HAD FOREIGN BODY GRANULOMATOUS AND LYMPHOID REACTION|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|03/09/2016|||DA|N|R||0HP|FTR|1.0|02/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||276452|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5488680|41343420|D|1||PATIENT REPORTED DIAGNOSED WITH BREAST IMPLANT ASSOCIATED ALCL PATIENT SOUGHT CONSULT AFTER EXPERIENCING A LOT OF SWELLING THE IMPLANT WAS REMOVED AND PATHOLOGY RESULTS CONFIRMED ALCL FURTHER FOLLOW-UP PROVIDED INDICATED IT WAS THE RIGHT BREAST CYTOPATHOLOGY REPORT STATES FINE NEEDLE ASPIRATION RIGHT BREAST - 5 ML OF CLOUDY ORANGE FLUID - BREAST ASPIRATE FROM IMPLANT CAPSULE FOLLOWED BY - POSITIVE ANTIBODIES CD30 STRONG- AND - NEGATIVE ANTIBODIES ALK1 CONCLUSIONS REPORTED AS THIS IMMUNOPHENOTYPE IS TYPICAL OF THAT SEEN IN BREAST-IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ADDITIONALLY PHYSICIAN NOTES RECEIVED DOCUMENTED A PRIOR 4 X 7 MM SIMPLE CYST AT 1100 OCLOCK IN THE RIGHT BREAST HISTOPATHOLOGY REPORT NOTED CAPSULE HAD FOREIGN BODY GRANULOMATOUS AND LYMPHOID REACTION|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|03/09/2016|||DA|N|R||0HP|FTR|1.0|02/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||276452|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5844861|51109570|D|1||HEALTHCARE PROFESSIONAL REPORTED A LEFT SIDE SUSPICION OF ALCL PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED THE EVENT OF Â¿SUSPICION OF ALCLÂ¿ WILL REMAIN CAPTURED AS LYMPHOMA FOR NOW THERE IS NO INTENTION OF PROSTHESIS REPLACEMENT HEALTHCARE PROFESSIONAL ADDITIONALLY REPORTED Â¿PATIENT ALSO PRESENTS SEROMAÂ¿ Â¿SLIGHTLY HARDENEDÂ¿ AND Â¿THICK CAPSULE AROUND DEVICEÂ¿|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/03/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5844861|51109569|N|1||THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FOLLOW UP HAS BEEN CONDUCTED TO DETERMINE THE FOLLOWING INFORMATION SERIAL NUMBER LOT NUMBER IMPLANT DATE PATIENT NAME PATIENT DATE OF BIRTH PATHOLOGICAL TESTING RESULTS DETERMINATION IF SURGERY WILL BE SCHEDULED AND DEVICE RELATIONSHIP OF THE REPORTED EVENTS DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/03/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5844861|55353371|D|1||MEDICAL PROFESSIONAL DETERMINED THAT WHILE THERE IS A LATE SEROMA THERE IS NO EVIDENCE OF ALCL AND ALL LATE SEROMAS ARE NOT ALCL PATIENT HAS HAD NO DIAGNOSTIC PROCEDURE OTHER THAN AN ULTRASOUND TO DIAGNOSIS THE PRESENCE OF FLUID THEREFORE THE EVENT OF LYMPHOMA WILL NOT BE USED AT THIS TIME|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/03/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5607727|43625363|N|1||MEDWATCH SENT TO FDA ON 04262016 THE REPORTER OF THE EVENT WAS ASKED TO RETURN THE PRODUCT FOR ANALYSIS ALLERGAN HAS NOT RECEIVED THE PRODUCT AT THIS TIME THEREFORE NO ANALYSIS OR TESTING HAS BEEN DONE THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF THE REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410420|04/26/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5672723|45694207|N|1||MEDWATCH SENT TO THE FDA ON 05232016 THE REPORTER OF THIS EVENT WAS NOT IDENTIFIED BY THE REGULATORY AGENCY ALLERGAN HAS NOT RECEIVED THE PRODUCT AT THIS TIME THEREFORE NO ANALYSIS OR TESTING HAS BEEN DONE THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT THE REPORTER OF THIS EVENT WAS NOT IDENTIFIED BY THE REGULATORY AGENCY THEREFORE NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE HISTORY REVIEW REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT WAS VERIFIED AND THERE WAS NOT ANY SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS IN ADDITION DHR FOR SHELL RUN NUMBER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING SHELL FABRICATION PROCESS ALL SHELLS WERE REVIEWED AS PART OF THE SHELL FABRICATION OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT FABRICATION MET THE REQUIRED SPECIFICATIONS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF THE REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|05/23/2016||||N|R||0HP|FTR|1.0|09/19/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1139476|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5672723|45694208|D|1||PHYSICIAN REPORTS PATIENT HAS BEEN DIAGNOSED WITH ANAPLASTIC LARGE CELL LYMPHOMA ALCL AT THE RIGHT BREAST IT CONCERNS A DIAGNOSE OF ALCL CD30+ AND ALK- FOLLOWING THE IDENTIFICATION OF PERIPROSTHETIC SEROMA WITH A BREAST IMPLANT THAT HAD BEEN IMPLANTED 10 YEAR AGO CAPSULECTOMY PERFORMED AND DEVICE EXPLANTED|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|05/23/2016||||N|R||0HP|FTR|1.0|09/19/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1139476|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6153064|61697996|N|1||ARTICLE CITATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA CASE REPORT OF AN UNDIAGNOSED FORM MANAGEMENT AND RECONSTRUCTION ALCL BY S ALHAMAD S GUERID EH EL FAKIR P BIRON C TOURASSE E DELAY PUBLISHED 062016 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6153076|61697270|N|1||THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION HEMATOMASEROMA BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ 137 6 1659-1669 BY HONGHUA HU PHD KHALID JOHANI AHMAD ALMATROUDI KAREN VICKERY PHD BVSC BRUCE VAN NATTA MD MARSHALL E KADIN MD GARRY BRODY MD MARK CLEMENS MD CHAN YOON CHEAH MD STEPHEN LADE MD PREETI AVINASH JOSHI MDPHD H MILES PRINCE MDPHD ANAND K DEVA BSCMED MBBS MS PUBLISHED JUNE 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6153076|61697271|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS TABLE 1Â¿ ARTICLE GOES ON TO STATE Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG OF TISSUE CAPSULE 49 Ã 106 CELLSMG OF TISSUE ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS P  005 IN CONTRAST SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED ARTICLE ADDITIONALLY REPORTS Â¿COMPARED WITH CLASSIC SYSTEMIC ALCL BREAST IMPLANTÂ¿ ASSOCIATED ALCL BEHAVES IN A MORE INDOLENT MANNER AND IS DIVIDED INTO PATHOLOGIC VARIETIES THE SEROMA-TYPE CONSISTING OF EFFUSIONS WITH AN ENCAPSULATING MARGIN OF CD30+ MALIGNANT LYMPHOCYTES THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE OR TESTED NEGATIVE FOR BACTERIAL INFECTION THIS REPORT WILL CAPTURE 12 CASES OF ALCL WHICH PRESENTED AS EFFUSION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5793065|54159657|D|1||MEDICAL STAFF REPORTS ALCL RELATED TO THE IMPLANT ON THE RIGHT SIDE ACL CD30+ ALK NEGATIVE EXPLANT SURGERY CAPSULECTOMY AND SAMPLING OF PALPABLE NODULES IN THE AXILLARY TAIL OF THE RIGHT BREAST AND THE AXILLARY HOLLOW RIGHT NO BREAK PERI-PROSTHETIC SERUM DOUBLE CAPSULE YELLOWING OF THE IMPLANT FLUID OUTPOURING CITRINE AND CLOUDY APPEARANCE AND TISSUE DEPOSITS THE DEVICE HAS BEEN EXPLANTED THIS RECORD RELATES TO THE RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5793065|69889264|D|1||MEDICAL STAFF REPORTS ALCL RELATED TO THE IMPLANT ON THE RIGHT SIDE ACL CD30+ ALK NEGATIVE EXPLANT SURGERY CAPSULECTOMY AND SAMPLING OF PALPABLE NODULES IN THE AXILLARY TAIL OF THE RIGHT BREAST AND THE AXILLARY HOLLOW RIGHT NO BREAK PERI-PROSTHETIC SERUM DOUBLE CAPSULE YELLOWING OF THE IMPLANT FLUID OUTPOURING CITRINE AND CLOUDY APPEARANCE AND TISSUE DEPOSITS THE DEVICE HAS BEEN EXPLANTED THIS RECORD RELATES TO THE RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5793065|49492130|D|1||MEDICAL STAFF REPORTS ALCL RELATED TO THE IMPLANT ON THE RIGHT SIDE ACL CD30+ ALK NEGATIVE EXPLANT SURGERY CAPSULECTOMY AND SAMPLING OF PALPABLE NODULES IN THE AXILLARY TAIL OF THE RIGHT BREAST AND THE AXILLARY HOLLOW RIGHT NO BREAK PERI-PROSTHETIC SERUM DOUBLE CAPSULE YELLOWING OF THE IMPLANT FLUID OUTPOURING CITRINE AND CLOUDY APPEARANCE AND TISSUE DEPOSITS THE DEVICE HAS BEEN EXPLANTED THIS RECORD RELATES TO THE RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5793065|68234084|D|1||MEDICAL STAFF REPORTS ALCL RELATED TO THE IMPLANT ON THE RIGHT SIDE ACL CD30+ ALK NEGATIVE EXPLANT SURGERY CASULECTOMY AND SAMPLING OF PALPABLE NODULES IN THE AXILLARY TAIL OF THE RIGHT BREAST AND THE AXILLARY HOLLOW RIGHT NO BREAK PERI-PROSTHETIC SERUM DOUBLE CAPSULE YELLOWING OF THE IMPLANT FLUID OUTPOURING CITRINE AND CLOUDY APPEARANCE AND TISSUE DEPOSITS THE DEVICE HAS BEEN EXPLANTED THIS RECORD RELATES TO THE RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5793065|49492129|N|1||MEDWATCH SENT TO FDA ON 07132016 B4 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE DOES NOT GENERALLY ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT SERIAL NUMBER IS NOT AVAILABLE AT THIS TIME IT IS NOT KNOWN IF THE DEVICE WILL BE RETURNED REQUEST FOR INFORMATION HAS BEEN PERFORMED DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL DEVICE HISTORY RECORD REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT FROM ORACLE WAS VERIFIED AND THERE WAS NOT ANY SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS IN ADDITION DHR FOR SHELL RUNS NUMBER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING SHELL FABRICATION PROCESS ALL SHELLS WERE REVIEWED AS PART OF THE SHELL FABRICATION OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT FABRICATION MET THE REQUIRED SPECIFICATIONS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6143087|61396767|D|1||ABSTRACT OF LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ REPORTED Â¿19 I-ALCLSÂ¿ CASES ONE OF THE TWO CLINICAL PRESENTATIONS REPORTED WAS Â¿TUMOR MASSÂ¿ 2 PATIENTS EXPERIENCED ALCL AND MASS THIS RECORD REPRESENTS THE 2 CASES OF ALCL WHICH PRESENTED AS TUMOR MASS HISTOPATHOLOGY REPORTS THAT MALIGNANT CELLS WERE CD30-POSITIVE AND WERE ALK NEGATIVE ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IN REGARDS TO TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL WAS PERFORMED IN 17 OUT OF 19 PATIENTS WITH ADDITIONAL TREATMENT BASED ON MOSTLY CHOP OR CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 OR IRRADIATION N = 119 CHOP ALONE OR ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL HAVE BEEN GIVEN IN TWO PATIENTSÂ¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH TREATMENTS WERE USED IN THESE 11 CASES MANUFACTURER OF DEVICES IS UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/02/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6143087|62805862|D|1||ABSTRACT OF LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ A B6-YEAR-OLD PATIENT WHO WAS IMPLANTED WITH AN UNKNOWN IMPLANT DEVICE MANUFACTURER UNKNOWN PATIENT WAS DIAGNOSED WITH ALCL THE CHART ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED A LEFT SIDE MASS IT IS UNKNOWN IF THE IMPLANT WAS REMOVED TREATMENT WAS REPORTED AS ADRIAMYCINE BLEOMYCINE VINBLASTINE AND DACARBAZINE ABVD AND RADIOTHERAPY 30GY FOLLOW-UP FOUND NO EVIDENCE OF DISEASE THIS REPORT WAS INITIALLY SENT TO REPRESENT TWO PATIENTS DUE TO THE DISCOVERY OF IDENTIFYING INFORMATION THIS SUPPLEMENTAL REPORT WILL NOW REPRESENT THE B6 YEAR-OLD PATIENT DEVICE AND MFR  9617229-2016-00195 HAVE BEEN SENT TO REPRESENT THE OTHER PATIENT PREVIOUSLY REPRESENTED THE INITIAL REPORT OF MFR  9617229-2016-00196|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/02/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6143087|61396766|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL AND LUMPNODULE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/02/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6177272|62460335|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 PATIENT WHO WAS IMPLANTED WITH A TEXTURED SALINE IMPLANT DEVICE MANUFACTURER UNKNOWN THE ARTICLE ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED A RIGHT SEROMA AND Â¿DISRUPTED IMPLANTÂ¿ TREATMENT REPORTED AS IMPLANT REMOVAL AND Â¿CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE AND PREDNISONE 6 CURES CHOP OR CHOP-LIKE FOLLOW-UP FOUND Â¿NO EVIDENCE OF DISEASEÂ¿|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6177272|62460334|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6139636|61290118|D|1||PHYSICIAN REPORTED LARGE BLOOD STAINED FLUID COLLECTION LEADING TO FURTHER EXPLORATION AND FIBRINOUS TISSUE WAS REMOVED AND SENT FOR HISTOLOGY DIAGNOSIS OF ALCL CONFIRMED BY EXPERT HAEMATOLOGY PANEL PHYSICIAN REPORTED EXPLANTED DUE TO PERSISTENT FLUID COLLECTION DIAGNOSIS OF BI-ALCL MADE AFTER THIS PROCEDURE ALCL WAS DIAGNOSED ON B6 2016|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRLP250|12/01/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2429970|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6139636|61290117|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP HAS BEEN PERFORMED AND DEVICE WILL NOT BE RETURNED IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT IN A SUPPLEMENTAL REPORT EVENT OF HEMATOMA WAS PREVIOUSLY REPORTED VIA RESPONSIVE PSR ON B6 2016 THE EVENTS OF LATE SEROMA AND LYMPHOMA-ALCL ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRLP250|12/01/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2429970|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5697584|46502156|D|1||THE FOLLOWING JOURNAL ARTICLE WAS REVIEWED Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORT OF 2 CASES AND REVIEW OF THE LITERATUREÂ¿ THE AUTHORS REPORTED THAT A PATIENT Â¿PRESENTED WITH A 6-WEEK HISTORY OF RIGHT BREAST SWELLINGÂ¿ Â¿NINE YEARS EARLIER THE PATIENT HAD UNDERGONE BILATERAL SUBMUSCULAR BREAST AUGMENTATION WITH 510-CC TEXTURED SALINE BIOCELL IMPLANTS ALLERGAN B64 THE PATIENTS MEDICAL HISTORY REVEALED A RECENT DIAGNOSIS OF CELIAC DISEASE CONFIRMED BY DUODENAL BIOPSY CLINICAL EXAMINATION SHOWED SWELLING AND ERYTHEMA OF THE RIGHT BREAST PERCUTANEOUS FLUID ASPIRATION PRODUCED 200 ML OF CLEAR YELLOW FLUID FLOW CYTOMETRIC IMMUNOPHENOTYPING OF THE ASPIRATE DEMONSTRATED A PHENOTYPICALLY ABERRANT POPULATION OF LARGE CELLS THAT EXPRESSED CD2 CD5 CD4 AND CD30 AND FAILED TO EXPRESS CD3 OR CD7 RESULTS OF IMMUNOHISTOCHEMICAL STAINING WITH HEMATOXYLIN AND EOSIN WERE NEGATIVE FOR ANAPLASTIC LYMPHOMA KINASE 1 ALK-L THE DIAGNOSIS WAS ALKÂ¿ ALCL RESULTS OF POSITRON EMISSION TOMOGRAPHY SCAN BONE MARROW ASPIRATE AND BIOPSY WERE DETERMINED TO BE NEGATIVE FOR DISEASE AND THE PATIENTS LEVEL OF LACTATE DEHYDROGENASE WAS NORMAL TREATMENT INCLUDED BILATERAL TOTAL CAPSULECTOMY AND IMPLANT REMOVAL WITHOUT IMPLANT REPLACEMENT APPROXIMATELY SIX MONTHS AFTER PRESENTING SYMPTOMS TO A HEALTH PROFESSIONAL AFTER REMOVAL THE IMPLANTS AND CAPSULES WERE SENT FOR FLOW CYTOMETRY AND CYTOGENETIC ANALYSIS IMMUNOHISTOCHEMICAL STAINING DID NOT SHOW ANY UNIQUE CELL POPULATIONS THERE WAS EVIDENCE OF SILICONE IN THE CAPSULE THROUGHOUT THE 20 MONTHS OF REGULAR FOLLOW-UP SINCE IMPLANT REMOVAL AND CAPSULECTOMY THE PATIENT HAS HAD NO SYSTEMIC EVIDENCE OF THE DISEASEÂ¿ THIS REPORT REPRESENTS THE RIGHT SIDE SEE MFR REPORT  9617229-2016-00066 FOR THE LEFT SIDE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5697584|46502155|N|1||B4 THE CORRESPONDING AUTHOR HAS DECLINED TO PROVIDE ALLERGAN FURTHER INFORMATION REGARDING EVENT PRODUCT PRODUCT RETURN OR PATIENT DETAILS THE EVENTS OF FLUID COLLECTION Â¿RECENT HISTORY OF CELIAC DISEASEÂ¿ ERYTHEMA AND ALCL ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6176870|62452744|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 PATIENT WHO WAS IMPLANTED WITH A LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN THE ARTICLE ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED SEROMA TREATMENT REPORTED AS IMPLANT REMOVAL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176870|62452743|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6011928|56911407|N|1||MEDWATCH SENT TO FDA ON 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN AUSTRALIA AND NEW ZEALAND Â¿ HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGYÂ¿ A LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS M MAGNUSSON T PAPADOPOULOS T CONNELL J LOFTS M LOCKE I HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6011928|56911408|D|1||THROUGH ALLERGANÂ¿S LITERATURE REVIEW OF RECENT JOURNAL ARTICLES WE RECEIVED THE FOLLOWING ARTICLE FROM MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN AUSTRALIA AND NEW ZEALANDÂ¿ HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGYÂ¿ TABLE 4 Â¿PRESENTATION OF BIA-ALCL N=46Â¿ IN THE ARTICLE REPORTS THE FOLLOWING 2 CASES OF Â¿SEROMA AND CAPSULAR CONTRACTURE CONTRALATERALÂ¿ THIS RECORD HAS BEEN CREATED THE CAPTURE THE 2 SEROMAS CONTRALATERAL EVENT OF CAPSULAR CONTRACTURE WILL BE CAPTURED IN MDR  9617229-2016-00146 THE ARTICLE DOES NOT PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL OR LOT INFORMATION OR SIDES OF ALCL DIAGNOSIS ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY AND REMOVAL OF IMPLANTS BOTH ON DISEASED AND NON-DISEASED SIDE ALL TUMORS WERE CD30 POSITIVE AND ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5665954|45480789|D|1||THE 2 BREAST IMPLANTS WERE IMPLANTED ON B6 2008 SINCE THEN ALL WAS FINE THEY HAVE REMAINED INTACT YESTERDAY B6 2016 PT WAS DIAGNOSED WITH ANAPLASTIC LARGE CELL LYMPHOMA ALCL CAUSED BY THE 2 IMPLANTS SHE IS SCHEDULED TO MEET WITH HER DOCTOR TODAY TO PLAN FOR THE EXPLANTING OF THE DEVICES|MEMORY GEL BREAST IMPLANT||05/18/2016||||*|*||0LP|FTR|2.0||MEMORY GEL BREAST IMPLANT|||3041 SKYWAY CIRCLE NORTH||IRVINE|US|MENTOR|75038|TX|75038||||True
5665954|45480789|D|1||THE 2 BREAST IMPLANTS WERE IMPLANTED ON B6 2008 SINCE THEN ALL WAS FINE THEY HAVE REMAINED INTACT YESTERDAY B6 2016 PT WAS DIAGNOSED WITH ANAPLASTIC LARGE CELL LYMPHOMA ALCL CAUSED BY THE 2 IMPLANTS SHE IS SCHEDULED TO MEET WITH HER DOCTOR TODAY TO PLAN FOR THE EXPLANTING OF THE DEVICES|MEMORY GEL BREAST IMPLANT||05/18/2016||||*|*||0LP|FTR|1.0||MEMORY GEL BREAST IMPLANT||5746123|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR|75038|TX|75038||||True
6139164|61260978|N|1||ARTICLE CITATION Â¿MARKED EOSINOPHILIA AS INITIAL PRESENTATION OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ BY NICOLA OROFINO FRANCESCA GUIDOTTI DANIELE CATTANEO MARIARITA SCIUMÃ UMBERTO GIANELLI AGOSTINO CORTELEZZI  ALESSANDRA LURLO PUBLISHED IN LEUKEMIA  LYMPHOMA PUBLISHED ELECTRONICALLY ON 17MAR2016 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LATE SEROMA LYMPHOMA-ALCL PRURITUS AND EOSINOPHILIA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/01/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6139164|61260979|D|1||JOURNAL ARTICLE MARKED EOSINOPHILIA AS INITIAL PRESENTATION OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORTS WE HERE DESCRIBE A CASE OF BI-ALCL IN A PATIENT WHO PRESENTED WITH HYPEREOSINOPHILIA AND DIFFUSE PRURITUS PATIENT PRESENTED WITH DISCOMFORT AND MODERATE PAIN IN THE LEFT BREAST AND A DIAGNOSIS OF CHRONIC SEROMA WAS MADE IN LEUKEMIA  LYMPHOMA 5711 2712-2715 DEVICE WAS REMOVED AND REPLACED WITH TEXTURED IMPLANT ALLERGAN PATIENTS SYMPTOMS PERSISTED AND THE REPLACEMENT IMPLANT WAS ALSO REMOVED ARTICLE STATES AS THE CHRONIC SEROMA CONTINUED A TRU-CUT BIOPSY WAS CARRIED OUT THREE YEARS LATER BUT ONLY REVEALED CHRONIC INFLAMMATIONÂ¿ ARTICLE GOES ON TO STATE A HISTOLOGICAL EXAMINATION OF THE PSEUDO-CAPSULE SHOWED THE DIFFUSE INFILTRATION OF LARGE CELLS WITH IRREGULAR ANAPLASTIC OR Â¿EMBRYO-LIKEÂ¿ NUCLEI AND AN ABUNDANT EOSINOPHILIC GRANULAR CYTOPLASM THE MALIGNANT POPULATION TESTED FOR CD30+ AND ALK-1 EXPRESSION AS BONE MARROW BIOPSY PERFORMED FOR STAGING PURPOSES WAS ALSO NEGATIVE A DIAGNOSIS OF BI-ALCL WAS MADE THIS FILE REPRESENTS THE DEVICE REMOVED PREVIOUS TO ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/01/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6196606|63054803|N|1||THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS CANNOT BE OBTAINED AT THIS TIME AS CONTACTFOLLOW UP INFORMATION WAS NOT PROVIDED OR FOUND DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS ARTICLE CITATION ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED WITH BREAST IMPLANT A NEW CASE ALVARO IBARRA MARCELA JACARD SOLEDAD TORRES PATRICIA FARDELLA MD AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 2016146S1-S26|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/21/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6144474|61423058|N|1||ARTICLE CITATION Â¿WHOLE EXOME SEQUENCING REVEALS ACTIVATING JAK1 AND STAT3 MUTATIONS IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMA BY PIERS BLOMBERY ELLA R THOMPSON KATE JONES GISELA MIR ARNAU STEPHEN LADE JOHN F MARKHAM JASON LI ANAND DEVA RICKY W JOHNSTONE AMIT KHOT H MILES PRINCE AND DAVID WESTERMAN PUBLISHED IN HAEMATOLOGICA ELECTRONICALLY PUBLISHED SEPTEMBER 2016 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LATE SEROMA AND LYMPHOMA-ALCL ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/05/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5978073|55648789|D|1||ALCL LEFT BREAST|BREAST IMPLANT||09/23/2016||04/04/2016||R|*||0HP|FTR|1.0||BREAST IMPLANT|||||||ALLERGAN|||||||True
5620587|44062743|N|1||B4 THE PHYSICIAN NOTED THE DEVICE IS NO LONGER AVAILABLE FOR RETURN THEREFORE ALLERGAN WILL NOT RECEIVE IT AND NO ANALYSIS OR TESTING WILL BE DONE THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL Â¿ INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF THE REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION NECROSIS NECROSIS MAY INHIBIT WOUND HEALING AND REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION PERMANENT SCAR DEFORMITY MAY OCCUR AS A RESULT OF NECROSIS DO NOT USE MICROWAVE DIATHERMY IN PATIENTS WITH BREAST IMPLANTS MICROWAVE DIATHERMY HAS BEEN REPORTED TO CAUSE TISSUE NECROSIS SKIN EROSION AND IMPLANT EXTRUSION|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|06/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||306845|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6176830|62457611|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 -YEAR-OLD PATIENT WHO WAS IMPLANTED WITH A RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN THE ARTICLE ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED SEROMA TREATMENT REPORTED AS IMPLANT REMOVAL FOLLOW-UP FOUND NO EVIDENCE OF DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176830|62457610|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5803927|49896517|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE DEFLATION DECREASED NIPPLE SENSATION LATE PRESENTING SEROMA AND CAPSULAR CONTRACTURE BAKER GRADE IV TREATMENT HAS OCCURRED PATIENT ADDITIONALLY REPORTED THAT FOLLOWING EXPLANT SURGERY THEY WERE DIAGNOSED WITH ALCL AND STATED THE CANCER DEVELOPED BECAUSE THEY ARE ALLERGIC TO THE PLASTIC HEALTH PROFESSIONAL CONFIRMED THAT THE PATIENT DOES NOT HAVE A CANCER DIAGNOSIS SEPARATE FROM ALCL PATIENT REPORTED THEY EXPERIENCED SWELLING DIMPLING WRINKLING AND TENDERNESS ON AND OFF FOR 10 YEARS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT YET BEEN RECEIVED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-560|07/19/2016||09/25/2015||R|Y||0HP|FWM|1.0|06/26/2006|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||578468|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5803927|49896516|N|1||THE EVENTS OF CAPSULAR CONTRACTURE NIPPLE SENSATION INCREASEDECREASE SEROMA AND DEFLATION WERE PREVIOUSLY REPORTED VIA ASR ON B6 2016 IN ADDITION TO LAB ANALYSIS RESULTS DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-560|07/19/2016||09/25/2015||R|Y||0HP|FWM|1.0|06/26/2006|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||578468|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6153092|61703506|N|1||THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ 137 6 1659-1669 BY HONGHUA HU PHD KHALID JOHANI AHMAD ALMATROUDI KAREN VICKERY PHD BVSC BRUCE VAN NATTA MD MARSHALL E KADIN MD GARRY BRODY MD MARK CLEMENS MD CHAN YOON CHEAH MD STEPHEN LADE MD PREETI AVINASH JOSHI MDPHD H MILES PRINCE MDPHD ANAND K DEVA BSCMED MBBS MS PUBLISHED JUNE 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6153092|61703507|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS TABLE 1Â¿ ARTICLE GOES ON TO STATE Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG OF TISSUE CAPSULE 49 Ã 106 CELLSMG OF TISSUE ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS P  005 IN CONTRAST SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED ARTICLE ADDITIONALLY REPORTS Â¿COMPARED WITH CLASSIC SYSTEMIC ALCL BREAST IMPLANTÂ¿ ASSOCIATED ALCL BEHAVES IN A MORE INDOLENT MANNER AND IS DIVIDED INTO PATHOLOGIC VARIETIESTHE LESS COMMON MASS-TYPE WITH A MORE CLINICALLY AGGRESSIVE INFILTRATING TUMORÂ¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE OR TESTED NEGATIVE FOR BACTERIAL INFECTION THIS REPORT WILL CAPTURE 5 CASES OF ALCL WHICH PRESENTED AS TUMOR MASS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6167285|62187250|D|1||ABSTRACT OF LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ REPORTS Â¿19 I-ALCLSÂ¿ CASES ARTICLE ADDITIONALLY STATES Â¿FIVE PATIENTS PRESENTED WITH ERYTHEMATOUS SKIN ERUPTIONÂ¿ THIS RECORD HAS BEEN CREATED TO CAPTURE 5 CASES OF ALCL WITH Â¿ERYTHEMATOUS SKIN ERUPTIONÂ¿ ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IN REGARDS TO TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL WAS PERFORMED IN 17 OUT OF 19 PATIENTS WITH ADDITIONAL TREATMENT BASED ON MOSTLY CHOP OR CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 OR IRRADIATION N = 119 CHOP ALONE OR ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL HAVE BEEN GIVEN IN TWO PATIENTSÂ¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH TREATMENTS WERE USED IN THESE 65 CASES MANUFACTURER OF DEVICES IS UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6167285|62187249|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL AND ERYTHEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST ERYTHEMA MAY ALSO OCCUR AS A NORMAL RESPONSE TO EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6157808|62108427|N|1||THE EVENT OF LYMPHOMA ALCL IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED THE AUTHOR HAS RESPONDED AND REFUSED TO PROVIDE ANY FURTHER INFORMATION DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL Â¿COMPREHENSIVE IMMUNOPHENOTYPIC ANALYSIS OF 64 CASES OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA SHOWS AN ACTIVATED CYTOTOXIC WITH A SILENT T-CELL RECEPTOR PATTERNÂ¿ ANA CLAUDIA FROTA LOPES L JEFFREY MEDEIROS MARK W CLEMENS MING CHAI HUI LIU ARIANNA DI NAPOLI STEPHEN LADE MITUAL AMIN KEN H YOUNG ROBERTO MIRANDA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5612275|43806327|D|1||I WAS DIAGNOSED WITH ALCL AFTER HAVING SILICONE BREAST IMPLANTS PLACED MY LEFT BREAST GREW APPROX 50 LARGER WITH SOME PAIN I HAD FINE NEEDLE ASPIRATION OF A STRAW COLORED FLUID AFTER TWO WEEKS I WAS GIVEN THE DIAGNOSIS OF ALCL ANAPLASTIC LARGE CELL LYMPHOMA I MET WITH A LYMPHOMA SPECIALIST AND BREAST SURGEON IN B6 2016 ON B6 2016 I UNDERWENT A CAPSULECTOMY OF MY LEFT BREAST AND BILATERAL REMOVAL OF THE BREAST IMPLANTS A PET SCAN REVEALED NO SYSTEMIC MIGRATION OF THE LYMPHOMA|SILICONE BREAST IMPLANTS||04/25/2016||||N|*||I|FTR|1.0||SILICONE BREAST IMPLANTS|||||||nan|||||||True
6143032|61396907|D|1||ABSTRACT OF LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ REPORTED Â¿19 I-ALCLSÂ¿ CASES ONE OF THE TWO CLINICAL PRESENTATIONS REPORTED WAS Â¿EFFUSIONÂ¿ ELEVEN PATIENTS EXPERIENCED ALCL AND EFFUSION THIS RECORD REPRESENTS THE 11 CASES OF ALCL WHICH PRESENTED AS EFFUSION HISTOPATHOLOGY REPORTS THAT MALIGNANT CELLS WERE CD30-POSITIVE AND WERE ALK NEGATIVE ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IN REGARDS TO TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL WAS PERFORMED IN 17 OUT OF 19 PATIENTS WITH ADDITIONAL TREATMENT BASED ON MOSTLY CHOP OR CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 OR IRRADIATION N = 119 CHOP ALONE OR ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL HAVE BEEN GIVEN IN TWO PATIENTSÂ¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH TREATMENTS WERE USED IN THESE 11 CASES MANUFACTURER OF DEVICES IS UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6143032|61396906|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL AND LATE SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6011805|56820798|D|1||THROUGH ALLERGANÂ¿S LITERATURE REVIEW OF RECENT JOURNAL ARTICLES WE RECEIVED THE FOLLOWING ARTICLE FROM MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN AUSTRALIA AND NEW ZEALAND Â¿ HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGYÂ¿ TABLE 5 Â¿TNM STAGING OF PATIENTS IN ANZ COHORTÂ¿ IN THE ARTICLE REPORTS AN ADDITIONAL THREE OCCURRENCES OF DEATH APPROX 2 CASES OF Â¿DEATH  MASS EXTENDING BEYOND CAPSULEÂ¿ THE ARTICLE DOES NOT PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL OR LOT INFORMATION OR SIDES OF ALCL DIAGNOSIS MANUFACTURER COULD NOT BE SPECIFIED AND ARTICLE STATES Â¿BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED FOR 571 OF IMPLANTS IN THIS SERIES ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY AND REMOVAL OF IMPLANTS BOTH ON DISEASED AND NON-DISEASED SIDE ALL TUMORS WERE CD30 POSITIVE AND ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6011805|56820797|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN AUSTRALIA AND NEW ZEALAND Â¿ HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGYÂ¿ A LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS M MAGNUSSON T PAPADOPOULOS T CONNELL J LOFTS M LOCKE I HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6011770|56819840|N|1||MEDWATCH SENT TO FDA ON 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN AUSTRALIA AND NEW ZEALAND Â¿ HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGYÂ¿ A LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS M MAGNUSSON T PAPADOPOULOS T CONNELL J LOFTS M LOCKE I HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6011770|56819841|D|1||THROUGH ALLERGANS LITERATURE REVIEW OF RECENT JOURNAL ARTICLES WE RECEIVED THE FOLLOWING ARTICLE FROM MEDICAL SAFETY BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN AUSTRALIA AND NEW ZEALAND - HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGY TABLE 4 PRESENTATION OF BIA-ALCL N=46 IN THE ARTICLE REPORTS THE FOLLOWING 1 CASE OF MASS WITH METASTATIC DISEASE AXILLA TABLE 4 AND DEATH  MASS WITH METASTATIC DISEASE TO ONE LYMPH NODE IN AXILLA TABLE 5 MANUFACTURER COULD NOT BE SPECIFIED AND ARTICLE STATES BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED FOR 571 OF IMPLANTS IN THIS SERIES THE ARTICLE DOES NOT PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL OR LOT INFORMATION OR SIDES OF ALCL DIAGNOSIS ARTICLE STATES ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY AND REMOVAL OF IMPLANTS BOTH ON DISEASED AND NON-DISEASED SIDE ALL TUMORS WERE CD30 POSITIVE AND ALK NEGATIVE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6153118|61701317|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS TABLE 1Â¿ ARTICLE GOES ON TO STATE Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG OF TISSUE CAPSULE 49 Ã 106 CELLSMG OF TISSUE ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS P  005 IN CONTRAST SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED ACCORDING TO TABLE 1 Â¿CLINICAL SUMMARY OF BREAST IMPLANTÂ¿ASSOCIATED ALCL PATIENTSÂ¿ THERE WAS 1 CASE OF ALCL PRESENT IN THE Â¿CAPSULEÂ¿ ARTICLE CLARIFIES THE Â¿CAPSULEÂ¿ CASE AS Â¿ONE PATIENT THE DIAGNOSIS OF BREAST IMPLANTÂ¿ASSOCIATED ALCL WAS AN INCIDENTAL FINDING WHILE UNDERGOING IMPLANT EXCHANGE FOR CAPSULAR CONTRACTUREÂ¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD TESTED NEGATIVE FOR BACTERIAL INFECTION THIS REPORT WILL CAPTURE 1 CASE OF ALCL PRESENTED WITH Â¿CAPSULEÂ¿ REPRESENTED BY TERM CODE CAPSULAR CONTRACTURE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6153118|61701316|N|1||THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION PATIENTS SHOULD BE ADVISED THAT CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWING INFECTION HEMATOMA AND SEROMA AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME CAPSULAR CONTRACTURE OCCURS MORE COMMONLY IN REVISION PATIENTS THAN IN PRIMARY AUGMENTATION OR RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE IS ALSO A RISK FACTOR FOR IMPLANT DEFLATION AND IT IS ONE OF THE MOST COMMON REASONS FOR REOPERATION PATIENTS SHOULD ALSO BE ADVISED THAT ADDITIONAL SURGERY MAY BE NEEDED IN CASES WHERE PAIN ANDOR FIRMNESS ARE SEVERE THIS SURGERY RANGES FROM REMOVAL OF THE IMPLANT CAPSULE TISSUE TO REMOVAL AND POSSIBLE REPLACEMENT OF THE IMPLANT ITSELF THIS SURGERY MAY RESULT IN LOSS OF BREAST TISSUE CAPSULAR CONTRACTURE MAY HAPPEN AGAIN AFTER THESE ADDITIONAL SURGERIES CAPSULAR CONTRACTURE MAY INCREASE THE RISK OF DEFLATION B4|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6167248|62147367|D|1||ABSTRACT OF LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ REPORTS Â¿19 I-ALCLSÂ¿ CASES ONE OF THE CLINICAL PRESENTATIONS REPORTED WAS Â¿MASS + SEROMAÂ¿ 6 PATIENTS EXPERIENCED  ALCL WITH Â¿MASS + SEROMAÂ¿ THIS RECORD HAS BEEN CREATED TO CAPTURE 6 CASES OF ALCL WITH Â¿MASS + SEROMAÂ¿ ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿  IN REGARDS TO TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL WAS PERFORMED IN 17 OUT OF 19 PATIENTS WITH ADDITIONAL TREATMENT BASED ON MOSTLY CHOP OR CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 OR IRRADIATION N = 119 CHOP ALONE OR ABVD FOLLOWING RADIATION WITHOUT  IMPLANT REMOVAL HAVE BEEN GIVEN IN TWO PATIENTSÂ¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH TREATMENTS WERE USED IN THESE 6 CASES MANUFACTURER OF DEVICES IS UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6167248|62147366|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL LATE SEROMA AND LUMPNODULE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6011872|56922006|N|1||MEDWATCH SENT TO FDA ON 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN B6 Â¿ HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGYÂ¿ A LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS M MAGNUSSON T PAPADOPOULOS T CONNELL J LOFTS M LOCKE I HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6011872|56922007|D|1||THROUGH ALLERGANÂ¿S LITERATURE REVIEW OF RECENT JOURNAL ARTICLES WE RECEIVED THE FOLLOWING ARTICLE FROM MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN B6 Â¿ HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGYÂ¿ TABLE 4 Â¿PRESENTATION OF BIA-ALCL N=46Â¿ IN THE ARTICLE REPORTS THE FOLLOWING 5 CASES OF Â¿MASS ONLYÂ¿ TWO RECORDS THAT CAPTURED THE EVENTS OF LYMPHOMA-ALCL AND MASS ONLY  WERE IDENTIFIED AND WERE PREVIOUSLY REPORTED THIS RECORD HAS BEEN CREATED TO CAPTURE THE REMAINING 3 OF THE 5 CASES NOTED IN THE ARTICLE OF LYMPHOMA-ALCL AND MASS ONLY MANUFACTURER COULD NOT BE SPECIFIED AND ARTICLE STATES Â¿BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED FOR 571 OF IMPLANTS IN THIS SERIESÂ¿ THE ARTICLE DOES NOT PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL OR LOT INFORMATION OR SIDES OF ALCL DIAGNOSIS ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY AND REMOVAL OF IMPLANTS BOTH ON DISEASED AND NON-DISEASED SIDE ALL TUMORS WERE CD30 POSITIVE AND ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6011849|56929012|D|1||THROUGH ALLERGANS LITERATURE REVIEW OF RECENT JOURNAL ARTICLES WE RECEIVED THE FOLLOWING ARTICLE FROM MEDICAL SAFETY BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN B6 - HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGY TABLE 4 PRESENTATION OF BIA-ALCL N=46 IN THE ARTICLE REPORTS THE FOLLOWING 35 CASES OF SEROMA ONLY SPECIFIED IN THE ARTICLE AS UNILATERAL LATE SEROMA EIGHTEEN RECORDS THAT CAPTURED THE EVENTS OF LYMPHOMA-ALCL AND SEROMA ONLY  WERE IDENTIFIED AND WERE PREVIOUSLY REPORTED THIS RECORD HAS BEEN CREATED TO CAPTURE THE REMAINING 17 OF THE 35 CASES NOTED IN THE ARTICLE OF LYMPHOMA-ALCL AND SEROMA ONLY MANUFACTURER COULD NOT BE SPECIFIED AND ARTICLE STATES BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED FOR B4 OF IMPLANTS IN THIS SERIES THE ARTICLE DOES NOT PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL OR LOT INFORMATION OR SIDES OF ALCL DIAGNOSIS ARTICLE STATES ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY AND REMOVAL OF IMPLANTS BOTH ON DISEASED AND NON-DISEASED SIDE ALL TUMORS WERE CD30 POSITIVE AND ALK NEGATIVE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6011849|56929011|N|1||MEDWATCH SENT TO FDA ON 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN B6 Â¿ HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGYÂ¿ A LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS M MAGNUSSON T PAPADOPOULOS T CONNELL J LOFTS M LOCKE I HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5834667|50817904|D|1||ACCORDING TO THE INFORMATION PROVIDED THE PATIENT WAS DIAGNOSED WITH ANAPLASTIC LARGE CELL LYMPHOMA ALCL THE LEFT PROSTHESIS ASSOCIATED WITH THIS COMPLAINT WILL NOT BE RETURNED TO MENTOR SHOULD ADDITIONAL INFORMATION ANDOR THE DEVICE BECOME AVAILABLE TO PE THIS COMPLAINT WILL BE REEVALUATED AT THAT TIME BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ACCORDING TO THE FDA THE INCIDENCE OF ALCL IN PATIENTS WITH BREAST IMPLANTS IS A VERY SMALL FRACTION OF THE 5-10 MILLION WOMEN WHO HAVE RECEIVED BREAST IMPLANTS WORLDWIDE AN INVESTIGATION OF THE DEVICE HISTORY RECORD REVEALED NO IRREGULARITIES A REVIEW OF THE NC SYSTEM AND COMPLAINT DATABASE REVEALED NO OTHER COMPLAINTS ASSOCIATED WITH LOT 6438477 THE MAIN SYMPTOMS OF ALCL IN WOMEN WITH BREAST IMPLANTS ARE LATE ONSET PERSISTENT SWELLING AND PAIN IN THE VICINITY OF THE IMPLANT AND PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL MENTOR CONCURS WITH FDAS POSITION THAT BECAUSE THE RISK OF ALCL APPEARS VERY SMALL FDA BELIEVES THAT THE TOTALITY OF EVIDENCE CONTINUES TO SUPPORT A REASONABLE ASSURANCE THAT FDA-APPROVED BREAST IMPLANTS ARE SAFE AND EFFECTIVE WHEN USED AS LABELED ANAPLASTIC LARGE CELL LYMPHOMA ALCL IS A KNOWN COMPLICATION ASSOCIATED WITH THESE DEVICES AND IS REFERENCED IN OUR IFU|MEMORY GEL SILTEX ROUND MODERATE PLUS PROFILE MAMMARY PROSTHESIS|3544751|07/29/2016|||DA|N|R||I|FTR|1.0||BREAST IMPLANT||6438477|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR WW LLC|75038|TX|75038||||True
5846884|51173307|D|1||ALCL|MEMORY GEL SILTEX ROUND MODERATE PLUS PROFILE MAMMARY PROSTHESIS|354-2513|08/04/2016||||N|R||0HP|FTR|1.0||BREAST IMPLANT||5933012|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR WW LLC|75038|TX|75038||||True
5695364|46431599|D|1||HEALTH PROFESSIONAL REPORTED THAT THE PATIENT SUFFERED SIZE INCREASE OF RECONSTRUCTED RIGHT BREAST APPROXIMATELY THREE YEARS AND FOUR MONTHS AFTER IMPLANTATION THE SIZE INCREASE WAS COMPATIBLE WITH SEROMA CONSERVATIVE TREATMENT WAS INITIATED CONSISTING OF ANTIBIOTIC THERAPY CORTICOSTEROIDS AND THE PATIENT WAS ADVISED TO REST THE RIGHT ARM IT IS PUNCTURED TWICE TO PERFORM HISTOLOGICAL ANALYSIS OF GERMINAL CELL THE RESULTS DETERMINED ATYPICAL CELLS FOR THIS REASON THE DEVICE WAS EXPLANTED AND A COMPLETE CAPSULECTOMY WAS MADE TO THE PATIENT THE PATHOLOGY REPORT ON THE CAPSULE WAS POSITIVE FOR ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA ALCL ASSOCIATED WITH BREAST IMPLANTS AS CD30 RESULTS HAVE NOT BEEN PROVIDED THIS CASE IS CURRENTLY A SUSPECTED-ALCL AND IS CAPTURED AS LYMPHOMA THE PATIENTS CONDITION PROGRESSED FAVOURABLY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX135-445|06/02/2016||||N|R||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2070807|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5695364|46431598|N|1||MEDWATCH SENT TO THE FDA ON 06022016 SEROMA AND RUPTURE WERE INITIALLY SUBMITTED TO THE FDA VIA 410 PSR ON 01212016 DEVICE WAS FOUND TO BE INTACT RUPTURE DID NOT OCCUR THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT PHYSICIAN HAS CONFIRMED THE DEVICE WILL NOT BE RETURNED PHYSICIAN HAS NOT RESPONDED TO FOLLOW-UP ATTEMPTS FOR COMPLETION OF ALCL QUESTIONNAIRE AND PATHOLOGY REPORTS DEVICE HISTORY REVIEW REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT WAS VERIFIED AND THERE WAS NOT ANY SCRAP RELATED WITH REPORTED EVENT ONLY ONE DEVICE WAS SCRAPPED IN ADDITION DHR FOR SHELL RUNS NUMBER 10008414 AND 10008555 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING SHELL FABRICATION PROCESS ALL SHELLS WERE REVIEWED AS PART OF THE SHELL FABRICATION OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT FABRICATION MET THE REQUIRED SPECIFICATIONS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL Â¿ INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF THE REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX135-445|06/02/2016||||N|R||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2070807|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5440576|38326420|D|1||ALCL CASE REPORT WE REPORT THE CASE OF A B6 WOMAN SHE HAS PREVIOUS HISTORY OF SMOKING AND MULTIPLE BREAST AUGMENTATION SURGERIES WITH IMPLANTS THE FIRST ONE WAS 20 YEARS AGO THEN 15 YEARS AGO AND THE LAST WAS 3 YEARS AGO B6 2012 SHE DENIED ANY HISTORY OF ALLERGIC REACTION TRANSFUSION OR MEDICAL PROBLEMS SHE WAS TAKING ASPIRIN 81MG AT THE MOMENT OF THE EVENT SHE WAS ADMITTED TO THE HOSPITAL IN B6 2016 BECAUSE A 5 MONTH HISTORY OF PROGRESSIVE SWELLING OF THE RIGHT ARM ALSO SHE HAD AN ERYTHEMATOUS RASH ON HER ARM EXTENDING THROUGH THE CHEST AND RIGHT BREAST THE SKIN WAS INDURATED WITH A FIRM LUMP IN THE RIGHT EXTERNAL QUADRANT OF THE RIGHT BREAST SHE HAD PAIN ON HER ARM BUT SHE DIDNT HAVE FEVER WE ORDERED AN MRI OF THE ARM INVOLVING THE BREAST IT SHOWED A FASCIAL HYPERINTENSITY AND SWELLING OF THE SOFT TISSUE ADDITIONALLY WE PERFORMED ROUTINE LABORATORIES THAT SHOWED HYPERLEUKOCYTOSIS OF 38000 WITH SEVERE EOSINOPHILIA OF 26000 THE HAEMOGLOBIN AND PLATELETS WERE NORMAL THE HS-CRP WAS 292 AND THE PROCALCITONIN WAS NEGATIVE THE LDH WAS 393 AND THE BETA-2 MICROGLOBULIN WAS 2000 THE KIDNEY AND LIVER FUNCTION TEST WERE UNREMARKABLE WE PERFORMED A PET SCAN THAT SHOWED HYPERMETABOLISM OF THE PREVIOUS DESCRIBED SWOLLEN AREA AND ENLARGEMENT AND HYPERMETABOLISM OF PERIHEPATIC LYMPH NODES THEREFORE A BIOPSY OF THE ARM WAS PERFORMED THE PATHOLOGIC SPECIMEN INCLUDED SKIN SOFT TISSUE FASCIA AND MUSCLE THE PATHOLOGY RESULT WAS CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA CD4+ CD30+ EMA+ ALT- SO A SURGICAL REMOVAL OF BOTH BREAST IMPLANTS WAS CARRIED OUT THE PATHOLOGY LAB CONFIRMED THAT AROUND THE IMPLANTS CAPSULE OF THE RIGHT BREAST WAS AN EXTENDED INFILTRATION OF NEOPLASTIC CELLS CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA WITH THE SAME IMMUNOHISTOCHEMISTRY PROFILE INTERESTINGLY THE NEOPLASTIC CELLS WERE SURROUNDED BY AN EOSINOPHIL-RICH INFLAMMATORY INFILTRATE THE LEFT IMPLANT DIDNT HAVE NEOPLASTIC CELLS THE IMPLANTS WERE ALLERGAN MODEL MHP WITH A VOLUME OF 130 CUBIC CENTIMETERS THEY WERE ROUND AND FILLED BY COHESIVE SILICONE CURRENTLY THE PT IS UNDER SYSTEMIC CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE DOXORUBICIN ETOPOSIDE VINCRISTINE AND PREDNISONE|ALLERGAN SILICONE BREAST IMPLANT||02/11/2016||||*|*||0HP|FTR|1.0||ALLERGAN SILICONE BREAST IMPLANT||||||US|ALLERGAN|||||MHP||True
5440576|38326420|D|1||ALCL CASE REPORT WE REPORT THE CASE OF A B6 WOMAN SHE HAS PREVIOUS HISTORY OF SMOKING AND MULTIPLE BREAST AUGMENTATION SURGERIES WITH IMPLANTS THE FIRST ONE WAS 20 YEARS AGO THEN 15 YEARS AGO AND THE LAST WAS 3 YEARS AGO B6 2012 SHE DENIED ANY HISTORY OF ALLERGIC REACTION TRANSFUSION OR MEDICAL PROBLEMS SHE WAS TAKING ASPIRIN 81MG AT THE MOMENT OF THE EVENT SHE WAS ADMITTED TO THE HOSPITAL IN B6 2016 BECAUSE A 5 MONTH HISTORY OF PROGRESSIVE SWELLING OF THE RIGHT ARM ALSO SHE HAD AN ERYTHEMATOUS RASH ON HER ARM EXTENDING THROUGH THE CHEST AND RIGHT BREAST THE SKIN WAS INDURATED WITH A FIRM LUMP IN THE RIGHT EXTERNAL QUADRANT OF THE RIGHT BREAST SHE HAD PAIN ON HER ARM BUT SHE DIDNT HAVE FEVER WE ORDERED AN MRI OF THE ARM INVOLVING THE BREAST IT SHOWED A FASCIAL HYPERINTENSITY AND SWELLING OF THE SOFT TISSUE ADDITIONALLY WE PERFORMED ROUTINE LABORATORIES THAT SHOWED HYPERLEUKOCYTOSIS OF 38000 WITH SEVERE EOSINOPHILIA OF 26000 THE HAEMOGLOBIN AND PLATELETS WERE NORMAL THE HS-CRP WAS 292 AND THE PROCALCITONIN WAS NEGATIVE THE LDH WAS 393 AND THE BETA-2 MICROGLOBULIN WAS 2000 THE KIDNEY AND LIVER FUNCTION TEST WERE UNREMARKABLE WE PERFORMED A PET SCAN THAT SHOWED HYPERMETABOLISM OF THE PREVIOUS DESCRIBED SWOLLEN AREA AND ENLARGEMENT AND HYPERMETABOLISM OF PERIHEPATIC LYMPH NODES THEREFORE A BIOPSY OF THE ARM WAS PERFORMED THE PATHOLOGIC SPECIMEN INCLUDED SKIN SOFT TISSUE FASCIA AND MUSCLE THE PATHOLOGY RESULT WAS CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA CD4+ CD30+ EMA+ ALT- SO A SURGICAL REMOVAL OF BOTH BREAST IMPLANTS WAS CARRIED OUT THE PATHOLOGY LAB CONFIRMED THAT AROUND THE IMPLANTS CAPSULE OF THE RIGHT BREAST WAS AN EXTENDED INFILTRATION OF NEOPLASTIC CELLS CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA WITH THE SAME IMMUNOHISTOCHEMISTRY PROFILE INTERESTINGLY THE NEOPLASTIC CELLS WERE SURROUNDED BY AN EOSINOPHIL-RICH INFLAMMATORY INFILTRATE THE LEFT IMPLANT DIDNT HAVE NEOPLASTIC CELLS THE IMPLANTS WERE ALLERGAN MODEL MHP WITH A VOLUME OF 130 CUBIC CENTIMETERS THEY WERE ROUND AND FILLED BY COHESIVE SILICONE CURRENTLY THE PT IS UNDER SYSTEMIC CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE DOXORUBICIN ETOPOSIDE VINCRISTINE AND PREDNISONE|ALLERGAN SILICONE BREAST IMPLANT||02/11/2016||||*|*||0HP|FTR|2.0||ALLERGAN SILICONE BREAST IMPLANT||||||US|ALLERGAN|||||MHP||True
5759530|48466890|D|1||PATIENT REPORTED LEFT BREAST CAPSULAR CONTRACTURE WITH SEROMA TOTAL CAPSULECTOMY AND LEFT BREAST EXCHANGE WAS PERFORMED SURGICAL LOG REPORTS THERE WAS 200 CC SEROUS FLUID UNDER PRESENT ON LEFT SEROLOGY + ALCL PATHOLOGY + ALCL CYTOLOGY REPORT DATED B6 2016 STATES LEFT BREAST FLUID HIGHLY ATYPICAL LYMPHOCYTES PRESENT CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE COMMENT THE MORPHOLOGY OF THE HIGHLY ATYPICAL CELLS SEEN IN SPECIMEN B IS SIMILAR TO THAT OF SPECIMEN A THESE CELLS DEMONSTRATE STAINING WITH CD30 THE OVERALL FEATURES ARE CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/29/2016|||DA|N|R||0HP|FTR|1.0|08/30/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180804|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5759530|48466889|N|1||MEDWATCH SENT TO FDA ON 06292016 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT IT IS NOT KNOWN IF THE DEVICE WILL BE RETURNED PATIENT DECLINED PERMISSION TO CONTACT DOCTOR FOR FURTHER INFORMATION AT THIS TIME DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/29/2016|||DA|N|R||0HP|FTR|1.0|08/30/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180804|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5759530|50477356|D|1||PATIENT REPORTED LEFT BREAST CAPSULAR CONTRACTURE WITH SEROMA TOTAL CAPSULECTOMY AND LEFT BREAST EXCHANGE WAS PERFORMED SURGICAL LOG REPORTS THERE WAS 200 CC SEROUS FLUID UNDER PRESENT ON LEFT SEROLOGY + ALCL PATHOLOGY + ALCL CYTOLOGY REPORT DATED B6 2016 STATES 62213FT BREAST FLUID HIGHLY ATYPICAL LYMPHOCYTES PRESENT CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE COMMENT THE MORPHOLOGY OF THE HIGHLY ATYPICAL CELLS SEEN IN SPECIMEN B IS SIMILAR TO THAT OF SPECIMEN A THESE CELLS DEMONSTRATE STAINING WITH CD30 THE OVERALL FEATURES ARE CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE62282|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/29/2016|||DA|N|R||0HP|FTR|1.0|08/30/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180804|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6176648|62440609|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF DEATH LYMPHOMA ALCL SEROMA LUMP AND ERYTHEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR AS A NORMAL RESPONSE TO EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5901883|52941731|D|1||HEALTHCARE PROFESSIONAL REPORTED PATIENT DIAGNOSED WITH LEFT SIDE ALCL ON B6 2015 PER SCAN AT HOSPITAL FOR PERI IMPLANT FLUID+ I+D INCISION AND DRAINAGE PATIENT WAS THEN REFERRED AN ONCOLOGIST GENERAL SURGEON WHO RECOMMENDED A CAPSULECTOMY LEFT SIDE CAPSULECTOMY PERFORMED ON B6 2015 CAPSULE WAS SENT FOR PATHOLOGY LYMPHOMA CELLS FOUND IN FIBROUS CAPSULE AND WITHIN A PERI-IMPLANT MASS ALK NEGATIVE AND CD30 POSITIVE ON B6 2015 PATHOLOGY REPORT NOTED  TENSIVE NECROSIS AND ACUTE INFLAMMATORY CELLS ON B6 2016 RECURRENT MASSES DIISCOVERED AND REPEAT PET SCAN ORDERED ON B6 2016 BIOPSY RECURRENT MASSES IMMUNOCHEMISTRY SENT ON B6 2016 PT EVALUATED BY PLASTIC SURGEON TREATMENT BEGAN B6 2016 WITH CHEMO CYTOXANADRIAMYCINVINCRISTINEPREDNISONE ON B6 2016 PATIENT WAS RECOMMENDED BY PHYSICIAN TO CHANGE TO BRENTUXIMAB MONOTHERAPY HEALTH PROFESSIONAL ADDITIONALLY REPORTED THAT THE PATIENT ALSO EXPERIENCED THE FOLLOWING SYSTEMIC SYMPTOMS FEVERS NIGHT SWEATS BREAST SKIN LESIONS PAIN REDNESS PALPABLE BREAST MASS PRESENT AT SURGERY SEROMA AND CAPSULAR CONTRACTURE BAKER GRADE NOT SPECIFIED DEVICE HAS BEEN REMOVED WITH NO REPLACEMENT|UNK SALINE IMPLANT|UNK SALINE IMPLANT|08/24/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5901883|52941730|N|1||B4 THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING DEVICE INFORMATION HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN BREAST SENSATION SEROMA NECROSIS AND LYMPHADENOPATHY |UNK SALINE IMPLANT|UNK SALINE IMPLANT|08/24/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5415251|38228137|N|1||IDEAL IMPLANT DID NOT SUBMIT THIS MDR WITHIN 30 DAYS OF BECOMING AWARE OF THE INCIDENT FOR THE FOLLOWING REASONS PER THE FDA REGULATIONS FOR REPORTABLE EVENTS A SERIOUS INJURY IS ONE THAT IS LIFE THREATENING RESULTS IN PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE OR NECESSITATES MEDICAL OR SURGICAL INTERVENTION TO PRECLUDE PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE PER THE DEFINITION NOTED ABOVE IDEAL IMPLANT INCORPORATED UNDERSTOOD THAT A COMMON SALINE BREAST IMPLANT DEFLATION WOULD NOT FALL WITHIN THE DEFINITION OF SERIOUS INJURY AND WOULD THEREFORE NOT BE CONSIDERED REPORTABLE ALTHOUGH SURGICAL INTERVENTION MAY BE PERFORMED TO REMOVE ANDOR REPLACE THE BREAST IMPLANT IT IS NOT MEDICALLY REQUIRED TO PRECLUDE PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE IMPLANTS ARE FILLED WITH NORMAL SALINE WHICH IS HARMLESSLY ABSORBED BY THE BODY A DEFLATION POSES MINIMAL RISK TO THE PATIENT AND IS NOT CONSIDERED SERIOUS IN THE ABSENCE OF AN ADDITIONAL SERIOUS CONDITION SUCH AS EXTRUSION TISSUE NECROSIS SEPSIS LYMPHOMA ALCL NEUROLOGIC PROBLEM BREAST MASS POSSIBLE AFFECT ON FETUS ETC BECAUSE A DEFLATION ABSENT OF AN ADDITIONAL SERIOUS PATIENT CONDITION DOES NOT POSE RISK TO THE PATIENT OF DEATH OR SERIOUS INJURY IDEAL IMPLANT DID NOT CONSIDER DEFLATION OR SURGERY TO REMOVE A DEFLATED IMPLANT TO BE A SURGICAL INTERVENTION TO PRECLUDE PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE A DEFLATION OR OTHER TYPE OF DEVICE MALFUNCTION IN WHICH A SERIOUS INJURY SERIOUS CONDITION OR DEATH IS REPORTED AS A CONSEQUENCE WOULD BE CONSIDERED REPORTABLE HOWEVER DURING A RECENT FDA INSPECTION PERFORMED 212016-232016 AN OBSERVATION WAS MADE THAT THIS DEFLATION SHOULD HAVE BEEN REPORTED TO THE FDA UPON LEARNING THAT FDA CONSIDERS ANY DEFLATION THAT WAS EXPLANTED TO BE REPORTABLE IDEAL IMPLANT BEGAN SUBMITTING REPORTS FOR PAST DEFLATIONS AND WILL CONTINUE TO REPORT ALL INSTANCES OF EXPLANTED DEFLATIONS IN THE FUTURE|IDEAL IMPLANT STRUCTURED BREAST IMPLANT|405|02/06/2016||12/04/2015||R|Y||001|FWM|1.0||SALINE-FILLED BREAST IMPLANT||61042|5005 LYNDON B JOHNSON FREEWAY|SUITE 900|DALLAS|US|IDEAL IMPLANT|75244|TX|75244||40501||True
6106949|60072476|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE DEVICE REMOVAL DUE TO SEROMA ADDITIONAL REPORT OF DX OF BIA ALCL ON SEROLOGY IMAGING REPORT PROVIDED A RIGHT SILICONE IMPLANT IS NOTED SOMEWHAT DEFORMED IN SHAPE THERE IS SIGNIFICANT AMOUNT OF FLUID SURROUNDING THE IMPLANT SEROMA APPEARED IN B6 2016 ALCL DIAGNOSIS DATE OF B6 2016 IT IS UNKNOWN IF THE EXPLANTED DEVICE WILL BE RETURNED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF125-375|11/16/2016||||*|*||0HP|FTR|1.0|11/08/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1359584|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6106949|60072475|N|1||THE EVENTS OF LYMPHOMA AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS IT IS CURRENTLY UNKNOWN IF THE EXPLANTED DEVICE WILL BE RETURNED AS THE REPORTER HAS CONFIRMED THAT DEVICE WAS SENT TO PATHOLOGY NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE HISTORY RECORD DHR REVIEW REVIEW OF DHR FOR WORK ORDER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING MANUFACTURING PROCESS ALL GEL BREAST IMPLANTS WERE REVIEWED AS PART OF THE ASSEMBLY OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT ASSEMBLY MET THE REQUIRED SPECIFICATIONS THE DHR ASSEMBLY REPORT FROM B4 WAS VERIFIED AND THERE WAS NOT ANY SCRAP RELATED WITH REPORTED EVENT ALL DEVICES WERE CONFORMANCE DURING MANUFACTURING PROCESS IN ADDITION DHR FOR SHELL RUN NUMBER B4 DID NOT IDENTIFY ANY DEVIATIONS ERRORS OMISSIONS OR NON-CONFORMANCES DURING SHELL FABRICATION PROCESS ALL SHELLS WERE REVIEWED AS PART OF THE SHELL FABRICATION OPERATIONS AND THESE TASKS WERE PERFORMED ACCORDING TO APPLICABLE CURRENT PROCEDURES TO ENSURE THAT FABRICATION MET THE REQUIRED SPECIFICATIONS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM WORK ORDER B4 WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANS AND OTHER MANUFACTURERS BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL IMPLANT PALPABILITYVISIBILITY HEMATOMASEROMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF125-375|11/16/2016||||*|*||0HP|FTR|1.0|11/08/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1359584|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5597788|43347569|D|1||ALCL BREAST IMPLANT ASSOCIATED|MCGHAN||04/20/2016||||N|*||0HP|FWM|1.0||TEXTURED BREAST IMPLANT SALINE||||||US|MCGHAN|||||||True
6141438|61344363|D|1||REPORTED EVENTS OF Â¿ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ AND Â¿LATE SEROMAÂ¿ OCCURRING WITH A MCGHAN STYLE 153 LUMEN DEVICE WAS FOUND WITHIN THE JOURNAL ARTICLE Â¿LONG-TERM OUTCOMES WITH THE MCGHAN STYLE 153 DUAL-LUMEN BREAST IMPLANT IMPLICATIONS FOR FUTURE IMPLANT DESIGNÂ¿ IN JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY 69 02 JUL 2016 PP 1211-1217 ARTICLE STATES Â¿ONE CASE 075 OF ANAPLASTIC LARGE CELL LYMPHOMA WAS DIAGNOSED AFTER THE DEVELOPMENT OF A LATE SEROMA TEN YEARS POST-OPERATIVELYÂ¿ NO FURTHER INFORMATION IS PROVIDED AS PATHOLOGICAL MARKERS CONFIRMING ALCL HAVE NOT BEEN RECEIVED THE EVENT WILL BE CAPTURED AS LYMPHOMA THE AFFECTED SIDE WAS NOT SPECIFIED|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|12/02/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6141438|61344362|N|1||ARTICLE CITATION LONG-TERM OUTCOMES WITH THE MCGHAN STYLE 153 DUAL-LUMEN BREAST IMPLANT IMPLICATIONS FOR FUTURE IMPLANT DESIGNÂ¿ BY DC HAMMOND AND WP SCHMITT PUBLISHED IN J PLAST RECONSTR AESTHET SURG ELECTRONICALLY PUBLISHED 07022016 FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME THE EVENTS OF LYMPHOMA AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL - ATTACHMENT ARTICLE - LONG-TERM OUTCOMESPDF|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|12/02/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5962723|55115726|N|1||MEDWATCH SENT TO FDA ON 09202016 ALLERGAN HAS INITIATED AN INVESTIGATION INTO THIS LATE REPORT B4 ARTICLE CITATION FIRST CASE REPORT IN MEXICO AND LATIN AMERICA OF ANAPLASTIC LARGE CELL LYMPHOMA IN A PATIENT WITH MAMMARY IMPLANTS TORRES-RIVERO CESAR RAMOS-GALLARDO GUILLERMO NAMBO-LUCIO M DE JESÃS VAQUERO-PÃREZ M MAR CIR PLÃST IBEROLATINOAM-VOL 42 Â¿ NO 2 APRIL Â¿ MAY Â¿ JUNE 2016  P 175-180 THE REPORTED EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING SERIAL NUMBER LOT NUMBER IMPLANTEXPLANT DATE IMPLANTINGEXPLANTING PHYSICIAN PATIENT DATE OF BIRTH DEVICE RETURN STATUS AND DEVICE RELATIONSHIP OF THE REPORTED EVENTS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL PAIN OF VARYING INTENSITY AND LENGTH OF TIME MAY OCCUR AND PERSIST FOLLOWING BREAST IMPLANT SURGERY PATIENTS SHOULD BE ADVISED TO CONTACT THEIR SURGEON IF THERE IS SIGNIFICANT PAIN OR IF PAIN PERSISTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/20/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5962723|55115727|D|1||THE FOLLOWING JOURNAL ARTICLE WAS REVIEWED Â¿FIRST CASE REPORT IN MEXICO AND LATIN AMERICA OF ANAPLASTIC LARGE CELL LYMPHOMA IN A PATIENT WITH MAMMARY IMPLANTS THE AUTHORS REPORT TO OUR KNOWLEDGE WE PRESENT THE FIRST CASE REPORTED BY A PLASTIC SURGEON IN MEXICO AND LATIN AMERICA IN A PATIENT WITH HISTORY OF BREAST AUGMENTATION AND UNILATERAL ASYMMETRY DUE TO LATE SEROMA AFTER 2 UNSUCCESSFUL PUNCTURES REMOVAL OF THE BREAST IMPLANT AND CAPSULECTOMY WERE SCHEDULED DIAGNOSIS OF ALCL WAS CONFIRMED IN THE PERIPROSTHETIC FLUID DEVICE DETAILS SPECIFIED AS PLACEMENT OF 290 CC TEXTURED COHESIVE GEL ANATOMICAL IMPLANTS MCGHAN MEDICAL CORPORATION B6 ADDITIONAL EVENT DETAILS INCLUDE A YEAR FROM THE PROCEDURE THE PATIENT PRESENTED DISCOMFORTS AND EDEMA IN THE RIGHT BREAST WHICH CEASED WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AT THE DOSE OF 120 MG A DAY FOR 7 DAYS LATER PROGRESS WAS SATISFACTORY UNTIL 2015 THAT IS 5 YEARS AFTER THESE SYMPTOMS AND 6 FOLLOWING THE INTERVENTION WHEN THE PATIENT PRESENTED AGAIN DISCOMFORTS AND EDEMA IN THE RIGHT BREAST IMAGING STUDIES WERE PERFORMED ON PATIENT THROUGH MAGNETIC RESONANCE MR DOCUMENTING THE PRESENCE OF ABUNDANT PERIPROSTHETIC FLUID IN THE AFFECTED BREASTÂ¿ Â¿THE SAMPLE WAS SENT FOR CYTOLOGICAL STUDY WHICH INFORMED CHRONIC MASTITIS WITH GRANOMALOTOUS REACTION AND NEGATIVE CULTURE HOWEVER THE GRADUAL INCREASE OF THE BREAST CONTINUED IN THE FOLLOWING MONTHS WHERE 2 NEW PUNCTURES WERE PERFORMED UNSUCCESSFULLY IN THE SECOND PUNCTURE FLUID WAS SENT AGAIN FOR MALIGNANCY STUDY BEFORE THE SUSPECTED POSSIBLE DUCTAL CARCINOMAÂ¿ Â¿THE PATIENT WAS AGAIN ASSESSED THROUGH ULTRASOUND ASSISTED IMAGING STUDIES AND MR WITHOUT FINDING ANOMALIES IN THE MAMMARY PARENCHYMA REASON WHY IT WAS OPTED FOR WITHDRAWAL OF THE IMPLANT WITH CAPSULECTOMY AND EXAMINATION OF THE BREAST TISSUE THROUGH TRANSOPERATIVE BIOPSYÂ¿ THE PATIENT HAS REJECTED ANY FURTHER TREATMENT AS THEY ARE CURRENTLY ASYMPTOMATIC|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/20/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5846890|51223996|D|1||ACCORDING TO THE INFORMATION PROVIDED THE PATIENT EXPERIENCED A RIGHT RUPTURE ALONG WITH ANAPLASTIC LARGE CELL LYMPHOMA ALCL BASED ON THE RESULTS OF THE LABORATORY EVALUATION PE IDENTIFIED THREE RENTS IN THE SHELL OF THE DEVICE THE FIRST RENT MEASURED APPROXIMATELY 3CM IN LENGTH THE TWO ADDITIONAL RENTS BOTH MEASURED APPROXIMATELY  1CM IN THE SHELL OF THE DEVICE AREAS OF SHELL WEAR WERE ALSO OBSERVED IN THE SHELL ALTHOUGH THE ROOT CAUSE OF THE RENTS COULD NOT BE DETERMINED SHELL WEAR SUGGEST IN-VIVO FOLDING OR CREASING OF THE DEVICE NO OTHER ANOMALIES WERE OBSERVED BREAST IMPLANTS ARE NOT LIFETIME DEVICES RUPTURE CAN OCCUR AT ANY TIME AFTER IMPLANTATION RUPTURE IS A KNOWN COMPLICATION ASSOCIATED WITH THESE DEVICES AND IS REFERENCED IN OUR PIDS BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINS LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ACCORDING TO THE FDA THE INCIDENCE OF ALCL IN PATIENTS WITH BREAST IMPLANTS IS A VERY SMALL FRACTION OF THE 5-10 MILLION WOMEN WHO HAVE RECEIVED BREAST IMPLANTS WORLDWIDE AN INVESTIGATION OF THE DEVICE HISTORY RECORD REVEALED NO IRREGULARITIES A REVIEW OF THE NC SYSTEM AND COMPLAINT DATABASE REVEALED NO OTHER COMPLAINTS OF THIS TYPE ASSOCIATED WITH LOT 5746123 THE MAIN SYMPTOMS OF ALCL IN WOMEN WITH BREAST IMPLANTS ARE LATE ONSET PERSISTENT SWELLING AND PAIN IN THE VICINITY OF THE IMPLANT AND PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL MENTOR CONCURS WITH FDAS POSITION THAT BECAUSE THE RISK OF ALCL APPEARS VERY SMALL FDA BELIEVES THAT THE TOTALITY OF EVIDENCE CONTINUES TO SUPPORT A REASONABLE ASSURANCE THAT FDA-APPROVED BREAST IMPLANTS ARE SAFE AND EFFECTIVE WHEN USED AS LABELED ANAPLASTIC LARGE CELL LYMPHOMA ALCL IS A KNOWN COMPLICATION ASSOCIATED WITH THESE DEVICES AND IS REFERENCED IN OUR PIDS|MEMORY GEL SILTEX ROUND MODERATE PLUS PROFILE MAMMARY PROSTHESIS|354-4507|08/04/2016||06/28/2016||R|Y||0HP|FTR|1.0||BREAST IMPLANT||5746123|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR WW LLC|75038|TX|75038||||True
5896122|52746118|N|1||MEDWATCH SENT TO FDA ON 08232016 THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING DEVICE SERIAL NUMBER IMPLANTEXPLANT DATE IMPLANTINGEXPLANTING PHYSICIAN PATIENT NAME PATIENT DATE OF BIRTH DEVICE RETURN STATUS PATHOLOGICAL MARKERS AND DEVICE RELATIONSHIP OF THE REPORTED EVENT HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/23/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5896122|52746119|D|1||HEALTHCARE PROFESSIONAL REPORTED ALCL OF AN UNKNOWN SIDE PATIENT HAS BEEN SENT FOR MRI AND PET SCAN NO OTHER INFORMATION IS AVAILABLE AT THIS TIME EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL PATHOLOGICAL MARKERS TO CONFIRM ALCL DIAGNOSIS HAVE BEEN RECEIVED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/23/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5818741|50320833|D|1||SWELLING OF RIGHT BREAST 13 YEARS AFTER IMPLANTS FNA RETURNED BIA ALCL AKL - NEG BREAST IMPLANTS REMOVED IN B6 B6 UNIVERSITY HAS THEM RESIDUAL LOCAL CELLS REMAINED AFTER FULL CAPSULECTOMY STARTED CHEMO B6 2016|INAMED BREAST IMPLANTS||07/21/2016||||N|*||I|FWM|1.0||INAMED BREAST IMPLANTS|||||||ALLERGAN|||||||True
5818741|50320833|D|1||SWELLING OF RIGHT BREAST 13 YEARS AFTER IMPLANTS FNA RETURNED BIA ALCL AKL - NEG BREAST IMPLANTS REMOVED IN B6 B6 UNIVERSITY HAS THEM RESIDUAL LOCAL CELLS REMAINED AFTER FULL CAPSULECTOMY STARTED CHEMO B6 2016|INAMED BREAST IMPLANTS||07/21/2016||||*|*||I|FWM|2.0||INAMED BREAST IMPLANTS|||||||ALLERGAN|||||||True
6011835|56821577|D|1||THROUGH ALLERGANÂ¿S LITERATURE REVIEW OF RECENT JOURNAL ARTICLES WE RECEIVED THE FOLLOWING ARTICLE FROM MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN AUSTRALIA AND NEW ZEALAND Â¿ HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGYÂ¿ TABLE 5 Â¿TNM STAGING OF PATIENTS IN ANZ COHORTÂ¿ IN THE ARTICLE REPORTS AN ADDITIONAL THREE OCCURRENCES OF DEATH ONE CASE OF Â¿DEATH  MASS WITH METASTATIC DISEASE TO MULTIPLE LYMPH NODESÂ¿ MANUFACTURER COULD NOT BE SPECIFIED AND ARTICLE STATES Â¿BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED FOR 571 OF IMPLANTS IN THIS SERIES THE ARTICLE DOES NOT PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL OR LOT INFORMATION OR SIDES OF ALCL DIAGNOSIS ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY AND REMOVAL OF IMPLANTS BOTH ON DISEASED AND NON-DISEASED SIDE ALL TUMORS WERE CD30 POSITIVE AND ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6011835|56821576|N|1||MEDWATCH SENT TO FDA ON 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN AUSTRALIA AND NEW ZEALAND Â¿ HIGHER RISK FOR MACROTEXTURED IMPLANTS SUPPORTS A BACTERIAL ETIOLOGYÂ¿ A LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS M MAGNUSSON T PAPADOPOULOS T CONNELL J LOFTS M LOCKE I HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL -|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176965|62446268|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿Â¿ REPORTED A PATIENT DIAGNOSED WITH ALCL ARTICLE REPORTED CASES OF BOTH Â¿IN SITU I-ALCLÂ¿ AND Â¿INFILTRATIVE I-ALCLÂ¿ IT IS UNKNOWN WHICH TYPE OF CASE THIS IS ARTICLE REPORTS A B6 PATIENT WHO WAS IMPLANTED WITH A RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN THE ARTICLE ADDITIONALLY PROVIDES THAT PATIENT EXPERIENCED SEROMA AND DISRUPTED IMPLANT TREATMENT REPORTED AS IMPLANT REMOVAL AND DEXAMETHASONE HIGH-DOSE ARACYTINE OXALIPLATIN DHAOX FOLLOW-UP FOUND NO EVIDENCE OF DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176965|62446267|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5808310|50110352|D|1||THOUSANDS OF KNOWN WOMEN ARE SICK FROM A SILICONE BREAST IMPLANTS EACH OF THEM KNOWS THE TRUTH NOW FDA HAS SOMEHOW ALLOWED THE SILICONE BREAST IMPLANT MFRS TO HIDE THE HIGH LEVEL OF TOXICITY OF SILICONE PLATINUM AND OF THE OTHER 35 + DANGEROUS CHEMICALS THAT USE TO MAKE SILICONE AND SALINE BREAST IMPLANTS THAT TRIGGER A BIOCHEMICAL MOLECULAR DISRUPTION THAT BRING UP SICKNESSES THAT WERE NOT PRESENT BEFORE THE IMPLANTS AND THAT GO AWAY AFTER THE EXPLANTS WITH SOME CASES OF IRREVERSIBLE DAMAGE ON NOVEMBER 17 2006 THE FDAS APPROVAL ORDER REQUIRED SIX VERY SPECIFIC POST-APPROVAL STUDIES CONDITIONS TWO OF THE STUDIES TO MONITOR LONG TERM SAFETY FOR TEN YEARS THEY WERE NOT FOLLOWED AND SO THERE IS NO SAFETY DATA FOR THOSE STUDIES THE ADJUNCT 5-YEAR STUDY HAD A LOW FU RATE OF 138 THE LARGE STUDY WAS ALLOWED TO BE CUT SHORT AT YEAR 7 INSTEAD OF 10 WITH A LOW FU RATE OF 201 AND IT WAS IGNORED THE CORE STUDY HAD A FU RATE OF 62 BUT THE REPORT SCHEDULE STOPS SHORT AT YEAR 6 INSTEAD OF 10 ON NOVEMBER 13 2012 THE FDA MENTOR PMA THE MANUFACTURE DOCUMENT STATES SHELF LIFE TO BE FIVE YEARS FROM THE DATE OF STERILIZATION YET THEY ARE MARKETED FOR UP TO 10 YEARS TO STAY IN THE BODY WITHOUT ANY SAFETY EVIDENCE THE B6 STUDY FROM 2013 RUN BY THE B6 FUNDED BY THE THREE BREAST IMPLANT MFRS DOES NOT QUALIFY AS AN INDEPENDENT STUDY FOR THE ASTOUNDING CONFLICT OF INTEREST IN REGARDS TO THE PLASTIC SURGEONS THAT PROFIT LARGELY FROM THE SILICONE BREAST IMPLANTS AND THE MFRS THEMSELVES THAT PROFIT FROM THEIR OWN SILICONE BREAST IMPLANTS ALL THE PREVIOUS SILICONE BREAST IMPLANT SYMPTOMS FROM THE 1990S ARE REPEATING THEMSELVES WITH THE CURRENT SILICONE BREAST IMPLANTS THUS PROVING RECURRING LACK OF SAFETY A FEW PEOPLE FOLLOWING THIS MATTER HAVE MYSTERIOUSLY DISAPPEARED BUT NOW THOUSANDS OF WOMEN HAVE GROUPED TOGETHER TO SHARE THEIR RECORDS WITH B6 AND FOR THEIR OWN PROTECTION THEY HAVE ALSO TAKEN MEASURES TO SHARE THEIR RECORDS AMONG THEMSELVES AND HAVE THOSE RECORDS SAFEGUARDED WITH THEIR OWN ATTORNEYS PRIVATE INTERESTS CANNOT SILENCE OR BUY OUT RECORDED MEDICAL EVIDENCE FROM THOUSANDS OF SICK WOMEN FROM SILICONE BREAST IMPLANTS ANY LONGER FDA IS RESPONSIBLE FOR PROTECTING THE PUBLIC HEALTH BY ASSURING THE SAFETY EFFICACY AND SECURITY OF HUMAN AND VETERINARY DRUGS BIOLOGICAL PRODUCTS MEDICAL DEVICE OUR NATIONS FOOD SUPPLY COSMETICS AND PRODUCTS THAT EMIT RADIATION SILICONE PLATINUM AND 35 + DANGEROUS CHEMICALS USED BY SILICONE AND SALINE BREAST IMPLANT MFRS TRIGGER BIOCHEMICAL MOLECULAR DISRUPTION THAT CAUSE SICKNESSES FATIGUE OR CHRONIC FATIGUE COGNITIVE DYSFUNCTION BRAIN FOG DIFFICULTY CONCENTRATING MEMORY LOSS MUSCLE PAIN AND WEAKNESS JOINT PAIN HAIR LOSS DRY SKIN AND HAIR POOR SLEEP AND INSOMNIA DRY EYES DECLINE IN VISION VISION DISTURBANCES HYPOHYPER THYROID SYMPTOMS HYPOHYPER ADRENAL SYMPTOMS ESTROGENPROGESTERONE IMBALANCE OR DIMINISHING HORMONES SLOW HEALING OF CUTS AND SCRAPES EASY BRUISING THROAT CLEARING COUGH DIFFICULTY SWALLOWING CHOKING REFLUX VERTIGO GASTROINTESTINAL AND DIGESTIVE ISSUES FEVERS NIGHT SWEAT INTOLERANT TO HEAT NEW AND PERSISTENT BACTERIAL AND VIRAL INFECTIONS SLOW CLEARING OF COMMON COLDS AND FLUES FUNGAL INFECTIONS YEAST INFECTIONS CANDIDA SINUS INFECTIONS SKIN RASHES EAR RINGING SUDDEN FOOD INTOLERANCE AND ALLERGIES HEADACHES SLOW MUSCLE RECOVERY AFTER ACTIVITY HEART PALPITATIONS CHANGES IN NORMAL HEART RATE OR HEART PAIN SORE AND ACHING JOINTS OF SHOULDERS HIPS BACKBONE HANDS AND FEET SWOLLEN AND TENDER LYMPH NODES IN BREAST AREA UNDERARM THROAT NECK GROIN BOUTS OF DEHYDRATION FOR NO REASON FREQUENT URINATION NUMBNESSTINGLING SENSATIONS IN UPPER AND LOWER LIMBS COLD AND DISCOLORED LIMBS HANDS AND FEET GENERAL CHEST DISCOMFORT SHORTNESS OF BREATH PAIN AND OR BURNING SENSATION AROUND IMPLANT AND OR UNDERARM LIVER AND KIDNEY DYSFUNCTION CRAMPING TOXIC SHOCK SYMPTOMS ANXIETY DEPRESSION AND PANIC ATTACKS SYMPTOMS OF OR DIAGNOSIS OF FIBROMYALGIA SYMPTOMS OF OR DIAGNOSIS OF LYME DISEASE SYMPTOMS OF OR DIAGNOSIS OF AUTO-IMMUNE DISEASE SUCH AS RAYNAUDS SYNDROME HASHIMOTOS THYROIDITIS RHEUMATOID ARTHRITIS LUPUS NONSPECIFIC CONNECTIVE TISSUE DISEASE MULTIPLE SCLEROSIS SYMPTOMS OF OR DIAGNOSIS OF ALCL LYMPHOMA SILICONE BREAST IMPLANTS BRING UP ALLERGIES NEVER EXPERIENCED BEFORE|SILICONE BREAST IMPLANT||07/16/2016||||Y|*||I|FTR|1.0||SILICONE BREAST IMPLANT|||||||MENTOR|||||||True
6153187|61697756|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS TABLE 1Â¿ ARTICLE GOES ON TO STATE Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG OF TISSUE CAPSULE 49 Ã 106 CELLSMG OF TISSUE ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS P  005 IN CONTRAST SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED ACCORDING TO TABLE 1 Â¿CLINICAL SUMMARY OF BREAST IMPLANTÂ¿ASSOCIATED ALCL PATIENTSÂ¿ THERE WAS 1 CASE OF ALCL WHICH PRESENTED WITH BOTH EFFUSION AND TUMOR THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE OR TESTED NEGATIVE FOR BACTERIAL INFECTION THIS REPORT WILL CAPTURE 1 CASE OF ALCL WHICH PRESENTED WITH BOTH EFFUSION AND TUMOR|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6153187|61697755|N|1||B4 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION HEMATOMASEROMA BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ 137 6 1659-1669 BY HONGHUA HU PHD KHALID JOHANI AHMAD ALMATROUDI KAREN VICKERY PHD BVSC BRUCE VAN NATTA MD MARSHALL E KADIN MD GARRY BRODY MD MARK CLEMENS MD CHAN YOON CHEAH MD STEPHEN LADE MD PREETI AVINASH JOSHI MDPHD H MILES PRINCE MDPHD ANAND K DEVA BSCMED MBBS MS PUBLISHED JUNE 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5350320|35251015|D|1||ALCL CASE REPORT B6 WOMAN WHO UNDERWENT BREAST IMPLANTATION 8-9 YEARS AGO IN CENTRAL ASIA AND THEN AUGMENTATION IN 2011 SHE FIRST NOTICED SWELLING AND PAIN AROUND B6 2015 OF HER RIGHT BREAST WHICH WAS FOUND TO HAVE A FLUID COLLECTION AT B6 ED AND WAS REFERRED TO B6 FOR FURTHER WORKUP MAMMOGRAPHY B6 2015 WAS BIRADS 2 SHOWING ONLY FLUID COLLECTIONS AS NOTED ON US AT B6 FLUID ANALYSIS FROM ASPIRATION B6 2015 SHOWED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA|SILICONE BREAST IMPLANT||01/04/2016||||Y|*||0HP|FTR|1.0||SILICONE BREAST IMPLANT|||||||nan|||||||True
5912356|53436714|N|1||IN RESPONSE TO FDA REPORT NUMBER B4 THE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING PHYSICIAN INFORMATION AND PERMISSION TO CONTACT HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|08/29/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5912356|53436715|D|1||PATIENT REPORTED VIA VOLUNTARY MEDWATCH SWELLING OF RIGHT BREAST 13 YEARS AFTER IMPLANTS FNA RETURNED BIA ALCL ALK - NEG BREAST IMPLANTS REMOVED IN B6 B6 UNIVERSITY HAS THEM RESIDUAL LOCAL CELLS REMAINED AFTER FULL CAPSULECTOMY STARTED CHEMO B6 2016 DEVICE IS A SALINE INAMED DEVICE AS PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED AND THE EVENTS HAVE NOT BEEN CONFIRMED BY A PHYSICIAN THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK SALINE IMPLANT|UNK SALINE IMPLANT|08/29/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5697379|46493992|N|1||MEDWATCH SENT TO THE FDA ON 06032016 LITERATURE CITATION HART ALEXANDRA M LECHOWICZ MARY JO PETERS KENDALL K HOLDEN JEANNINE CARLSON GRANT W Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORT OF 2 CASES AND REVIEW OF THE LITERATUREÂ¿ AESTHETIC SURGERY JOURNAL 2014 VOL 346 884-894 FIRST PUBLISHED ONLINE 01AUG2014 THE CORRESPONDING AUTHOR HAS DECLINED TO PROVIDE ALLERGAN FURTHER INFORMATION REGARDING EVENT PRODUCT PRODUCT RETURN OR PATIENT DETAILS THE EVENTS OF SEROMA AND ALCL ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5697379|46493993|D|1||THE FOLLOWING JOURNAL ARTICLE WAS REVIEWED Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORT OF 2 CASES AND REVIEW OF THE LITERATUREÂ¿ THE AUTHORS REPORTED THAT A PATIENT HAD UNDERGONE BILATERAL BREAST AUGMENTATION 16 YEARS EARLIER 425-CC TEXTURED ROUND SALINE IMPLANTS WERE PLACED SUBGLANDULARLY THE MANUFACTURER OF THE IMPLANTS WAS NOT KNOWN PATIENT PRESENTED WITH ACUTE ENLARGEMENT OF THE RIGHT BREAST ULTRASONOGRAPHY SHOWED A FLUID COLLECTION AROUND THE RIGHT INTACT BREAST IMPLANT ULTRASOUND-GUIDED FLUID ASPIRATION SHOWED CD30+ ALKÂ¿ ALCL THE CELLS WERE POSITIVE FOR CD45 CD5 CD4 BUT FAILED TO EXPRESS CD34 CD20 CD68 OR CD10 THE PATIENT UNDERWENT BILATERAL CAPSULECTOMIES AND IMPLANT REMOVAL APPROXIMATELY TWO MONTHS AFTER PRESENTATION IMMEDIATELY AFTER REMOVAL THE IMPLANTS AND CAPSULES WERE EXAMINED FOR MALIGNANCY FLOW CYTOMETRY CYTOGENETIC ANALYSIS AND IMMUNOHISTOCHEMICAL STAINING FAILED TO IDENTIFY ANY UNIQUE CELL POPULATIONS THE PATIENT DID NOT RECEIVE ANY ADDITIONAL TREATMENT AND WAS FREE OF DISEASE AT PATIENTS 15-MONTH FOLLOW-UP VISIT PATIENT CONTINUES TO BE MONITORED CLOSELY BECAUSE OF CHRONIC PAIN IN THE AFFECTED BREASTÂ¿|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5725674|47409581|N|1||MEDWATCH SENT TO FDA ON 06152016 B4 THESE EVENTS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE SERIAL OR LOT NUMBER WAS NOT AVAILABLE EXACT IMPLANT DATE COULD NOT BE SPECIFIED THE DEVICE WILL NOT BE RETURNED DEVICE LABELING ADDRESSES BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/15/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5725674|47409582|D|1||VOLUNTARY MEDWATCH 5061844 REPORTED ALCL BREAST IMPLANT ASSOCIATED SIDE UNSPECIFIED DEVICE DESCRIPTION PROVIDED AS MCGHAN TEXTURED BREAST IMPLANT SALINE FOLLOW-UP WITH HEALTH PROFESSIONAL REPORTS Â¿AUGMENTATION OF MCGHAN TEXTURED SALINE IMPLANT 360 CC IMPLANTED SUB MUSCULARÂ¿ ULTRASOUND FOUND Â¿CONTIGUOUS WITH THE MEDIAL ASPECT OF THIS PATIENTÂ¿S LEFT BREAST IMPLANT THERE APPEARS TO BE AN ELLIPTICAL FLUID COLLECTIONÂ¿AREAS OF DENSE SHADOWING ARE SEEN WITHIN THE TWELVE OÂ¿CLOCK RAY OF THE LEFT BREAST THESE CORRESPOND WITH PREVIOUSLY IDENTIFIED BENIGN APPEARING CALCIFICATIONS WITHIN THIS REGION OF THE LEFT BREASTÂ¿ PHYSICIAN REFERRAL NOTE DESCRIBES A Â¿BREAST MASSÂ¿ THAT THE PHYSICIAN BELIEVES IS A Â¿INFLAMMATORY RESPONSE TO A BREAST IMPLANT IN THE LEFT BREASTÂ¿ ULTRASOUND OF THE LEFT BREAST STATES Â¿PALPABLE LUMP IN THE LEFT BREAST SWELLINGITCHING ALONG THE SURGICAL SCARÂ¿ FINDINGS STATE Â¿SMALL BENIGN OIL CYSTS AGAIN IMAGED AT THE 1100 AND 1200 POSITIONS OF THE LEFT BREAST BENIGN THERE IS FLUID ABOUT THE PERIPHERY OF THE IMPLANTÂ¿ OPERATIVE REPORT STATES Â¿PATIENT WHO PRESENTED TO MY OFFICE WITH SWELLING AND DISCOMFORT OF THE LEFT BREAST PATIENT WAS DIAGNOSED WITH A LEFT BREAST SEROMA WE SENT IT FOR CULTURE AND CYTOLOGY BOTH OF WHICH WERE NEGATIVEÂ¿ DEVICE WAS REMOVED AND NOT REPLACED PATIENT HAD Â¿CAPSULECTOMY AND BIOPSYÂ¿ IN ADDITION TO CHEMOTHERAPY ADDITIONAL OPERATIVE REPORT FOLLOWING PRIOR DEVICE REMOVAL DETAILS REMOVAL OF A Â¿LEFT BREAST MASS CHEST WALL MASSÂ¿ DESCRIBED AS Â¿VERY LARGE IT WAS OVER 3 CM IT WAS VERY HARD FAIRLY WELL CIRCUMSCRIBEDÂ¿ SURGICAL PATHOLOGY REPORT NOTES Â¿LARGE CELLS ARE POSITIVE FOR CD30Â¿NEGATIVE FOR ALK1Â¿ DIAGNOSIS PROVIDED AS Â¿BREAST IMPLANT Â¿ ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ ALCL DIAGNOSIS OCCURRED APPROXIMATELY 5 MONTHS AFTER EXPLANT SURGERY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/15/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
